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Summary 
 
Age-related macular degeneration (AMD) is the leading cause of visual 
impairment in the developed world. Whilst the pathogenesis is complex and not 
fully understood, changes to the choroidal vasculature in AMD have been 
demonstrated using histology. Advances in imaging technology, particularly 
long-wavelength optical coherence tomography (OCT), allow in vivo visualisation 
and investigation of this structure. The aim of this work is to determine whether 
changes to the choroidal vasculature are detectable in AMD using in vivo imaging. 
This was achieved through the evaluation of parameters for quantifying the 
structure, and the application of a machine learning approach to automated 
disease severity classification, based on choroidal appearance.  
 Participants with early AMD (n=25), neovascular AMD (nAMD; n=25), and 
healthy controls (n=25) underwent imaging with a non-commercial long-
wavelength (λc=1040 nm) OCT device. Subfoveal choroidal thickness, choroidal 
area, and luminal area were significantly lower in the nAMD group than the 
healthy and early AMD groups, whilst vessel ratio was significantly greater 
(P<0.05 in all cases). There was no significant difference in visible vessel 
diameter, choroidal vascularity index, luminal area ratio, or luminal perimeter 
ratio between the groups. No significant differences were found between the 
healthy and early AMD groups for any of the eight vascular parameters assessed.  
Classification of the disease groups based on choroidal OCT images was 
demonstrated using machine learning techniques. Textural features within the 
images were extracted using Gabor filters, and K-nearest neighbour, support 
vector machine, and random forest classifiers were assessed for this 
classification task. Textural changes were most pronounced in late-stage disease, 
although attribution to pathology or pharmacological intervention (anti-VEGF 
treatment) was not possible. Changes were also discernible in the early AMD 
group, suggesting sensitivity of this approach to detecting vascular involvement 
in early disease.  
iv 
 
 In conclusion, structural changes to the choroidal vasculature in AMD are 
detectable in vivo using OCT imaging, demonstrated with both manual and 
automated analysis techniques. Whilst changes were most prominent in late-
stage disease, subtle structural changes in early AMD were identified with 
texture analysis, warranting further investigation to improve our understanding 
of choroidal involvement in the pathogenesis of early AMD. 
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1 Introduction 
 
1.1 Outline  
This thesis describes a series of studies designed to detect structural changes 
in the choroidal vasculature of patients with age-related macular degeneration 
(AMD), using in vivo imaging. AMD is the leading cause of visual impairment in the 
developed world, and has been estimated to affect 8.7% of people aged 45-85 (Wong 
et al. 2014). It is generally experienced as visual distortion and a progressive loss of 
central vision, causing difficulties with simple daily tasks such as reading, face 
recognition, and ability to drive. This often results in loss of independence, and 
feelings of isolation, with up to 45% of people with AMD showing clinical signs of 
depression (Dawson et al. 2014). With increasing life expectancy, the prevalence of 
AMD is predicted to rise, reaching 196 million people worldwide in 2020, and 288 
million by 2040 (Wong et al. 2014). Treatment is currently only available for the wet 
sub-type of AMD (accounting for ~10% of cases), in the form of intravitreal anti-
VEGF injections. The vision loss associated with dry AMD is irreversible, and is 
typically managed by provision of visual aids through low vision services. This lack 
of early intervention, coupled with the relatively high cost of pharmacological 
therapy (~£550-£815 per injection; British Medical Association 2017), imposes a 
considerable economic burden on healthcare services.  
Although the underlying pathogenesis of AMD is not yet fully understood, it is 
known that changes to the choroidal blood supply contributes to the retinal 
degeneration seen in AMD (Zarbin 2004). Traditionally, histological techniques 
have been used to identify these changes ex vivo, but advances in imaging technology 
increasingly allows in vivo visualisation of this structure. In particular, optical 
coherence tomography (OCT) imaging now provides a means for fast, non-invasive 
imaging of the posterior eye, and is becoming increasingly prevalent in both primary 
and secondary care. Although this technology is primarily used for retinal imaging, 
it has recently been optimised for choroidal imaging (Ferrara et al. 2016). A number 
of parameters for quantifying the choroidal structure have been described, 
including choroidal thickness, and vessel diameter. However, these parameters are 
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not yet used in clinical assessment. Development and optimisation of such 
parameters may provide novel methods of early diagnosis or monitoring of AMD.  
Machine learning is a contemporary and increasingly popular approach to 
complex image analysis problems, including medical image analysis and computer 
aided diagnosis (Wernick et al. 2010; Alpaydin 2014; de Bruijne 2016). There are 
two main aspects to this approach; feature extraction, and prediction. For instance, 
structural or textural features may be extracted from an OCT image, and algorithms 
are trained to make predictions from these features, such as disease classification. 
To date, this approach has not been applied to automated disease classification of 
AMD severity, using choroidal OCT images. Accurate classification of disease status 
using this method would support the hypothesis that the choroid has a significant 
role in AMD pathogenesis, and that these structural changes are detectable using 
OCT imaging. It would also confirm that machine learning is a feasible approach for 
assessing structural change to the choroid in AMD.  
This thesis initially reviews the current literature regarding physiological and 
pathological variations in the choroid, the current understanding of AMD 
pathogenesis (particularly choroidal involvement), application of OCT to choroidal 
imaging, and image analysis techniques. The following chapters describe the 
development of protocols for image acquisition, processing, and analysis. Previously 
described methods for quantifying the choroid are evaluated and assessed for 
repeatability, as well as the application of machine learning techniques to the 
classification of AMD from choroidal OCT images. The results from this automated 
approach are discussed in relation to potential clinical application of choroidal 
investigation in AMD, and other pathologies involving the choroid.  
 The principle aim of the work described in this thesis is to determine 
whether structural changes to the choroidal vasculature in AMD are detectable 
using in vivo OCT imaging.  
To achieve this, three supplementary aims are as follows:  
1) To optimise protocols for image acquisition and processing for enhanced 
visualisation of the choroidal vasculature.  
2) To evaluate parameters describing the choroidal vasculature, including 
assessment of inter-session repeatability.  
  Chapter 1 – Introduction 
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3) To explore the feasibility of applying machine learning techniques to 
automated classification of AMD by disease severity, based on choroidal 
appearance.  
 
1.2 The healthy eye 
Before considering the pathology, it is important to have an understanding of 
the basic structural and functional properties of the tissue or structure in question. 
This section provides an overview of the principle structures implicated in the 
pathophysiology of AMD (anterior to posterior); the retina, retinal pigment 
epithelium (RPE), Bruch’s membrane, and the choroid. The typical physiological 
ageing changes for each structure have also been outlined.   
 
1.2.1 Retina 
When viewed histologically, the retina can be divided into a number of 
distinct layers, as seen in Figure 1.1. These layers are representative of the highly 
organised cellular structure of the retina, with each comprising a number of specific 
cell types. The ultimate purpose of the retina is the absorption of light and the 
Figure 1.1 Light microscope image of a vertical section through the human retina, showing the 
distinct layers, and the types of retinal cell. The vitreous is adjacent to the ILM, and the RPE 
neighbours the photoreceptors. OLM = outer limiting membrane; ONL = outer nuclear layer; 
OPL = outer plexiform layer; INL = inner nuclear layer; IPL = inner plexiform layer; GCL = 
ganglion cell layer; ILM = inner limiting membrane. Image from Kolb (2014). 
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conversion, through a process known as phototransduction, into a neural signal for 
transmission to the brain (via the optic nerve). In AMD, it is primarily the outer 
retina containing the light-sensitive photoreceptors that is affected, with other 
structures becoming increasingly disrupted with disease progression.  
 
1.2.2 Macula 
The macula is the region of the retina centred on the fovea, and is responsible 
for high acuity vision. Anatomically, the macula is defined as the region of retina in 
which the ganglion cell layer is more than one cell in thickness. This has an 
approximate diameter of 5.5 mm (Hogan et al. 1971). For simplicity, clinical grading 
systems generally define the macula as a circle of 6 mm diameter, centred on the 
foveal pit (Bird et al. 1995; AREDS 2001a; Figure 1.2). This corresponds to 
approximately the central 20° of visual field. The macula is surrounded by the 
vascular arcades branching from the optic nerve head, but the central 500 µm of the 
fovea is avascular, to allow for uninterrupted high acuity vision (Hendrickson 2005). 
A higher concentration of pigment in the macula gives it a darker appearance in 
retinal images than the surrounding retina (Snodderly et al. 1984a).  
Figure 1.2 Retinal photograph of a healthy right eye. The vascular arcades can be seen 
encircling the macula, which appears more pigmented than the rest of the retina. The overlaid 
grid is 6 mm in diameter, demonstrating the total size of the macular region by standard 
clinical definition (Bird et al. 1995; AREDS 2001a). Image acquired by L. Terry during conduct 
of this study.  
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There are two types of photoreceptor in the human retina; rods and cones 
(Figure 1.3). Rods provide monochromatic vision optimised for scotopic conditions. 
Cones are responsible for colour vision and high acuity vision, and hence are of high 
density at the macula. Both types of photoreceptor have an inner and outer segment. 
The outer segment contains a stack of membranous discs embedded with 
photopigments, which are formed at the base of the outer segment, and then migrate 
along its length before being shed at the apex and phagocytosed by the RPE (Strauss 
2005). The inner segment contains a high number of mitochondria and other sub-
cellular components required for energy production and maintenance of the cell.  
Photoreceptors require large amounts of energy to function, particularly in 
the dark when the rod cells are most active. In daylight, rod responses are 
suppressed, reducing total energy consumption by >75% (Okawa et al. 2008).  
Oxygen is required for this energy production process, hence the high oxygen 
demand of the outer retina, particularly under scotopic conditions (Lamb and Pugh 
2004). As the fovea is avascular, it receives this oxygen solely from the choroidal 
supply (through Bruch’s membrane and the RPE), clearly demonstrating the 
importance of choroidal circulation in maintaining high acuity vision.  
Figure 1.3 Schematic of the two types of photoreceptor, showing the inner and outer segments. 
The outer segments are surrounded by apical processes from the RPE (not shown). Image 
adapted from Dubuc (2014). 
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1.2.3 Retinal pigment epithelium 
The RPE is a monolayer of pigmented hexagonal-shaped cells with a regular 
arrangement, located between Bruch’s membrane and the outer neural retina 
(photoreceptors). At the apical surface, long microvilli extend to surround the rod 
and cone cells, increasing the area of contact between the photoreceptors and the 
RPE. The cells of the RPE are bound together by tight junctions, forming part of the 
blood-retina barrier (Campbell and Humphries 2012).  
The RPE has numerous functions (as summarised in Figure 1.4), including 
the transportation of water, nutrients and ions from the choroid to the outer retina 
and sub-retinal space. The protein RPE65 found in RPE cells is required for the 
isomerisation of all-trans-retinal to 11-cis-retinal; an essential component of the 
visual cycle (Redmond et al. 1998). Furthermore, the highly pigmented RPE absorbs 
stray light not absorbed by photoreceptors, protecting the retina from photo-
oxidative damage (Strauss 2005).  
The RPE is also responsible for the phagocytosis of shed photoreceptor outer 
segments. However, the structure is susceptible to oxidative damage since these 
outer segment membranes have a high polyunsaturated fatty acid content, and are 
easily oxidised if not disposed of (Beatty et al. 2000). Incomplete digestion of these 
membranes is thought to result in a build-up of the pigment lipofuscin, which itself 
leaves the RPE prone to further oxidative damage (Margrain et al. 2004). The RPE is 
protected from this damage by light absorbing pigments including melanin, and 
Figure 1.4 A schematic summary of the functions of the RPE. Abbreviations include: OS = outer 
segments; MV = microvilli; PEDF = pigment epithelium derived factor; VEGF = vascular 
endothelial growth factor; Epithel = epithelial. Image from Strauss (2005). 
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antioxidant enzymes such as catalase (Simó et al. 2010). Furthermore, the adjacent 
photoreceptors contain antioxidant carotenoids including lutein and zeaxanthin, 
believed to help minimise oxidative damage (Beatty et al. 2000; Strauss 2005).  
In addition, the RPE maintains the retina and adjacent structures by 
producing growth and other factors, including vascular endothelial growth factor 
(VEGF) and pigment epithelium derived factor (PEDF). These factors have pro- and 
anti-angiogenic properties respectively, and are essential for maintaining choroidal 
health and structure. However, these factors also have a pivotal role in the 
development of neovascular membranes in wet AMD (Bhutto et al. 2005; Section 
1.4.3).  
 
1.2.4 Bruch’s membrane 
Bruch’s membrane is a thin (2-4 µm), acellular layer of extracellular matrix 
located between the RPE and the choroidal vessels. The membrane acts as a barrier, 
allowing metabolites and waste products to pass from the choroid to the outer 
retina and vice versa. It is structurally comparable to the renal glomerulus, providing 
a basis for commonality between aspects of retinal and kidney disease (Kim et al. 
1997; Weiner et al. 2011).  
 
1.2.4.1 Ageing changes 
 With age, Bruch’s membrane becomes thicker for a number of reasons, 
including increased deposition of oxidised metabolic waste and cross-linking of 
collagen fibres (Ramrattan et al. 1994; Booij et al. 2010). Lipids and advanced 
glycation end-products, along with basal laminar and linear deposits have all been 
found to accumulate with age, and alter the permeability of the membrane (Guymer 
et al. 1998; Yamada et al. 2006; Booij et al. 2010). An increase in collagen cross-
linking has also been identified, as well as a reduced membrane permeability in aged 
eyes (Karwatowski et al. 1995; Guymer et al. 1998). Finally, a reduction in the 
integrity and flexibility of the elastic layer of Bruch’s membrane has been shown in 
early age-related disease (Loffler and Lee 1986; Chong et al. 2005). These ageing 
changes to Bruch’s membrane are thought to act as a barrier to the exchange of 
metabolites between the choroid and the RPE and outer retina (Guymer et al. 1998).  
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1.2.5 Choroid 
The choroid is a highly vascularised structure located between the RPE and 
sclera, and forms the uveal tract, along with the iris and ciliary body. It is comprised 
of three layers – the choriocapillaris; a dense capillary bed adjacent to Bruch’s 
membrane; and the Sattler and Haller layers, comprising medium and large blood 
vessels respectively, with the latter being adjacent to the sclera (Figure 1.5). The 
choriocapillaris is fed by (and drains into) these larger vessels. The choroid is 
supplied by the short posterior ciliary arteries (deriving from the ophthalmic 
artery), and drained by the vorticose veins into the ophthalmic veins (Snell and 
Lemp 1998).  
Advances in imaging technology (particularly OCT imaging, see Section 1.6.1) 
have facilitated investigation of the choroid in vivo. The healthy choroid has a 
reported mean subfoveal thickness ranging from 196 µm to 354 µm (Margolis and 
Spaide 2009; Ikuno et al. 2010; Rahman et al. 2011; Ding et al. 2011; Lee et al. 
2013c). This demonstrates the large variability in choroidal thickness between 
individuals. The choroid is thicker temporally than nasally, and superiorly than 
inferiorly (Ikuno et al. 2010; Tan et al. 2014). Variations in choroidal thickness due 
to several factors are discussed in more detail in Section 1.3.  
The choriocapillaris is comprised of small capillaries, typically ranging from 
~7-10 µm in diameter, measured with histology (Ramrattan et al. 1994; Spraul et al. 
Haller layer 
Sattler layer 
Figure 1.5 Schematic of the choroid and its surrounding structures, showing the distribution of 
the large and medium vessels as well as the choriocapillaris (not to scale). Image adapted 
from Remington (2005). 
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1996). Reported mean diameter of the large choroidal vessels with in vivo OCT 
imaging ranges from 122.5 µm to 159.8 µm in young, healthy eyes (Yang et al. 2013; 
Bittencourt et al. 2014; Park and Oh 2014).  
Primarily, the vasculature of the choroid supplies metabolites to the outer 
retina and removes waste products from the retina; the capillaries are fenestrated 
to allow these molecules to pass through the vessel walls. Photoreceptors are highly 
metabolically active, and approximately 90% of the oxygen delivered to the 
photoreceptors is supplied by the choroidal circulation (Ahmed et al. 1993). In the 
macula, photoreceptors are densely packed to maximise high acuity vision, and 
there is no retinal vasculature. It has been hypothesised that this physiology makes 
the macula more susceptible to metabolic deprivation and hence age-related 
damage than the rest of the retina where a dual blood supply is present (Penfold et 
al. 2001; Provis et al. 2005).  
Another proposed function of the choroid is thermoregulation, facilitated by 
the very high blood flow, protecting the retina from damage in extreme 
temperatures (Parver 1991). In low temperatures, the choroid may act as a heat 
source, warming the retina, and in high temperatures, it may act as a heat sink, 
directing heat away from the retina. This also applies to the heat generated during 
exposure of the eye to bright light. However, this theory of thermoregulation 
provided by the choroid is not universally accepted (Nickla and Wallman 2010). The 
pigment within the choroid absorbs stray light within the eye not already absorbed 
by the photoreceptors or RPE, reducing intra-ocular scatter.  
It has also been suggested that the choroid plays a role in emmetropization, 
and has been shown to change in thickness to move the position of the chick retina 
made functionally myopic or hyperopic using lenses (Irving et al. 1992; Wildsoet 
and Wallman 1995). Following the removal of the defocussing lenses, the eye 
compensated in the opposite direction, returning to emmetropia (Wildsoet and 
Wallman 1995). In humans, optical defocus has been shown to interrupt the natural 
diurnal rhythm in choroidal thickness (see Section 1.3.6), suggesting the role of 
defocus (particularly hyperopic) in the development of myopia.  
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1.2.5.1 Ageing changes 
Ageing has been shown to affect the choroid in a number of ways. Advancing 
age increases capillary spacing, and reduces the number and diameter of vessels 
(Ramrattan et al. 1994). Doppler flowmetry has been used to identify a reduction in 
choroidal blood flow and choroidal volume with age (Riva et al. 1994). This 
disrupted supply of metabolites and removal of waste products may leave the retina 
susceptible to degenerative ageing changes, including hypoxia and build-up of 
metabolic waste products (see Section 1.4.3; Chakraborty et al. 2012; Chakraborty 
et al. 2013).  
 To conclude, the choroid plays an important role in maintaining the health of 
the outer retina and RPE. Changes to these structures are therefore likely to have a 
detrimental effect on retinal integrity, inhibiting retinal function, and resulting in a 
decrease in visual acuity. Ageing has been shown to alter the composition of both 
the choroidal vasculature and Bruch’s membrane, rendering the outer retina at risk 
of degenerative changes, particularly at the macula.  
 
1.3 Factors affecting choroidal structure  
Several factors have been shown to affect choroidal structure, both 
physiological and pathological (Table 1.1). It is unsurprising that a number of factors 
associated with the circulatory system manifest in the choroid, a highly vascular 
structure. In particular, age, smoking, and hypertension have been associated with 
an increased risk of both cardiovascular disease and AMD development 
(Chakravarthy et al. 2010).  
This section outlines the literature addressing detectable variations in 
choroidal structure, including physiological factors, and ocular and systemic 
pathology. It is important to account for these factors in the study of choroidal 
structure, so that relevant variables are controlled for in study design and data 
analysis, where possible. This ensures that any difference detected in the structure 
can be attributed to the variable being studied, rather than variation resulting from 
other confounding factors. Whilst choroidal thickness is the most common measure 
reported in the literature, other parameters that describe choroidal structure are 
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also discussed. All choroidal measurements discussed in this chapter were obtained 
from OCT images, unless otherwise stated.  
Table 1.1 Factors associated with choroidal thickness and/or structure. 
Physiological factors Pathological factors 
Non-modifiable Modifiable 
Age Caffeine intake Systemic hypertension 
Sex Water intake Diabetes mellitus 
Refractive error Alcohol intake Age-related macular degeneration 
Axial eye length Smoking Central serous chorioretinopathy 
 Time of day Posterior uveitis 
 
1.3.1 Age and sex 
Studies have shown a decrease in choroidal thickness with age (Nishida et al. 
2012; Wong et al. 2013; Jonas et al. 2014). Regression models have been developed 
to describe the relationship between these variables. Margolis and Spaide (2009), 
Ikuno et al. (2010), and Coscas et al. (2012) found choroidal thickness to decrease 
by 1.56 µm, 1.4 µm, and 1.95 µm per year of age respectively. Agawa et al. (2011) 
found a significant correlation between choroidal thickness and age in eyes with an 
axial length >25 mm (myopic eyes only). This is in agreement with Barteselli et al. 
(2014) who found macular choroidal volume to decrease by 0.32 mm3 for every 
decade of life (from a mean total volume of 5.56 mm3), in high myopes. Given these 
identified changes, and the demonstrated decrease in choroidal perfusion, age 
should be controlled for in any study of choroidal structure.  
In the Beijing Eye Study (n=3233), a significantly higher choroidal thickness 
was found in men than women (mean difference 28.5 µm with multivariate analysis; 
Wei et al. 2013). The mean age in this study was 64.6 years. A study of 93 young, 
healthy Danish participants found the subfoveal choroid to be 18% thicker in men 
than women, when adjusted for age and axial eye length (AEL; Li, Larsen and Munch 
2011). The authors state that this observation may help explain the sex-linked 
prevalence of choroid-related conditions such as central serous chorioretinopathy 
(CSC), AMD, and myopia.  
CSC is an idiopathic condition causing a detachment of the retinal layers from 
the RPE at the macula, resulting in the accumulation of fluid in the sub-retinal space. 
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The choroid has been found to be substantially thicker in this condition than in 
healthy subjects, with reported mean thicknesses ranging from 421 µm to 505 µm 
in the affected eye (Imamura et al. 2009; Pryds and Larsen 2012; Yang et al. 2013). 
This condition occurs more frequently in men than women, who typically have a 
thicker choroid (Li et al. 2011; Wei et al. 2013). Conversely, a thinner choroid is 
generally observed in late-stage AMD (see Section 1.4.5) where the disease 
prevalence has been reported to be higher in women (Evans 2001; Rudnicka et al. 
2012). Furthermore, large population studies have reported a higher prevalence of 
myopia and higher degrees of myopia in women (Sperduto et al. 1983; Wang et al. 
1994; Wong et al. 2000), where the choroid is generally thinner (see Section 1.3.2). 
However the existence of such a relationship is still debatable, as other studies have 
not found a significant difference between the sexes, or suggest that women tend 
slightly towards hyperopia when compared to men (Katz et al. 1997; Shimizu et al. 
2003).  
Given the evidence for a difference in choroidal thickness between men and 
women, and with advancing age, any study of choroidal thickness should attempt to 
control for these factors.  
 
1.3.2 Refractive error and axial eye length 
A number of studies have identified a relationship between choroidal 
thickness and refractive error (Ikuno et al. 2010; Agawa et al. 2011; Coscas et al. 
2012; Tan et al. 2014; Barteselli et al. 2014). A study of 124 healthy individuals of 
Chinese ethnicity, showed the choroid to be thickest among emmetropes, becoming 
progressively thinner among low, moderate and high myopes (Tan et al. 2014). The 
same trend was demonstrated for retinal thickness, but this variation was smaller 
than that of choroidal thickness. However, the study was limited to emmetropes and 
myopes (refractive error range -10.00D to +0.50D), since only 0.7% of the Chinese 
population under 30 years of age are hyperopic, making patient recruitment 
challenging (Wu et al. 2001; Tan et al. 2014). Furthermore, Nishida et al. (2012) 
found subfoveal choroidal thickness to have a significant inverse correlation with 
myopic refractive spherical equivalent, as well as with age and logMAR visual acuity 
in high myopes. The authors suggest choroidal thickness as an important predictor 
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of visual acuity in high myopia, and that it may have epidemiologic significance with 
increasing myopia worldwide.  
Coscas et al. (2012) found the choroid to be thinner in high myopes (with 
over -6.00D of myopia), but no significant difference between emmetropes and 
moderate myopes (under -6.00 D of myopia), whilst Agawa et al. (2011) also found 
a significant positive correlation between choroidal thickness and magnitude of 
myopia. In contrast, Ikuno et al. (2010) reported only a borderline positive 
correlation between these variables, although participants with high myopia (over 
-6.00 D) were excluded from this study. Jonas et al. (2014) conducted multivariate 
regression analysis and found choroidal thickness to decrease by 15 µm per dioptre 
increase in myopia.  
 These findings are consistent with those of Barteselli et al. (2014), who 
assessed 98 eyes using a volumetric analysis, due to the nature of the pathological 
myopia included in the study. Features of pathological myopia, such as lacquer 
cracks, often result in an uneven thickness across the choroid (Wang et al. 2013); 
sampling thickness at a single point or points may therefore not be a true 
representation of overall choroidal thickness. Barteselli and colleagues found a 
decrease in choroidal volume in highly myopic eyes, particularly those with 
coexisting myopic traction maculopathy or a history of choroidal 
neovascularisation. The authors suggest this severe thinning of the choroid in these 
individuals is likely to lead to insufficient metabolic supply to the macula, and these 
patients should undergo closer clinical follow-up.  
Despite this correlation, the majority of population-based studies have 
identified no significant association between refractive error and risk of developing 
AMD (Klein et al. 2004). If anything, increased risk of AMD development has been 
associated with high degrees of hyperopia rather than myopia (Ikram et al. 2003). It 
is unclear why this is the case, although there have been several theories presented. 
Firstly, hyperopic eyes tend to have a higher retinal thickness as well as choroidal 
thickness. This may lead to a higher demand for metabolites per unit area of retina, 
increasing the likelihood of a deficit. Secondly, hyperopic eyes tend to have a shorter 
AEL and therefore a thicker and more compact sclera. This increased stiffness may 
restrict choroidal flow, thereby restricting exchange of metabolites and increasing 
risk of hypoxia and oxidative stress (see Section 1.4.3).  
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Due to the optics of the eye, AEL and refractive error are closely related 
(myopes often have a longer axial length and vice versa; Llorente et al. 2004; Foster 
et al. 2010). It is therefore unsurprising that a relationship between choroidal 
thickness and AEL has also been identified (Ikuno et al. 2010; Agawa et al. 2011; Li 
et al. 2011; Wei et al. 2013; Sanchez-Cano et al. 2014; Barteselli et al. 2014).  
 Li et al. (2011) used a linear regression model to show that choroidal 
thickness decreased by 58.2 µm per mm increase in AEL, whilst Sanchez-Cano et al. 
(2014) found a similar decrease of 43.8 µm per mm. Likewise, Barteselli et al. (2014) 
demonstrated a decrease in choroidal volume of 0.49 mm3 per mm increase in AEL 
in high myopes (from a mean volume of 7.74 mm3 in emmetropes). Other studies 
have also documented a significant negative correlation between choroidal 
thickness and AEL (Ikuno et al. 2010; Agawa et al. 2011; Wei et al. 2013), all in Asian 
populations.  
 The possible effect of OCT image magnification should be considered here. 
Transverse image magnification is known to be different in eyes with different AEL 
(see Sections 2.3.4 and 3.1). This does not affect axial measurements, such as 
subfoveal choroidal thickness, but will affect regional thickness or volume 
measurements. However, the majority of the studies described in this section used 
axial measurements only, or acquired measurements with a Spectralis OCT 
(Heidelberg Engineering, Heidelberg, Germany) which makes a compensation for 
AEL on image scaling, based on corneal curvature and the defocus setting on the 
instrument (Barteselli et al. 2014). This should therefore minimise this error in 
these studies.  
There is substantial evidence of a relationship between choroidal thickness 
and refractive error/AEL. Consequently, any study of choroidal structure should 
control for the potential effect of refractive error and AEL.  
 
1.3.3 Caffeine intake 
Several studies have identified a decrease in choroidal thickness following 
consumption of coffee, or more specifically caffeine (Vural et al. 2014; Zengin et al. 
2015; Altinkaynak et al. 2015; Dervişoğulları et al. 2016). The largest of these 
studies involved 62 healthy individuals in the study group, and 54 healthy controls 
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(Vural et al. 2014). The study group consumed 100 ml of Turkish coffee (57 mg of 
caffeine), whilst the control group were given 100 ml water. The study group 
demonstrated a significant decrease in choroidal thickness from just 5 minutes 
following caffeine administration; this effect lasted for at least 4 hours but peaked 
after 2 hours, with a mean decrease in thickness of ~50 µm. No significant variation 
in choroidal thickness was reported in the control group.  
Altinkaynak and colleagues (2015) produced very similar findings, with a 
mean decrease in choroidal thickness of approximately 66 µm, peaking after 2 
hours. However, in this study, administration was via a 200 mg caffeine capsule. 
Following the same administration method, Zengin et al. (2015) found a mean 
decrease in thickness of ~26 µm. Although this is a smaller decrease compared to 
other studies, only two time points were measured; 1 hour and 3 hours after caffeine 
administration. The maximum difference may have been between these time points, 
as indicated by the other studies described here.   
This is consistent with Okuno et al. (2002), who found that 100 mg of caffeine 
(approximately the amount found in a single cup of many popular beverages) 
decreased the microcirculation in both the optic nerve head (ONH) and choroid-
retina by 6%. Similarly, Lotfi and Grunwald (1991) reported a 13% decrease in 
macular blood flow 1 hour after administration of 200 mg of caffeine.  
In this context, it is interesting to note that a study in 2014 of over 37,000 
people in the USA, aged ≥2 years, found the mean caffeine intake from beverages to 
be 165 mg per day (Mitchell et al. 2014). This included only self-reported caffeinated 
beverage consumers, defined as ≥21 ‘beverage occasions’ within a 7 day period. In 
those aged ≥65 years (the likely age group for an AMD cohort), mean caffeine 
consumption was 207 mg; of which 159 mg was from coffee, 32 mg from tea, and 16 
mg from carbonated soft drinks. Of caffeine consumers aged ≥65 years in the UK, 
mean daily consumption was ~114 mg; 50 mg from coffee, 39 mg from tea, and 25 
mg from energy and soft drinks (Fitt et al. 2013). It therefore seems pertinent to 
consider recent consumption of these beverages, considering the demonstrated 
effect of caffeine on choroidal thickness.   
These findings strongly suggest that caffeine consumption causes a 
significant decrease in choroidal thickness; an effect seen as quickly as 5 minutes 
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following administration, and lasting for at least 4 hours. Given the scale of caffeine 
consumption in the population, this factor should be controlled for, wherever 
possible, in studies using choroidal parameters as outcome measures.  
 
1.3.4 Water and alcohol intake 
Mansouri et al. (2013) conducted the water drinking test (WDT) on 25 
healthy participants to investigate the effect of water consumption on choroidal 
thickness. This involved drinking 1000 ml of water within a 5 minute period. The 
authors report an increase in both peripapillary and macular choroidal thickness, 
by a maximum of 5.7% and 4.3% respectively. Choroidal volume also increased, by 
6.4% and 3.9% respectively. This is a relatively small, yet significant, increase in 
choroidal thickness following water consumption, but choroidal thickness appeared 
to peak at different points in the study for each individual (ranging from 15 minutes 
to 120 minutes following the WDT). On a day-to-day basis, the majority of 
individuals are unlikely to consume a large volume of water over this short time 
period, hence water drinking is unlikely to have a significant effect on the outcomes 
of the majority of choroidal studies.  
Alcohol consumption has also been shown to cause a short-term increase in 
choroidal thickness; ~15 µm within a 30 minute period, and returning to baseline 
within 2 hours (Kang et al. 2016). In the Beijing Eye Study however, there was found 
to be no significant association between long-term alcohol consumption and 
subfoveal choroidal thickness (Wei et al. 2013). Since the potential effects of ethanol 
are small and short-term (<2 hours), it is unlikely that this will have significant 
implications on clinical or research measurements of choroidal thickness.  
 
1.3.5 Smoking 
Sizmaz et al. (2013) measured choroidal thickness in 17 otherwise healthy 
smokers, and 17 non-smoker controls. No significant difference in choroidal 
thickness was found between the two groups at baseline, but a statistically 
significant decrease in mean thickness of around 30 µm was identified following the 
smoking of a single standard cigarette. This did not return to baseline for at least 3 
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hours. Ideally this study would be extended to investigate the duration of smoking-
induced choroidal thinning, but ethical issues arise from ‘heavy’ smokers abstaining 
from smoking for this length of time. Neither smoking duration nor the habitual 
number of cigarettes smoked per day were found to have a significant correlation 
with choroidal thickness. During the 3 hour period, there was no fluctuation in 
thickness in the control group who did not smoke a cigarette. All participants 
refrained from smoking and drinking caffeinated drinks for a period of 8 hours prior 
to baseline measurements to control for the effects of these substances. The authors 
suggest a possible link between the decrease in choroidal thickness and decreased 
blood flow to the choroid following smoking, which may in part explain the 
underlying physiology of smoking as a risk factor for AMD (see Section 1.4.2). This 
being said, increased retinal oxidative stress resulting from smoking is likely a 
significant contributor to this association (Tan et al. 2007).  
In contrast to these findings, Ulaş et al. (2014) recruited 30 ‘long-term’ 
smokers (≥10 year history; one pack per day minimum for the last 12 months), along 
with 40 healthy, ‘never-smoking’ controls. Choroidal thickness was found to 
increase (by 10-25 µm) in the central, nasal and temporal segments of the fundus, 
within 5 minutes of smoking. This returned to baseline within 1 hour. Again, there 
was no significant difference found in baseline choroidal thickness (or retinal 
thickness) between the study and control groups, which suggests minimal long-term 
effects of smoking on choroidal thickness. This is in agreement with Kantarci et al. 
(2016), who also found no difference in choroidal thickness between long-term 
smokers (≥20 year history) and non-smoking controls.  
Choroidal thickness measurements collected by Sizmaz and colleagues 
(2013) commenced 60 minutes after smoking, by which time choroidal thickness as 
measured by Ulaş et al. (2014) had returned to baseline. Both study groups 
underwent the same period of abstinence, but normal blood parameters were used 
as part of the inclusion criteria for the latter of the studies, which may have affected 
the results, given the association between long-term smoking and cardiovascular 
disease.  
However, the mean age of participants in these studies was between 29 years 
and 50 years. In contrast, Sigler et al. (2014) showed the choroid to be thinner in 
smokers than non-smokers in older eyes (mean age 78 years) with and without 
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early AMD. These findings may suggest that smoking has a greater effect on 
choroidal structure in older eyes, resulting in an increased risk of AMD development 
in this group.  
Given that these studies report changes in choroidal thickness following 
cigarette smoking, albeit over different time periods and in different age groups, it 
would seem prudent to control for this variable in future study designs investigating 
the choroid. There is no apparent long-term effect of smoking on choroidal thickness 
in younger eyes, despite its association with cardiovascular disease and 
development of late-stage AMD. However, there is evidence that in older eyes, 
history of smoking may be associated with thinning of the choroid.  
 
1.3.6 Diurnal variation 
It is well established that daily rhythms occur in the eye, including 
fluctuations in intraocular pressure (IOP), corneal thickness, and AEL (Harper et al. 
1996; Liu 1998; Stone et al. 2004). However, it wasn’t until 2009 that a diurnal 
change in choroidal thickness of the human eye was proposed. Brown et al. (2009) 
used partial coherence interferometry to estimate choroidal thickness in vivo, at 3-
hourly intervals between 7am and 10pm. Choroidal thickness was found to vary 
over the day, and the authors described it as ‘likely a dynamic parameter influenced 
by oscillations in IOP or the cardiac cycle’.  
 
1.3.6.1 Patterns and peaks  
Studies have since investigated this relationship using OCT imaging. There is 
much debate in the literature as to the pattern of these diurnal changes, and the 
times at which the maximum and minimum thickness typically occur. Chakraborty 
et al. (2011) measured choroidal thickness in 30 young adults, over 2 consecutive 
days. The choroid was found to be thinnest at midday, and increased in thickness 
progressively through time points at 3pm, 6pm, and 9pm, at which point the study 
ended. The mean amplitude of change during this time was ~10 µm, a small change 
when compared to the mean choroidal thickness of 256 ± 49 µm. In the same study, 
a small diurnal fluctuation of AEL was identified; in near exact anti-phase to the 
variation in choroidal thickness (a phase gap of 11 hours 56 minutes; Figure 1.6). 
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Choroidal thickness and IOP also appear to fluctuate in anti-phase, however there 
has been no definitive relationship identified between these variables (Chakraborty 
et al. 2011; Lee et al. 2013c).  
This diurnal pattern in choroidal thickness is supported by a further study in 
which choroidal thickness peaked at 9:02pm in 15 young emmetropes (Chakraborty 
et al. 2013). This was in agreement with Toyokawa et al. (2012), who reported 
greater subfoveal and nasal choroidal thicknesses in the evening than in the 
morning. No significant difference was found in the thickness of the temporal 
choroid. Again, this study found only small mean differences (~10-20 µm), and was 
limited in size, comprising 12 older Japanese subjects (62.6 ± 14.5 years).  
Osmanbasoglu et al. (2013) reported no significant diurnal variation of 
choroidal thickness during working hours (measurements collected at 9am and 
4pm only). However, these time points fall either side of the choroidal thickness 
minimum identified by Chakraborty and colleagues (2011), which may explain the 
absence of a significant difference (see Figure 1.6). In younger subjects however, 
choroidal thickness had a tendency to be higher in the afternoon than in the 
morning.  
Other studies have shown choroidal thickness to peak somewhere between 
8am and 9am and then decrease throughout the working day, although the rate of 
this decrease seems to slow towards 5pm (Tan et al. 2012; Lee et al. 2013c). These 
Figure 1.6 Choroidal thickness and AEL were found to be in almost exact anti-phase. IOP 
showed a similar trend to AEL. IOP = intraocular pressure; AL or AEL = axial eye length; CT = 
choroidal thickness. Image from Chakraborty et al. (2011). 
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studies found a mean diurnal amplitude of 33.7 µm and 13.4 µm respectively. The 
more recent of these studies (Lee et al. 2013c) used 100 healthy participants, by far 
the largest study to date on choroidal diurnal variation. Neither of these studies 
continued past 5pm, so it was not possible to place the time of minimum choroidal 
thickness. However, they appear to be around 12 hours out of phase with the 
findings of Chakraborty et al. (2011) and Toyokawa et al. (2012), despite being of 
similar study design. A number of smaller studies have shown choroidal thickness 
to peak in the morning, with times ranging from 6am to 11am (Han et al. 2015; 
Kinoshita et al. 2016; Zhao et al. 2016). In all cases, the mean amplitude of the 
variation was <20 µm. Kinoshita and colleagues (2016) attributed the majority of 
this variation to fluctuation in luminal (vessel) area rather than stromal 
(surrounding tissue) area.  
 A diurnal variation pattern was also identified by Usui et al. (2012), who 
measured choroidal thickness at 3-hourly intervals over a 24 hour period using a 
long-wavelength OCT (1060 nm). The choroid was found to be thinnest at 6pm and 
thickest at 3am (mean subfoveal choroidal thickness of 271.9 ± 103.5 µm, and 290.8 
± 110.8 µm respectively). This appears to be out of phase with the aforementioned 
findings by approximately 6 hours, and the amplitude of change is almost double 
that found by Chakraborty et al. (2011).  
The diurnal pattern of choroidal thickness, and particularly the time of peak 
thickness, remains disputed in the literature. There is some speculation that this is 
related to caffeine intake, which was not controlled for in the majority of these 
studies. The reported decrease in choroidal thickness following caffeine 
consumption is in the order of 26-66 µm (see Section 1.3.3); larger than the mean 
diurnal variation amplitude identified by these studies (all <34 µm). No significant 
diurnal variation was found in the no-caffeine control group of one such study (Vural 
et al. 2014). Despite the exact pattern and amplitude of these apparent diurnal 
changes, it seems prudent to control for time of day when assessing the choroid.  
 
1.3.6.2 Retinal thickness 
Whilst the retina is not the primary focus of this thesis, it is worth considering 
any diurnal changes to the structure, given its proximity to the choroid. A number of 
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studies have found no diurnal variation in retinal thickness in healthy individuals 
(Larsen et al. 2005; Polito et al. 2006; Jo et al. 2011; Han et al. 2015). Read et al. 
(2012) found no significant variation in total retinal thickness over a 10 hour period, 
although a small but significant variation in the thickness of the foveal outer 
segment layer (7 ± 3 µm) was identified. Jo et al. (2011) found a small variation in 
retinal thickness with TD-OCT, but attributed this to limited repeatability of the 
device rather than true tissue variation. Another study found a small but significant 
decrease in retinal thickness in the nasal and inferior subfields towards the evening, 
however this fluctuation is again close to the resolution of the OCT device and 
repeatability (Ashraf and Nowroozzadeh 2014).    
 In macular oedema, however, diurnal changes have been identified. Kotsidis 
et al. (2012) measured retinal thickness over a 24-hour period, in 53 diabetic 
patients with clinically significant macular edema (CSME), 22 diabetic patients 
without macular pathology, and 36 healthy individuals. Both control groups 
displayed mean retinal thickness variation throughout the day of 2 µm, which was 
not significant. The CSME group demonstrated a mean absolute change of 49 µm (a 
relative change of 17%), with a minimum thickness at 3pm. Visual acuity was 
poorest at 7am in individuals with CSME, when the retina was thickest. The authors 
speculate that this variation in macula thickness is likely due to the effect of gravity 
and hydrostatic pressure on oedema formation, or nocturnal hypotension leading to 
decreased retinal perfusion overnight.  
 Retinal thickness does not appear to alter throughout the day in healthy eyes, 
although diurnal changes have been shown in macular oedema. Therefore, this 
factor should be considered in clinical assessment of the retina in these patients.  
 
1.3.7 Systemic associations 
There are many other factors that have been found to affect choroidal 
thickness and choroidal blood flow. These include systemic hypertension, 
hypercholesteremia, obesity, Alzheimer’s disease, sleep apnea, exercise, pregnancy, 
and medications including acetazolamide, sildenafil nitrate, and vasopressin. More 
detail on the effects of these can be found elsewhere (Riva et al. 1997; Dallinger et 
al. 1998; Vance et al. 2011; Bogner et al. 2011; Wong et al. 2013; Alwassia et al. 2013; 
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Takahashi et al. 2013; Bayhan et al. 2014a; Bayhan et al. 2014b; Kara et al. 2014; 
Yumusak et al. 2016).  
Hypertension is the most relevant of these factors to this work, due to its high 
prevalence in the older population. Masis et al. (2011) undertook a retrospective 
analysis of 112 patients with systemic arterial hypertension and 15 healthy patients. 
They found the choroid to be significantly thinner in patients with systemic 
hypertension than non-hypertensive patients (mean subfoveal choroidal thickness 
136.24 ± 46 µm and 173.72 ± 38 µm respectively). However, the control group was 
relatively small in this study. This is in agreement with the findings of Akay et al. 
(2015), although this was in young hypertensive adults (mean age 23.8 ± 2.8 years). 
In contrast to this, Alwassia et al. (2013) investigated the effect of exercise-induced 
acute hypertension on choroidal thickness in 15 healthy patients with a mean age of 
60.6 ± 10.4 years. They found a significant increase in systolic blood pressure 
following a cardiac exercise stress test, but no change in choroidal thickness. These 
findings suggest that only pathological, chronic hypertension is associated with a 
significant change in choroidal thickness.  
This highlights the importance of collecting demographic data relating to 
medical and ocular history when investigating choroidal thickness. Since the 
choroid is highly vascular tissue, it may be advisable to measure blood pressure at 
imaging sessions, for consideration when conducting inter-session or inter-group 
analysis.  
 
1.3.8 Ocular pathologies 
A number of studies have investigated structural changes to the choroid at 
different stages of AMD; these are discussed in detail in Section 1.4.5. Choroidal 
structural changes have also been identified in other common posterior ocular 
conditions, including diabetic retinopathy, central serous chorioretinopathy (CSC), 
and posterior uveitis (Regatieri 2012a; Bittencourt et al. 2014). These identified 
pathological changes are discussed in the following section.  
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1.3.8.1 Diabetic retinopathy 
The effect of diabetes mellitus on choroidal thickness and choroidal blood 
flow has been investigated (Nagaoka et al. 2004; Esmaeelpour et al. 2011; Regatieri, 
Branchini 2012a; Unsal et al. 2014). A reduction in choroidal thickness in type-1 
diabetics was demonstrated when compared to non-diabetic controls, with a mean 
difference of ~90 µm between the healthy and diabetic groups (Esmaeelpour et al. 
2012). This was the case in eyes with and without diabetic retinopathy (DR). To 
investigate the effect of disease severity on choroidal thickness, Esmaeelpour et al. 
(2011) utilised a non-commercial long-wavelength OCT (1060 nm) to image 42 eyes 
of type-2 diabetics; divided into 4 groups based on macular involvement; no 
maculopathy (M0), microaneurysms (M1), exudates (M2) and clinically significant 
macular oedema (CSME); as well as 16 non-diabetic controls. Mean subfoveal 
choroidal thickness was found to be 214 ± 55 µm, 208 ± 49 µm, 205 ± 54 µm, 211 ± 
76 µm, and 327 ± 74 µm respectively. Subfoveal choroidal thickness was shown to 
be reduced by ~35% in all diabetic eyes, regardless of disease stage. However, the 
groups in this study were small (n=12-19 eyes per group) and may not be 
representative of the variability within each disease state. In the Beijing Eye Study, 
which had a far larger sample albeit of a different ethnicity, there was no significant 
association between choroidal thickness and presence of diabetes (Wei et al. 2013).  
A number of studies have investigated choroidal thickness in different stages 
of DR; non-proliferative retinopathy (NPDR) with and without maculopathy 
(specifically CSME), and proliferative retinopathy (PDR) with a history of panretinal 
photocoagulation (PRP) treatment (Regatieri et al. 2012a; Unsal et al. 2014). 
Patients with untreated PDR were excluded. Both studies found the choroid to be 
significantly thinner in patients with NPDR with CSME, as well as in patients with 
PDR treated with PDP, when compared to a healthy control group. Neither study 
identified a statistically significant difference in choroidal thickness between 
patients with NPDR without CSME and the control group. In other words, both 
studies identified reduced choroidal thickness in diabetes, but only in eyes with 
macular oedema or advanced retinopathy treated with PRP.  
In contrast to these findings, Kim et al. (2013) found the subfoveal choroid to 
be significantly thicker in PDR. Eyes were classified by severity into 2 NPDR groups 
(mild-moderate and severe), and 2 PDR groups (untreated, and treated with PRP). 
24 
 
Eyes that received treatment within the previous 12 months were excluded, to avoid 
the potential effect of laser-induced choroidal swelling. The group with the highest 
mean choroidal thickness was the treatment-naïve PDR (363.6 ± 74.9 µm). Eyes with 
PDR and a history of PRP treatment were found to have far thinner choroids (239.8 
± 57.4 µm). This may explain the difference in findings to the previous studies, which 
included only treated eyes in the PDR group and found a reduction in thickness. Eyes 
with CSME were found to have thicker choroids than those without oedema (mean 
difference ~50 µm). There was no significant difference between the no-DR control 
group and the two NPDR groups. Some thinning was noted in the no-DR and early 
NPDR groups when compared to healthy non-diabetic controls (mean difference 
~14 µm and ~31 µm respectively), in agreement with the studies described above. 
The authors speculate that this thinning may be due to vascular constriction or 
choriocapillaris loss secondary to hypoxia.  
Nagaoka et al. (2004) used laser Doppler flowmetry to assess choroidal blood 
flow in the foveal region of type-2 diabetics. Choroidal blood flow was found to be 
significantly reduced in all diabetic groups, including those with no DR. The largest 
reduction in blood flow was seen in NPDR with CSME (58.5% lower than non-
diabetic controls). Their findings indicate that choroidal changes may precede DR in 
a subset of patients. Similar evidence has been reported for AMD, suggesting a link 
between disrupted blood flow and structural changes (as described in Section 1.4.5).  
Cho et al. (2013a) and Takahashi et al. (2008) investigated the effects of PRP 
treatment on choroidal thickness and choroidal blood flow respectively in patients 
with severe PDR. Subfoveal choroidal thickness was shown to increase 1 week 
following PRP, from 318.1 ± 96.5 µm to 349.9 ± 108.3 µm (Cho et al. 2013a). These 
changes in choroidal thickness did not correlate with changes in macular thickness. 
The authors comment that changes in choroidal circulation may not be the primary 
factor causing PRP-induced macular oedema. Choroidal blood flow was found to 
increase by 46% from baseline to 1 month after PRP treatment (Takahashi et al. 
2008). Again, there was no significant correlation between this increase and 
macular thickness changes. The authors suggest that the increase in choroidal blood 
flow induced by PRP may be caused by vasodilation of choriocapillaries in the foveal 
region. Previous or current treatment for severe PDR may therefore skew results of 
studies on choroidal thickness in diabetics if not controlled for.  
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1.3.8.2 Central serous chorioretinopathy 
As mentioned previously, CSC has been shown to be associated with vascular 
hyperpermeability and a very thick choroid (Imamura et al. 2009; Pryds and Larsen 
2012; Yang et al. 2013; Kuroda et al. 2013). Imamura and colleagues found the mean 
subfoveal choroidal thickness to be 505 ± 124 µm in 19 patients with CSC, compared 
to 287 ± 76 µm in healthy individuals. The choroid has also been shown to be thicker 
bilaterally than in healthy controls, even if subretinal fluid was observed unilaterally 
(in the region of 324 to 387 µm in the unaffected eye; Pryds and Larsen 2012; Yang 
et al. 2013). The authors suggest that the increased choroidal thickness may be 
caused by increased hydrostatic pressure in the choroid. The vessel lumen of the 
large choroidal vessels has also been demonstrated to be larger in eyes with CSC and 
(to a lesser extent) fellow unaffected eyes (Yang et al. 2013; Kuroda et al. 2016). 
Pryds and Larsen (2012) investigated the effects of verteporfin photodynamic 
therapy (PDT) on the choroid in patients with unilateral CSC. Complete resorption 
of subretinal fluid was found in all eyes at 1-month follow-up, with choroidal 
thickness decreasing significantly following treatment in both the treated area and 
the foveal area. The authors conclude that the process causing choroidal thickening 
in CSC appears to spread laterally within the choroid, affecting not only the visible 
pathological area of choroid.  
 
1.3.8.3 Posterior uveitis  
 Also known as choroiditis, posterior uveitis is associated with an increase in 
choroidal thickness in the active (inflammatory) stage. This condition is often a 
manifestation of an underlying systemic inflammatory condition, such as 
sarcoidosis, Vogt-Koyanagi-Harada (VKH) syndrome, or Behçet’s disease. VKH 
disease in particular has been shown to present with a markedly thick choroid 
(Maruko et al. 2011; Takahashi et al. 2014), often making it impossible to visualise 
the posterior boundary of the choroid in OCT images (Nakayama et al. 2012). 
Maruko and colleagues (2011) found the mean choroidal thickness to be 805 ± 173 
µm at presentation, dropping to 341 ± 70 µm following 2 weeks of corticosteroid 
treatment (n=16 eyes). They suggest this marked thickening of the choroid may be 
due to inflammatory infiltration and increased exudation, and that OCT could serve 
to evaluate choroidal involvement in the disease as well as monitoring treatment.  
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 In contrast, chronic uveitis has been associated with a significant reduction 
in choroidal thickness and vessel diameter (Bittencourt et al. 2014). Takahashi et al. 
(2014) evaluated the convalescent stage of VKH disease, i.e. patients with no 
remaining active inflammation. They found the choroid to be thinner in those with 
severe ‘sunset glow’ fundus (caused by depigmentation) compared to healthy 
controls; with a mean subfoveal choroidal thickness of 144 ± 72 µm and 227 ±            
58 µm respectively. An inverse correlation between choroidal thickness and disease 
duration was also demonstrated, possibly caused by latent choroidal inflammation 
during the convalescent stage of VKH disease, the authors suggest.  
 Given the relationship between choroidal thickness and several common 
conditions including diabetes mellitus, CSC, and posterior uveitis, these pathologies 
should be considered as confounding factors in the design of studies investigating 
choroidal structure. Patients with a history of these conditions should be excluded 
from studies of choroidal vasculature in healthy eyes or other specified pathology.  
 To summarise, many variables have been shown to affect choroidal 
structure, both physiological and pathological. The choroid becomes thinner with 
increasing age, axial eye length, and degree of myopia, as well as following the 
consumption of caffeine. Smoking and diurnal variation have also been shown to 
affect choroidal thickness, although these effects are not as clear from the literature. 
Several systemic pathologies have been shown to result in a thinner choroid, 
including chronic hypertension and diabetes mellitus. Increased choroidal thickness 
and vessel diameter can result from ocular diseases, including CSC and active 
posterior uveitis. With so many variables affecting choroidal structure, it is 
important to consider and control for as many of these as possible in the design of 
studies investigating the choroid.  
 
1.4 Age-related macular degeneration 
AMD is a painless condition affecting the macula, usually bilaterally but 
asymmetrically, resulting in the loss or distortion of central vision. The condition 
presents in later life (usually >55 years), and affects the individual’s ability to carry 
out high acuity tasks, such as reading, driving, and face recognition. It does not affect 
peripheral vision. Whilst treatments exists for the neovascular subtype (discussed 
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later), there are currently no effective treatments for the atrophic subtype of the 
disease (although lifestyle advice has been shown to slow progression; Seddon et al. 
2006). Consequently, the development of new therapies is a large area of research. 
A comprehensive understanding of the pathogenesis of AMD is beneficial, to ensure 
this research is effective. Furthermore, it is imperative that sensitive methods of 
detecting and monitoring early disease are developed to facilitate early intervention 
and evaluation of these new therapies.   
The following provides an overview of the pathogenesis of AMD, with an 
emphasis on choroidal involvement, along with an overview of the prevalence, 
clinical presentation, and current classification and treatment.  
 
1.4.1 Prevalence and incidence 
In 2014, a systematic review estimated the global prevalence of AMD (of any 
stage) to be 8.69% in those aged 45-85 years (Wong et al. 2014). A breakdown of 
prevalence in different age groups can be seen in Table 1.2. Furthermore, there is 
expected to be a 3-fold increase globally in the number of people aged 60 and over 
between 2005 and 2050 (Chamie 2005). This ageing population would result in a 
continued rise in prevalence of AMD over the coming years. In fact, the projected 
number of people with AMD in 2020 is 196 million, increasing to 288 million by 
2040 (Wong et al. 2014).  
Table 1.2 Estimated prevalence figures for a Caucasian population based on a review by Klaver 
et al. (2004) of 7 epidemiological studies.  
Age (years) Early AMD (%) Late AMD (%) 
65-74 15 1 
75-84 25 5 
85+ 30 13 
 
In the United Kingdom, the prevalence of late-stage AMD has been estimated 
as 4.8% and 12.2% in those aged over 65 and 80 years respectively (Owen et al. 
2012). The condition is responsible for over half of all visual impairment 
registrations in the UK; more than all other ocular conditions combined (Bunce et 
al. 2010; Rees et al. 2014).  
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Vision loss from AMD can be devastating, and is often associated with loss of 
independence, loss of income, isolation, and depression. It has been reported that 
almost one third of people with AMD suffer from depression (Brody et al. 2001), 
even amongst those receiving anti-VEGF treatment (see Section 1.4.4; Casten and 
Rovner 2013). This is substantially higher than the percentage found in the general 
population of older adults (~12%; Steffens et al. 2009).  
 
1.4.2 Risk factors 
Several risk factors for the development of AMD have been identified, 
including age, smoking, previous cataract surgery, genetics, race, diet and light 
exposure (particularly to short-wavelength light). Notably, the primary modifiable 
risk factor is smoking, which has been shown to produce a 4-fold increased risk of 
late-stage AMD (Tan et al. 2007). More information about these risk factors can be 
found in reviews by Evans (2001) and Chakravarthy et al. (2010). The underlying 
connection of these factors to AMD pathogenesis is briefly explained in Section 1.4.3.  
 
1.4.3 Aetiology and pathogenesis 
There are two distinct end points to the condition; atrophic AMD (dry or non-
exudative), and neovascular AMD (wet or exudative). The disease is often 
asymptomatic in the early stages, but sometimes presents with symptoms of mild 
distortion. From the early stage, the disease may progress to one of two potential 
late-stages. In the atrophic subtype, a central scotoma typically develops as large 
areas of the macular atrophy (termed geographic atrophy; GA). In the neovascular 
subtype (nAMD), new blood vessels grow from beneath the macula, which leak and 
haemorrhage causing sudden central vision loss. Example retinal photographs and 
cross-sectional scans of each AMD subtype can be seen in Figure 1.7.  
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The pathogenesis of AMD is complex and not yet fully understood. To date, 
the literature has outlined several processes believed to contribute to the 
development of the condition, to a greater or lesser extent. These include oxidative 
stress, metabolic insufficiency, chronic inflammation and choroidal vascular 
changes (Beatty et al. 2000; Zarbin 2004; Ambati and Fowler 2012). AMD is closely 
linked to age-related changes, hence these changes will be discussed here, with their 
Figure 1.7 Example retinal photographs and macular cross-sectional OCT images of each 
major AMD subtype. Solid black lines indicate the scan line through the fovea. The following 
features are visible in each stage: multiple small drusen (early AMD); choroidal neovascular 
membrane (neovascular AMD; nAMD); atrophy of outer retinal layers, RPE and choroid 
(geographic atrophy; GA). Images acquired by L. Terry during conduct of this study.  
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believed implications in the development of the condition. The three leading 
theories for the development of AMD are outlined below; oxidative stress, 
inflammation, and hypoxia.  
 
1.4.3.1 Oxidative theory 
Oxidative stress is a process resulting in cellular damage caused by reactive 
oxygen species (ROS) and free radicals, and has been implicated in damage to both 
the RPE and the choriocapillaris in both AMD and ageing (Beatty et al. 2000). This 
theory is summarised in Figure 1.8. The macula is susceptible to oxidative damage 
for several reasons. Firstly, there is a high consumption of oxygen by the 
photoreceptors, which are at highest concentration in the macula. Secondly, the 
retina is exposed to high light levels, particularly blue light, which has been 
associated with the development of AMD (Margrain et al. 2004); a finding that 
explains why excessive exposure to sunlight is a risk factor for the development of 
the condition (Sui et al. 2013). Thirdly, a high dietary intake of polyunsaturated fatty 
acids (found in high concentrations in photoreceptor outer segments) has been 
associated with AMD (Beatty et al. 2000; Seddon et al. 2001; Chong et al. 2009). 
Smoking is also a contributing factor to oxidative stress, with cigarette smoking 
having been identified as a major risk factor for the development of late-stage 
macular degeneration (Klein et al. 1998; Mitchell et al. 2002; Tan et al. 2007).  
Mitochondria are the main source of endogenously formed ROS in the 
photoreceptors and RPE, as a consequence of the mitochondrial respiratory chain. 
Although these are important for cell signalling, mitochondrial DNA is particularly 
susceptible to oxidative damage by ROS, which can result in cell death, mutation, 
and/or overproduction of ROS (Ambati and Fowler 2012). This mitochondrial 
dysfunction has been demonstrated as a feature of ageing, and is thought to underlie 
the development of AMD, through excessive oxidative damage and resultant 
impaired function of the RPE and outer retina (Jarrett and Boulton 2012; Ferrington 
et al. 2016).  
Antioxidants have been shown to protect against oxidative damage in the 
retina, including vitamins A, C, and E, and enzymes such as catalase (Beatty et al. 
2000). The naturally occurring pigments lutein and zeaxanthin are collectively 
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known as macular pigment. These antioxidant carotenoids are also believed to help 
protect the retina by filtering out blue light and quenching ROS, and reacting with 
free radicals (Snodderly 1995). The pigment concentration peaks at the centre of 
the fovea, where protection is most needed, and diminishes with eccentricity 
(Snodderly et al. 1984b). A decline in the concentration of macular pigment with age 
has been demonstrated; it has been suggested that this leaves the macula more 
susceptible to oxidative damage (Beatty et al. 2001). This is the basis for attempting 
to increase the concentration of antioxidants at the macula (possibly with high dose 
supplements of antioxidants combined with zinc, like in the AREDS trial; AREDS 
2001b) which could have a potential prophylactic effect on AMD progression (Roth 
Figure 1.8 Summary of the oxidative theory of AMD development. The arrows depict the 
theoretical pathways followed in the development of AMD, with supporting evidence (blue) of 
the principle connections. Feedback loops in RPE dysfunction indicated by dashed arrows.  
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et al. 2004). It has also been shown that several factors influence the density of 
macular pigment, including smoking, iris colour and sex; this is consistent with these 
also being risk factors for AMD (Chakravarthy et al. 2010). It is likely a combination 
of these contributing factors (decrease in macula pigment, exposure to high light 
levels, and a high concentration of polyunsaturated fatty acids), coupled with the 
very high oxygen demand of the outer retina, that results in oxidative stress.  
Oxidative stress has been implicated in damage to the choriocapillaris and 
RPE (Beatty et al. 2000). There is strong evidence to support that lipofuscin is 
derived, in part, from oxidative damage to photoreceptor outer segments, and 
incomplete phagocytosis of the outer segments within the RPE (Kennedy et al. 1995; 
Holz et al. 2001). Lipofuscin itself is thought to drive oxidation through its photo-
reactive component A2-E (Beatty et al. 2000; Margrain et al. 2004), further 
damaging the RPE and impairing phagocytosis of outer segments. This cycle results 
in an increased concentration of fatty acids from incomplete digestion of outer 
segments, which are highly vulnerable to oxidation (Beatty et al. 2000). Ultimately, 
this impairs the RPE, which may cause an imbalance in the production of factors 
such as VEGF and PEDF. This could lead to the development of a neovascular 
membrane (Frank et al. 1996; Witmer et al. 2003) or RPE cell death resulting in 
geographic atrophy (Roth et al. 2004); the two end points of AMD. 
 
1.4.3.2 Inflammation theory 
Excessive (chronic) inflammation with involvement of the complement 
system has also been associated with AMD; it is outlined by Hageman et al. (2001), 
Johnson et al. (2001), Anderson et al. (2002), and Figure 1.9. This theory stems from 
RPE dysfunction (discussed in the oxidative theory) causing a breakdown of the 
blood-retina barrier via the formation of drusen, thickening of Bruch’s membrane 
and disruption of the tight junctions between RPE cells (Cunha-Vaz et al. 2011; 
Klaassen et al. 2013). This is supported by evidence of inflammatory components 
found in drusen, including immunoglobin and fragments of complement system 
proteins C3 and C5 (Johnson et al. 2000). These proteins have been linked to the 
expression of VEGF, which may contribute to the development of choroidal 
neovascularisation (Nozaki et al. 2006).  
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There is also evidence of a genetic predisposition to AMD by the Complement 
Factor H (CFH) gene, which codes for the CFH protein involved in inhibiting the 
complement cascade (Donoso et al. 2010). If this gene is faulty, the complement 
system is not properly regulated, triggering an immune response resulting in 
excessive inflammation. This in turn has been hypothesised to result in AMD-
associated choriocapillaris degeneration (Chirco et al. 2016).  
 
 
Figure 1.9 Summary of the inflammation theory of AMD development. The arrows depict the 
theoretical pathways followed in the development of AMD, with supporting evidence (blue) of 
the main connections. Feedback loop in drusen formation indicated by dashed arrow.  
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1.4.3.3 Hypoxia theory 
The role of hypoxia and metabolic insufficiency at the RPE and outer retina 
caused by reduced choroidal blood flow and perfusion has been suggested as the 
primary trigger of AMD (Sarks 1976; Feigl 2007), and an overview can be seen in 
Figure 1.10. As discussed in Section 1.2.4, age-related changes to Bruch’s membrane 
result in reduced permeability of this membrane, acting as a barrier to metabolic 
Figure 1.10 Summary of the hypoxia theory of AMD development. The arrows depict the 
theoretical pathways followed in the development of AMD, with supporting evidence (blue) of 
the main connections. Feedback loops in VEGF expression and drusen formation indicated by 
dashed arrows.  
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exchange between the choriocapillaris, RPE and outer retina (Guymer et al. 1998). 
This impaired diffusion to and from the choroid promotes the formation of more 
drusen, further impairing the transport of metabolites through Bruch’s membrane 
(Curcio 2001; Feigl et al. 2007). A review by Stefánsson et al. (2011) proposed that 
ageing and early AMD changes (including retinal elevation, oedema, drusen and 
choroidal ischaemia) increase retinal hypoxia due to the reduced oxygen flux from 
the choroid to the outer retina. This is according to Fick’s law of diffusion, and is a 
result of the increased distance between the choriocapillaris and retina. 
These changes are coupled with RPE dysfunction (discussed in the oxidative 
theory) causing an imbalance of RPE-derived growth factors that leads to vascular 
changes in the choriocapillaris (Witmer et al. 2003; Schlingemann 2004). The 
vessels of the choriocapillaris decrease in density and diameter (Sarks 1976; 
Ramrattan et al. 1994), as well as a general reduction in choroidal thickness in AMD 
(discussed in more detail in Section 1.4.5). This disruption to the normal blood 
supply to the outer retina likely leads to further reductions in the supply of 
metabolites to the macula, which is already susceptible due to its lack of a dual blood 
supply and the extremely high oxygen demand of the photoreceptors (Provis et al. 
2005; Figure 1.11). The combination of these ageing changes results in a hypoxic 
retina, which is exacerbated in scotopic conditions due to the increased oxygen 
demand of the photoreceptors (Stefánsson et al. 2011). This chronic ischaemia 
upregulates VEGF production in the RPE (Feigl 2007; Stefánsson et al. 2011), and 
possibly also stimulates excessive inflammation (see inflammation theory); 
ultimately resulting in neovascularisation or RPE atrophy.   
Figure 1.11 Oxygen profile for different depths in the feline retina. In the outer retina, the 
partial oxygen pressure reaches near zero. X=0 and X=L are the boundaries of the 
photoreceptor outer segments, and X=2L represents the vitreous-retina border. Figure from 
Wang and Linsenmeier (2007). 
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1.4.3.4 Pathogenesis summary 
There is significant overlap in these theories (Figure 1.8 to Figure 1.10); it is 
likely a combination of several of these processes happening simultaneously that 
results in the development of AMD. Regardless of the specific pathways followed or 
their relative contributions, the potential end points remain the same; development 
of a neovascular membrane, or atrophy of the outer retina, RPE and choriocapillaris. 
It is the expression of VEGF and an imbalance between this and other angiogenesis 
factors that result in the neovascular end point (Frank et al. 1996; Witmer et al. 
2003) and severe loss of central vision.  
The ‘tipping point’ for the progression to nAMD appears to be different for 
each person, with many individuals with early AMD never reaching this threshold. 
Consider a single threshold for this exudative change; this limit is raised or lowered 
with age, genetics, smoking, diet, and other risk factors discussed previously. For 
example, an individual with a genetic predisposition is more likely to progress to 
nAMD, despite other risk factors being minimised (e.g. non-smoker, good diet, 
minimal UV exposure). Conversely, even if all risk factors are met (e.g. a 90 year old 
heavy smoker with a poor diet), lacking these associated genetic variations may 
keep the threshold low enough to prevent the progression to nAMD. Although this 
is theoretical, it provides a potential explanation as to why some individuals 
progress to late-stage AMD, where others do not.  
It is evident that the choroid plays a fundamental role in the pathogenesis of 
AMD, as it is the sole supply of metabolites to the macula. Although the thickness of 
the choroid has been shown to decrease in AMD (see Section 1.4.5), the changes to 
the vessels themselves have been largely assessed using histology, and have not 
been extensively studied in vivo (Sarks 1976; Ramrattan et al. 1994). Having the 
ability to image the choroidal vascular structure in the living eye using OCT brings 
new opportunities to study these vessels, in particular how the vascular structure 
changes throughout the disease process. This provides potential for the 
development of non-invasive analysis techniques to detect and monitor the 
condition.  
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1.4.4 Treatment and prevention 
There are currently no effective treatments available for dry AMD, however 
there are prophylactic measures that can be taken to minimise the risk of 
progression to nAMD. This involves considering the modifiable risk factors for the 
condition. For instance, age, sex, and genetics clearly cannot be altered, but patients 
can be advised to stop smoking and improve their diet by reducing dietary fat and 
increasing intake of antioxidants (Chakravarthy et al. 2010). There is also some 
evidence for the benefit to individuals susceptible to AMD of taking antioxidant 
supplements, although this is disputed (AREDS 2001b; Chong et al. 2007; Evans and 
Lawrenson 2012). For individuals who suffer from visual loss due to AMD, 
rehabilitation services are available (e.g. Low Vision Service Wales) to assist the 
individual in maintaining their quality of life and independence.  
 Anti-VEGF therapy can be used in the treatment of nAMD, delivered via 
intravitreal injection. These agents block expression of VEGF produced by the RPE, 
lessening its angioproliferative effects, and hence preventing the growth of new 
vessels. Commonly used anti-VEGF drugs include ranibizumab (Lucentis) and 
bevacizumab (Avastin), which are delivered to the posterior pole via intravitreal 
injection. These treatments have been shown to be effective in halting the 
development of neovascular membranes, and improve visual acuity in many cases 
(Rosenfeld et al. 2009; Martin et al. 2011; Martin et al. 2012). More recently, another 
anti-VEGF drug (aflibercept; Eylea) was introduced, with efficacy equivalent to 
ranibizumab (Heier et al. 2012). This has shown potential benefit for cases of nAMD 
with persistent fluid when treated with ranibizumab and/or bevacizumab (Cho et 
al. 2013b). The nature and effectivity of these treatments evidences the crucial role 
of VEGF in the pathogenesis of nAMD. However, this is an invasive therapy, with 
associated adverse effects, including ocular pain and risk of endophthalmitis and 
rhegmatogenous retinal detachment (Falavarjani and Nguyen 2013; Sanabria et al. 
2013).  
 
1.4.5 Structural changes to the choroid  
1.4.5.1 Ex vivo 
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Although the choroid has been implicated in the pathogenesis of AMD, 
changes to the vascular structure have predominantly been identified using 
histology. A decrease in the density of the choriocapillaris with advancing AMD has 
been identified (Ramrattan et al. 1994; Spraul et al. 1999), as well as a reduction in 
the diameter of the capillary lumen (Sarks 1976; Ramrattan et al. 1994; McLeod et 
al. 2009). McLeod and colleagues also reported a decrease in vascular area and loss 
in capillary fenestration in late-stage AMD (in both the wet and dry subtypes). They 
concluded that choriocapillaris atrophy occurred secondary to RPE atrophy. 
However, there is uncertainty over the pathogenesis, since choriocapillaris loss has 
been identified in eyes without RPE atrophy also (Seddon et al. 2016). Despite this, 
a significant decrease in vascular area was identified with advancing disease 
severity, which is consistent with previous findings. The presence of ‘ghost’ vessels 
(empty capillaries that were once blood-filled) in early AMD has been used to 
suggest disease-related capillary loss, rather than a congenitally lower vascular 
density causing these individuals to be prone to degenerative changes (Whitmore et 
al. 2015).  
Although the majority of histological changes identified in AMD have been at 
the level of choriocapillaris, these vessels are very small (typically ~7-10 μm), which 
is nearing the resolution limit of OCT imaging, and therefore cannot be reliably 
imaged using this technique (see Section 1.5.2). Considering the vessels which can 
be resolved with OCT imaging, Spraul et al. (1999) identified a reduction in the 
number of large choroidal vessels in AMD. No significant difference in vessel 
diameter or choroidal thickness was found between the groups. However, this is 
based on a single study with limited sample size (51 eyes with AMD, and 40 age-
matched controls); this highlights the need for further investigation into structural 
changes to the choroid in AMD, ideally utilising advances in in vivo imaging 
techniques. The limitations of ex vivo measurement using histology are discussed in 
Section 1.6.2.  
 
1.4.5.2 In vivo 
To have a potential clinical application, changes to the choroidal structure 
must be detectable in vivo. A number of studies have identified a reduction in 
choroidal thickness in patients with AMD, using in vivo imaging (Chung et al. 2011; 
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Sigler and Randolph 2013; Lee et al. 2013b; Esmaeelpour et al. 2014a; Adhi et al. 
2014; Lindner et al. 2015; Yiu et al. 2015; Lu et al. 2016). However, it is debated in 
the literature at which stage in the disease process this thinning occurs.  
Considering firstly the early disease stage, Sigler and Randolph (2013) found 
the choroid to be significantly thinner in early AMD (115 ± 40 µm) when compared 
to healthy controls (235 ± 49 µm). Conversely, Wood et al. (2011) measured 
choroidal thickness beneath the fovea, and at 0.5 mm intervals across the central 4 
mm of choroid horizontally and vertically (centred on the fovea). No significant 
difference in choroidal thickness was identified between the early AMD and control 
groups at any location. However, these were relatively limited in sample size (n= 51 
and n=16 healthy eyes, and n=39 and n=16 early AMD eyes, respectively); these 
studies may therefore have been under-powered to detect small differences in 
choroidal thickness between groups. Additionally, the potential effects of diurnal 
variation or caffeine intake were not controlled for in these studies.  
Other studies have also found no significant difference in choroidal thickness 
between early AMD and controls (Kim et al. 2011; Jonas et al. 2014). The more 
recent of these studies included 204 eyes with AMD, and 228 age-matched control 
eyes, and found no significant difference in subfoveal choroidal thickness between 
the control group and the four AMD subgroups (dry AMD, and nAMD sub-divided by 
predominant feature into; pigment epithelial detachment (PED), retinal oedema, or 
sub-retinal fibrotic scarring). However, this study did not control for the potential 
effect of diurnal variation, and all patients in the nAMD group were under 
bevacizumab therapy at the time of data collection. Medical treatment of nAMD with 
anti-VEGF has been associated with a reduction in choroidal thickness (Yamazaki et 
al. 2012), as discussed in Section 1.4.6. Kim et al. (2011) found choroidal thickness 
in early AMD (186.62 ± 62.02 µm) to be thinner than that of a control group (241.97 
± 102.87 µm), although this difference did not reach statistical significance. No 
significant difference was found between nAMD (226.46 ± 102.87 µm) and the early 
AMD or control groups. However, due to the retrospective nature of this study, 
diurnal variation and caffeine intake were not controlled for, potentially resulting in 
increased variance and therefore reduced the likelihood of significance. 
Ko et al. (2013) reported an inverse correlation between choroidal thickness 
and drusen area, which was independent of age and sex. They hypothesised that a 
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thinner choroid leads to a decreased blood flow and decreased waste removal from 
the outer retina, resulting in drusen formation. This disrupts the RPE, Bruch’s 
membrane and the choriocapillaris, leading to unhealthy or atrophied 
photoreceptors and a reduction in visual acuity (similar to the hypoxia theory of 
AMD; see Section 1.4.3.3). This is in line with their finding of a positive correlation 
between drusen area and logMAR visual acuity (VA). Ko and colleagues go on to 
suggest drusen load (square root of drusen area) as a useful biomarker in the 
management of AMD, as well as a potential outcome parameter of clinical trials in 
dry AMD. 
Several studies have found significant thinning in intermediate or late-stage 
neovascular disease (Lee et al. 2013b; Esmaeelpour et al. 2014a; Yiu et al. 2015; Lu 
et al. 2016). Esmaeelpour et al. (2014a) acquired long-wavelength OCT images from 
patients with bilateral intermediate AMD (n=21), intermediate AMD with nAMD 
fellow eye (n=21), and healthy controls (n=24). The choroid was found to be 
thinnest in eyes with intermediate AMD (149 ± 60 µm) and a diagnosis of nAMD in 
the fellow eye (171 ± 78 µm), followed by bilateral intermediate AMD (222 ± 98 µm), 
and finally healthy eyes (259 ± 95 µm). There was no significant difference in 
thickness between the two eyes in patients with unilateral nAMD, despite the 
difference in disease stage. Since disease state of the fellow eye was the only 
difference between the groups in this study, these findings suggest a symmetry in 
the pathogenesis of AMD, and may explain why unilateral development of choroidal 
neovascularisation (CNV) is a major risk factor for progression to nAMD in the 
fellow eye (Chew et al. 2014). The difference between bilateral intermediate AMD 
and healthy controls was not statistically significant; this may be limited by the 
relatively small size of each disease group in this study.  
 The most marked reduction in choroidal thickness is typically observed in 
GA, when compared to healthy eyes. Lindner et al. (2015) found a mean difference 
between groups of ~80 µm, whilst the difference identified by Adhi et al. (2014) was 
~110 µm, and this thinning was evident in all vascular layers of the choroid.  
 Considering variations in the appearance of the disease, advances in imaging 
technology have revealed a distinct phenotype of drusen, termed reticular 
pseudodrusen (RPD). These are often visible on colour retinal photographs and OCT, 
although visualisation may be enhanced using fundus autoflorescence or infrared 
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imaging (Sohrab et al. 2011). The prevalence of RPD in AMD populations varies 
greatly, due in part to differences in imaging modalities used, with reported values 
of 8.4% in early AMD, 22.1% to 36% in nAMD, and 29% to 92.3% in atrophic AMD 
(Hogg 2014; Wilde et al. 2016). Several studies have compared choroidal thickness 
in eyes with AMD with and without RPD. Presence of RPD in AMD has been 
associated with macular choroidal thinning, with mean differences ranging from 40 
µm to 155 µm when compared to AMD without RPD (Switzer et al. 2012; Garg et al. 
2013; Haas et al. 2014; Zheng et al. 2016). Additionally, eyes with RPD have been 
shown to have reduced vessel density (Zheng et al. 2016), resulting in a narrow and 
sparse appearance of choroidal vessels (Ueda-Arakawa et al. 2014) and a lack of 
detectable choriocapillaris (Sohrab et al. 2012). This may explain why RPD have 
been strongly linked to development of late-stage AMD (both nAMD and GA; Hogg 
2014), due to increased disruption to metabolic supply.  
Polypoidal choroidal vasculopathy (PCV) is categorised by some as a subtype 
of nAMD with a distinct clinical appearance, although others regard it as a 
neovascular manifestation of several diseases, such as CSC (Koh et al. 2013). It is 
characterised by multiple detachments of the RPE and neurosensory retina 
secondary to fluid leakage from networks of abnormal choroidal vessels. This 
subtype has been shown to have increased choroidal thickness when compared to 
typical nAMD, with Kim et al. (2011) reporting a mean subfoveal thickness of 319.9 
± 64.0 µm, and 226.5 ± 102.9 µm respectively. Koizumi et al. (2011) reported a 
similar trend, with mean choroidal thicknesses of 293.4 ± 73.1 µm and 244.6 ± 72.3 
µm respectively. This relationship was significant, even when adjusting for age, sex, 
and refractive error distribution. The authors also reported that those with a 
subfoveal choroidal thickness of 300 µm or more were 5.6 times more likely to have 
PCV, and speculated that the development of PCV may be due to altered choroidal 
circulation similar to that seen in CSC (see Section 1.3.8.2).  
Another study involving 87 participants demonstrated a significant 
thickening of the choroid in eyes with PCV (mean choroidal thickness of 438.3 ± 87.8 
µm), in contrast with choroidal thinning in eyes with nAMD and early AMD (mean 
choroidal thickness of 171.2 ± 38.5 µm, and 177.4 ± 49.7 µm respectively; Chung et 
al. 2011). The authors suggest that there may be differences in the pathogenic 
mechanisms of PCV and AMD which explain these findings. Therefore, PCV should 
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be classified as a separate group to nAMD where possible, particularly when 
choroidal parameters are used as outcome measures. However, since the estimated 
prevalence rate of PCV in groups of presumed AMD is 4% to 9.8% in Caucasian 
populations (Koh et al. 2013), this may not have significant implications. This is 
more likely to be significant in Asian populations, where the estimated prevalence 
of PCV in presumed AMD is 23.9% to 54.7%. Furthermore, a number of more recent 
studies have identified a thicker choroid in PCV than typical AMD, although this did 
not reach statistical significance (Koizumi et al. 2015; Ting et al. 2016; Wei et al. 
2016). 
Although choroidal thickness is the most commonly reported parameter, a 
handful of studies have reported methods of quantifying changes to the choroidal 
vessels in AMD. From OCT imaging, both choroidal and luminal area have been 
shown to be significantly lower in nAMD than healthy eyes (Sonoda et al. 2014; Wei 
et al. 2016). The more recent of these studies also identified a reduction in the ratio 
of luminal area to choroidal area, suggesting attenuation of vessels in the disease; 
this ratio was termed choroidal vascularity index (CVI). This is consistent with the 
decrease in vascular density in AMD noted with histology (Spraul et al. 1999).  
Using laser Doppler flowmetry, foveolar choroidal blood flow and blood 
volume have been shown to be reduced by an average of 37% and 33% respectively 
in eyes with dry AMD, compared to healthy age-matched controls (Grunwald et al. 
1998). There was no difference in blood velocity between groups. Quantification of 
choroidal blood flow with optical coherence tomography angiography is becoming 
feasible, with preliminary findings indicating a distribution of blood flow speeds 
associated with atrophic and neovascular lesions, with lower speeds typically found 
at the extremities of the lesions (Ploner et al. 2016; Ferrara et al. 2016; see Section 
1.5.3.3).  
To summarise, the evidence suggests that the choroid changes in AMD, and 
that such changes are detectable in vivo. These changes appear to be associated with 
disease severity and subtype, and are particularly evident in late-stage disease. 
Choroidal thickness is the most commonly reported parameter in the current 
literature, although this measurement is highly variable between individuals. Other 
methods of quantifying the vasculature to describe these changes are limited (e.g. 
vessel diameter, see Section 1.7.1). The development and optimisation of 
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parameters describing the choroidal structure may provide increased sensitivity to 
the detection of differences between subgroups, including disease severity.  
 
1.4.6 Anti-VEGF therapy and choroidal structure 
 Anti-VEGF therapy has also been implicated in structural changes to the 
choroid, and RPE atrophy. This is likely due to the role of VEGF in maintaining 
healthy choroidal structure (see Section 1.2.3). Rahman et al. (2013) conducted a 
retrospective case-controlled study, and found no gross difference in subfoveal 
choroidal thickness between treated and untreated nAMD groups. However, this 
was cross-sectional in study design, and limited by sample size (n=15 per group). 
Yamazaki et al. (2012) conducted a longitudinal study comprising 40 patients with 
unilateral nAMD and fellow eye unaffected by neovascularisation or geographic 
atrophy. Patients underwent intravitreal injections of ranibizumab (IVRs) monthly 
for 3 months, then as needed over the following 9 months. Mean subfoveal choroidal 
thickness was found to decrease following the anti-VEGF therapy, from 244 ± 62 µm 
at baseline to 226 ± 68 µm at 3 months, which remained almost constant until 12 
months when the study ended. This decrease in choroidal thickness was found to be 
independent of the number of IVRs (mean 5.8 ± 2.9), the subtype of nAMD, or any 
previous treatments. The authors suggest that IVRs may have a pharmacologic effect 
on the underlying choroid as well as the neovascular lesion itself, which could 
explain the decrease in choroidal thickness following treatment.  
 These findings are in agreement with Ting et al. (2016), who report a mean 
decrease in subfoveal choroidal thickness of ~10 µm after 3 months of anti-VEGF 
therapy (P=0.08), and ~25 µm after 6 months (P<0.01), with no further change until 
12 months when the study ended. Bevacizumab was the predominant agent used 
(77% of injections), and a similar trend in choroidal thickness was identified in 
treatment of PCV. Again, there was no correlation with number of injections or 
nAMD subtype, although this should be interpreted with caution, since the number 
of injections was typically low (3.9 ± 1.3 after 6 months, and 5.6 ± 2.1 after 12 
months). There was also no change in the fellow eye during the study period, for 
either the typical nAMD or PCV group. This suggests that local anti-VEGF therapy 
has no direct effect on the choroid in the fellow eye, and thus need not be an 
exclusion criterion for study of the fellow eye in these cases.  
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Similarly, a significant decrease in macular choroidal thickness (~35 µm) 
was identified following 3 months of aflibercept therapy (Koizumi et al. 2015). The 
majority of this change (~22 µm) was found within the first month. The effect of 
intravitreal injections is important when investigating choroidal changes in nAMD, 
since patients newly diagnosed with this disease stage typically begin treatment 
immediately. Choroidal changes caused by the anti-VEGF agent must be 
distinguished from choroidal changes due to pathology in patients with a history of 
treatment with anti-VEGF therapy.  
 
1.4.7 Clinical classification of AMD 
Classification of disease type and severity is commonly used in the clinical 
management of several ocular diseases, including AMD, based on underlying 
pathophysiology. In clinical research, disease classification is often used to group 
participants according to disease stage for cross-sectional studies, and to allow 
disease progression monitoring in longitudinal studies. To be useful for these 
applications, methods of ascertaining a classification should utilise commonly 
available imaging equipment, and be sensitive to clinical features of each class.  
There are a number of established methods of AMD classification (Klein et al. 
1991; Bird et al. 1995; AREDS 2001a; Ferris et al. 2005; Danis et al. 2013), one of the 
earliest being the ‘Wisconsin Age-related Maculopathy Grading System’ (Klein et al. 
1991). This system was devised based on previous methods for grading AMD and 
DR, and has been independently assessed for performance (Sparrow et al. 1997). 
Since its development, it has been used over many years for grading purposes in the 
Beaver Dam Eye Study (Klein et al. 2007), and has spawned a number of new 
systems, e.g. the International Classification and Grading System (Bird et al. 1995), 
and the Age Related Eye Disease Study Group Grading System (AREDS 2001a). Both 
of these methods were devised to enable multicentre grading and classification of 
AMD for a large-scale epidemiological study and clinical trial respectively. These 
systems define an age limit (over which retinal features seen are likely attributable 
to AMD) of 50 and 55 years respectively.  
Variations of the AREDS system have since been produced, including the 
Simplified Severity Scale (Ferris et al. 2005; Ferris et al. 2013), which involves less 
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demanding grading protocols, and approximates 5-year risk of development of 
advanced disease. More recently, the AREDS2 system was established for the 
multicentre AREDS2 clinical trial (Danis et al. 2013). Again, this was based upon the 
AREDS system, but adopting the modern assumption that the standard optic disc 
diameter is 1800 µm in size, rather than 1500 µm as assumed by previous systems.  
This altered the size of the grid overlay used during grading.  
 The published approaches are all based upon documenting the presence, 
frequency and location of retinal features associated with AMD, such as drusen and 
pigmentary abnormalities, from retinal photographs. The features only within a pre-
defined macular region are considered, assumed to be a circle of 6000 µm diameter 
centred on the fovea (with the exception of the AREDS2 system, which is of 7200 µm 
diameter). This region is subdivided into three annular regions, by two additional 
circles of 1000 µm and 3000 µm diameter, both centred on the fovea.  The outer two 
annular regions are each further subdivided into 4 equally-sized regions, 
representing inferior, superior, nasal, and temporal areas (see Figure 1.12). These 
map sectors were defined by the Early Treatment Diabetic Retinopathy Study 
Research Group (ETDRS 1991).  
These classification systems utilise 30° or 35° stereoscopic retinal 
photography to gain a degree of insight into depth information e.g. areas of fluid 
N1 T1 N2 T2 
S1 
S2 
I1 
 
 I2 
F 
1mm 
Figure 1.12 Grid overlay for use with AMD classification and grading, with standard sizing 
used. Notations indicate nasal (N), temporal (T), inferior (I) and superior (S) quadrants in the 
inner (1) and outer (2) rings, as well as the foveal subfield (F). Image adapted from AREDS 
(2001b). 
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collection. Other imaging modalities that would enhance clinical signs of AMD have 
been considered, such as fluorescein angiography, however the benefits of this 
technique were deemed to not outweigh the invasive nature, and the risk of 
anaphylaxis and death (AREDS 2001a).  Since this time, advances in non-invasive 
imaging technology now allow a far more detailed appreciation of such information, 
for example OCT imaging. However, such techniques are yet to be incorporated into 
AMD disease classification systems. Choroidal features are not included in any 
classification system, due to the poor visibility of these structures in retinal 
photography, and the limited understanding of choroidal changes in AMD at the time 
of development.  
The clinical use of stereoscopic retinal photography has largely been 
replaced by OCT imaging in conjunction with conventional 45° digital retinal 
photography. Since OCT provides a high resolution view of the retinal layers, some 
clinical features of AMD such as small drusen may be visible on OCT but not on 
retinal photography. Following anti-VEGF therapy for nAMD (which was not used at 
the time of development of these classification systems), intra-retinal and sub-
retinal fluid are often reabsorbed. This makes the typical signs of this disease stage 
difficult or impossible to see with photography in some cases, resulting in 
misclassification. In light of new imaging equipment and treatment methods, the 
established classification systems may no longer be appropriate in many cases. An 
adapted protocol was therefore adopted for the classifications in this thesis (see 
Section 4.2).   
In summary, AMD presents a substantial problem due to its prevalence, 
debilitating visual symptoms, and lack of cheap and effective treatments 
(particularly for early and atrophic AMD). Opportunities to develop new therapies 
are likely to be identified through an improved understanding of the exact 
pathogenesis of AMD. Retinal signs such as drusen, pigmentary changes, and intra-
retinal fluid are currently used to diagnose and monitor AMD. However, presence of 
the latter sign is indicative of nAMD, by which stage vision is often significantly 
reduced and intervention is typically required. Considering the suggested role of 
hypoxia in AMD, the choroid may provide information predictive of change to the 
overlying retina.  
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Although the choroid has been implicated in AMD pathogenesis, it is still 
unclear of the exact mechanisms behind this. Exploiting advances in in vivo imaging 
may help improve our understanding of the role of the choroid in AMD progression, 
and provide a potential new approach to diagnosing and monitoring the condition. 
Although subfoveal choroidal thickness is commonly reported in studies of the 
choroid, this parameter has high variability, and does not describe the vascular 
structure. Optimisation of existing parameters, and development of new parameters 
to describe the structure, may provide increased sensitivity to choroidal change 
throughout the AMD disease process.  
 
1.5 Optical coherence tomography  
Optical coherence tomography (OCT) is an optical imaging modality, enabling 
in vivo 3-D visualisation of biological tissue. It is non-invasive, and provides a 
micron-level resolution view of internal structures, making it ideal for medical 
diagnostic purposes. Ophthalmic diagnosis is one of the most clinically developed 
OCT applications, particularly for retinal diseases such as AMD, and OCT imaging is 
routinely undertaken in hospitals and some high street optometry practices. This 
section briefly describes the principles and development of OCT technology, and 
how it has been optimised for imaging the deeper ocular structures pertinent to this 
work, including the choroid.  
 
1.5.1 Basic principles  
The earliest measurements of a one-dimensional axial scan (equivalent to an 
ultrasound a-scan) were in the 1980s (Fujimoto et al. 1986; Fercher, Mengedoht and 
Werner 1988), with cross-sectional two-dimensional scans (equivalent to an 
ultrasound b-scan) being demonstrated in the early 1990s (Huang et al. 1991). The 
first in vivo OCT imaging studies of the human retina followed in 1993 (Fercher er 
al. 1993; Swanson et al. 1993). Since this time, there has been a tremendous growth 
in the number of publications and citations in the field; from 19 publications in 1996, 
to 1081 in 2006, to 4853 in 2016 (number of search results for ‘optical coherence 
tomography’ on PubMed.gov for each given year). Commercial OCT instruments are 
48 
 
now commonplace in hospitals, medical imaging centres and high street optometry 
practices.   
OCT is based on the principle of low-coherence optical interferometry. 
Fundamentally, OCT is analogous to ultrasound, measuring backscattered 
(reflected) light from within the imaged structure. The sampling depth is 
determined by the optical equivalent of echo time delay in ultrasound. By obtaining 
measurements at regular intervals (with increasing depth), OCT is able to produce 
an axial a-scan. Moving the scanning system laterally allows a series of adjacent a-
scans to be obtained, producing a cross-sectional b-scan. Lateral movement in one 
direction is used to form a two-dimensional b-scan, whilst movement in two 
directions forms a 3-D c-scan.  
The design of OCT is based on a Michelson interferometer, which produces 
an interference pattern by splitting a beam from a light source into two paths, using 
a semi-silvered mirror (Figure 1.13A). To produce interference fringes, each path is 
of a different length or comprised of a different material (with a different refractive 
index; n). This results in a phase difference, as the light from one path will return to 
the central mirror before the light from the other path. Once the light returns to the 
semi-silvered mirror, the two paths are recombined, and directed to a 
photodetector. The phase difference between the light from each path is evident 
from the amplitude of the detected signal (resulting from constructive and 
destructive interference).  
The retina is a multi-layered structure, with each layer having different 
reflective properties. It is therefore possible to assess the reflectivity at different 
depths in the retina and discern the individual layers, given sufficient resolution. 
The interferometer within an OCT instrument splits the beam of light in half; the 
beam that enters the eye, and a reference beam (Figure 1.13B). When the beam 
passes into the eye, a small portion of the light is reflected by each retinal layer. The 
reflected beam can be matched to the reference beam by adjusting the position of a 
reference mirror, until the two optical paths lengths are equal. The position of the 
reference mirror allows the reference path length to be ascertained, enabling the 
construction of an image with several predetermined depth points within the retina 
(a-scan). However, light scattering and absorption within the sample ultimately 
limit the depth to which useful OCT imaging is possible (Huang et al. 1991).  
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1.5.2 Resolution 
Several parameters define how useful an imaging modality is, for both 
clinical and research purposes. One of the main advantages of using OCT for medical 
imaging is the complete decoupling of axial (depth) resolution and transverse 
(lateral) resolution (Hitzenberger 2003). The axial resolution is determined by the 
coherence length of the light used and, unlike scanning laser ophthalmoscopy, is not 
influenced by the numerical aperture of the eye nor aberrations arising from the 
Figure 1.13 Schematic diagram of (A) a Michelson interferometer, and (B) optical coherence 
tomography. The return paths and photodetector are shown off-axis for demonstrative 
purposes. Image adapted from Terry (2017).  
A 
B 
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cornea or lens. Transverse resolution is defined by the size of the focussed 
transverse spot of the optical beam.  
Axial image resolution is important for visualising individual layers of the 
retina, and is related to the spectral bandwidth of the imaging light source used as 
described in Equation 1.1 (Drexler 2004).  
 
∆𝑧 =
2ln⁡(2)𝜆2
𝜋Δ𝜆
 
 
Equation 1.1 
 
where:  
∆z is the axial resolution,  
∆λ is the spectral bandwidth of the light source,  
λ is the centre wavelength of the light source used for imaging (assuming a Gaussian  
   spectrum). 
 
Commercial OCT instruments commonly use broad-bandwidth 
superluminescent diode (SLD) light sources, emitting ~50 nm bandwidths centred 
at ~850 nm, resulting in ~5 µm axial resolution in tissue (n=1.4). Schmitt (1999) 
identifies three parameters as requirements for the ideal OCT light source; emission 
in the near infrared spectrum, a high irradiance, and a short temporal coherence 
length. The coherence length is a finite distance over which light maintains some 
degree of coherence, and is inversely proportional to the spectral bandwidth of the 
light source. Although SLDs satisfy the first two of these parameters and are 
relatively cheap to manufacture, they have a long coherence length, which limits the 
axial resolution. To overcome this limitation, ultrabroad-bandwidth, solid state 
femtosecond Titanium:sapphire lasers have been used, which provide excellent 
resolution but are very expensive and less portable than SLDs, limiting their use to 
research rather than clinical application.  
As previously mentioned, transverse resolution for OCT imaging is defined 
by the size of the focussed transverse spot of the optical beam (Equation 1.2; Drexler 
2004).  
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Δ𝑥 = (
4𝜆
𝜋
) (
𝑓
𝑑
) 
 
 
Equation 1.2 
where:  
∆x is the transverse resolution 
d is the spot size on the objective lens 
f is the focal length of the objective lens 
λ is the centre wavelength of the light source used for imaging (assuming a Gaussian  
   spectrum) 
 
High transverse resolution images can be obtained by using a high numerical 
aperture (i.e. a reduced spot size) at the expense of a reduced depth of focus. 
Transverse image resolution of the retina is generally limited by pathological or 
normal ageing changes to the intraocular media (i.e. cataracts) and ocular 
aberrations, although this can be minimised using adaptive optics techniques (see 
Drexler and Fujimoto (2008) for a comprehensive review).  
 Other important parameters of OCT for research and clinical use are data 
acquisition time (must be short to minimise motion artefacts and maximise patient 
comfort and exposure safety), detection sensitivity (often compromised in order to 
keep acquisition time to a minimum), image penetration depth in tissue, and image 
contrast (Drexler and Fujimoto 2008).  
 
1.5.3 Types of OCT 
Early clinical devices were ‘Time Domain OCT’, although these have been 
almost entirely superseded by the newer generation ‘Frequency Domain OCT’, with 
the recent introduction of swept-source systems bringing new opportunities in 
imaging of the deeper structures. OCT angiography has also become commercially 
available, allowing enhanced imaging of vascular structures by using adapted image 
processing techniques in conjunction with conventional OCT imaging, to detect 
blood flow. An explanation of each type of OCT and their advantages and limitations 
are outlined in the following section.  
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1.5.3.1 Time Domain OCT  
The method of adjusting the reference mirror to measure the reflectivity at 
each data point is known as Time Domain OCT (TD-OCT). The need for manual 
movement within the system results in slow image acquisition (~4000 a-scans/sec) 
and hence difficulty in collecting sufficient data to allow for 3-D imaging (Drexler 
2004; Povazay et al. 2007). This was a major limitation of the early commercial 
instruments, such as the Stratus OCT (Carl Zeiss Meditec, Inc., Dublin, CA) system, 
which is now considered obsolete. Furthermore, TD-OCT displays an inverse 
relationship between axial resolution and signal-to-noise ratio (SNR), limiting the 
resolution attainable by this method of imaging (Choma et al. 2003).  
 
1.5.3.2 Frequency Domain OCT 
The alternative to TD-OCT is Frequency (or Fourier) Domain OCT (FD-OCT). 
This modality assesses the interferometry data in the frequency domain, using 
Fourier transforms to directly obtain the depth-reflectivity profile. FD-OCT 
measures reflectivity along an entire a-scan simultaneously rather than 
sequentially, negating the requirement of a mobile reference mirror. Consequently, 
FD-OCT has a substantially higher a-scan acquisition rate (by approximately 50 
times; Leitgeb, Hitzenberger and Fercher 2003; Drexler 2004; Povazay et al. 2007), 
facilitating the acquisition of 3-D images in a clinically feasible time period (~5 
seconds). FD-OCT has been demonstrated as having higher sensitivity than TD-OCT 
to macular pathologies, including AMD, diabetic macular edema (DME), and uveitis-
related maculopathies (Choma et al. 2003; Gupta et al. 2008; Forooghian et al. 2008; 
Sayanagi et al. 2009; Cukras et al. 2009; Major et al. 2014).  
There are two different methods of acquiring the interferometry data in FD-
OCT; Spectral Domain (SD-) and Swept Source (SS-) OCT. Both use Fourier 
transforms to produce depth-reflectivity profiles which comprise the final OCT 
image (van Velthoven et al. 2007). These techniques are described in more detail in 
the following section.   
Spectral Domain OCT 
The first of these methods (SD-OCT) uses a broadband light source with a 
spectrometer as the detector. The spectral components are spatially encoded rather 
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than time encoded (as in TD-OCT), and a dispersive element is used to spectrally 
distribute the different wavelengths from the light source. The interferometer 
encodes the depth information from the sample across the spectrum, before it is 
spectrally dispersed and imaged by a high speed camera. A single exposure of light 
can be used to build a full-depth scan, resulting in a higher acquisition speed than 
TD-OCT.  
Swept Source OCT  
SS-OCT uses a photodiode detector and a rapidly tuned light source to 
acquire the spectral signature from the sample. Conversely to SD-OCT, the spectral 
components are time encoded rather than spatially encoded, but without the need 
for a mobile reference mirror as in TD-OCT. The use of this type of detector results 
in a higher acquisition rate, reducing image acquisition time whilst maintaining the 
use of 3-D imaging.  Swept source technology is utilised in the latest generation of 
OCT devices; for example, the DRI OCT Triton (Topcon Corp, Tokyo, Japan) has a 
scan rate of 100,000 a-scans/sec, whereas its predecessor, the spectral domain 
Topcon 3D OCT-2000, operates at half this rate (50,000 a-scans/sec).  
Additionally, the sensitivity (defined as the SNR for a perfect sample 
reflector) is independent of both scan depth and source bandwidth, unlike other 
modalities (Choma et al. 2003). This allows visualisation of deeper structures with 
more clarity. The DRI OCT Triton provides choroidal thickness maps for operators 
to evaluate choroidal thickness with minimal time and effort (Hirata et al. 2011). 
This is potentially useful for monitoring choroidal thickness in pathologies known 
to affect choroidal thickness, such as CSC, AMD, pathologic myopia, and angioid 
streaks (Ellabban et al. 2012; Jirarattanasopa et al. 2012; Ohno-Matsui et al. 2012).  
 Klaver et al. (2012) conducted a population-based study on retinal and 
choroidal thickness measured by SS-OCT. A total of 111 participants aged 55 and 
over were included from the Rotterdam Study (Hofman et al. 2007), and 93% of 
scans acquired were deemed to be of high quality. They concluded that the long-
wavelength SS-OCT was fast and relatively easy to use, and provides opportunities 
for evaluating retinal and choroidal thickness in large studies. A disadvantage of 
these swept source systems is the cost to manufacture, and hence the cost to the end 
user.  
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1.5.3.3 OCT angiography 
Optical coherence tomography angiography (OCTA) is a recently developed 
approach to non-invasive vascular imaging. It employs motion contrast to identify 
blood flow, by comparing backscattered signal between rapidly acquired sequential 
OCT images. Point by point signal correlation is used to identify spatial change 
between the images. Areas of no difference between repeated scans are deemed 
stationary, whilst differences in signal are attributed to motion of erythrocytes in 
the blood vessels (Ferrara et al. 2016). Both the retinal and choroidal 
microvasculature may be viewed with OCTA.  The acquisition time of an OCTA scan 
is typically 2-4 times that of an SS-OCT volume scan (~2 seconds), and is comparable 
to a conventional SD-OCT volume scan (~5 seconds). To ensure consistency 
between sequential images, eye tracking and image registration techniques are 
typically employed.   
Injection of contrast material is not required for this technique, providing an 
advantage over the current gold standard angiography techniques; fluorescein 
angiography and indocyanine green angiography. Furthermore, OCTA acquires 
volumetric data, unlike the 2-D photography used in traditional angiography. 
Different layers of the vasculature can therefore be isolated and viewed 
independently with OCTA. For example, the retinal vasculature can typically be 
separated into the superficial plexus and deep plexus, and the choriocapillaris can 
often be visualised. However, since the majority of OCTA devices are adapted from 
conventional OCT devices, the wavelength at which they operate limits visualisation 
of the structures beneath the RPE (see Section 1.6.1.1).  
Since OCTA requires motion to identify vasculature, stationary fluid leakage 
is not easily detectable, as with traditional angiography. Artefacts are inherent in 
OCTA imaging, which commonly arise from eye motion, or overlying vascular 
structures or media opacities (for more detail on artefacts in OCTA, see Spaide et al. 
2015). Unlike other angiography methods, OCTA provides an image representing a 
single time-point, where all vessels are visualised simultaneously. This cannot be 
differentiated into vascular filling and emptying stages (e.g. arteriovenous phase, 
laminar venous phase), as can be investigated from the time-course following 
injection of contrast material.  
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Despite these limitations, OCTA has been shown to be capable of detecting 
changes in choroidal blood flow, indicating the presence of CNV in AMD, and 
capturing microvascular abnormalities in diabetic eyes and vascular occlusions (Jia 
et al. 2014; de Carlo et al. 2015). Although OCTA shows promise for future use in 
clinical identification of vascular changes in pathology, it was not utilised in this 
thesis for a number of reasons. Firstly, this technology was not commercial available 
at the outset of this work. Secondly, it is not optimised for imaging the deeper 
structures, and the SNR of the deeper choroid is often low. Finally, areas of 
particularly high or low flow velocity have been shown to generate signals outside 
the detection range of the device, resulting in artefacts (Spaide et al. 2015; Ferrara 
et al. 2016). The effect of AMD on blood flow and the impact this has on OCTA 
imaging is not yet fully understood. Since the aim of this thesis was to identify 
structural changes to the vasculature in AMD, it seemed pertinent to utilise an 
established imaging technique based on structure reflectivity rather than blood 
flow.  
 
1.6 OCT imaging of the choroid  
Since choroidal imaging in vivo is a relatively new technique, protocols for 
quantifying the vasculature are not well established. The following section contains 
an overview of OCT optimisation for imaging deeper structures, including the 
choroid. This is followed by a review of histological studies of the choroid in AMD, 
and explores how these quantification techniques may be used to inform study 
design for in vivo choroidal analysis.   
 
1.6.1 Optimisation of OCT for choroidal imaging 
There are limitations that should be considered when imaging the choroid 
with conventional SD-OCT instruments. For example, there is a decrease in imaging 
sensitivity with increased depth in the structure, termed ‘signal roll-off’. 
Additionally, light scattering by the ocular tissue and optical media results in a 
reduction of the OCT signal. These factors limit the SNR, and ultimately the 
sensitivity of the imaging system. In an attempt to overcome these limitations, 
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alterations to conventional OCT have been made to optimise visualisation of the 
deeper structures, including long-wavelength OCT and enhanced depth imaging.  
 
1.6.1.1 Light source wavelength 
The majority of commercial SD-OCT instruments utilise a light source with a 
central wavelength of ~800-860 nm. A table of the specifications of several 
commercial OCT devices can be found in Appendix A. More recently, OCT 
instruments utilising a longer wavelength light source in the region of 1050 nm have 
been developed. These provide better visualisation of the deeper structures, 
particularly beneath the RPE. The RPE has a high concentration of melanin pigment, 
which is highly scattering and absorbing. However, the optical properties of melanin 
are strongly wavelength-dependent, with longer wavelengths suffering less from 
scatter and absorption. This allows improved visualisation of the choroid with long-
wavelength OCT devices. This may be clinically useful for diagnosing early stage 
pathologies known to affect the choroid including AMD, particularly when 
accompanied by choroidal neovascularisation (Povazay et al. 2003; Unterhuber et 
al. 2005).  
Long-wavelength OCT also has the advantage of reduced image degradation 
due to scatter caused by opacities in the intraocular media, such as cataracts and 
corneal opacities (since these are also wavelength-dependent), resulting in a higher 
SNR. This enables clinically useful data to be collected in a wider range of subjects, 
particularly those with other age-related ocular conditions such as AMD or diabetic 
retinopathy (Povazay et al., 2007; Drexler and Fujimoto 2008). Additionally, since 
1050 nm is not visible to the human eye, patients will not exhibit the reflex to track 
the scanning line during image acquisition, which is commonly reported with 
conventional-wavelength OCT.  
Assuming the water content of the vitreous to be ~90% and the average 
human axial eye length to be ~25 mm, one can estimate the comparative OCT signal 
loss at various wavelengths. There is a reduction of detectable signal from the retina 
from ~89.4% at 800 nm to ~48.4% at 1060 nm (Hammer et al. 1995; Unterhuber et 
al. 2005). This is largely due to the absorption spectrum of water (Figure 1.14). This 
may be compensated for by increasing the power of the light source, although not 
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exceeding standards for continuous corneal irradiance (ANSI 2000; ICNIRP 2013). 
Images obtained at 1050 nm have been shown to penetrate ~200 µm deeper into 
the choroid than those obtained at 800 nm (Unterhuber et al. 2005).  
 The water absorption spectrum has two wavelength regions where 
absorption is relatively low; below ~950 nm, and a narrow band between 1040-
1100 nm. Three different lasers are also shown in Figure 1.14, displaying the 
suitability of two of these for use in posterior eye imaging, with corresponding water 
absorption minima of ~800 nm and ~1050 nm. The third laser (MenloSystems) is 
clearly unsuitable for this purpose. However, this fiber laser may have clinical 
applications for in vivo imaging of the anterior segment, where the path of light 
through water-filled cavities is shorter prior to reaching the target structure 
(Drexler 2004). The Visante OCT (Carl Zeiss Meditec, Inc., Dublin, CA) uses an SLD 
at 1310 nm for anterior eye imaging, including the anterior segment, cornea and 
lens (e.g. to collect clinical data for LASIK or intraocular lens (IOL) surgery).  
 
1.6.1.2 Enhanced depth imaging 
Prior to the introduction of commercial long-wavelength OCT devices, 
alterations in acquisition techniques were made to optimise visualisation of the 
deeper structures using conventional-wavelength OCT systems (Spaide et al. 2008). 
These techniques are collectively known as enhanced depth imaging (EDI).  
SD-OCT inherently suffers from depth-dependent signal roll-off; this is a 
reduction in the SNR with increasing distance from the ‘zero delay line’ (the depth 
of highest image sensitivity). In clinical OCT imaging, the retinal structures are 
Figure 1.14 Output spectra of three different lasers: Ti:sapphire laser (black line, left), 
photonic crystal fiber-based source (grey line, centre), and a MenloSystems laser (black line, 
right), overlaid with a water absorption spectrum (broken line). Image from Drexler (2004). 
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typically of most interest, and therefore are positioned close to the zero delay line. 
However, this limits the capabilities of SD-OCT for imaging the choroid, which is 
located further from the zero delay line. In EDI, the position of the reference mirror 
is adjusted to invert the image, bringing the choroid closer to the zero delay line. EDI 
is available in the acquisition software of many newer commercial OCT instruments 
(Regatieri et al. 2012b). EDI has been shown to be effective for imaging the choroid 
in healthy individuals as well as those with choroidal abnormalities, including AMD, 
CSC, and CNV in high myopia (Fujiwara et al. 2009; Imamura et al. 2009; Margolis 
and Spaide 2009; Sigler and Randolph 2013).  
However, OCT devices optimised for imaging the deeper structures (e.g. long-
wavelength light sources) are likely to outperform conventional SD-OCT 
instruments with EDI. Visualisation of the deeper structures can be further 
enhanced with image processing techniques, which are discussed further in Section 
2.3.  
 
1.6.2 Comparison to histology 
Histology is considered the gold standard method of informing and 
validating OCT measurements of the retina and choroid (Toth et al. 1997; Yabushita 
et al. 2002; Drexler and Fujimoto 2008). Pre-dating OCT, histology has contributed 
a large amount to the pool of knowledge on the physiology of the posterior pole, 
including the choroidal vasculature (McLeod and Lutty 1994). Light microscopes 
have a far higher spatial resolution than OCT (~0.2 µm versus ~5 µm), allowing for 
repeatable measurements of small features, including the thickness of Bruch’s 
membrane (~3 µm) and lumen diameters within the choriocapillaris (~8 µm; 
Ramrattan et al. 1994).   
 To investigate choroidal vasculature in vivo, methods of quantifying 
structures can be adapted from previously used ex vivo techniques. There have been 
several publications using histological analysis to investigate changes to the choroid 
in AMD (Sarks 1976; Ramrattan et al. 1994; Spraul et al. 1996; Spraul et al. 1999; 
McLeod et al. 2002; McLeod et al. 2009; see Section 1.4.5). These studies utilise light 
microscopy to visualise the choroidal vasculature, and quantify based upon vessel 
diameter and density.  
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Ramrattan et al. (1994) studied histologic sections of 95 normal human 
maculae and 25 maculae with various stages of AMD. Thickness of Bruch’s 
membrane was measured, as well as length and cross-sectional diameter of the 
capillary lumen in the choriocapillaris (measured parallel and perpendicular to 
Bruch’s membrane respectively), in addition to total choroidal thickness (Figure 
1.15). These were measured 8 times at regularly spaced intervals of 140 µm, and 
averaged. Although measurements of these small structures are possible using 
histology, this feature size is below the resolution limit of current OCT instruments 
and hence cannot currently be measured in vivo. However, it may be possible to 
transfer the concept of lumen length and diameter measurements used in this study 
to the deeper, larger choroidal vessels which can be resolved. Spraul et al. (1996; 
1999) followed a similar approach, extending their histological analysis of the 
choriocapillaris to incorporate diameters of the larger choroidal arteries and veins.  
 To ensure that these measurement techniques are transferrable to OCT 
images, the imaging modalities must be comparable (i.e. the areas or relative high 
or low reflectivity on OCT must relate directly to retinal or choroidal structures on 
light microscopy). Several studies have demonstrated the comparability of OCT 
imaging and histology (Gloesmann et al. 2003; Anger et al. 2004; Curcio et al. 2011; 
Figure 1.16).  
Figure 1.15 Diagram illustrating the measurements performed on histologic sections of 
choroid: (1) thickness of Bruch’s membrane; (2) capillary lumen length; (3) capillary diameter; 
(4) choroidal thickness; (5) total distance (1120 µm) along which measurements were made at 
140 µm intervals. Bruch’s membrane has been exaggerated for demonstrative purposes. 
Image from Ramrattan et al. (1994).  
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 Curcio et al. (2011) manually measured thickness of 21 physiological layers 
of retina and choroid (including the choriocapillaris and choroid) at 25 lateral 
locations, in 18 donor eyes. These locations were distributed nasally and temporally 
within the central 6 mm of posterior pole, centred on the foveal pit. Measurements 
were made perpendicularly to the RPE, using the ‘lengths’ tool in IPLab, a 
commercial image analysis program (Scanalytics, Fairfax, VA). The histologic 
measurements and boundary selection were compared to that of ex vivo OCT 
(Spectralis). The measurement methods were very different between the two 
techniques, however the authors concluded that newer OCT systems can accurately 
identify retinal and choroidal layer boundaries, with good agreement to histologic 
measurements with light microscopy.  
 It should be noted that whilst histology provides high-resolution images, 
there are significant limitations. Firstly, availability of donor eyes is limited, 
particularly those from young individuals. Secondly, histology is an ex vivo 
technique, requiring an excised eye with no circulation. When considering 
visualisation of the choroid, a highly vascular structure, histology may not be the 
most appropriate approach, since the structure can be expected to change without 
blood flow.  
Figure 1.16 Ex vivo section of monkey fovea imaged using (A) light microscopy and (B) UHR-
OCT.  Image adapted from Anger et al. (2004). 
A 
B 
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For example, the mean macular choroidal thickness of healthy eyes 
measured using histological methods has been reported as 125.7 ± 44.1 µm (Curcio 
et al. 2011) and 139 ± 51 µm (Spraul et al. 1999). This is far lower than the published 
literature on mean choroidal thickness measured using in vivo OCT imaging (ranging 
196 to 354 µm; see Section 1.2.5). The same is true for the mean diameter of the 
large choroidal vessels, reported as 37.1 µm with histological examination (Spraul 
et al. 1999), and ranging from 123 to 160 µm with in vivo OCT imaging (Bittencourt 
et al. 2014; Park and Oh 2014). Curcio and colleagues (2011) identified a mean 
difference between histological and OCT retinal volume measurement of 14.5%, 
attributed to tissue shrinkage during the histological sample preparation process. 
Tissue shrinkage in the choroid was not investigated due to the poor visibility of the 
choroid-scleral boundary in the OCT images. Based on the differences in mean 
choroidal thickness and vessel diameters between the methods reported in the 
literature, the preparation process of histological samples is likely to have a 
substantial effect on the choroidal structure. In fact, choroidal thickness has been 
shown to reduce to approximately half its in vivo value following histologic fixation 
(Li et al. 2016; Figure 1.17).  
In summary, although we are well informed about ex vivo choroidal structure 
from histological techniques, in vivo techniques such as OCT can provide 
information regarding choroidal vasculature in the functioning eye, and in a clinical 
setting. OCT is an established and effective method of imaging the human retina in 
vivo, comparable to histology (albeit with a reduced resolution, and allowing for 
Figure 1.17 Horizontal macular sections comparing histological preparation (post-
enucleation; A) with in vivo EDI OCT imaging (B). The choroid was found to be half the 
thickness following enucleation, with a reduction in the large choroidal vessel diameter 
(arrowheads). Image from Li et al. (2016).   
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tissue shrinkage). More recent developments in OCT imaging, such as EDI and long-
wavelength light sources, facilitate optimised visualisation of the choroidal 
structure. The technique is non-invasive, and allows for quick and easy acquisition 
of high resolution 3-D images of the posterior pole, in both clinical and research 
settings. However, the majority of clinical analysis of these images is qualitative, 
with only minimal quantitative analysis available on commercial systems (generally 
limited to retinal layer thickness maps and manual calliper measurements). Section 
1.7 describes various image analysis techniques that may be employed to quantify 
structural features within OCT images.  
 
1.7 Image analysis techniques 
To gain useful information from a clinical image, structural features must 
undergo evaluation (for example, assessing the integrity of the retinal layers). This 
may be a qualitative evaluation by a skilled clinician, or may involve manual or 
automated analysis to quantify the features. There are two stages to image analysis: 
image preparation and data extraction. The first of these aims to optimise image 
quality, typically with regard to noise reduction and feature enhancement. This is 
followed by data extraction, which may be qualitative or quantitative, depending on 
the purpose of the analysis. In clinical assessment, this is often qualitative analysis, 
whereby clinicians will screen images for signs of pathology (e.g. identifying intra- 
or sub-retinal fluid in OCT images). In research, quantitative analysis is more 
common, for example comparing retinal or choroidal thickness between disease and 
control groups.  
These two processes are collaborative, with image preparation being tailored 
to the type of data to be extracted. For example, enhancement of certain features is 
commonly applied to improve their visualisation. Conversely, the type of data to be 
extracted is also limited by the images themselves; image resolution being a 
common limiting factor. This section explores approaches to data extraction from 
OCT images, including manual parameters, automated segmentation, and machine 
learning techniques. With consideration to these approaches, image preparation 
techniques are discussed in Section 2.3.  
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1.7.1 Manual choroidal vasculature quantification 
For a parameter to be effective at describing the vascular structure, it should 
meet a set of criteria. For clinical feasibility, it should be easily applicable to existing 
imaging techniques (e.g. OCT), with minimal processing time and user input (to 
minimise inter-observer variation). Parameters should be sensitive to detecting 
differences between groups, for example, between disease and control groups (for 
diagnosis), or over time (for monitoring). For biological parameters, this is often 
difficult to achieve due to large variations between individuals, and between repeat 
measurements, often due to confounding factors. For instance, subfoveal choroidal 
thickness has high variability between individuals, and is affected by many short-
term factors including time of day and caffeine intake (see Section 1.3). Parameters 
should therefore also demonstrate good intra- and inter-session repeatability.  
The parameter most commonly used to describe the choroid is choroidal 
thickness. This is typically measured subfoveally, or at defined locations relative to 
the foveal pit or ONH, using digital callipers. Alternatively, it may be obtained using 
automated segmentation algorithms (see Section 1.7.2). Other vascular parameters 
have been evaluated to describe the vasculature itself, including vessel diameter 
(Yang et al. 2013; Park and Oh 2014), thickness of the choroidal sublayers (Haller’s 
and Sattler’s layer; Park and Oh 2014; Esmaeelpour 2014b), and assessment of the 
ratio of vessel lumen to surrounding stromal tissue (Branchini et al. 2013; Sonoda 
et al. 2015).  
 
1.7.1.1 Vessel diameter 
Vessel diameter has been investigated as a potential parameter to describe 
the choroidal vasculature in pathological and healthy eyes (Yang et al. 2013; 
Bittencourt et al. 2014; Park and Oh 2014). Yang et al. (2013) performed manual 
diameter measurement of the largest visible vessel with a zone of width 4500 µm, 
centred on the fovea (Figure 1.18). This was measured perpendicularly to Bruch’s 
membrane at the widest point of the lumen. Two masked observers performed the 
measurements, and measurements were re-performed if the inter-observer 
difference was >15%. In cases with a difference ≤15%, the mean of the two values 
was used. Line scans (average of 100 b-scans) acquired using the Spectralis OCT 
were utilised in this study. This parameter was used to demonstrate vascular 
64 
 
engorgement in CSC, both in the affected and fellow eye (vessel diameters of 305 ± 
101 µm and 251 ± 98 µm respectively, versus 140 ± 40 µm in the control group). 
However, only a single vessel per eye was used in analysis, with small sample sizes 
(n=15 per group). The measurement protocol provides no assessment of changes to 
the smaller choroidal vessels.  
Bittencourt et al. (2014) measured vessel diameter in Haller’s layer at 3 
locations within a single foveal b-scan (subfoveal, 2 mm nasally and 2 mm 
temporally). This was repeated for two further b-scans, 2 mm superior and 2 mm 
inferior to the foveal b-scan. A mean was calculated from these measurements, and 
was shown to be smaller in eyes with chronic posterior non-infectious uveitis than 
healthy controls (123 ± 37 µm and 160 ± 32 µm respectively). Park and Oh (2014) 
followed a similar protocol, and measured the diameter of large choroidal vessels at 
Figure 1.18 Example OCT b-scan from an eye with CSC (A), the fellow eye (B), and a healthy 
control eye (C). Arrowheads denote the posterior choroidal boundary, and subfoveal choroidal 
thickness is shown by the long white arrows. The shorter vertical arrows represent the 
diameter of the largest vessel lumen. Image from Yang et al. (2013).  
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locations 750 µm nasal, temporal, inferior and superior of the fovea. Large vessels 
were defined as measuring ≥100 µm in adults, and ≥80 µm in children, based upon 
unpublished pilot data. Mean choroidal vessel diameters were 123 ± 21 µm (age 
30.7 ± 4.3 years) and 103 ± 16 µm (age 6.7 ± 1.9 years). This difference was 
statistically significant, despite there being no significant difference in choroidal 
thickness between the groups.  
 
1.7.1.2 Haller’s and Sattler’s layer thickness 
Although these measurement protocols include multiple vessels per eye, 
limitations associated with sampling selection (i.e. representation of the population 
within those structures sampled) are inherent. To minimise the effects caused by 
individual vessel quantification, several studies have used choroidal sublayer 
thicknesses to quantify the choroidal vasculature (Sim et al. 2013; Branchini et al. 
2013; Park and Oh 2014; Esmaeelpour 2014b; Adhi et al. 2015; Lu et al. 2016). This 
is based upon differentiation of the large and medium vessel populations, i.e. 
Haller’s layer and Sattler’s layer.   
The thickness of these two choroidal sublayers has been documented in 
healthy eyes. Park and Oh (2014) found the large vessel layer thickness to be 238.3 
± 55.9 µm and the medium vessel layer to be 88.5 ± 28.4 µm in adult eyes. These 
values are similar to the findings of Branchini et al. (2013), who measured layer 
thicknesses of 204.3 ± 65.9 µm and 52.9 ± 20.6 µm respectively. These digital 
calliper measurements were taken from three locations; subfoveal, and 750 µm 
nasally and temporally. This same manual measurement protocol was utilised to 
demonstrate significant thinning of both vascular layers in diabetic retinopathy and 
geographic atrophy (Adhi et al. 2013; Adhi et al. 2014). The control groups in these 
studies consisted of healthy eyes, with good agreement in vessel layer thicknesses 
to previous findings. However, these measurement protocols required manual 
calliper measurement at several pre-defined point locations in the image, again 
introducing sampling limitations. To further minimise this limitation, segmentation 
of the choroidal boundaries was used to obtain thickness measures averaged over a 
defined region, for example ETDRS subfields.  
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Sim et al. (2013) assessed the repeatability and reproducibility of a novel 
segmentation protocol to identify the large and medium vessel layers, in eyes with 
DR. Two observers manually segmented three boundaries; outer border of RPE, 
choroidoscleral junction, and the Haller-Sattler layer boundary (Figure 1.19). This 
intra-choroidal boundary was defined as the top of the hypo-intense areas of large 
vessel lumen (the Haller layer). The Sattler layer included the choriocapillaris, as 
this was deemed indistinguishable due to its small thickness. High reproducibility 
in choroidal thickness within a standard ETDRS grid was found, with a mean inter-
observer difference of 4.1 µm and 13.7 µm for the Haller and Sattler layers 
respectively. Intra-observer repeatability was also assessed, resulting in coefficients 
of repeatability (CoR) of 35.2 µm (29.6%) and 29.2 µm (26.0%) respectively. The 
authors concluded that the choroidal vascular sublayers can be quantified in eyes 
with DR, with good repeatability and reproducibility. A similar segmentation 
protocol was used to demonstrate a reduction in the area of Sattler’s layer (as a 
percentage of total choroidal area) in intermediate AMD (41.1%), when compared 
to early AMD and healthy controls (Lu et al. 2016). No significant difference was 
found between eyes with early AMD (47.6%) and healthy controls (47.2%).  
Esmaeelpour et al. (2014b) developed an automated algorithm to segment 
the Haller and Sattler layers in images acquired with a long-wavelength OCT, in eyes 
with and without dry AMD. Mean thickness of Haller’s layer and Sattler’s layer 
Figure 1.19 Example b-scan with manually segmented boundaries within the choroid. Black 
arrowheads (A) and yellow line (B) indicate the boundary between the Haller and Sattler 
layers. Black stars (A) denote areas with ambiguous boundary definition. Image adapted from 
Sim et al. (2013).  
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within a standard ETDRS grid were calculated. For healthy eyes, intra-session CoR 
(as a percentage of mean thickness) were 18% and 23% for Haller’s and Sattler’s 
layer respectively, whilst inter-session CoR were 19% and 26%. For the AMD group, 
intra-session CoR were 22% and 44% respectively, whilst inter-session CoR were 
21% and 34%. This is comparable to the repeatability of manual segmentation in 
diabetic eyes reported by Sim and colleagues (2013). Both vascular layers were 
found to be significantly thinner in intermediate AMD with nAMD fellow eye 
diagnosis, when compared to healthy eyes and to bilateral intermediate AMD 
(Esmaeelpour 2014a). There was no difference between the eyes with intermediate 
AMD and the nAMD fellow eye, although both layers were thinner in the nAMD eyes 
than the healthy group. Although this algorithm showed feasibility for automated 
segmentation of the choroidal sublayers, it is not currently available outside the 
institution in which it was developed.  
 
1.7.1.3 Thresholding and binarisation 
In OCT images, varying intensity is representative of reflectivity of the 
imaged structure. Structures with high reflectivity appear bright (e.g. pigment), 
whilst those with low reflectivity appear dark (e.g. fluid). In the choroid, the vessel 
lumen have low reflectivity and appear darker than the surrounding stromal tissue, 
which has higher reflectivity. This relative difference in intensity can be used to 
distinguish between the vessel lumen and stroma, within the choroidal structure. By 
defining a ‘cut-off’ intensity value, greyscale images may be converted to binary 
images, with pixels below this intensity threshold becoming black and pixels above 
the threshold becoming white. This technique is known as thresholding, and can be 
used to identify lumen and stroma within a choroidal image. From these binary 
images, the percentage lumen or stroma can be easily ascertained.  
Thresholding of OCT images has been applied in several investigations of 
choroidal structure in vivo (Branchini et al. 2013; Sonoda et al. 2015; Agrawal 
2016a; Kuroda et al. 2016). Two main methods of automated thresholding have 
been utilised; Otsu global thresholding and Niblack’s autolocal thresholding (Otsu 
1979; Niblack 1986). Otsu’s method determines a single threshold value applied to 
every pixel within the image, using an iterative method to minimise intra-class 
variance. Branchini et al. (2013) applied this method to OCT scans of healthy eyes 
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(n=42), to determine the ratio of choroidal stroma to vessel lumen. A ratio of 0.27 ± 
0.08 was found, suggesting a greater proportion of vessel lumen in the choroidal 
layer. This was conducted for a single averaged b-scan through the foveal pit, and 
therefore included vessels from all depths within the choroid. This was conducted 
on a conventional-wavelength OCT (Cirrus HD-OCT; Carl Zeiss Meditec, Inc., Dublin, 
CA), prior to the advent of EDI; the authors suggest that the use of long-wavelength 
OCT may be beneficial to this methodology. Otsu thresholding has since been 
applied to enface images (at a constant depth beneath the RPE; see Section 2.3.3) 
acquired with the Topcon DRI OCT Triton (Kuroda et al. 2016). These images were 
of healthy eyes (n=26) and eyes with CSC (n=40). Vascular area (defined as the 
percentage of vessel lumen in the binarised image) was found to be significantly 
higher in eyes with CSC, although the authors acknowledge that the protocol of 
threshold selection was gross, and should be improved to distinguish stroma from 
lumen.  
Niblack’s autolocal thresholding defines a threshold based upon mean and 
standard deviation pixel intensity within a predefined neighbourhood size. The 
threshold is therefore not consistent across the image. This method accounts for 
fluctuation in mean intensity across the image (i.e. regions of relative high or low 
intensity). This is particularly pertinent to the use of OCT images, as areas of low 
relative contrast may result from overlying media opacities or retinal features (e.g. 
CNV). Sonoda et al. (2014) outlined a protocol for thresholding OCT cross-sectional 
scans using a modified Niblack method. The luminal and stromal areas were 
automatically calculated for 20 healthy eyes and 15 eyes with active nAMD pre- and 
post- photodynamic therapy (PDT). A variation of this protocol has been verified on 
healthy eyes (Figure 1.20), and a parameter was developed to quantify the vascular 
status of the choroid, termed choroidal vascular index (CVI; Agrawal et al. 2016a). 
This was calculated by dividing luminal area by total choroidal area; on average, 
approximately 66% of the subfoveal choroid was found to be vascular in healthy 
eyes. This analysis has since been used to investigate the choroidal vasculature in 
several ocular diseases, including nAMD, CSC, VKH disease, panuveitis, and diabetes, 
with promising results (Wei et al. 2016; Agrawal 2016b; Agrawal 2016c; Agrawal et 
al. 2016d; Tan et al. 2016; Koh et al. 2017).  
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1.7.2 Automated segmentation 
The resolution of modern OCT systems allows visualisation of several intra-
retinal layers and individual choroidal vessels. The number of studies utilising OCT 
has created a demand for fast, automated methods of segmentation (boundary 
identification) and quantification of features. Retinal layer segmentation has a clear 
clinical use in gaining a quick insight into the health and integrity of the retinal 
layers, with many commercial OCT instruments now providing reliable and 
repeatable on-board segmentation software (Giani et al. 2010; Terry et al. 2016; 
Hanumunthadu et al. 2017). This information is often presented to the clinician as 
layer thickness maps, which are quickly generated, relatively easy to interpret, and 
can be compared to a database of healthy, age-matched individuals. However, 
segmentation of the well-defined retinal layers and the somewhat less-defined 
choroidal vessels and posterior choroidal boundaries are very different tasks, each 
presenting unique obstacles to overcome. The following section briefly outlines 
recent developments in automated layer segmentation software and choroidal 
vessel segmentation algorithms (for examples, see Figure 1.21).  
Figure 1.20 Niblack’s autolocal thresholding applied to a cross-sectional SD-OCT scan of a 
healthy eye. Luminal (dark) and stromal (bright) areas are identified (A). A central region of 
interest (1.5 mm in width) is identified (B). The binarised image is used to produce segmented 
vessels (C). Vessel segmentation overlay on original b-scan (D). Image adapted from Agrawal, 
Gupta, et al. (2016).  
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1.7.2.1 Choroid and intra-retinal layer segmentation 
Commercial OCT devices are supplied with on-board analysis software, 
which is usually capable of producing automated segmentation of the retina, and 
often a number of intra-retinal layers. The definition and number of layers varies 
greatly between devices, with some now even incorporating automated choroidal 
layer segmentation, for example the Topcon DRI OCT Triton (Figure 1.21B). The 
repeatability of this particular algorithm is assessed in Section 3.4. Although these 
algorithms are convenient for fast clinical review of acquired images, this on-board 
software is almost universally restricted to use on images acquired by the parent 
device, limiting its application in a research capacity.  
Beyond on-board OCT analysis software, there are a number of fully 
automated intra-retinal layer segmentation algorithms have been developed. These 
have mostly been developed at research institutions, and are device-independent 
(i.e. allow input of images from multiple OCT devices). This section outlines these 
segmentation algorithms, including their potential applications and limitations. 
Each algorithm is assessed against a list of criteria, including number of layers, 
availability of the software, and ongoing development; a summary can be seen in 
Table 1.3. The published accuracy and reproducibility of each algorithm is 
discussed, where this information is available.  
Figure 1.21 Examples of automated feature segmentation on OCT images. (A) Intra-retinal 
layer segmentation with the Iowa Reference Algorithms. (B) Choroidal layer segmentation 
with the DRI OCT Triton (Topcon) on-board analysis software. (C) Choroidal vessel 
segmentation; image from Kajić et al. (2013). Images in A and B acquired by L. Terry during 
conduct of this study.  
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Table 1.3 Comparison of intra-retinal layer segmentation algorithms.  
Algorithm/ 
software 
Number of intra-
retinal layers 
Choroidal 
segmentation? 
Free to 
use?  
Continued 
development? 
Iowa Reference 
Algorithms 
11 Yes Yes Yes 
DOCTRAP 7 No Unknown Yes 
Orion 7 No No  Yes 
OCTSEG 6 No Yes No 
 
Iowa Reference Algorithms 
 The Iowa Reference Algorithms (Retinal Image Analysis Lab, Iowa Institute 
for Biomedical Imaging, Iowa City, IA) contains OCT Explorer for viewing and 
annotating images, and OCT Segmenter which is capable of segmenting 11 retinal 
layers and 2 choroidal layers in 3-D macula OCT images (Abràmoff et al. 2010; Zhang 
et al. 2015; Sonka and Abràmoff 2016; Figure 1.21A). It can import images exported 
from several commercial OCT devices, as well as standard image formats including 
‘.tif’ and ‘.jpg’. These algorithms are based on graph-theory and contextual 
information from neighbouring b-scans, and are documented in detail by Abràmoff 
et al. (2010). They were adapted for SD-OCT by Garvin et al. (2009) from an 
algorithm by Li et al. (2006), originally designed for TD-OCT.  
Garvin and colleagues (2009) validated the intra-retinal layer segmentation 
using images from 24 healthy eyes, manually segmented by two experienced 
ophthalmologists as a reference standard. A software boundary positioning error of 
5.69 ± 2.41 µm was found, which was very comparable to the inter-observer 
variability of 5.71 ± 1.98 µm. Philip et al. (2016) validated the choroidal 
segmentation on healthy eyes (n=18), demonstrating good agreement between SD-
OCT and SS-OCT, with automated and manual boundary placement. At the time of 
writing, these algorithms are still undergoing further development, and support is 
available from the developers (https://www.iibi.uiowa.edu/content/iowa-
reference-algorithms-human-and-murine-oct-retinal-layer-analysis-and-display; 
accessed 11th January 2017).   
DOCTRAP 
 An alternative segmentation algorithm is the Duke Optical Coherence 
Tomography Retinal Analysis Program (DOCTRAP; Duke University, Durham, NC). 
This algorithm is also based on graph theory, and is capable of segmenting 7 layers 
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in normal eyes, as accurately as expert graders (Chiu et al. 2010). The software has 
been shown to produce automated thickness values with good agreement with the 
on-board segmentation of Spectralis and Cirrus HD-OCT in DME (Lee et al. 2013a; 
Willoughby et al. 2017). It has also been shown to accurately and reproducibly 
segment retinal boundaries in images containing drusen and GA, producing 
potentially useful metrics representing RPE changes in AMD (Chiu et al. 2012). 
Srinivasan et al. (2014a) applied this software to OCT images of mice retinae with 
and without pathology, and found the software to accurately segment retinal layer 
boundaries when compared to manual segmentation. The DOCTRAP software 
package also has the facility for manual segmentation, although it is not widely 
available outside the institution in which it was developed 
(https://olv.duke.edu/tech/3383; accessed 11th January 2017).  
Orion 
 Orion is a device-independent 7 layer segmentation software package 
produced by California-based company Voxeleron. This automated algorithm has 
been shown to have good agreement with manual segmentation by experts, and has 
excellent repeatability across all reported layers (Oakley et al. 2014). To date, the 
majority of studies utilising this algorithm aimed to investigate retinal changes in 
optic neuritis and multiple sclerosis, rather than retinal pathology (Saidha et al. 
2011; Syc et al. 2012). This software was released commercially in 2014, and is 
undergoing further development (http://www.voxeleron.com/orion; accessed 11th 
January 2017).  
OCTSEG 
 The Optical Coherence Tomography Segmentation and Evaluation GUI 
(OCTSEG) is a MATLAB-based retinal layer segmentation algorithm under 
development at The Pattern Recognition Laboratory (University of Erlangen-
Nuremberg, Germany). The output from this software has been shown to be 
comparable to manual segmentation results on normal and glaucomatous eyes 
(Mayer et al. 2010). However, the focus of the currently published work is on 
glaucoma and the ONH, and only the retinal nerve fibre layer (RNFL) is discussed in 
any detail. This suggests that the algorithm may not be optimised for application to 
macular scans. Development on this algorithm has now ceased, and no technical 
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support is available (https://www5.cs.fau.de/research/software/octseg; accessed 
11th January 2017).  
 To conclude, each of these algorithms has limitations, and are likely 
optimised for differing applications, dependent on which structure or layer is 
intended for assessment. It is important to note that none of these algorithms are 
approved for clinical use, and are currently intended for research use only. Of these 
algorithms, the Iowa Reference Algorithms is capable of segmenting the most intra-
retinal layers, and is the only one to include automated choroidal segmentation. 
Lastly, it is freely available for download and use, and support from the developers 
is available. Further detail on this software, as well as an evaluation of repeatability 
and agreement with on-board segmentation of two commercial OCT systems 
(Topcon 3D-OCT 1000 and Zeiss Cirrus HD-OCT), can be found in Section 3.1 (and 
Terry et al. 2016; Appendix G).   
 
1.7.2.2 Choroidal vessel segmentation 
Until recently, limitations in commercial OCT technology have restricted 
analysis of the choroid to calliper measurement or manual segmentation. 
Advancements such as long-wavelength light sources and EDI have been 
accompanied by a limited number of publications describing algorithms to allow 
automated choroidal vessel segmentation (Zhang et al. 2012; Duan et al. 2013; Kajić 
et al. 2013). These have used a variety of techniques to differentiate the vessel lumen 
from surrounding stromal tissue.  
Zhang et al. (2012) modelled choroidal vessels as 3-D tube-like objects to aid 
vessel detection, and segmented vessels by thresholding voxels (3-D pixels) 
obtained by the vessel detection algorithm. The authors showed this automated 
method to have high reproducibility, but the sample size was relatively low (n=24), 
and restricted to healthy individuals. Furthermore, only around half of the repeat 
scans (24 of 43) were of sufficient image quality to warrant further analysis. For 
clinical application of this technique, further optimisation would be required. This 
study was conducted using a Cirrus HD-OCT, although the authors suggested that 
the use of a long-wavelength OCT may result in a larger percentage of images 
providing useful measurements.  
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Duan et al. (2013) produced enface images at a constant depth beneath the 
RPE, and applied algorithms to filter noise and threshold. This was combined with 
segmentation of overlying retinal vessels to remove resulting shadows from the 
binarised image, before vessel diameter and thickness analyses were conducted. 
This methodology was found to not be reliable for the choriocapillaris, and 
processing times were fairly extensive (~20 minutes per volume scan), limiting 
their application to large datasets. Furthermore, the images used in this study were 
of a small number of healthy eyes (n=8) and there is no published data on its 
performance in eyes with pathology.  
 Kajić et al. (2013) developed a fully automated vessel segmentation 
algorithm using 3-D edge filtering and projection of probability cones to determine 
the likely position of a vessel core (Figure 1.21C). Images from a non-commercial 
long-wavelength OCT were used, and the authors claimed that the algorithm could 
produce results even in tomograms with a low SNR. The applied processing took 5-
10 minutes per volume scan on an average desktop machine (2 GHz, 8 GB RAM), and 
the algorithm was tested successfully on both healthy eyes (n=45), and eyes with 
dry AMD (n=10; Esmaeelpour et al. 2014b). The authors cautioned that since the 
technique was developed using images from a non-commercial OCT, it would be 
expected that the algorithms would require adapting for optimised performance on 
commercial OCT devices.  
 In summary, each of these approaches to choroidal analysis appear to have 
different strategies of segmenting and assessing choroidal vasculature, with 
associated limitations. At present, none of these algorithms are at a stage of 
development to be released outside the institutions in which they were produced, 
or to be applied clinically. These algorithms are therefore not utilised in this thesis. 
However, a custom thresholding protocol of enface choroidal images is evaluated in 
Section 3.2. The development of OCTA has led to a migration in research interest for 
many groups investigating choroidal vasculature from conventional OCT to OCTA 
(see Section 1.5.3.3). However, analysis of these images is typically qualitative at this 
stage, as quantitative analysis is limited (Koustenis et al. 2016).  
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1.7.3 Machine learning  
Machine learning is the study and construction of algorithms that are capable 
of learning from and making predictions on data. Training data is used to form the 
basis of the algorithm, providing features from which predictions are based when 
novel data is encountered. This technique is ideal for big data, where designing and 
programming explicit algorithms for each given task is unfeasible. There are many 
established methods of feature extraction, algorithm training, and validation; a 
detailed description and evaluation of these can be found in Chapter 5.  
All of the image analysis methods described in Sections 1.7.1 and 1.7.2 are 
limited by visualisation of the choroid in OCT images. This can largely be attributed 
to limited SNR and the relatively low contrast of the choroidal vessels caused by 
signal roll-off (although averaging could ameliorate this to some extent). In similar 
cases, machine learning approaches have been utilised, to identify more complex 
textural features within a region of poor contrast (Wernick et al. 2010; Alpaydin 
2014; de Bruijne 2016). The simplest way to assess the viability of such a method is 
to determine whether texture changes are detectable with advancing disease. This 
approach is based on mathematically extracting shape and orientation information 
from images, which reflect the underlying physiological structure.  
Clinical classifications are established for AMD (see Section 1.4.7), and can be 
used to establish the ‘true’ classification of data, upon which to train the learning 
algorithms. This is known as the ground truth, and is used for testing the accuracy 
of the algorithms. Successful classification of novel images into disease groups 
(based on severity or subtype) indicates that differences are detectable in the 
structure between groups or with advancing disease, and that automated 
classification is feasible using machine learning algorithms. To the author’s 
knowledge and at the time of writing, no automated techniques have been 
developed to classify images by AMD disease severity, based on choroidal 
appearance (keyword searches for “machine learning” AND “choroid” on PubMed, 
Web of Science, and Scopus; 28th April 2017). Therefore, studies described in this 
section fall into two categories; applying machine learning techniques to the 
detection of AMD from OCT images, and to the classification of AMD from retinal 
photographs. See Chapter 5 for more detail on the techniques described here.  
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1.7.3.1 AMD detection from OCT images 
 Only one study has applied machine learning principles to automated 
classification of OCT images based solely on choroidal appearance (Koprowski et al. 
2013). A retrospective analysis of 1000 OCT images was conducted. Morphological 
and texture features were extracted from the choroidal region, and were used to 
build a classifier using ‘decision trees’ from 600 of the images. The remaining 400 
were used for validation and testing. The random forest classifier (RFS) uses a series 
of weak (only slightly better than chance) binary decision trees; a majority decision 
from multiple trees is utilised for the final classification (Breiman 2001). The 
features were based upon number of ‘objects’ in the image, average position of the 
centre of gravity in the x- and y-axis, and standard deviation of the mean brightness 
of pixels within the objects. Ophthalmological diagnosis into one of three groups was 
used as the ground truth, to assess accuracy of the classifier. The three groups used 
were nAMD or DME, ischemia of the inner retinal layers, and scarring fibrovascular 
tissue. Classification accuracy was 73%, 83% and 69% respectively. In this study, 
the choroid layer was defined as all portions of the image posterior to the RPE, which 
included the sclera. Furthermore, since this was a retrospective analysis, the images 
were not optimised for choroidal visualisation during acquisition. Crucially, the 
feature classification was, at least in part, dependent on differences in choroidal 
appearance caused by overlying retinal features, rather than solely changes to the 
choroidal morphology. For instance, the authors comment that the neovascular 
group displayed characteristic shadows in the choroid caused by retinal changes, 
and a global reduction in brightness was evident in the ischaemic group. From this, 
no conclusion could be drawn with regard to differences in the choroidal 
vasculature between disease groups.  
 Srinivasan (2014b) extracted features from 45 OCT images, using multiscale 
Histograms of Oriented Gradient (HOG) descriptors. This essentially describes the 
shape of objects by assessing the strength and orientation of the spatial gradients in 
the image (Dalal and Triggs 2005). These features were used to train a support 
vector machine (SVM)-based classifier to identify images into one of three groups; 
normal, dry AMD, or DME. SVM is based on the theoretical mapping of features in 
space and determination of the optimal plane to best separate the data into classes 
based upon these features (Cortes and Vapnik 1995; Kim et al. 2002). Classification 
accuracies of 86.7%, 100% and 100% were achieved for the normal, dry AMD, and 
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DME groups respectively. Srinivasan and colleagues describe the insufficiency of a 
single b-scan for diagnosing retinal diseases, hence volume scans were utilised for 
this study. Within a single volume scan, a representation of 33% b-scans of a single 
disease state was found experimentally to be the optimum cut-off for detection rate 
(i.e. if a third or more of the b-scans were classified as AMD, a final classification of 
AMD was given for that eye). Prior to feature extraction, images were cropped 
axially to 40 pixels above and 5 below the mean lower boundary of the retina. This 
excluded the majority of the choroid from this analysis.  
 Albarrak et al. (2016) also utilised HOG descriptors for automated detection 
of AMD from OCT volume scans. This feature detection methodology avoids 
segmentation-based methods which rely on high contrast features and are generally 
time consuming. Similarly to the work of Srinivasan and colleagues, SVM classifiers 
were trained for automated classification, although this time there were only 2 
groups; AMD (n=72) and normal (n=68). Parameters relating to feature extraction 
refinement were experimentally optimised, achieving a classification performance 
ranging from 86% to 100%. The Area Under the Receiver Operator Characteristic 
Curve (AUC) was used to assess performance in this study. This method of assessing 
performance is independent of the decision threshold chosen, and demonstrates 
increased sensitivity in ANOVA tests (Bradley 1997). Unlike the other methods 
discussed in this section, Albarrak and colleagues utilised 3-D feature extraction, 
rather than considering 2-D b-scans individually. However, due to the requirement 
of non-excessive computation time, parameters were constrained to a relatively 
small range.  
Artificial neural networks are a commonly used approach to computational 
classification, modelled on biological neural networks, such as those behind image 
recognition in the human brain (Lippmann 1987; Specht 1990). This is a ‘deep 
learning’ technique, and features are self-learnt by the classifier through a series of 
feed-back and feed-forward loops. This negates the need for ‘hand-crafted’ features 
such as the HOG descriptors described previously, which can introduce an element 
of bias. However, very large datasets are typically required to train a classifier with 
high accuracy (Krizhevsky et al. 2012). The largest study to date to apply these 
techniques to classification of OCT images is Lee et al. (2017). Convolutional neural 
networks (CNN) were used to automatically classify normal (n=1259) versus AMD 
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(n=347) based on retinal appearance, achieving a sensitivity of 88.6% and 
specificity of 87.8%. Apostolopoulos et al. (2016) applied CNN to a smaller dataset; 
n=269 intermediate AMD, and n=115 without AMD. Their ‘RetiNet C’ algorithm 
achieved an AUC of 99.7%. From these studies, CNN appears to be a promising 
technique for automated screening and computer-aided diagnosis of AMD using 
volumetric OCT images.  
 
1.7.3.2 AMD classification from retinal photographs 
 Machine learning techniques have also been applied to automated detection 
and classification of AMD from retinal photographs. Parvathi and Devi (2007) 
optimised algorithms for drusen detection, using log-Gabor filters for feature 
extraction. This is an established texture-based technique, using a series of linear 
filters of varying frequency and orientation to localise and extract information (Jain 
and Farrokhnia 1990).  
 Kankanahalli et al. (2013) advanced from disease detection, and evaluated 
automated classification by AMD severity. A subset of 600 subjects from the AREDS 
study were selected for analysis (divided equally between nAMD, GA, and control 
patients). Visually salient features (relatively prominent textural features) were 
extracted from retinal photographs, and used to train random forest classifiers for 
4 different severity classes; AREDS categories 1-4 (AREDS 2001a). For a 3-class 
severity problem (i.e. combining categories 1 and 2), an accuracy of 91.8% was 
achieved. Priya and Aruna (2011) also attempted to classify images into disease 
groups, although this time by type of disease rather than severity. A Kirsch operator 
(another method of edge detection) was used to extract features, predominantly 
describing blood vessels visible in the retinal photographs. These were used to train 
a probabilistic neural network to classify into 3 groups; normal, dry AMD, and wet 
AMD. This method achieved sensitivity of 94% and specificity of 95%. However, 
these were coarse groups with distinct differences in retinal appearance, so a high 
classification accuracy was to be expected.  
 In summary, machine learning techniques have been applied to detection of 
AMD from OCT images, as well as disease severity classification from retinal 
photographs. The results show potential for automated disease detection using a 
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variety of feature extraction techniques (e.g. Gabor filters, HOG descriptors) and 
classifier training methodologies (e.g. random forest, SVM, and neural networks). 
Since the choroid is known to be implicated in the pathogenesis of AMD, but 
methods of quantifying the vasculature have significant limitations (see Section 
1.7.1), machine learning should be explored as an alternative approach to analysis. 
To date, no algorithms have been optimised for automated classification of AMD by 
disease severity (early- and late-stage AMD) based upon textural appearance of the 
choroid.  
 
1.8 Project overview and aims 
It is clear from the literature that structural changes to the choroid have been 
identified in AMD, although these are not typically detectable in the early disease 
stage. However, the hypoxia theory of AMD suggests that changes to the choroid are 
linked to signs of early disease, such as drusen development (Feigl 2007). A number 
of factors make detecting these changes difficult in vivo. Firstly, choroidal thickness 
is the most common parameter used to quantify the structure. The normal variation 
in this parameter is large, and differences in mean thickness between disease groups 
would therefore need to be large to reach statistical significance. Furthermore, 
relatively small changes in early disease may be masked by other factors shown to 
cause fluctuations in choroidal thickness, difficult to control for in experimental 
study design (e.g. smoking and cardiovascular associations such as hypertension).  
Other parameters have therefore been explored to describe the vessels 
themselves, such as vessel diameter and choroidal vascularity index. Although 
imaging technology now allows for optimised visualisation of the choroid, inherent 
image noise and signal lost to the overlying structure continue to limit the ability to 
differentiate vessel lumen from surrounding tissue. The main aim of this thesis was 
therefore to determine whether structural changes to the choroidal vasculature in 
AMD are detectable using long-wavelength OCT imaging, and whether they have any 
potential clinical value in detecting or monitoring AMD. This was addressed by 
evaluating methods for vessel quantification, adapted from previously described 
protocols (Sohrab et al. 2012; Bittencourt et al. 2014; Sonoda et al. 2014). This 
included assessment of the repeatability of vascular parameters.  
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Since the majority of these analysis techniques require input from an 
observer, they are often time consuming, limiting their clinical application. Machine 
learning algorithms have been shown to be capable of automated classification of 
medical images (Wernick et al. 2010). Once classifiers have been developed using a 
training set of images, no further subjective input is required to establish a 
classification of a previously unseen image. This makes machine learning algorithms 
ideal for integration into clinical image analysis software. As an example, on-board 
OCT image analysis software could be made capable of producing a likely disease 
diagnosis from a newly acquired image, providing a fast and accurate tentative 
diagnosis for triaging busy hospital clinics. This could ensure that clinical 
assessment and treatment be delivered to those requiring most urgent care and 
minimise false positive referrals into secondary care.  
As a step towards this ultimate aim, the feasibility of these techniques for 
classifying choroidal OCT images by AMD disease severity was evaluated. Following 
classifier training, features with the strongest relationship with disease stage (i.e. 
contributing to classification) were extracted to provide information on how the 
vasculature differs between disease states. For example, different spatial 
frequencies may peak in each disease stage, which could be linked to changes in 
vessel diameter or density. Relating the features to vascular parameters may further 
our understanding of vascular changes in AMD, and the role of the choroid in the 
pathogenesis of the condition.  
The main aim of this thesis is to determine whether structural changes to the 
choroidal vasculature in AMD are detectable using in vivo OCT imaging.  
To achieve this, three supplementary aims are as follows:  
1) To optimise protocols for image acquisition and processing for enhanced 
visualisation of the choroidal vasculature.  
2) To evaluate parameters describing the choroidal vasculature, including 
assessment of inter-session repeatability.  
3) To explore the feasibility of applying machine learning techniques to 
automated classification of AMD by disease severity, based on choroidal 
appearance.  
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2 Development of image acquisition and processing protocols 
 
Advances in OCT imaging and analysis techniques, particularly the advent of 
long-wavelength OCT, have facilitated reliable imaging of the choroid in vivo. 
However, given the novelty of choroidal OCT imaging, definitive imaging protocols 
and analysis methods have not yet been established. The best approach to these 
tasks is not evident from the literature, with published approaches typically tailored 
to the immediate aims of each study. This chapter discusses the development of 
imaging and analysis protocols utilised in the studies in this thesis. An overview of 
the imaging system and techniques used in this thesis is provided, followed by the 
image processing steps undertaken following acquisition. The results of two pilot 
studies are then presented, which were used to inform protocol design for further 
data collection.  
 
2.1 Long-wavelength (1040 nm) OCT system 
The investigations presented in this thesis have utilised a non-commercial 
long-wavelength (1040 nm) SD-OCT to produce 3-D images of the posterior pole. 
This system was selected to benefit from the long-wavelength light source, which 
can penetrate deeper into the retinal structures (including the highly pigmented 
RPE). This provides improved visualisation of the choroid and choroid-scleral 
junction, in comparison with conventional systems. Furthermore, penetration 
through media opacities such as cataracts is improved (Povazay et al. 2007), which 
are prevalent in the elderly target population. This wavelength also has the benefit 
of being outside the visible spectrum, preventing the common observer response of 
tracking the scanning line during image acquisition. See Section 1.6 for more detail 
on long-wavelength OCT and imaging the choroid. An overview of the specifications 
of this system are shown in Table 2.1.  
This OCT system also allows the scanning parameters to be freely adjusted, 
including scan width, number of a-scans per b-scan, spacing of b-scans, number of 
b-scans per volume, and horizontally- or vertically-oriented raster scanning. This is 
in contrast to most commercial devices, which restrict image acquisition to pre-set 
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parameters with only limited customisability, likely to maximise compatibility with 
the on-board software analysis. This customisability allows for acquisition of a 
range of image types, from small, very highly sampled images to wide scanning 
areas, covering more retina than the majority of commercial OCT systems. 
Additionally, an 800 × 600 pixel LCD micro-display is used to present a fixation 
target, which can be customised for each patient. For example, a large cross or 
peripheral fixation target can be used for a patient with a central scotoma.  
Table 2.1 Specifications of the long-wavelength OCT system utilised in this thesis. 
Central wavelength (λc) ~1040 nm 
Imaging rate 47,000 a-scans/sec 
Axial resolution  ~5 µm in tissue (RI=1.4) 
Lateral resolution (theoretical) ~6 µm 
Refractive error range Up to ± 6.00 dioptres 
 
 Whilst this non-commercial device provides a number of distinct advantages, 
the limitations must also be considered. Firstly, the graphical user interface (GUI) 
for image capture is not designed for commercial use and consequently is not easily 
accessible to inexperienced users. The system requires considerable training to be 
used effectively. The focus of the instrument must be manually adjusted, and is 
calculated from the patient’s biometry and refractive error. Manual alignment of the 
eye with the imaging system is based solely on the live OCT image, whereas 
alignment on commercial devices is usually supplemented by a live infrared image, 
making the process easier for the operator. The image capture software has an 
enface OCT facility enabling visualisation of an image following acquisition, to 
ensure the absence of gross eye movements and blinks, providing an opportunity to 
repeat an image if necessary. There is no capacity for instant review or analysis of 
images, as is commonly incorporated in commercial devices. Images must be 
exported and manually processed prior to analysis, and subsequent analysis such as 
thickness maps must be produced by other means, which can be time consuming. 
This is extremely limited in comparison to most on-board commercial review 
software that enable near-instant review and analysis.  
 Eye tracking systems are becoming increasingly common in newer 
commercial systems (e.g. Cirrus HD-OCT). These track the location of the eye, and 
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attempt to correct for small eye movements. They may pause a scan during blinks 
or gross eye movements, and resume once fixation has been re-established. This is 
particularly valuable for patients with poor fixation or a high blink rate, and can 
minimise patient discomfort caused by refraining from blinking for a period of time. 
However, this facility was not incorporated in this OCT device. Other limitations of 
this non-commercial system include higher rates of instrument down-time to allow 
for repairs and alterations, and a restricted availability of such devices. Although a 
commercial long-wavelength instrument became available during the course of this 
work (Topcon DRI OCT Triton), to date there are only a handful of these devices in 
clinical use in the UK. This is likely due to the current cost of this device, which 
exceeds that of its conventional OCT counterparts, due in part to the addition of 
swept-source technology.  
At the outset of this project, the light source of the non-commercial device 
had been in use for approximately 5 years, and in this time had lost ~25% of its 
power. A noticeable reduction in image quality over this period was observed, due 
to restricted imaging penetration depth of the system. To address this issue, a new 
‘identical’ light source was installed, following completion of the repeatability study 
(Chapter 3) but prior to commencement of data collection from patients with AMD 
(Chapter 4 onward).  
The 1040 nm OCT is able to acquire a volumetric scan in ~5 seconds; a 
duration widely considered clinically acceptable. During this time, the patient is 
required to fixate a target and avoid eye movements and blinking. A longer 
acquisition time would allow for either image averaging or higher scan density, 
improving image quality and/or SNR. However, since dry eye is particularly 
prevalent in the elderly population, increasing the acquisition time is an unrealistic 
approach. Experience suggests the standard acquisition time of 5 seconds may 
potentially be challenging for patients with a reduced tear break-up time, although 
artificial tears can be used to reduce discomfort during image acquisition.   
 
2.2 Scan parameters 
An advantage of the 1040 nm non-commercial system is the ability to control 
the scanning parameters (e.g. scan angle). In comparison, the majority of 
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commercial OCT devices are limited to a small range of pre-set scan parameters, the 
most common being 6 × 6 mm, or 20° × 20° (512 × 128 pixels) as found on Topcon 
and Zeiss instruments respectively. Unless otherwise stated, all studies in this thesis 
utilise 20° × 20° isometric scans, consisting of 512 a-scans per b-scan, and 512 b-
scans per volume. This provided equal spatial sampling in the X and Z planes (Figure 
2.1). To allow comparison between devices, averaging in the Z-plane was used to 
produce equivalent volumes (512 ×  128 pixels) where appropriate. However, 
images of this size were under-sampled, limiting image resolution. This is discussed 
further in Section 2.4.2.  
In addition, an averaged line scan through the fovea was collected to provide 
an image with a high SNR. This was 36° (4096 a-scans) in width to encompass 
visualisation of the ONH, and was an average of 16 b-scans of the same region. The 
volume scans would ideally also undergo averaging to a similar extent, however this 
would require increased acquisition time or loss of sampling, and suffer from the 
challenges associated with 3-D image registration (Markelj et al. 2012; Lee et al. 
2015). Since instant review of images was not possible, multiple images of each type 
were collected from each individual, to ensure high image quality. Table 2.2 outlines 
the parameters of the standard images collected as part of this thesis. Some 
parameters required optimisation to address the aims of the studies in this thesis; 
these preliminary studies are presented in Section 2.5. 
 
Y 
X 
Z 
Figure 2.1 Series of consecutive b-scans within a 20° × 20 (512 × 512) macular volume scan.  
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Table 2.2 Scan parameters used in this thesis for the 1040 nm OCT device. Parameters 
requiring further investigation with preliminary studies are indicated in the final column.  
Parameter Volume scan Line scan Further investigation required? 
Scan size 20° × 20° 36° Yes – volume scans under-sampled 
Scan dimensions 
(pixels) 
512x512x1024 4096x1024 No – consistent with literature 
Repeat images  3 3 No – sufficient to exclude outliers 
Wavelength 1040 nm 1040 nm No – extensive literature 
Power output <2.5 mW <2.5 mW Yes – ensure safety and quality 
 
Although the scan sizes described above are generally accepted as the clinical 
norm for retinal imaging, choroidal imaging is a relatively new field and few 
established imaging protocols have been developed. A pilot study in Section 2.5 
describes the development of a protocol for maximising choroidal visualisation with 
long-wavelength OCT imaging. However, it is first necessary to consider the post-
processing steps and measurement techniques to be applied to the acquired images.  
 
2.3 Post-processing  
Following acquisition, all long-wavelength OCT images were saved as 
proprietary (spectral) data files (.FD1) and required pre-processing before viewing 
and/or analysis. The following describes the processing steps applied to all images 
obtained using the long-wavelength OCT in this thesis (Figure 2.2), and image 
scaling considerations made during the analysis process.  
 
2.3.1 Conversion from spectral data to image data 
All long-wavelength OCT images were converted from spectral data (.FD1) to 
image data (.TIF). This was performed using customised software written in 
MATLAB (The MathWorks, Inc., Natick, MA). During this process, images underwent 
dispersion correction. The purpose of this correction was to address a mismatch 
between the two arms of the interferometer within the OCT system. Since different 
wavelengths of light travel at different speeds through a material, the light is 
dispersed (in time rather than in space) when it returns to the photodetector. To 
correct for this, a rectangular region of interest (ROI) was manually selected, ideally 
through a high-contrast section of retina and choroid. From this region, a factor to 
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correct the dispersion was calculated and applied across the entire image stack. A 
high-specification computer (Intel Core i7-4790 CPU at 3.6 GHz, with 16 GB RAM) 
was used to minimise processing time (approximately 5 minutes per 512 × 512 
volume scan).  
Figure 2.2 Series of image pre-processing steps (white rectangles) that all scans acquired with 
the 1040 nm OCT device underwent. Blue rhombi represent image types; green rhombi 
represent outcome measure categories, and the section in which they are investigated is 
specified.  
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2.3.2 Image preparation and artefact correction 
Although images were optimised during the acquisition process, inevitably 
artefacts and noise were inherent. Artefacts were commonly a result of poor fixation 
or ocular motion during acquisition, or due to the optics of the eye and the 
instrument itself (e.g. low levels of stray light within the imaging system). The effects 
of such artefacts may be minimised using post-processing techniques. The following 
processes were carried out sequentially to all long-wavelength OCT images using 
the Java-based image processing package Fiji, an open source distribution of ImageJ 
(Rasband; National Institute of Health, USA; Schindelin et al. 2012).  
 
2.3.2.1 Transform and crop  
Images were collected using a technique similar to EDI (see Section 1.6), 
positioning the choroid close to the zero delay line during acquisition. This 
optimised visualisation of the choroidal vessels, however images appeared inverted 
(choroid at the top of the image and retina below). Images underwent vertical 
transformation (inverting to place the retina above the choroid) for consistency 
with the format familiar to users of commercial OCT devices, and to allow for image 
input into automated retinal layer segmentation software (see Section 3.1).  
Vertical cropping of images was used prior to stack registration, to remove 
reflection artefacts likely due to stray light within the imaging system. This had the 
added benefit of reducing file size, by removing portions of the image containing 
structures irrelevant to the analysis (i.e. excess vitreous and post-choroid). This 
reduced processing times for subsequent steps described here.  
 
2.3.2.2 Stack registration  
Due to the raster-scanning pattern used during acquisition of the volume 
scans, small involuntary eye movements resulted in misalignments between 
adjacent b-scans within the volume. Stack registration was therefore used to align 
all b-scans according to a ‘global anchor’ (Figure 2.3). The StackReg plugin 
(Thévenaz et al. 1998) allowed the user to define the global anchor slice; for these 
images, the b-scan corresponding to the centre of the foveal pit was used as the 
global anchor. The algorithm used common features between adjacent b-scans to 
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register all slices within the volume to the selected slice. This registration was 
essential for viewing enface images and prior to averaging of adjacent b-scans.  
Artefacts in the image as described above could provide strong features for 
alignment by the algorithm. This would lead to inappropriate registration, as these 
artefacts may not be present in the exact same location in each b-scan. To overcome 
this, these artefacts were removed prior to stack registration, using cropping. 
Translational transforms (images moved only in the X and Y plane) were used for 
these images, to prevent magnification or rotation of the b-scans, as would occur in 
alternative forms of transformation, such as scaled rotation.  
  
2.3.3 Noise reduction and image enhancement  
The preceding steps were applied to all images acquired with the 1040 nm 
OCT (both volume and line scans), to produce images in TIFF format for further 
analysis. The following describes processing steps applied to reduce noise, or 
enhance certain features within the image. The processing steps applied were 
selected to optimise the image with respect to the desired outcome measure, and 
were therefore dependent on the particular feature(s) to be assessed (Figure 2.2).  
 
 
Figure 2.3 Macular volume scan without stack registration (A) and with stack registration (B). 
Note the misalignment of b-scans in the Z-direction pre-registration, and the artefacts at the 
top and bottom of the image post-registration, caused by vertical translation to align each b-
scan.  
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2.3.3.1 Z-projection and image scaling  
Z-projection was utilised to average adjacent b-scans within a volume scan, 
reducing noise to enhance visualisation of the choroidal layer and vessel boundaries 
(Figure 2.4). This produced 2-D representations of the volume, which were used for 
manual calliper measurement of choroidal thickness or vessel size. Typically, 5 
adjacent b-scans centred on the foveal pit were included in this averaging, equating 
to a total separation between b-scans of ~50 μm. This minimised noise whilst 
maximising spatial resolution; averaging over a greater number of b-scans (i.e. a 
higher total separation between slices) resulted in a decrease in boundary definition 
due to varying location of the boundary in image space.  
There were several potential projection types, including the use of a 
maximum, minimum, or median intensity, or summing the intensities across 
adjacent b-scans. Speckle (a type of high frequency noise) is inherent in OCT images, 
causing corresponding pixels in consecutive slices to vary in intensity (these may be 
higher or lower than the average intensity). If minimum, maximum, or sum of pixel 
intensities were applied, each pixel was considered in the averaging process, 
regardless of its representative value. To prevent inclusion of erroneous pixel 
intensities, the median intensity was used. The limitation of Z-projection was the 
loss of spatial localisation, since adjacent b-scans were not of the exact same retinal 
location.  
Z-projection was also used for the line scans, to produce high quality line 
scans through the foveal pit by averaging several b-scans. This was equivalent to 
A B 
Figure 2.4 Single b-scan through the foveal pit (A), taken from a 20° × 20° (512 × 512) volume. 
Following z-projection of 5 consecutive b-scans (B), much of the high-frequency noise has been 
removed and the retinal and choroidal structures are more easily distinguished.  
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highly averaged line scan processing on the majority of commercial OCT devices. 
The number of averaged b-scans varies between commercial devices; those with a 
faster acquisition rate and retinal tracking (to compensate for small eye 
movements) generally average a larger number of b-scans (up to 100). Since the 
non-commercial device used in this thesis did not have retinal tracking, any 
misaligned slices following stack registration were manually identified and 
excluded prior to averaging of line scans.  
Image scaling was also used to make the 1040 nm OCT volume scans (512 × 
512) comparable in size to commercial equivalents (typically 512 × 128; Section 
3.1). This involved decreasing the number of slices in the image, by averaging every 
4 slices (i.e. Z=0.25 scaling using averaged down-sampling). This technique used the 
neighbourhood of known pixel values surrounding the unknown pixel to calculate 
an interpolated value for the pixel in question.  
 
2.3.3.2 Reslice and flatten 
Stack reslice was used to construct orthogonal slices through an image, 
generating a ‘side-view’ of adjacent b-scans. This was used to produce enface images 
from the acquired volume scans. This allowed visualisation of choroidal cross-
sections of a fixed depth below the retina, from a perspective akin to retinal 
photography. Stack registration was crucial prior to this step, to ensure alignment 
of adjacent b-scans within the volume.  
Despite this process, the images often retained a residual curve due to the 
optics of the visual system. Producing an enface image from this would be of 
inconsistent depth in the choroid (Figure 2.5). To overcome this, a custom program 
written in MATLAB was used to ‘flatten’ the b-scans prior to stack reslice (see 
Appendix B). Several points lying on the RPE-choroid boundary were manually 
identified on 5 predetermined b-scans throughout the stack. This boundary was 
selected as it was well-defined and easy to identify in the images (unlike the 
posterior choroidal boundary), and was consistent in shape across the foveal pit 
(unlike the inner retinal layers). The program interpolated between the identified 
points on each b-scan to produce semi-automated segmentation of the anterior 
choroidal boundary. This was then interpolated between slices to produce a 
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boundary for each b-scan in the stack. Vertical translation of pixel columns (a-scans) 
was automatically applied to align the segmented boundaries to a flat plane. Again, 
scaled rotation was not used, to prevent the introduction of transverse scaling 
errors.  
 
2.3.3.3 Noise reduction  
Applying a mean or median filter replaces each pixel with the mean or 
median value of its neighbours, including itself. This has the effect of eliminating 
pixel values which are unrepresentative of their surroundings i.e. noise reduction. A 
convolution filter is based on a kernel system, which describes the shape, size and 
weighting of the neighbouring pixels to be represented in the average. More 
weighting can be given to the central pixel to limit the influence of surrounding 
pixels on the outcome. The effects of various kernels can be seen in Figure 2.6. A         
Figure 2.5 Flattening images using semi-automated segmentation of the anterior choroidal 
boundary ensured greater consistency of choroidal depth in the enface view. In the unaltered 
image, the reslice plane (yellow line) incorporates sclera towards the edges of the b-scan. The 
brightness and contrast of the enface images have been manipulated to enhance the vessels.  
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3 × 3 square kernel with equal weighting given to each pixel was applied to the 
enface OCT images to reduce the effect of unrepresentative pixel intensities caused 
by speckle (Figure 2.7).  
Larger kernels (e.g. 5 × 5) will give smoother, less noisy images, however this 
will result in the loss of high-frequency image information. Anisotropic kernels can 
also be applied solely in one direction (X or Y), to average pixels in a single 
orientation. This could be of potential benefit for OCT imaging, due to the decoupling 
of axial and transverse resolution (see Section 1.5.2). An anisotropic kernel could be 
applied to enhance retinal layers by applying averaging horizontally only, in b-scan 
view. For this thesis however, enhancement of retinal layers was not required, so 
this directional process was not applied.  
Figure 2.6 Examples of kernels commonly used in convolving filters, and the effects they have 
on the central pixel. 
A B 
Figure 2.7 Enface choroidal OCT image before (A) and after (B) application of convolution blur. A 
3 × 3 kernel with equal pixel weighting was used to reduce high frequency noise (speckle).  
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2.3.3.4 Brightness and contrast 
Adjusting the brightness of an image adds or subtracts a bias to every pixel 
within the image, altering the overall perceived intensity, whilst maintaining the 
absolute differences between pixels. Brightness was manually adjusted to 
subjectively improve visualisation of the retinal layers and choroidal structures. 
Contrast adjustment alters the proportional luminance according to the relative 
intensity of each pixel. Since this can result in saturation of boundaries such as the 
RPE, which may have led to errors in interpreting exact boundary positions, contrast 
adjustment was not used in image quantification. 
 
2.3.4 Magnification and scaling 
OCT images are affected by magnification in the transverse plane; therefore 
to ensure accurate quantifiable measurements the images required scaling. The 
magnification effect results from the optics of the imaging instrument and the 
subject’s eye. Transverse OCT dimensions should be corrected for axial length to 
counter this effect (Odell et al. 2011).  
To appreciate the potential magnitude of this effect, we consider two eyes; 
one with an axial length of 20 mm (likely a hyperope), and one with an axial length 
of 28 mm (likely a myope). Using Equation 2.1, the first of these eyes will have a 
magnification factor of 0.80x, the second will have a magnification factor of 1.16x. 
Therefore, for a retinal feature of 100 µm, the measured size would be calculated as 
80 µm and 116 µm respectively; an error of up to 20 µm, which would be considered 
significant.  
Prior to the correction of any magnification effects, the size in microns was 
calculated from the size in pixels measured from the image. A lateral scaling factor 
was calculated for each image using the following equations (Littmann 1982; 
Bennett et al. 1994):  
 
𝐿𝑎𝑡𝑒𝑟𝑎𝑙⁡𝑠𝑐𝑎𝑙𝑖𝑛𝑔 =
2𝜋𝑅. (
𝐴
360)
𝑁𝑝
 
 
 
Equation 2.1 
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where: 
Np = number of pixels in the scan 
A = input scan angle (°) 
R = retina to nodal point distance, or vitreous chamber depth (mm) 
 
R can be calculated as follows: 
𝑅 =
𝐴 − 1.6
1.34
 
 
Equation 2.2 
 
where:  
A = axial eye length (AEL; mm) 
1.6 mm is the cornea to principle plane distance (from Bennett et al. 1994) 
1.34 is the assumed group refractive index of the eye 
 
 From Equations 2.1 and 2.2, a 20° × 20° (512 × 512) volume scan obtained 
from an eye with AEL = 24 mm would have lateral scaling of 11.38 µm/pixel. At least 
2 adjacent pixels are required to resolve an edge, which in this case would have a 
combined size of 22.76 µm. This is larger than the lateral resolution limit of the OCT 
(~6.3 µm), and would therefore be under-sampled. A 5° ×  5° scan of the same 
dimensions on the same eye would have lateral scaling of 2.85 µm/pixel, which 
would be over-sampled. Over- and under-sampling are explained in more detail in 
Section 2.5.1. For this research, lateral scaling was calculated from the measured 
AEL of each eye, and used to convert image size in pixels to feature size in microns. 
A detailed investigation of the effect of AEL-dependent lateral scaling is outlined in 
Section 3.1.  
Since the axial scaling is determined by the bandwidth of the light source 
(Huang et al. 1991; Drexler and Fujimoto 2008), the axial component of an OCT 
image is independent of AEL, and is the same for all eyes. However, an axial scaling 
factor must still be applied to convert the number of image pixels to a physical size 
in microns. For the long-wavelength OCT, the axial scaling in air was empirically 
determined to be 2.66 µm/pixel, which equated to 1.90 µm/pixel in tissue (n=1.4). 
Therefore, an axial scaling factor of 1.90 µm/pixel was applied to all images from the 
long-wavelength device.  
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2.4 Measurement techniques 
Histological measures, as outlined in Section 1.6.2, are considered the gold 
standard for informing quantification of OCT images. This section describes the 
development of measurement techniques used in this thesis, and the associated 
limitations of such quantification.  
 
2.4.1 Manual measurement approaches 
For this thesis, manual measurement of choroidal thickness and vessel 
diameter were carried out using digital callipers in Fiji. All non-foveal retinal 
locations were identified considering transverse magnification, as described in the 
previous section. Measurements were taken vertically on the image, regardless of 
the slope of the retina, for ease of axial scaling conversions. However, since the 
retina typically follows a convex curve in OCT images, axial measurements may not 
be truly representative, particularly in locations further from the foveal pit (Figure 
2.8). To minimise the effects of this, images were acquired with the retina as ‘flat’ as 
possible, through careful alignment of the imaging system. The program to 
translationally align a-scans to a flat plane (RPE) was therefore only required for 
images to be viewed enface.  
Figure 2.8 Choroidal thickness was manually measured axially (grey arrow). For curved 
images, this was not the same as choroidal thickness perpendicularly to the RPE, particularly 
further from the foveal pit (black line; exaggerated).  
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The choroid was defined as the area enclosed by the posterior boundary of 
the RPE and the choroid-scleral boundary, identified by the visible bright sclera and 
the outer border of the choroidal stroma. This was selected as the posterior 
choroidal boundary, as it has been shown to be more reproducible than alternative 
boundaries, such as the outer border of the choroidal lumen, or the inner border of 
the sclera, as shown in Figure 2.9 (Vuong et al. 2016).  
In terms of quantifying the choroidal vascular structure itself, there were 
several approaches that could be taken. The first approach was manual calliper 
measurement of vessel diameters (Figure 2.10A). Again, these were measured 
axially for ease of scaling conversions. As an alternative, manual segmentation of the 
vessels was a possibility (Figure 2.10B), to obtain vessel area, vessel density, and a 
ratio of vessel to surrounding tissue.  
Figure 2.9 Horizontal averaged b-scan from a Spectralis OCT, with three potential posterior 
choroidal boundaries displayed. Vascular choroidal thickness (VCT) uses the outer border of the 
vessel lumen. Stromal choroidal thickness (SCT) uses the outer border of the choroidal stroma. 
Total choroidal thickness (TCT) uses the inner border of the sclera (arrowheads), which was 
found to be visible in only 43% of participants. Image from Vuong et al. (2016).  
Figure 2.10 Potential manual choroidal parameter measurements. (A) Calliper measurements; 
subfoveal choroidal thickness (longest white line) and vessel diameters (three shorter white 
lines). (B) Hand segmentation of the vessel lumen.  
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  Another approach was to use the enface view for quantification, providing 
visualisation of a fixed depth across the choroid simultaneously. Again, calliper 
measurements or hand segmentation could be used, yielding similar parameters to 
those discussed previously. Alternatively, thresholding techniques could be applied 
to binarise the images (Figure 2.11). The ratio of black to white (i.e. vessel lumen to 
surrounding tissue) could then be established with image processing software, and 
provide an output representative of the entire choroid at a single plane of set depth 
in the choroid. This limited potential misrepresentation through sampling 
individual vessels.  
2.4.2 Limitations of manual measurements 
Whilst these manual techniques are simple and easy to apply, they are 
associated with significant limitations. The choroid is a 3-D dense vascular network, 
however only a 2-D section through this structure is visualised in each tomogram. 
Therefore these images lack perspective of the angle at which any given vessel has 
been ‘sectioned’. If vessels are sectioned obliquely, a true vessel cross-section is not 
visible, although it may have a similar shape (see Figure 2.12). Vessel diameters will 
tend to be over-estimated using this method.  
Figure 2.11 Example of an enface image of choroidal vessels (A) and the same image having 
undergone binarization using thresholding techniques (B). Note the artefact from an overlying 
retinal vessel (arrow). Image from Duan et al. (2013).  
A B 
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Furthermore, from a 2-D section in isolation it was not possible to assess 
whether the apparent cross-section is simply a segment through an arching vessel 
(see Figure 2.13). Unlike the retina, the choroidal structure varies greatly between 
individuals. There is no regular structure akin to retinal layers, and the blood vessels 
do not appear to follow set patterns like that of the vascular arcades supplying the 
inner retina. It was therefore not possible to select a corresponding vessel on each 
individual, and there was no simple way to ensure that sampled vessels were 
representative of the entire choroid. The use of enface images addressed this 
limitation in-part, by encompassing all vessels at a predetermined depth below the 
RPE. However, these were still 2-D samples of the volume, and in addition suffered 
from other limitations such as artefacts from overlying structures (e.g. retinal blood 
vessels as demonstrated in Figure 2.11).  
Figure 2.12 The angle at which a vessel is bisected (red lines) has a great effect on the 
resulting apparent vessel ‘diameter’ (blue arrows). Without knowledge of the directionality of 
the vessel relative to the 2-D plane being viewed, it is difficult to ensure appropriate 
measurement. 
Figure 2.13 Without perspective from surrounding slices, a 2-D vessel section (A) can arise 
from bisection of a vessel of unknown directionality (B and C), or a section through an arching 
vessel (D). The red lines indicate the plane at which the vessel in each example could be 
bisected to produce a similar 2-D luminal shape.  
A B 
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To minimise the impact of these issues, established histological techniques 
often utilise sampling approaches, for example, averaging measurements across 
multiple vessels. Although this usually improves measurement repeatability, the 
method of vessel selection is still associated with known limitations of sampling, 
including potential bias and misrepresentation. To overcome these limitations, the 
entire choroidal volume within the scan region should be included in the analyses. 
However, averaging techniques used to reduce noise are limited (e.g. Z-projection), 
and the individual b-scans remain relatively noisy. In similar cases, texture analysis 
has previously been used to extract information in an attempt to quantify structure 
(Koprowski et al. 2013; Srinivasan 2014b; Albarrak et al. 2016).  
Finally, as with the majority of manual quantification techniques, the 
measurements described here are time-consuming, and can inherently suffer from 
significant inter- and intra-observer variability. This greatly limits the potential 
clinical value of such measurements. To overcome these limitations, the 
employment of automated analysis methods should be considered. As discussed in 
Section 1.7.3, machine learning techniques are a powerful tool for this type of 
analysis (see Chapter 5).   
 
2.5 Optimising scan parameters and protocols  
When collecting data of this type, a protocol must be established detailing the 
parameters of the images acquired. This ensures consistency within the dataset, and 
optimises the dataset for the purpose for which it was collected. These parameters 
include (but are not limited to) scan angle, a-scans per b-scan, b-scans per volume, 
and number of repeat images acquired. In addition, the higher the power of the light 
source in the imaging device, the better the image quality. For safety reasons 
however, power output must be capped at a pre-defined level for ocular imaging 
(ANSI 2000; ICNIRP 2013). The following section outlines pilot studies undertaken 
for parameter selection and imaging protocol development, including investigations 
of image sampling and light source power.  
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2.5.1 Pilot study 1: Effect of lateral sampling on choroidal vessel visualisation 
2.5.1.1 Background 
Although long-wavelength OCT allows visualisation deeper into the 
choroidal structure, contrast of this region is often limited due to signal roll-off. One 
potential method to increase visualisation is to increase the sampling density of the 
scan (i.e. increase the number of a-scans per unit area of choroid), and thus utilise 
the full optical resolution of the device. Increasing the number of a-scans per b-scan, 
and b-scans per volume would have this effect, but would also greatly increase the 
image acquisition time. Therefore, reducing the scan angle would be the preferable 
option to achieve this.  
 The theoretical resolution limit of this non-commercial OCT system is ~6 µm. 
This is inherent to the optics of the human eye, and will be the limiting factor of 
image resolution for images with sampling exceeding this level (i.e. over-sampling). 
If an image is sampled below this limit, image resolution is further limited by the 
sampling rate; this is called under-sampling. Since a minimum of two adjacent pixels 
are required to resolve an edge, sampling rate must be at least half the resolution 
limit to resolve the edge (~3.09 µm/pixel).  
A list of sampling rates for a range of scan widths can be seen in Table 2.3, 
calculated using Equation 2.1, and a standard AEL of 24 mm. The conventional scan 
size of commercial OCT devices is typically 20° × 20° which is substantially under-
sampled, limiting the lateral image resolution. The smaller the scan angle, the 
greater the sampling (i.e. the fewer microns of structure represented per image 
pixel). Greater degrees of over-sampling allow for more averaging during post-
processing without loss of spatial information from the image. However, the 
limitations of decreasing the scan size are the reduction in number of vessels within 
the imaging field, and the loss of localisation information. The ideal scan size for 
visualising the choroidal vasculature would maximise lateral image resolution 
whilst maintaining a reasonable field of view. Beyond the point where the sampling 
rate is equal to the theoretical resolution limit of the system (equating to ~5.6° scan 
width), no further improvement in image quality would be expected, since the 
resolution is limited by optics of the eye.  
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Table 2.3 Lateral sampling rates for different sized scans, assuming a scan size of 512 × 512 
pixels of an eye with an AEL of 24 mm. The sampling rate approximately equal to half the 
theoretical resolution of the imaging system is highlighted in grey.  
Scan width (°) Lateral sampling rate (µm/pixel) Under/over sampled? 
20 11.33 Under  
10 5.66 Under 
9 5.10 Under 
8 4.53 Under 
7 3.97 Under 
6 3.40 Under 
5.6 3.09 Equal 
5 2.83 Over 
4 2.27 Over 
 
The aim of this study was to demonstrate the effects of lateral sampling, and 
to investigate the extent to which these effects impact OCT image quality. To achieve 
this, images with a range of scan sizes underwent both objective and subjective 
image quality analysis. The scan sizes assessed represented images with a lateral 
sampling rate close to the theoretical resolution limit of the device (from Table 2.3). 
Three observers familiar with OCT images were enrolled to grade image quality 
based on pre-defined criteria. The agreement between observers was assessed to 
ensure grading consistency.  
 
2.5.1.2 Methods 
Participants  
Young, healthy participants (n=9) were recruited for this study from staff, 
students, and volunteers at the School of Optometry and Vision Sciences, Cardiff 
University. Mean age (±SD) was 25.9 ± 2.8 years. AEL was measured using an 
average of 5 readings from an IOLMaster (Carl Zeiss, Jena, Germany). Mean AEL and 
refractive error (mean sphere) were 24.7 ± 1.8 mm and -2.00 ± 2.77 D respectively. 
All participants had visual acuity of 0.1 logMAR (6/7.5) or better.  
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Image acquisition and preparation  
Each participant underwent long-wavelength OCT imaging of the right eye. 
512 ×  512 macular volume scans were obtained, for scan sizes from 8° ×  8° to            
4° × 4°, in 1° intervals. In addition, 512 × 512 macular volume scans of 20° × 20° 
visual angle were acquired (the clinical standard; to be used for reference only). 
Participants did not undergo pupil mydriasis, and all images were acquired under 
minimal room lighting.  
Following conversion from spectral data to image data, a predetermined set 
of processing steps were followed to prepare the images for assessment (see Figure 
2.14). This included vertical cropping and stack registration, as described in Section 
2.3.2. To enable visualisation of both the large- and medium-sized choroidal vessels 
in this task, depths of 75% and 50% of the choroidal thickness beneath the foveal 
pit were isolated. An area was selected with a height of 5 pixels and the full width of 
the scan, centred on each of the two depths, and resliced to produce two enface 
views of 5 consecutive slices each. A convolving filter was applied to reduce speckle, 
using a 3 × 3 kernel of equal weighting. Each set of 5 slices were then averaged using 
Figure 2.14 Image processing protocol. (A) A single b-scan through the foveal pit, with minimal 
processing, showing 75% depth in the choroid (dashed line). (B) Enface view of the choroid at 
this depth. (C) Convolving blur applied to the enface view. (D) Average of 5 consecutive images 
in the stack with convolving blur, and adjusted brightness. 
A 
B 
C 
D 
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Z-projection, and the resulting images were converted to 8-bit to allow manual 
adjustment of brightness, to subjectively maximise visibility of the choroidal vessels. 
The result was two enface images, at 75% and 50% choroidal depth respectively. 
Image contrast was not adjusted, as it was to be used as one of the quality grading 
criteria.  
It was important to consider the effects of image magnification during 
presentation. It was likely that a more ‘zoomed out’ image (i.e. the wider scans), 
would be perceived as better quality, due to the presence of more vessels, and the 
lack of visibility of smaller vessels, which may be masked by background noise. To 
control for this effect, the central 3° of each image was isolated, and scaled to 410 × 
410 pixels (the number of pixels in the 4° image following cropping to 3°). A size of 
3° was selected to prevent bias from identification of the true 4° scans by the 
presence of misalignments surrounding the image caused by the stack registration 
process. Images were scaled up in size rather than down to prevent pixel averaging 
that may artificially improve perceived image quality. An example is shown in Figure 
2.15. During presentation for grading, the screen resolution was set such that 
images were presented over 410 × 410 screen pixels, removing the possible effects 
of aliasing (spatial sampling of pixels during image presentation).   
Grading protocol  
Three independent observers who were masked to the images and were not 
involved in the collection of the images were used for grading image quality. These 
Figure 2.15 The same area of choroid sampled at 75% depth, imaged using (A) 4° and (B) 8° 
scanning protocols. The central 3° of visual angle of each image has been cropped and scaled 
to 410 × 410 pixels. The 8° scan has a more pixelated appearance, and the extent of over-
sampling of the 4° scan is evident when comparing the perceived quality of the images. 
A B 
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were experienced optometrists familiar with viewing similar ophthalmological 
images. A total of 45 enface choroidal OCT images at 75% depth (5 scan widths per 
eye) were presented three times each in a random order (135 presentations in 
total). In cases where two identical images were randomised into consecutive order, 
the latter image was swapped with the following image.  
The graders were provided with simple instructions (see Appendix C) a day 
prior to the grading sessions, to familiarise themselves with the protocol. The 
grading session began with a training session, in which 5 test images with a variety 
of image qualities were presented. The graders were encouraged to record a grade 
for these images, although these results were not included in the analysis. These test 
images were collected from the fellow eye of a subset of participants, and hence 
were not included in the main presentation, but were of similar quality for training 
purposes.  
Graders were given unlimited time to record grades for two criteria; overall 
contrast of the image, and edge definition of the vessels (described below). Graders 
were not permitted to return to previous images once they had been graded. Both 
criteria were graded on a 5-point scale (Ludewig et al. 2010), as follows:  
1. Poor 
2. Restricted 
3. Sufficient 
4. Good 
5. Excellent 
The overall contrast of the image was graded according to the difference in 
luminance between the vessel lumen and surrounding tissue. Edge definition was 
based upon the apparent luminance profile, with a distinct edge receiving a higher 
grade. Diagrammatic examples, which were included in the grading instructions, are 
shown in Figure 2.16.  
This entire process was repeated for the 50% depth images on a different 
day, to minimise fatigue effects. The same computer monitor was used by the three 
graders on both days to ensure consistent image presentation, and negating the 
need for monitor calibration.  
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Objective quality assessment  
 As an objective measure, the number of misalignments due to image 
registration failure were counted for each unscaled image at 75% choroidal depth. 
This was not repeated at 50% depth, as the number of misalignments would be 
consistent at any depth. Due to the size of the larger vessels, misalignments were 
likely to be more evident at 75% depth. Misalignments were classed as visible 
horizontal lines of poor continuity in the enface view (Figure 2.17). This was carried 
out independently of the subjective quality grading, by a single observer who was 
masked to the randomised images.  
 
Statistical analysis  
The data were checked for normality using a Shapiro-Wilk test (P>0.05). A 
repeated measured ANOVA was used to determine whether the differences in 
subjective grades between the scan sizes were statistically significant (P<0.05). A 
post-hoc Bonferroni correction was applied to ascertain where the significant 
differences were, at a 95% significant level. Where normality could not be assumed 
Figure 2.17 Schematic demonstrating poor continuity in an enface image, due to ‘failings’ of 
the stack registration process. Each arrow indicates one misalignment.  
Figure 2.16 Schematics demonstrating both criteria: (A) optimum image quality, Grade 5; (B) 
low contrast; (C) low edge definition.  
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(Shapiro-Wilk P≤0.05), a Friedman test was used, with a post-hoc Wilcoxon signed 
ranks test.  
 To assess observer repeatability and inter-observer agreement, single 
measures intra-class correlation coefficients (ICC) were calculated. These 
coefficients were interpreted as follows: 0.01-0.2, slight agreement; 0.21-0.4, fair 
agreement; 0.41-0.6, moderate agreement; 0.61-0.8, substantial agreement; >0.8, 
almost perfect agreement (Landis and Koch 1977).  
 
2.5.1.3 Results 
Subjective assessment 
 The mean subjective image quality results from the three graders can be seen 
in Table 2.4. For 75% choroidal depth, smaller scan angles were generally associated 
with higher grading scores for contrast and edge definition of the vessels. The mean 
scores for edge definition were consistently poorer than contrast. For the 50% 
choroidal depth, there was no obvious association between scan angle and 
subjective image quality. For both grading criteria, inter-observer variability was 
similar for each of the scan sizes, and there was a similar level of variability for each 
of the criteria (Figure 2.18). However, there was a higher degree of inter-observer 
variability for both criteria at 50% depth than at 75% depth (as represented by the 
error bars).  
Table 2.4 Mean subjective image quality grade (1=poor; 5=excellent) for images of varying 
scan size, by three observers.  
Scan size (°) Mean image quality grade 
Overall contrast Edge definition 
75% depth 50% depth 75% depth 50% depth 
4 2.77 2.47 2.74 2.36 
5 2.53 2.38 2.43 2.36 
6 2.54 2.53 2.26 2.58 
7 2.31 2.44 2.07 2.40 
8 2.21 2.41 1.88 2.04 
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  For 75% choroidal depth, a repeated measures ANOVA determined that the 
difference in mean contrast grade between scan sizes was statistically significant 
(P<0.05). With Bonferroni correction, a difference in contrast grade was found only 
between the 4° and 8° scans. Since normality could not be assumed for edge 
definition grades (Shapiro-Wilk, P < 0.05), a Friedman test was used. A post-hoc 
Wilcoxon signed ranks test identified a significant difference between all sizes, with 
the exception of consecutive sizes, e.g. 4° and 5° (Table 2.5). For 50% choroidal 
depth, a repeated measures ANOVA determined that there were no significant 
differences in the contrast and edge definition grades for different sized scans 
(P=0.926 and P=0.252, respectively).  
  
Figure 2.18 Mean grades (1=poor; 5=excellent) for varying scan sizes. Mean data from the 
three independent observers is presented at 75% and 50% depth, for both grading criteria. 
Error bars represent the range of grades assigned by the three observers.  
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Table 2.5 Pairwise comparison of mean grades of contrast (black) and edge definition (grey) 
at 75% depth, following a repeated measures ANOVA with post-hoc Bonferroni correction, and 
a Friedman test with post-hoc Wilcoxon signed ranks test, respectively. The significance values 
for each comparison are included in the table.  
Scan size (°) 4 5 6 7 8 
4 - 0.656 0.905 0.193   0.029* 
5 0.106 - 1.000 0.338 0.649 
6   0.024* 0.398 - 0.440 0.127 
7   0.012*   0.049* 0.271 - 0.440 
8   0.012*   0.012*   0.018* 0.271 - 
*significant at the 0.05 level 
 
Statistical analysis showed substantial to almost perfect intra-observer 
agreement for all three graders at both choroidal depths (Table 2.6). At 50% depth, 
edge definition grades had a higher consistency than contrast grades for all 
observers, however at 75% depth this was only substantial for Grader 2. Inter-
observer agreement was almost perfect for both grading criteria at 75% depth, and 
substantial for both criteria at 50% depth (Table 2.7).  
Table 2.6 Intra-class correlation coefficient (ICC) for intra-observer consistency in both 
grading criteria, for both choroidal depths.  
Grader Intra-class correlation coefficient 
Overall contrast Edge definition 
75% depth 50% depth 75% depth 50% depth 
1 0.846 0.794 0.850 0.888 
2 0.652 0.623 0.813 0.758 
3 0.728 0.698 0.740 0.719 
 
Table 2.7 Intra-class correlation coefficient (ICC) for inter-observer consistency between the 
three graders in both grading criteria, for both choroidal depths. 
Intra-class correlation coefficient 
Overall contrast Edge definition 
75% depth 50% depth 75% depth 50% depth 
0.859 0.774 0.860 0.800 
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Objective assessment 
The largest scans had, on average, 2.8 ± 2.5 misalignments, compared to 5.7 
± 3.2 for the smallest scans (Table 2.8). Scans ≥6° in size demonstrated less 
variability in the number of misalignments (failure of image registration) between 
individuals, as shown by the error bars in Figure 2.19.  
A repeated measures ANOVA determined that mean number of 
misalignments differed significantly between scan sizes (P<0.05). However, with 
Bonferroni correction, no statistically significant differences were found in the 
number of misalignments between any of the scan sizes. Least significant difference 
adjustment was then applied, producing statistically significant differences at a 95% 
significance level in the number of misalignments between 4° and 6°, 4° and 7°, 4° 
and 8°, 5° and 7°, and 5° and 8° scans (Table 2.9).  
Table 2.8 Number of misalignments per image for each participant (A-I), for a single observer.  
Scan size (°) Number of misalignments Mean Standard 
deviation A B C D E F G H I 
4 4 9 6 8 2 2 10 2 8 5.7 3.2 
5 4 4 6 8 1 0 9 1 13 5.1 4.3 
6 5 4 4 5 0 2 5 0 6 3.4 2.2 
7 2 3 5 3 2 0 3 0 7 2.8 2.2 
8 3 2 4 6 0 0 2 1 7 2.8 2.5 
Total 18 22 25 30 5 4 29 4 41 
Figure 2.19 Mean (± SE error bars) number of misalignments of image registration for various 
scan sizes. Smaller scan sizes result in a higher average number of misalignments in the stack 
registration software. 
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Table 2.9 Pairwise comparisons of number of misalignments, following a repeated measures 
ANOVA with post-hoc least significant difference adjustment (equivalent to no correction). 
Post-hoc Bonferroni correction shown in grey boxes (italics). The significance values for each 
comparison are included in the table. 
Scan size 
(°) 4 5 6 7 8 
4 - 0.540   0.010*   0.008*   0.012* 
5 1.000 - 0.105   0.029*   0.023* 
6 0.100 1.000 - 0.282 0.242 
7 0.080 0.294 1.000 - 1.000 
8 0.117 0.232 1.000 1.000 - 
*significant at the 0.05 level 
 
2.5.1.4 Discussion and conclusions  
For 75% choroidal depth, wider scan angles were associated with poorer 
subjective image quality on both criteria assessed. This indicates that an increase in 
sampling rate (i.e. a smaller scan), provides higher perceived image quality. At 50% 
depth, no significant association was found between subjective image quality and 
scan size, potentially due to crowding effects caused by a higher density of vessels 
per image (i.e. higher spatial frequency). This may be perceived as a less prominent 
‘background’ in the image, arising from a higher ratio of vessel lumen to surrounding 
tissue at this depth (Figure 2.20). Furthermore, it is more likely that at this depth, 
some smaller vessels may not be resolved due to the optical limits of the OCT, 
resulting in a perceived increase in noise in the image background. This may also 
have the effect of lowering the background luminance, reducing the perceived 
contrast of the image. High frequency noise (inherent to this imaging technique) 
likely reduced the ability of the observer to appreciate differences in image quality 
between the scan sizes, which may explain the findings at 50% choroidal depth, 
where the typical feature size (i.e. vessel size) was smaller.  
The number of vessels visible in the smaller scans was relatively low, 
particularly when factoring in patient misalignments and the parts of the image lost 
to the stack registration process. Furthermore, image acquisition was more difficult 
for the smaller scans, due to limited field of view when aligning the imaging system.  
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For the objective analysis, scans ≥6° in size demonstrated more consistent 
stack registration.  Statistical analysis revealed significantly fewer misalignments in 
6° images when compared to smaller images, whilst no further improvement 
beyond this was identified (P<0.05). With a Bonferroni correction however, these 
differences were not significant. The 7° and 8° images displayed a similar number of 
misalignments due to stack registration as the 6° images. These results suggested 
that an image of 6° or greater was optimal for minimising the number of 
misalignments due to stack registration. This was consistent with the expectations 
of stack registration, since images of a smaller area of choroid were likely to have 
fewer similar features between b-scans, and were therefore more prone to 
registration failures.  
Statistical analysis showed strong intra-observer agreement for each of the 
three graders. When comparing the grades from the three observers, both grading 
criteria showed near-perfect agreement. This consistency allowed more confidence 
in the reliability of the results produced by the graders.  
The use of a 5-point grading scale is a potential limitation. This allowed for 
grader indecisiveness i.e. assigning a grade of 3. A forced choice grading scale (e.g. a 
4-point or 6-point scale) may have eliminated any effects of this central-tendency 
bias. A 4-point scale may not have provided a spread of data wide enough to 
distinguish between images of reasonable and good quality, so a 6-point grading 
scale may have been preferable. However, other studies have defended the use of 5-
Figure 2.20 The same 7° scan sampled at (A) 75% depth, and (B) 50% depth. The image at 
50% depth has a higher vessel density, and a higher apparent ratio of visible lumen to 
background. 
A B 
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point grading scales similar to the one used in this study, such as the well-
established Likert scale (Likert 1932; Ludewig et al. 2010).  
Overall, larger vessels had higher subjective image quality with a higher 
sampling rate (i.e. smaller scan size) in terms of contrast and vessel definition. 
Although this subjective difference was statistically significant, it was small and 
unlikely to be clinically significant. For smaller vessels, there was no difference 
between any of the scan sizes, suggesting that different imaging protocols were not 
required for visualising vessels of different sizes.   
Considering all the findings of this pilot study, a medium-sized scan 
equivalent to the theoretical resolution limit of the imaging system (~6°) would be 
optimal to balance optimal subjective image quality with field of view, whilst 
minimising misalignments of the stack registration software. The 6° scan size had 
the additional benefit of ease of alignment during image acquisition, whilst 
maintaining the majority of the perceived benefits related to over-sampling.  
In summary, this pilot study has demonstrated the effects of image sampling 
on perceived image quality, with the optimum scan size found to be 6°. The clinical 
standard for volume scans is 20° × 20°, and the majority of commercial devices do 
not allow absolute flexibility in scan size (typically limited to a handful of pre-set 
specifications). Furthermore, the macula is defined clinically as the central 6 mm 
centred on the fovea, which approximately equates to the central 20° of visual angle. 
It is possible that scans smaller than this may fail to represent the clinical 
appearance of macular pathology, as defined by clinical classification systems 
(AREDS 2001a). For these reasons, the standard 20° scan angle will be primarily 
utilised in this thesis. However, since these images are under-sampled, 36° line 
scans comprising 4096 pixels will also be used to provide an over-sampled image, 
with a wide field of view. A comparison of these two types of image for quantifying 
the choroidal vasculature can be found in Section 3.2.  
 
2.5.2 Pilot study 2: Light source power output  
2.5.2.1 Background  
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Another variable which has a direct effect on image quality is the power output 
of the imaging light source. Typically, the higher the power output, the better the 
image quality. However, this is limited by guidelines outlined by the International 
Commission on Non-Ionizing Radiation Protection (ICNIRP 2013) and the American 
National Standards Institute (ANSI 2000), which describe the safety standards for 
ocular exposure to a laser beam of a given wavelength, assuming a pupil size of             
7 mm.  
A change in the power output of the light source could directly affect both the 
penetration depth and the relative intensity of the structures imaged (Drexler and 
Fujimoto 2008). To ensure consistency between OCT images, particularly for the 
purpose of comparison, it was important that the imaging parameters and 
conditions remained as similar as possible between imaging sessions. Consequently, 
it was deemed necessary to investigate the power output characteristics of the light 
source within the long-wavelength OCT system over time. Any trends or variations 
in the power output may be taken into account when establishing the imaging 
protocol, to maximise the reliability and repeatability of the images.  
 
2.5.2.2 Methods 
A handheld PM100D energy meter (Thorlabs, Newton, NJ) was used to 
measure the power output of the long-wavelength OCT light source over a 5 hour 
period. The initial measurement was taken following light source activation and 
completion of the system self-calibration (lasting approximately 90 seconds). 
Measurements were obtained at a distance of 30 mm from the anterior surface of 
the OCT system’s objective lens, as this is the approximate distance between the 
instrument and the patient’s eye during image acquisition. A subsequent 
measurement was obtained every 5 minutes for 150 minutes (2.5 hours), at which 
stage the measurement frequency was reduced to 30 minute intervals for a further 
150 minute period. The power output was assessed over a 300 minute period (5 
hours), since this was the upper limit of likely use per day throughout this research.   
For safety reasons, the imaging beam was blocked at the objective lens using 
an infra-red card between readings, in line with the standard operating procedures 
of the device, and ethical approval. A control measurement was also taken with the 
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equipment in situ, with the infra-red card blocking the beam. The detector of the 
meter was set to measure the power output at 1040 nm; the wavelength of the light 
source. Room lighting was minimal, to mimic the conditions of image acquisition.  
 
2.5.2.3 Results 
Following initialisation of the light source, a steep decline in power output 
was observed over the first 30 minutes. The rate of decline then slowed over the 
subsequent 20 minutes, until reaching an equilibrium at around 70 minutes (Figure 
2.21). The power output did not fluctuate after this point.  
 
2.5.2.4 Discussion and conclusions 
As the light source power output declined most steeply during the first 30 
minutes, imaging should be avoided during this period. Although images obtained 
during this period would have a greater reflectivity and appear to be of ‘better 
quality’, they would not be directly comparable to images collected after this period, 
due to intensity change. After this initial ‘warming up’ period, the change in power 
output was minimal over the following 4 hours.   
 Furthermore, all power measurements were within the recommended safe 
levels for a light source at 1040 nm (2.5 mW of continuous corneal irradiance; ANSI 
2000). As long as this limit is observed, this light source is safe for imaging human 
participants.  
Figure 2.21 The power output of the long-wavelength OCT light source declined steeply over a 
30 minute period following initialisation (Time = 0), after which time it stabilised.  
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To conclude, all imaging protocols in this thesis included a 30 minute latency 
period following light source activation, prior to image acquisition. This minimised 
variation between imaging sessions attributed to power output of the imaging light 
source.  
 
2.5.3 Image acquisition and processing summary  
The aforementioned image acquisition, processing and potential analysis 
protocols are summarised in Table 2.10. The image acquisition protocols for use in 
this research have been described, including the imaging system and scan 
parameters. A series of image processing steps have been defined, but are 
dependent on the structure or parameter to be investigated. With regard to image 
analysis, a number of limitations of conventional analysis methods, such as manual 
calliper measurements, have been outlined. An evaluation of such parameters is 
conducted in Section 3.2. A machine learning approach to analysis with potential to 
overcome these limitations is developed and validated in Chapter 5.  
Table 2.10 Summary of the image acquisition, processing, and potential analysis protocols 
used in this research. Protocols requiring further investigation are discussed in Chapter 3.  
Variable Protocol 
Imaging system 1040 nm non-commercial OCT 
Scan size 20° × 20° (512 × 512 × 1024 pixels) 
6° × 6° (512 × 512 × 1024 pixels) 
36° (4096 × 1024 pixels) 
Number acquired 3 repeat images of each type 
Initialisation time 30 minutes 
Pupil size ≥ 5 mm (mydriasis with 0.5% Tropicamide) 
Image pre-processing protocol See flowchart in Figure 2.2 Series of image 
pre-processing steps (white rectangles) that 
all scans acquired with the 1040 nm OCT 
device underwent. Blue rhombi represent 
image types; green rhombi represent 
outcome measure categories, and the section 
in which they are investigated is specified.  
Choroidal parameters (to be 
developed) 
Choroidal thickness (digital calliper) 
Vessel diameters (digital calliper) 
Percentage vessel lumen (thresholding) 
Choroidal volume (automated segmentation) 
Automated texture analysis (machine learning) 
AMD disease clinical classification  Adapted protocol required 
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3 Evaluation of analysis techniques 
 
A number of parameters for describing the choroid and the choroidal 
vasculature have previously been described (see Section 1.7). The majority of the 
literature evaluating these parameters used images acquired with conventional-
wavelength (~850 nm) OCT devices. This chapter evaluates several of these 
parameters on images from a non-commercial long-wavelength (~1040 nm) OCT 
device, as well as introducing a novel parameter to quantify the vessel structure. All 
studies conducted here were on healthy eyes, to establish the repeatability of 
parameter measurement prior to application in disease. The importance of ocular 
biometry for lateral scaling of OCT images is also explored.  
 
3.1 Effect of lateral scaling on OCT quantification 
The transverse size of any retinal or choroidal feature in an OCT image can be 
calculated using the appropriate ocular biometry and instrument meta-data 
(Littmann 1982; Bennett et al. 1994). The following describes a study investigating 
the importance of lateral scaling considerations for quantifying OCT images.  
 
3.1.1 Background 
Commercial OCT devices are generally manufactured with on-board retinal 
layer segmentation software. Contemporary software is commonly limited to retinal 
thickness and a small number of intra-retinal layers, and is almost universally 
restricted to use on images acquired by the parent device. Furthermore, on most 
contemporary OCT devices (e.g. Topcon 3D OCT-1000, and Zeiss Cirrus HD-OCT), 
this software does not make lateral scaling compensation for ocular biometry (i.e. 
AEL). Differences in the definition of the posterior retinal boundary, along with the 
diversity of segmentation methods, also makes quantitative comparisons between 
the devices difficult.  
The Iowa Reference Algorithms (Retinal Image Analysis Lab, Iowa Institute 
for Biomedical Imaging, Iowa City, IA) are a publically available, graph theory-based 
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approach to 3-D segmentation of the retinal layers in spectral domain OCT images 
(Garvin et al. 2009; Abràmoff et al. 2010; Antony et al. 2011). The software has 
previously been shown to be capable of identifying 7 retinal layer boundaries, 
providing results comparable to hand segmentation by two ophthalmologists 
(Garvin et al. 2009). OCT Explorer version 3.5 is capable of segmenting 10 intra-
retinal layers in addition to providing conventional retinal thickness values (inner 
limiting membrane (ILM) to RPE). These algorithms have been shown to generate 
layer thicknesses, comparable to a retinal specialist, in healthy participants using 
Cirrus HD-OCT 5000 images (Lee et al. 2010). Furthermore, it has been shown to 
produce comparable results to the on-board Spectralis OCT software on images 
from participants with diabetic macular edema (Sohn et al. 2013).  
A lateral scaling factor for any OCT image can be determined using:  
(i) An estimate of the retina to principal plane (a hypothetical plane at which 
all the refraction in the lens system can be considered to happen) 
distance, taken as AEL minus 1.6 mm for the purposes of this study 
(representing the cornea to principal plane distance, from Gullstrand’s 
exact schematic eye; Bengtsson and Krakau 1992).  
(ii) The scan angle of an image in air.  
(iii) An estimate of the bulk ocular refractive index.  
The on-board software of two commercial (Topcon and Zeiss) instruments 
used in this study provide only a single lateral scaling value for all patients 
regardless of AEL, resulting in an error in the reported size of the image which scales 
with AEL. This error manifests as a discrepancy between the fixed size ETDRS grid 
(which does not compensate for AEL) and the AEL-dependent image size. Therefore, 
the position of retinal layer measurements and hence the regional thickness values 
become AEL-dependent; an important consideration when comparing different OCT 
instruments. Converting all image files to a compatible TIFF format allowed input of 
an independently calculated, AEL-dependent lateral scaling into the Iowa Reference 
Algorithms, for images from all devices.  
The following study had one primary and two secondary aims:  
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Primary aim:  
1) To investigate the importance of biometric considerations and image scaling 
by comparing the segmentation of the Iowa Reference Algorithms on images 
from various (conventional and long-wavelength) OCT devices using both 
fixed-AEL and AEL-dependent scaling.  
Secondary aims:  
2) To evaluate the inter-session repeatability of the intra-retinal layer 
segmentation performed by the Iowa Reference Algorithms and the on-board 
commercial segmentation software, on healthy eyes.  
3) To assess agreement in retinal thickness values generated by the Iowa 
Reference Algorithms and the on-board commercial segmentation software.  
Since the primary aim is the most pertinent to this thesis, it will be discussed 
here in detail.  A detailed report addressing the two secondary aims (not directly 
relevant to this work) can be found in Terry et al. (2016) and Appendix G.  
 
3.1.2 Methods and protocols  
 
Participants  
Healthy participants (n=25) were recruited from staff, students and 
volunteers at the School of Optometry and Vision Sciences, Cardiff University. All 
participants had a corrected visual acuity of 0 logMAR (6/6) or better using an 
ETDRS chart and a refractive error (mean sphere) of less than ±6.00 dioptres in the 
test eye.  
Exclusion criteria included: posterior ocular pathology such as age-related 
macular degeneration and glaucoma; ocular hypertension (>21 mmHg); narrow 
iridocorneal angles (grade 1 or less assessed by Van Herick); and significant corneal 
or lenticular opacities (Lens Opacities Classification System III grade 4 or more for 
any criteria; Chylack et al. 1993). Grade 4 was selected due to the enhanced imaging 
performance of long-wavelength OCT in the presence of media opacities (Povazay 
et al. 2007). Participants with systemic conditions including diabetes, uncontrolled 
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hypertension and neurological disease were also excluded, as were those taking 
medication known to affect retinal function.  
One eye was selected as the test eye for each participant; this was the eye 
with the better visual acuity (or lower refractive error if one eye was outside the 
refractive range). An average of 4 IOP measurements were taken using non-contact 
tonometry (Topcon CT-1), and one drop of tropicamide 0.5% was instilled into the 
test eye of each participant prior to imaging. Retinal photographs were obtained to 
ensure participants did not have posterior eye disease. AEL (anterior corneal 
surface to RPE) was measured using optical biometry (IOLMaster).  
 
OCT imaging 
Following mydriasis, all participants underwent OCT imaging using a non-
commercial long-wavelength (1040 nm) SD-OCT, a Topcon 3D-OCT 1000, and a 
Zeiss Cirrus HD-OCT 5000. Imaging undertaken with the long-wavelength OCT was 
performed below the recommended maximum power limit for a 10 second exposure 
(less than 2.5 mW at the cornea; ANSI 2000).  
Volume scans centred on the fovea were acquired using each device. To allow 
comparison, all images from the commercial instruments were obtained from a     
20° × 20° field of view, comprised of 512 × 128 a-scans, and were acquired by a 
single trained operator.  
 
Data analysis  
The long-wavelength OCT images underwent dispersion correction to 
convert the raw spectral data (FD1 file format) to logged image data (TIFF file 
format), using custom software in MATLAB. The images were then exported to Fiji, 
where they were converted to 8-bit and cropped along the Y-axis to remove 
artefacts. The images then underwent translational stack registration, and further 
y-axis cropping to remove artefacts from this process (omitting this step resulted in 
misidentification of these artefacts as retinal layer boundaries by the Iowa 
algorithms). The images were then imported to the Iowa Reference Algorithms, 
along with the images from the two commercial instruments which were unaltered. 
In addition, the commercial device images were converted to TIFF format using Fiji 
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and re-imported to the Iowa Reference Algorithms, to allow for manual scaling 
input.  
All OCT images underwent automated retinal layer segmentation using the 
Iowa Reference Algorithms. Retinal thickness was taken as the distance from the 
most anterior hyper-reflective line (corresponding to the ILM) to the posterior of 
the most posterior hyper-reflective line (corresponding to the outer boundary of 
RPE). Mean thickness values for the retina and 10 intra-retinal layers were obtained 
for the foveal subfield and the inner and outer rings of a standard ETDRS grid on all 
images (see Figure 3.1).  
For the commercial instruments, the metadata supplied by the manufacturer 
was used in determining voxel (3-D equivalent of pixel) size, in order to demonstrate 
the importance of correct lateral scaling. In all other cases, including the long-
wavelength OCT images, lateral scaling factors were calculated from the scan angle, 
AEL and an assumed bulk ocular index of 1.336 (Littmann 1982; Bennett et al. 
1994). The axial scaling of each pixel was calculated assuming a mean refractive 
index of the retinal layers of 1.4, 1.38, and 1.36 for the long-wavelength, Topcon, and 
Zeiss instruments respectively (Sidman 1957; Terry et al. 2016). These represent 
the assumptions for refractive index made for each device, and were provided by 
Figure 3.1 ETDRS grid and example 10 intra-retinal layer segmentation. (A) Standard ETDRS 
grid showing the foveal subfield (black). The inner ring is an average of the four parafoveal 
subfields (dark grey) and the outer ring of the four perifoveal subfields (light grey). (B) 10 
layer (11 boundary) segmentation of a long-wavelength OCT image, produced by the Iowa 
Reference Algorithms. The left half of the image shows the image prior to segmentation. Image 
from Terry et al. (2016). 
Layers 1-10 (top to bottom; as defined by the software): retinal nerve fibre layer (RNFL); 
ganglion cell layer (GCL); inner plexiform layer (IPL); inner nuclear layer (INL); outer 
plexiform layer (OPL); outer plexiform layer-Henle fibre layer to boundary of myoid and 
ellipsoid of inner segments (HFL/ONL); photoreceptor inner/outer segments (IS/OS); 
inner/outer segment junction to inner boundary of outer segment photoreceptor/retinal 
pigment epithelium complex (IS/OSJ); outer segment photoreceptor/retinal pigment 
epithelium complex (OPR); retinal pigment epithelium (RPE). 
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the manufacturers of the commercial devices. The percentage differences between 
the fixed-AEL and AEL-dependent scaled measurements were calculated for the two 
commercial devices.  
The mean differences in total retinal thickness between the commercial 
devices and the long-wavelength OCT (assumed as ground truth for this analysis) 
were calculated. This was performed for both fixed-AEL scaling and AEL-dependent 
scaling for the commercial devices. The relationship between retinal thickness 
discrepancies of the scaling methods and AEL was evaluated using Spearman’s rank 
correlation.  
 
3.1.3 Results  
Twenty-five eyes from 25 participants were included in the study. The mean 
age of the participants was 34.9 ± 13.5 years (range 20 to 62 years). Sixteen 
participants were female (64%). The mean AEL and refractive error (mean sphere) 
were 23.7 ± 1.3 mm (range 21.6 to 26.6) and -0.58 ± 1.93 dioptres (range -4.50 to 
+3.00) respectively. The maximum cylindrical power was 3.00 dioptres.  
Table 3.1 Total retinal thickness measurements (mean ± SD; µm) using AEL-dependent and 
fixed-AEL scaling (with the exception of the 1040 nm OCT images). The percentage difference 
between the two scaling methods is shown.  
 Fovea Inner ring Outer ring 
AEL-dependent 
scaling 
1040 nm 270.9 ± 16.8 335.2 ± 17.4 294.0 ± 20.6 
Topcon 284.6 ± 17.0 342.2 ± 18.2 293.2 ± 21.6 
Zeiss 284.8 ± 17.6 347.6 ± 18.3 300.6 ± 21.0 
Fixed-AEL scaling  Topcon 281.5 ± 16.9 342.8 ± 18.0 295.2 ± 21.8 
Zeiss 280.8 ± 17.5 347.0 ± 18.0 302.0 ± 21.4 
Percentage 
difference 
Topcon 1.1% 0.2% 0.7% 
Zeiss 1.4% 0.2% 0.5% 
 
Mean retinal thickness measurements produced with both scaling methods 
can be seen in Table 3.1. The images from the long-wavelength device only 
underwent AEL-dependent scaling, to serve as the ‘ground truth’ for comparison to 
the other devices. Correcting for individual AEL with the Iowa Reference Algorithms 
yielded mean differences of less than 2% in total retinal thickness in all cases, when 
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compared to the fixed-AEL scaled thickness measurements. This difference was 
largest in the foveal subfield. In general, the measured retinal thickness was greatest 
for the Zeiss images, followed by the Topcon, and finally the long-wavelength OCT.  
The Iowa Reference Algorithms returned automated segmentation of 10 
intra-retinal layers for all images. These values underwent AEL-corrected lateral 
scaling as described previously. The percentage difference of these corrected values 
from the fixed-AEL scaling values ranged from -15% to +26% (corresponding to 
Topcon GCL layer/Zeiss RNFL, and Zeiss GCL layer respectively, both in the foveal 
subfield; Table 3.2).  
Table 3.2 Mean thickness (µm) of 10 intra-retinal layers produced by segmentation using the 
Iowa Reference Algorithms with AEL-dependent scaling. Percentage difference from fixed-AEL 
scaling shown in italics, to the nearest percentile (commercial devices only). The largest 
percentage differences are highlighted in grey.  
 
Layer Fovea Inner ring Outer ring 
Topcon Zeiss 1040 
nm 
Topcon Zeiss 1040 
nm 
Topcon Zeiss 1040 
nm 
RNFL 7.0 
-7% 
5.9 
-15% 
5.2 
- 
25.5 
0% 
25.2 
0% 
24.2 
- 
39.3 
-9% 
40.9 
-7% 
39.3 
- 
GCL 17.0 
-15% 
13.4 
26% 
17.2 
- 
48.5 
0% 
52.4 
1% 
50.5 
- 
24.7 
3% 
27.2 
7% 
29.3 
- 
IPL 29.3 
1% 
27.5 
-4% 
24.4 
- 
42.5 
1% 
40.7 
-2% 
39.9 
- 
35.3 
3% 
37.3 
0% 
36.0 
- 
INL 17.7 
-10% 
22.5 
-4% 
18.9 
- 
37.8 
-1% 
43.2 
-1% 
37.5 
- 
28.1 
0% 
32.9 
1% 
29.6 
- 
OPL 23.0 
3% 
20.7 
0% 
20.3 
- 
29.6 
1% 
28.0 
0% 
30.0 
- 
26.2 
2% 
24.1 
2% 
28.4 
- 
OPL-
HFL ~ 
BMEIS 
120.8 
0% 
122.3 
0% 
116.5 
- 
95.5 
1% 
96.9 
1% 
90.3 
- 
79.7 
1% 
79.4 
1% 
71.6 
- 
IS/OS 13.9 
0% 
11.7 
0% 
14.8 
- 
12.6 
2% 
10.3 
1% 
13.7 
- 
12.5 
-1% 
10.2 
-1% 
13.0 
- 
IS/OSJ ~ 
IB_RPE 
17.0 
1% 
19.7 
1% 
17.3 
- 
11.7 
0% 
14.0 
0% 
12.6 
- 
10.3 
0% 
15.5 
-2% 
15.8 
- 
OPR 20.1 
-1% 
20.7 
-1% 
20.6 
- 
19.8 
1% 
21.3 
0% 
20.7 
- 
18.5 
1% 
17.8 
2% 
15.2 
- 
RPE 18.6 
1% 
15.5 
0% 
15.6 
- 
18.6 
0% 
15.5 
-1% 
15.5 
- 
18.6 
-1% 
15.3 
-1% 
15.5 
- 
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Discrepancies in fixed-AEL scaled retinal thickness measurements between 
the commercial and long-wavelength devices showed a strong correlation with AEL, 
for the commercial instrument data, in both the foveal subfield and the outer ring 
(Spearman rank ρ>0.50, P<0.05 in all cases), although only moderate to weak for the 
inner ring (Spearman ρ<0.50). In all cases, the correlation was reduced to an 
insignificant level when the AEL-dependent scaling was used in the comparisons 
between data from the three devices (Figure 3.2).  
 
3.1.4 Discussion  
The Iowa Reference Algorithms produced automated segmentation of 10 
intra-retinal layers on all images from all three devices. A substantial impact of AEL-
corrected lateral scaling on mean intra-retinal layer thickness values was 
demonstrated, particularly for the inner retinal layers. If an AEL-dependent lateral 
scaling is not used, the ETDRS grid (defined in mm units at the retinal surface) will 
overlay a smaller or larger area of retina, depending on the AEL. The ETDRS subfield 
sizes could vary by up to 30%, assuming a normal AEL range of 20 - 28 mm which is 
Figure 3.2 Difference in retinal thickness measurements between devices (µm) versus AEL 
(mm) for the foveal subfield, as produced by the Iowa Reference Algorithms using both scaling 
methods. The 1040 nm OCT images underwent AEL-dependent scaling only, and serves here as 
ground truth.  
*significant at the 0.05 level 
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a little larger than for the cohort of this study. Due to the physiological shape of the 
retina (particularly at the foveal pit), a relative difference in size of the ETDRS grid 
would impact the mean thickness measurements of a given region (Figure 3.3). This 
is reflected in the percentage differences in thickness between the two scaling 
methods, shown in Table 3.2. Appropriate scaling to account for AEL is therefore an 
important consideration for any quantitative retinal thickness analysis, particularly 
in cross-sectional applications.  
Refractive index assumptions for retinal tissue used by each device could 
result in a small difference in axial scaling. Knowing the assumption made by each 
device, a difference in absolute thickness values between instruments of between 
1.4% and 2.9% would be expected, with largest thickness values from the Zeiss 
images (n=1.36), then Topcon images (n=1.38), and finally the long-wavelength OCT 
(n=1.4). This expectation was consistent with the findings in Figure 3.2.  
Discrepancies in retinal thickness measurement between images from the 
long-wavelength and commercial systems were significantly correlated with AEL for 
the foveal and outer ring subfields, using the fixed-AEL scaling. When the AEL-
dependent scaling was used throughout this analysis, all these correlations were 
reduced and were no longer significant (Figure 3.2). This effect is consistent with 
the expected transverse magnification error that arises when fixed-AEL scaling is 
used for images from either of the commercial instruments. The Iowa Reference 
Algorithms allow for direct input of transverse scaling factors prior to image 
segmentation which should be used, where possible, to reduce these demonstrated 
magnification errors.  
Figure 3.3 Differences in AEL-dependent scaling result in a larger or smaller area of retina 
residing within each region of the ETDRS grid (dashed lines). Difference in foveal subfield size 
shown (1 mm in diameter) for lateral scaling assuming an AEL of 20 mm and 28 mm.  
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To conclude, lateral magnification errors affect the consistency and reliability 
of generated thickness values, and are therefore an important consideration in 
quantitative OCT retinal layer analysis. Furthermore, the Iowa Reference 
Algorithms provide a convenient mechanism to apply an accurate AEL-dependent 
lateral scaling to images from any OCT device. This approach should be followed 
where any quantitative analysis with a lateral aspect (i.e. not solely axial 
measurements) is undertaken. These findings are directly applicable not only to 
retinal analysis, but also to choroidal analysis, the principle topic of this thesis. 
Although the likely effect of this error is relatively small, AEL-dependent scaling will 
be incorporated wherever appropriate.  
 
3.2 Choroidal parameter development 
A number of methods of quantifying the choroidal vasculature have been 
previously assessed (see Section 1.7.1). To be an effective parameter, measures 
must be feasible, repeatable, and sensitive to detecting difference between groups 
(cross-sectional) or change over time (longitudinal). Since the images in this thesis 
were acquired using a non-standard OCT device, previously used parameters must 
be validated on these images, prior to application to disease. This section includes 
an evaluation of a number of previously described choroidal measures for feasibility 
and repeatability. These include subfoveal choroidal thickness, vessel diameter, and 
proportion of vessel lumen. The use of a novel parameter describing structure 
complexity is also assessed in Section 3.2.4.  
Inter-session repeatability was established using the dataset described in 
Section 3.1, comprising volume and line scans of healthy eyes, which underwent pre-
processing as described in Figure 2.2. All study participants were asked to refrain 
from drinking tea or coffee on the days of data collection, to control for any potential 
effect of caffeine intake on the choroidal structure (see Section 1.3). To minimise the 
effect of diurnal variation, both imaging sessions were conducted at the same time 
of day. Bland-Altman plots and CoR were used to assess repeatability. A comparison 
is made between the use of volume scans and line scans for the measurement of 
these parameters, where appropriate. Measurement protocols for each parameter 
are described in the following sections, and were performed by one observer, who 
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was masked to previous measurements. All processing steps were undertaken using 
Fiji, unless otherwise stated.  
 
3.2.1 Subfoveal choroidal thickness 
The first parameter assessed was subfoveal choroidal thickness (SFCT). This 
is the most commonly described and applied parameter in the literature, and is one 
of the simplest to perform through manual digital calliper measurement.  
 
3.2.1.1 Methods 
SFCT was defined as a vertical measurement beneath the lowest point of the 
foveal pit, from the posterior border of the outermost hyper-reflective line (RPE) to 
the posterior choroidal stroma, as described by Vuong et al. (2016). For the volume 
scans, surrounding b-scans were used to localise the deepest point of the foveal pit, 
and this b-scan was used for the measurement. The zoom and adjust brightness 
functions were freely used to enhance visualisation of the anterior and posterior 
choroidal boundaries. A single digital calliper measurement was manually 
performed for each volume scan and line scan in the dataset.  
 
3.2.1.2 Results 
 Volume and line scans were acquired from 25 participants at 2 sessions. As 
discussed in Sections 2.2 and 2.5.1, the line scans were over-sampled and underwent 
greater averaging, providing a higher SNR than the volume scans. Of the 25 eyes 
imaged, visibility of the posterior choroidal boundary in the volume scans was poor 
for 4 of the eyes. These 4 eyes were excluded from all volume scan analysis. 
However, this boundary was visible in the line scans of all 25 eyes; hence no eyes 
were excluded from the line scan analysis. For comparison between the scan types, 
a separate analysis of the line scans was performed, excluding the same 4 eyes. The 
demographics of the study participants can be found in Table 3.3. In general, the 
eyes excluded from the volume scan analysis had a shorter AEL and were more 
hyperopic than the included eyes, although this was based on only 4 excluded eyes 
and it is therefore difficult to assess the significance of this observation.  
 Chapter 3 – Evaluation of analysis techniques 
127 
 
Table 3.3 Demographics (mean ± SD) of all study participants, and subdivided into those that 
were included and excluded from the analysis of the volume scans.   
 All participants Included Excluded 
n 25 21 4 
Age (years) 34.9 ± 13.5 36.4 ± 14.1 26.8 ± 4.3  
AEL (mm) 23.7 ± 1.3 23.9 ± 1.3 22.7 ± 1.0 
Refractive error (mean 
sphere; dioptres) 
-0.60 ± 1.9 -0.80 ± 1.9 0.44 ± 1.8 
 
 Mean SFCT of all eyes measured from the line scans was 341.1 ± 132.0 µm, 
although this reduced to 297.1 ± 91.1 µm following exclusion of 4 eyes (Table 3.4). 
SFCT of the excluded eyes (measured from the line scans) ranged from 537 µm to 
595 µm. When the same 4 eyes were removed from the line scan analysis also (for 
comparison only), SFCT was very comparable between scan types (paired t-test, 
P=0.769). Inter-session repeatability was very similar for volume and line scans 
(CoR ~7%). The variation in SFCT between individuals was very high, ranging from 
85.5 to 594.7 µm. There was no significant difference in SFCT between Session 1 and 
Session 2 (paired t-test, P>0.05 in all cases).  
Table 3.4 Mean (± SD) subfoveal choroidal thickness (SFCT) and inter-session CoR in µm and as 
a percentage of the mean SFCT. The larger dataset of line scans is shown separately.  
Scan type Mean SFCT (µm) Range (µm) CoR (µm) CoR (%) 
Volume (n=21) 295.3 ± 87.8 88.0 - 448.7 20.5 6.9 
Line (n=21) 297.1 ± 91.1 85.5 - 457.9 21.1 7.1 
Line (n=25)   341.1 ± 132.0 85.5 - 594.7 24.1 7.1 
 
3.2.1.3 Discussion 
Mean SFCT in this cohort was 341.1 ± 132.0 µm. This is similar to the findings 
of Rahman et al. (2011), who reported a mean thickness of 332 ± 90 µm in a healthy 
cohort of similar age (38 ± 5 years) imaged using Spectralis OCT. The variation in 
thickness between eyes was greater in the present cohort, as was the age range of 
participants (20-62 versus 30-49 years). This may in part account for the variation 
in choroidal thickness, since the choroid has been shown to thin with age (see 
Section 1.3.1). As a result of the demonstrated large variation between healthy 
individuals, large differences in mean choroidal thickness between disease groups 
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(or a large sample size) would be required to reach statistical significance. This 
parameter may therefore not be sensitive to small differences between groups.  
 Conversely, a number of studies have reported a lower mean SFCT than these 
findings (Ding et al. 2011; Lee et al. 2013c). The majority of participants in the 
present study were Caucasian, whilst these two studies were of Asian eyes, which 
are typically more myopic and have a longer AEL, where one would expect thinner 
choroids (see Section 1.3.2). For instance, Lee et al (2013c) reported a mean SFCT 
of ~270 µm, with a mean AEL of 25.11 ± 1.43 mm and a mean refractive error of -
3.27 ± 2.48 D. The difference in mean SFCT between studies could be explained by 
the demographics of the cohorts.  
The inter-session CoR of SFCT was ~24 µm; this represents the normal 
variability that can be expected between imaging sessions with this measurement 
technique in a young, healthy population. Changes between sessions of greater than 
this value may indicate change in the structure beyond normal variation, which 
could be associated with pathology. Rahman et al. (2011) assessed the repeatability 
of SFCT measurements in young, healthy participants (n=50). Intra-observer CoR 
was found to be 23 µm, whilst inter-observer CoR and intra-session CoR were 32 µm 
and 34 µm respectively. Inter-session repeatability was not assessed, but in the 
present study was found to be slightly lower than these values. This may be due to 
the OCT devices used in the studies; Rahman et al. acquired images using a 
conventional-wavelength commercial OCT with EDI, whilst a long-wavelength OCT 
was used in this study. This long-wavelength device may therefore provide an 
advantage over the conventional commercial OCT devices in terms of repeatability 
of SFCT measurement.  
Inter-session repeatability of SFCT was very similar for volume and line 
scans acquired from the same eyes. However, 4 of the 25 eyes were excluded from 
the volume scan analysis due to poor visibility of the posterior choroidal boundary. 
These eyes had the greatest SFCT of the sample (all >530 µm), therefore suffered 
most from the inherent signal roll-off with depth in the images. The SNR was low at 
the posterior choroidal boundary, causing the boundary to be poorly defined and 
not possible to accurately locate. This boundary could be visualised on the line scans 
of all four of these eyes, likely due to the reduced image noise resulting from 
averaging during image processing.  
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There was minimal difference in SFCT measurements acquired from the line 
scans and volume scans. Measurements from these scan types are therefore directly 
comparable. However, since the posterior choroidal boundary was visible in a 
higher proportion of the line scans, this scan type is preferable for use in manual 
measurement of SFCT.  
Since SFCT is a sampled measurement (i.e. measured at a single location), it 
may not be representative of the sub-macular choroid as a whole. An averaged 
measurement of choroidal thickness over a defined area is likely to be more suitable 
for this task. However, since this requires manual segmentation of the anterior and 
posterior choroidal boundaries, it is time consuming and therefore not feasible for 
clinical application. Methods of automated segmentation for fast regional choroidal 
thickness measurement are explored in Section 3.4.  
 
3.2.2 Visible vessel diameter and vessel ratio  
Vessel diameter has been described in the literature as a method for 
quantifying the choroidal vasculature. Approaches to measurement technique vary, 
with some authors measuring the largest visible vessel within a given distance from 
the fovea (Yang et al. 2013), whilst others measure the largest vessel at a predefined 
distance and direction from the fovea (Bittencourt et al. 2014; see Section 1.7.1). 
However, these measurements are susceptible to high inter-observer variability. 
For instance, Yang et al. (2013) defined the limit of acceptable measurement 
difference between observers as 15%. Since the mean vessel diameter of their 
control group was 140 µm, this equates to a difference of ~21 µm. In an attempt to 
minimise the effects of this potential error, this section evaluates the use of multiple 
measurements to produce a mean value for visible vessel diameter (VVD).  
In addition to vessel diameter, Bittencourt et al. (2014) outlined the use of a 
ratio of vessel diameter to choroidal thickness in describing the vasculature. This 
parameter is also evaluated in this section, and will be referred to here as ‘vessel 
ratio’.  
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3.2.2.1 Methods  
VVD was defined as a vertical measurement of the hypo-reflective vessel 
lumen, taken at the point of maximum diameter. For the volume scans, surrounding 
b-scans were used to localise the deepest point of the foveal pit, and this b-scan was 
used for the measurement. The zoom and adjust brightness functions were freely 
used to enhance visualisation of the vessel lumen boundaries. A single digital 
calliper measurement was manually performed for each of the three largest visible 
vessels within 3000 µm nasally and temporally of the fovea (Figure 3.4). This 
ensured that the same area of choroid was included in the volume scans (width 
~6000 µm) and line scans (width ~11000 µm). The vessel ratio (VR) was also 
calculated (VR=VVD/SFCT).  
 
3.2.2.2 Results 
 Of the 25 participants, 4 were excluded from the volume scan analysis due to 
poor visibility of the choroidal vessels. These were the same 4 eyes as were excluded 
from the SFCT analysis (see Section 3.2.1). It was possible to obtain VVD 
measurements from the line scans of all 25 participants.   
 Mean VVD measured from the line scans of all eyes was 152.8 ± 35.7 µm, 
although this reduced to 142.7 ± 28.3 µm following exclusion of 4 eyes (Table 3.5). 
VVD of the excluded eyes (measured from the line scans) ranged from 187 µm to 
231 µm. When these eyes were excluded from the line scan analysis, mean VVD was 
still significantly larger in the line scans than the volume scans (paired t-test, 
P<0.05). Inter-session repeatability was slightly better for the measurements from 
the line scans than the volume scans (CoR of 14.7% versus 21.2%). There was no 
Figure 3.4 Measurement of VVD from a line scan. The three largest vessels were manually 
measured vertically, at the point of maximum diameter (white lines) using digital callipers. 
The mean of these was taken as VVD.  
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significant difference in VVD between Session 1 and Session 2 (paired t-test, P>0.05 
in each case).  
 
Table 3.5 Mean (± SD) visible vessel diameter (VVD) and inter-session CoR in µm and as a 
percentage of the mean VVD. The larger dataset of line scans is shown separately.  
Scan type Mean VVD (µm) Range (µm) CoR (µm) CoR (%) 
Volume (n=21) 122.6 ± 28.8 58.9-185.2 25.9 21.2 
Line (n=21) 142.7 ± 28.3 99.8-186.8 24.0 16.8 
Line (n=25) 152.8 ± 35.7 99.8-231.2 22.4 14.7 
 
 The mean ratio of VVD to SFCT (vessel ratio) was 0.49 ± 0.17 (Table 3.6). The 
vessel ratio of the 4 excluded eyes ranged from 0.33 to 0.39 (due to the high SFCT). 
The CoR of this parameter was lower for the line scans than the volume scans.  
 
Table 3.6 Mean (± SD) vessel ratio and inter-session CoR (also as a percentage of the mean 
vessel ratio). The larger dataset of line scans is shown separately.  
Scan type Mean VR Range CoR CoR (%) 
Volume (n=21) 0.44 ± 0.10 0.30-0.67 0.15 34.6 
Line (n=21) 0.52 ± 0.17 0.32-1.18 0.10 19.1 
Line (n=25) 0.49 ± 0.17 0.32-1.18 0.09 18.4 
 
 The relationships between these parameters and SFCT can be seen in Figure 
3.5. A strong positive correlation was found between the variables, with thicker 
choroids generally having a larger VVD (Spearman’s ρ>0.5; P<0.05). One outlier was 
identified in the VR correlation and was removed from further analysis. A strong 
negative correlation was found between SFCT and vessel ratio (Spearman’s ρ>0.5, 
P<0.05).  
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3.2.2.3 Discussion  
  Based on these repeatability findings, a change in VVD of >22.4 µm is 
required to indicate change in the structure beyond normal inter-session variation. 
Although this is a large difference given the mean vessel diameter, differences 
exceeding this value have been demonstrated with OCT imaging between disease 
and control groups, in both central serous chorioretinopathy (CSC) and posterior 
uveitis (Yang et al. 2013; Bittencourt et al. 2014). The mean absolute difference in 
VVD between sessions was 9.0 µm, which equates to ~5.9% of mean vessel 
diameter. This is far lower than the 15% acceptance criteria employed by Yang et al. 
(2013).  
 Vessel measurements obtained from the line scans were significantly larger 
than those from the volume scans, even when the same 4 images were excluded 
from both sets (paired t-test, P<0.05). Measurements of VVD are therefore not 
directly comparable between scan types. The cause of this discrepancy is unclear, 
Figure 3.5 Scatter plots showing the relationship between (A) mean visible vessel diameter and 
(B) vessel ratio, as a function of subfoveal choroidal thickness. Spearman’s rho (ρ) and 
significance value (P) given. The outlier in plot B was removed prior to correlation testing but 
is included here for demonstrative purposes.  
ρ = 0.805 
P < 0.001 
 
ρ = -0.792 
P < 0.001 
 
A 
B 
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although it may be associated with the averaging of multiple b-scans during image 
processing of line scans. If the b-scans are misaligned, spatial resolution is reduced. 
It is possible that if the stromal space between vessel lumen is small, it may be lost 
during averaging of misaligned b-scans. Although care was taken to ensure this 
error was minimised during image processing, it is likely that a small amount of 
misalignment remained, which may in part explain these findings. The mean VVD of 
the line scans was 152.8 ± 35.7 µm, which is consistent with the healthy control 
group of previous studies; for example the findings of Yang et al. (2013) and 
Bittencourt et al. (2014), who reported mean vessel diameters of 140 ± 40 µm, and 
160 ± 32 µm respectively.  
 A strong positive correlation was found between SFCT and VVD. This 
suggests that, in general, the maximum choroidal vessel size is larger in thicker 
choroids. This is consistent with the findings of Park and Oh (2014), who identified 
a strong positive correlation between these variables in both adults and children. 
Additionally, a strong negative correlation was identified between SFCT and VR; i.e. 
the vessel ratio was lower for thicker choroids. The mean VR in the total sample 
(n=25) was 0.49; therefore the mean diameter of the 3 largest choroidal vessels was 
approximately half of the SFCT. This is lower than the VR of 0.61 reported by 
Bittencourt et al. (2014) on 23 healthy, young participants, despite similar mean 
vessel diameter values. The difference is attributable to the mean SFCT between the 
studies (261.6 ± 45.6 µm versus 341.1 ± 132.0 µm). The far greater variation in 
choroidal thickness in the current cohort (particularly in the upper range) may 
contribute to the difference in VR.  
 One outlier was identified in the correlation of SFCT and VR (Figure 3.5 
Scatter plots showing the relationship between (A) mean visible vessel diameter 
and (B) vessel ratio, as a function of subfoveal choroidal thickness. Spearman’s rho 
(ρ) and significance value (P) given. The outlier in plot B was removed prior to 
correlation testing but is included here for demonstrative purposes. B). This 
participant had a particularly thin choroid (SFCT of 85.5 µm). The largest vessels 
were identified to measure VVD, however these were typically not located directly 
beneath the fovea. In this case, the largest vessels were located elsewhere, in a 
location where the choroid was thicker than beneath the fovea. Since the choroid is 
typically physiologically thickest beneath the fovea, the VR is usually less than 1. 
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However, the VR of this participant was 1.2, as the VVD was larger than the SFCT. 
Since this study was on a healthy cohort and this measure did not follow the 
physiological norm, this measure was classed as an outlier and removed from the 
correlation analysis. However, it should be noted that the vessel ratio may exceed 1 
in pathological eyes, particularly in cases of subfoveal choroidal atrophy.  
Inter-session repeatability of VVD was better for the line scans than the 
volume scans. Due to the averaging applied during processing of the line scans, the 
SNR is higher, and the vessel lumen appear more defined than in the volume scans. 
This allowed greater accuracy in localisation of the lumen boundaries, which likely 
explains the difference in CoR between the scan types. The 4 eyes excluded from the 
volume scan analysis were those with high SFCT (>530 µm) in which visualisation 
of the posterior choroidal boundary was not possible. It was large vessels that were 
of interest for this evaluation, which are located in the outer choroid (Haller’s layer), 
and hence suffer most from signal roll-off in those with a thicker choroid, limiting 
visualisation of the vessel lumen. Despite this, VVD measurements (and hence VR 
calculations) were feasible on all eyes using the line scans. Line scans are therefore 
preferable for manually quantifying vessel diameter in this manner.  
 
3.2.3 Choroidal area, luminal area, and choroidal vascularity index 
The measurements evaluated in Sections 3.2.1 and 3.2.2 were 1-dimensional, 
i.e. lengths. They therefore suffer from the limitations of sampling, since a 
measurement of a single location (or an average of multiple locations) is used to 
describe the structure. These protocols also consider only axial measures for ease 
of image scaling. To minimise the effect of sampling, 2-dimensional measurements 
have previously been considered, including choroidal area and luminal area. These 
are the 2-dimensional counterparts to choroidal thickness and vessel diameter 
respectively, but consider the entire choroid visible in the b-scan, rather than at 
fixed locations. A protocol for obtaining these parameters from OCT line scans using 
image binarization has been described by Sonoda et al. (2014), and has been applied 
to several ocular pathologies (see Section 1.7.1.3).  
Considering VR (the ratio of VVD to SFCT), the corresponding 2-D 
measurement is the ratio of luminal area to choroidal area. This parameter has been 
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previously described by Agrawal et al. (2016a), and termed Choroidal Vascularity 
Index (CVI). This section evaluates the application of these methods to line scans of 
healthy eyes acquired using a non-commercial long-wavelength OCT device.  
 
3.2.3.1 Methods 
 The protocol described by Sonoda et al. (2014) was applied to measure 
choroidal area, luminal area and stromal area, with minor modifications. Firstly, the 
image was cropped to a rectangular area 3000 µm wide (equivalent to the inner ring 
of the ETDRS grid), centred on the deepest point of the foveal pit. The zoom and 
adjust brightness functions were then used freely to enhance visualisation of the 
boundaries of the choroid. The boundaries of the central 1500 µm of choroid were 
selected from the basal margin of the RPE to the choroidal-scleral border, using the 
polygon selection tool (Figure 3.6A). This area was added to the ‘ROI manager’ in 
Fiji.  
 Three large choroidal vessels were identified (it was not possible for these to 
all exceed 100 µm in this dataset, as stated in the original protocol). The mean 
brightness of these vessel lumen was measured, within a circle of 9 pixel diameter, 
using the oval selection tool. The image minimum brightness was adjusted to this 
value to minimise noise (Figure 3.6B), and the image was converted to 8-bit.  
Figure 3.6 Protocol summary for image binarization and parameter measurement. (A) Area 
selection. (B) Adjustment of brightness. (C) Niblack auto local thresholding (Niblack 1986). (D) 
Overlay of binarised image perimeter. 
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Prior to thresholding, a median filter was applied to minimise remaining 
speckle in the image. This was not included in the original protocol, which was 
optimised for images acquired with the Spectralis OCT. Since the images in the 
current dataset were acquired on a non-commercial device, only minimal post-
processing had been applied, and some high frequency noise remained. Following 
the median filter, images underwent Niblack autolocal thresholding (Niblack 1986; 
Figure 3.6C). The binarised image was then converted to a RGB image to allow use 
of the ‘threshold color’ tool. This tool was used to produce an automated outline of 
the binarised perimeter across the image (i.e. the luminal areas). This selection was 
added to the ROI manager, and was combined with the previous selection to produce 
an outline of the luminal areas in the central 1500 µm of choroid only (Figure 3.6D).  
Automated measurements of the choroidal area (CA) and luminal area (LA) 
were then produced using the Analyse>Measure tool in Fiji (with the sum of the 
black areas in pixels taken as LA). The stromal area (SA) was then calculated from 
these values (SA=CA-LA). These values were in pixels, and were converted to mm2 
by multiplying by both the axial and transverse scaling factors. The choroidal 
vascularity index (CVI) was also calculated (CVI=LA/CA) for each image.  
 
3.2.3.2 Results 
 All 25 participants were included in this analysis. Mean choroidal area within 
the central 1.5 mm was 0.484 mm2, of which vessel lumen accounted for 0.367 mm2 
(75.8%). Variation in CA between eyes was high, and ranged from 0.14 to 0.87 mm2. 
CVI ranged from 0.683 to 0.900. There was no significant difference between Session 
1 and Session 2 for any of the parameters (paired t-test, P>0.05 in all cases). Inter-
session repeatability of each parameter is shown in Table 3.7.  
Table 3.7 Mean (± SD) choroidal area (mm2), luminal area (mm2), stromal area (mm2), and 
choroidal vascular index (CVI). Inter-session CoR is given for each parameter, including as a 
percentage of the mean value.  
Parameter Mean ± SD Range CoR CoR (%) 
Choroidal area 0.484 ± 0.178 0.142-0.865 0.051 10.51 
Luminal area 0.367 ± 0.148 0.118-0.730 0.042 11.53 
Stromal area 0.117 ± 0.047 0.024-0.221 0.033 29.01 
CVI 0.758 ± 0.055 0.683-0.900 0.048 6.39 
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The correlation of LA and CVI with CA can be seen in Figure 3.7. A strong 
positive correlation was found between CA and LA, with thicker choroids generally 
having a larger LA (Spearman’s ρ>0.5; P<0.05). There was no linear correlation 
between CA and CVI (Spearman’s ρ=-0.193).  
 
3.2.3.3 Discussion 
 Mean CA in the central 1.5 mm2 was 0.484 ± 0.178 mm2. This is comparable 
to the findings of Gupta et al. (2017), who reported a value of 0.452 ± 0.094 mm2 in 
healthy eyes (n=273). On average, vessel lumen accounted for 75.8% of choroidal 
area, although this value ranged from 68.3 to 90.0% between individuals. This is 
higher than the mean values of 65.4% reported by Sonoda et al. (2014) and 65.6 ± 
2.3% (range 60.1 to 71.3%) by Agrawal (2016a), on healthy individuals using this 
protocol. Following the same protocol, Gupta et al. (2017) reported a CVI of 55.5%, 
which is far lower than the present study. However, this was on an older cohort with 
ρ = 0.987  
P < 0.001 
 
ρ = -0.193  
P = 0.355 
 
A 
B 
Figure 3.7 Scatter plot showing relationship between (A) luminal area and (B) choroidal 
vascular index (CVI), as a function of choroidal area. Spearman’s rho (ρ) and significance value 
(P) given.  
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a mean age of 60.1 ± 6.8 years, which may explain some of the difference between 
these findings.  
This protocol was optimised for images from the Spectralis OCT, whereas the 
current study utilised a non-commercial long-wavelength device. The images from 
the commercial device undergo pre-processing, including averaging of 100 b-scans 
to improve SNR. This may contribute to the discrepancy between these values of 
CVI. Branchini et al. (2013) reported a light to dark pixel ratio of 0.27, which equates 
to a CVI of 78.7%. This is a more similar value to the findings of the current study. 
Images in that study were acquired on a Cirrus OCT device, and utilised an 
alternative thresholding method, which may contribute to the difference in findings 
between studies.  
Both CA and LA had a reasonable CoR (0.051 mm2 and 0.042 mm2 
respectively). A change in CA of >0.051 mm2 (or luminal area of > 0.042 mm2) would 
suggest structural change beyond normal variation. Following the same 
measurement protocol, Sonoda et al. (2014) identified a mean difference between 
eyes with AMD and healthy controls of ~0.049 mm2 in CA and ~0.033 mm2 in LA, 
which is slightly lower than these values. However, mean differences exceeding 
these CoR values have been demonstrated in CSC and diabetic retinopathy (Agrawal 
2016b; Gupta et al. 2017).  
 There was a strong positive correlation between CA and LA, which is 
unsurprising given the relationship between SFCT and VVD demonstrated 
previously. There was no correlation between CA and CVI. This indicates that there 
is no relationship between SFCT and proportion of vessel lumen. This is in contrast 
to the VR parameter evaluated in Section 3.2.2, which showed a strong negative 
correlation. However, this finding is in agreement with Wei et al. (2016) who found 
CVI to not be influenced by choroidal thickness.  
 In conclusion, all the parameters evaluated are feasible for application to line 
scans acquired by the non-commercial long-wavelength OCT device. All parameters 
demonstrated reasonable inter-session repeatability. However, CVI should be used 
with caution due to limited agreement with the published literature, and the use of 
a protocol not optimised for use with this OCT device.  
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3.2.4 Enface analysis 
The previous method of quantifying vessel area ratio considered the entire 
choroidal depth in a single b-scan. This includes a spectrum of vessel sizes, from the 
small vessels of the choriocapillaris to the large vessels of Haller’s layer. During 
image thresholding, fine detail from the anterior choroid is often lost (as can be seen 
in Figure 3.6D). Pathology primarily affecting this smaller vasculature may therefore 
not be detectable using this method. An alternative measurement method would be 
to quantify all vessels at a predefined depth in the choroid. Sohrab et al. (2012) 
analysed enface OCT images of the choroid at varying depth, producing a parameter 
they termed ‘choroidal vascular density’. This was defined as the ratio of black pixels 
(representing vessel lumen) to total image pixels (similarly to CVI at a fixed 
choroidal depth), following a custom thresholding protocol. Due to the ambiguity of 
this term (density may be taken to represent vessels per unit area), this parameter 
will be referred to here as ‘luminal area ratio’.  
Measuring vessel lumen area relative to total area does not provide 
information on the size of features in the image, in this case vessels. For instance, a 
choroid containing many small vessels may produce a similar luminal area ratio to 
a choroid with fewer large vessels. A novel parameter was therefore evaluated for 
describing feature complexity. The perimeter of the vessel lumen in a binarised 
image is relatively simple and easy to obtain, and can be reported as a proportion of 
total image pixels, termed ‘luminal perimeter ratio’. This section evaluates the 
feasibility and repeatability of quantifying the vasculature at a set choroidal depth 
using enface OCT images.  
 
3.2.4.1 Methods  
As outlined in Section 2.3.3.2 (and Appendix B), all volume scans were 
flattened to the outermost hyper-reflective line (RPE) to ensure that a consistent 
choroidal depth was selected across the image. To account for the large variation in 
SFCT in this cohort, a percentage depth from RPE to posterior choroidal boundary 
was utilised, rather than an absolute depth beneath the RPE. An arbitrary depth of 
50% was selected to ensure sufficient vessel resolution (i.e. to avoid inclusion of the 
small vessels of the choriocapillaris). This depth also minimised inclusion of sclera 
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at the edges of the enface image, caused by the physiological thinning of the choroid 
with increased distance from the fovea (as seen in Figure 3.8).  
The processing steps are summarised in Figure 3.8. Firstly, a rectangular 
region was selected at 50% choroidal depth, of full image width and height of 5 
pixels. This was resliced then underwent median Z-projection to produce an enface 
image. The artefacts from stack registration were cropped from the image. The 
image was then duplicated, and a median filter applied to each image, one with a 
radius of 4 pixels (to remove high frequency noise) and the other with a radius of 50 
pixels. The first image was then divided by the second to control for any large 
intensity fluctuation across the image. This step was necessary to prepare the image 
for application of a global Otsu threshold to produce a binarised image.  
 The luminal area ratio (LAR) was calculated by dividing the number of black 
pixels by total image pixels. Similarly to the measurement of LA in the previous 
section, the image was converted to RGB, and ‘color threshold’ tool was used to 
measure the perimeter of the luminal area. The perimeter was divided by total 
image pixels to produce luminal perimeter ratio (LPR), a gross measure of feature 
complexity.  
 To test the discriminative abilities of the parameters, different choroidal 
depths were used as a proxy for different disease states. The above protocol was 
therefore repeated to produce an additional set of enface image at 25% choroidal 
depth from the RPE, where vessels should appear anatomically different (Spraul et 
Figure 3.8 Summary of protocol for producing binarised enface images at 50% choroidal 
depth.  
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al. 1999). A Wilcoxon signed ranks test was used to test whether the difference 
between depths was statistically significant.  
 
3.2.4.2 Results 
Since this analysis was using the volume scans, the 4 eyes with poor 
visualisation of the choroidal vessels were excluded (as for the previous analyses). 
The mean LAR at 50% choroidal depth was 0.595 ± 0.031. The mean LPR was 0.113 
± 0.002. There was no significant difference between Session 1 and Session 2 for 
either parameter (Wilcoxon, P>0.05). Inter-session repeatability is shown in Table 
3.8.  
Table 3.8 Mean (± SD) luminal area ratio and luminal perimeter ratio at 50% depth. Inter-
session CoR given for each parameter, including as a percentage of the mean value.  
Parameter Mean ± SD Range CoR CoR (%) 
Luminal area ratio 0.595 ± 0.031 0.527 - 0.644 0.033 5.48 
Luminal perimeter ratio 0.113 ± 0.002 0.096 - 0.156 0.012 10.75 
 
A representative example of the binarised enface images at 25% and 50% 
choroidal depth can be seen in Figure 3.9. In general, the images at 50% displayed 
larger vessels. A comparison between choroidal depths at Session 1 can be seen in 
Figure 3.10. The mean LAR at 50% and 25% depth was 0.599 ± 0.031 and 0.594 ± 
0.030 respectively. This difference was not statistically significant (Wilcoxon, 
P=0.970). The mean LPR at 50% and 25% depth was 0.111 ± 0.017 and 0.125 ± 
0.012 respectively. This difference was statistically significant (Wilcoxon, P<0.001). 
Figure 3.9 Binarised enface OCT images from the same eye show larger vessels at 50% depth 
(A) than at 25% depth (B) beneath the RPE.  
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3.2.4.3 Discussion 
 On average, vessel lumen accounted for 59.5 ± 3.1% of choroidal tissue at 
50% depth. This is similar to the findings of Kuroda et al. (2016), who reported a 
value of 53.8 ± 4.3% on healthy eyes. This was using a similar protocol, including 
Otsu thresholding, and was conducted on images acquired using a commercial long-
wavelength OCT device. However, these values are lower than those reported by 
Sohrab et al. (2012). Following a custom analysis program to process and threshold 
images, they found vessel lumen to constitute 75.9 – 88.4% of the middle vessel 
layer and 79.3 – 87.2% of the outer vessel layer. This study was conducted on images 
from a Cirrus HD-OCT. The difference in values between the studies is likely 
attributable to the differences in thresholding protocol and OCT device (and 
therefore image scaling) used.  
 Both LAR and LPR had a reasonable inter-session CoR (0.033 and 0.012 
respectively). Therefore to indicate structural change beyond normal variation, an 
increase in these values of >3.3% and >1.2% would be required. When applying the 
protocol to eyes with early AMD, the mean difference between the disease and 
control groups was 3.3% in the middle vessel layer (Sohrab et al. 2012). To date, it 
has not been applied to late-stage AMD. Kuroda et al (2016) identified a large mean 
difference in this parameter between their CSC and control groups (~11.0%). It is 
therefore feasible for this difference to be detectable in pathology. To the author’s 
knowledge, no previous studies have investigated LPR in choroidal OCT imaging, or 
in AMD patients.  
Figure 3.10 Comparison of Session 1 mean luminal area ratio (A) and mean luminal perimeter 
ratio (B) for enface slices at 50% and 25% choroidal depth. Error bars represent the standard 
error of the mean. The difference between depths was not significant for luminal area ratio 
(P=0.970), but was significant for luminal perimeter ratio (P<0.001). 
 Chapter 3 – Evaluation of analysis techniques 
143 
 
 When comparing the two different depths in the choroid, there was no 
significant difference in LAR. This indicates that either there is no difference 
between these depths, or that this parameter is not sensitive enough to detect a 
small difference between the two choroidal depths. Given the physiology of the 
choroidal structure, and the detectable difference in vessel appearance perceived by 
the observer (as seen in Figure 3.9), one can assume that there is truly little 
difference in LAR between 50% and 25% choroidal depth. However, since these are 
healthy eyes, it is possible that a change in this parameter would be detectable 
between disease and control eyes, attributed to vessel changes such as dropout (e.g. 
AMD) or engorgement (e.g. CSC).  
 Conversely, LPR was significantly higher at 25% than 50% depth in the 
choroid. This novel parameter provides a gross measure of feature complexity, with 
finer detail features (i.e. multiple small vessels) yielding a higher ratio. This may 
therefore be useful in quantifying differences in feature complexity between disease 
and control groups, which could be attributable to structural change such as vessel 
dropout, known to occur in AMD (Ramrattan et al. 1994; Chirco et al. 2016).  
In conclusion, both parameters evaluated are feasible for application to 
enface images acquired with this non-commercial long-wavelength OCT device. 
Both parameters demonstrated reasonable inter-session repeatability. It should be 
noted that the use of LAR alone does not fully describe the features within the enface 
image, and it is possible for two images with obvious differences in vessel structure 
to yield similar results. LPR can therefore be used alongside this parameter as a 
gross measure of vessel complexity.  
 
3.2.5 General discussion  
In this section, a total of eight parameters (including one novel parameter) 
were evaluated for feasibility and inter-session repeatability on a dataset 
comprising images of 25 healthy eyes, acquired with a non-commercial long-
wavelength OCT device. All parameters were feasible and demonstrated reasonable 
repeatability (CoR ranging from 5.5% to 18.4%). Each parameter will therefore be 
applied to a dataset comprising images of early and late-stage AMD, along with 
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healthy age-similar controls, to assess their sensitivity to detecting difference in 
structure between disease stages (see Section 4.4).  
 Several parameters were measured on both line and volume scans, to 
identify which scan type was more appropriate to use. Although the inter-session 
repeatability was usually similar between scan types, 4 eyes were excluded from 
some of the volume scan analyses due to poor visualisation of the vessels. No eyes 
were excluded from the analyses of the line scans. Therefore, line scans should be 
used (where possible) to conduct 1-D or 2-D measurements of the b-scans. However, 
volume scans are required for the production of enface images, and hence the enface 
parameters that were evaluated. Therefore, both scan types should be collected for 
the AMD dataset, and quantified according to Table 3.9.  
Table 3.9 Summary of parameters for quantification of choroidal vasculature using each scan 
type.  
Line scan Volume scan 
Subfoveal choroidal thickness (SFCT) Luminal area ratio (LAR) 
Visible vessel diameter (VVD) Luminal perimeter ratio (LPR) 
Vessel ratio (VR)  
Choroidal area (CA)  
Luminal area (LA)  
Choroidal vascular index (CVI)  
 
3.3 Three-dimensional analysis of choroidal vasculature 
The OCT volume scans acquired represent the choroid in three-dimensions. 
The low contrast and low SNR inherent to these choroidal images would be expected 
to make 3-D structural analysis difficult. However, given the availability and value 
of many 3-D techniques in other areas (e.g. 3-D skeletonization/connectivity; 
Kohjiya et al. 2006; Reif et al. 2012; Jin and Kim 2017), it was necessary to further 
explore the feasibility of a 3-D analysis approach.  
The first stage of 3-D analysis is to identify the features of interest within an 
image, in this case the choroidal vessel lumen throughout the volume scan. Most 
simply this could be achieved using a manual segmentation approach. However, this 
is time-consuming and open to subjectivity, and was therefore not considered a 
feasible approach for a large numbers of volume scans. Therefore, automated 
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segmentation of the choroidal vessels, similar to the approaches described in 
Section 1.7.2.2 (Zhang et al. 2012; Kajić et al. 2013), was attempted using Fiji. To 
maximise the likelihood of success and limit the impact of low contrast and poor 
SNR previously identified, it was decided that the 6° volume scans would be used, 
which were shown to provide optimum image quality due to greater image sampling 
(see Section 2.5.1).  
Images were resliced to produce an enface view, and underwent noise 
reduction (median filtering), as described in Section 3.2.4 (enface analysis). Otsu 
thresholding was then applied to the enface images to automatically identify the 
vessel lumen. To evaluate the feasibility of this technique as a precursor to 3-D 
analysis, the results from individual binarised image frames were compared to 
manual segmentation by a clinical observer familiar with OCT images of the choroid 
(an example is shown in Figure 3.11).  
Although there was similarity between the binarised images produced 
through manual and automated segmentation, the Otsu thresholding resulted in a 
large number of high frequency noise artefacts, particularly in low contrast regions 
of the image. In an attempt to minimise this, a median filter was used to remove 
outliers, which were defined as clusters of black or white pixels with a radius ≤2 
pixels. Despite this, some regions remained (visible particularly in the lower part of 
Figure 3.11C). These regions were generally not consistent between neighbouring 
image frames, and hence produced poor continuity during attempted construction 
of a 3-D model (Figure 3.12).  
Figure 3.11 Comparison of choroidal vessel identification methods. An enface image was 
produced from a 6° volume scan, which underwent noise reduction (A). From this image, the 
vessel lumen were manually segmented (B) and automatically segmented using Otsu 
thresholding (C).  
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Unlike the highly-averaged line scans used to establish choroidal area in 
Section 3.2.3, these volume scans did not undergo averaging, resulting in maintained 
spatial resolution but a relatively low SNR. Furthermore, the contrast between the 
vessel lumen and surrounding tissue was low, despite the image enhancement 
during post-processing (median filtering). This resulted in inconsistent vessel 
segmentation between image frames, which was not sufficient for subsequent 3-D 
analysis. It was therefore decided that 3-D structural analysis of the choroidal 
vasculature was not feasible on this dataset. However, this should be revisited with 
the advent of swept source long-wavelength OCT, which demonstrates reduced 
signal roll-off and a higher scanning rate (see Section 1.5.3), facilitating the 
acquisition of higher quality images than those acquired for this study.  
Texture analysis has been shown to be an effective technique for automated 
extraction of shape and orientation information from OCT images with relatively 
low contrast and SNR (Koprowski et al. 2013; Srinivasan 2014b; Albarrak et al. 
Figure 3.12 A 3-D model of the choroidal vasculature in the 6° × 6° volume scan, produced 
using automated Otsu thresholding to identify the vessel lumen. The vascular structure is 
largely obscured by high frequency noise in the binarised image.  
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2016). The application of this technique to describing changes to the choroidal 
structure in AMD is explored in Chapter 5.  
 
3.4 Automated choroidal segmentation 
Since the majority of parameters described in Section 3.2 required manual 
measurement, they were time consuming, relied on an experienced observer, and 
are likely limited by inter-observer variability (see Section 2.4.2). This in turn limits 
the feasibility of application of these parameters to clinical assessment. This section 
therefore evaluates two methods for automated segmentation of the choroidal layer, 
as a means of producing fast, automated choroidal thickness and volume 
measurements, with a view to clinical application.  
The majority of data presented in this thesis were obtained using a non-
commercial long-wavelength OCT, principally due to control of scan parameters (a 
facility generally restricted on commercial devices) and the increased penetration 
necessary for choroidal imaging. However, the Topcon DRI OCT Triton was released 
in Europe in March 2015; after commencement of this work. With the availability of 
a commercial equivalent of the equipment described in this thesis, it can reasonably 
be expected that future work would be conducted using such a device, particularly 
for applications in a clinical setting. The following therefore describes a short 
investigation of the imaging system capabilities, and the on-board analysis of this 
device, as well as the performance of a device-independent segmentation software 
on these images.  
 
3.4.1 Background 
As described in Section 3.1, the Iowa Reference Algorithms is device-
independent software for multi-layer segmentation of OCT images. In 2015 (version 
4.0), a choroidal segmentation module was added, allowing automated choroidal 
thickness values to be produced for images from multiple OCT devices. Since the 
commercial devices used in Section 3.1 were not optimised for choroidal imaging, 
the capabilities of this segmentation were not evaluated. However, a commercial 
long-wavelength OCT dataset would be ideal for this purpose, since it is optimised 
for choroidal visualisation in a clinical setting.  
148 
 
The on-board analysis software of the DRI OCT Triton is capable of producing 
automated segmentation of the choroidal layer on images acquired on the device, 
within minutes of image acquisition. This can be used to generate choroidal 
thickness maps which can be reviewed by the clinician.  
The aim of the following study was to investigate the intra-session 
repeatability of both choroidal segmentation algorithms on images from a 
commercial SS-OCT device, and to determine the agreement in automated choroidal 
thickness measurements.  
 
3.4.2 Methods and protocols 
Healthy participants (n=24) were recruited from staff, students and 
volunteers at the School of Optometry and Vision Sciences, Cardiff University. All 
participants had no known ocular pathology. Two 20° × 20° (512 × 256) macular 
volume scans were acquired from the same eye within a 15 minute period, using the 
Topcon DRI OCT Triton (λc≈1050 nm). Participants did not undergo mydriasis prior 
to imaging, and images were acquired under minimal room lighting.  
All images underwent fully automated choroidal segmentation with the on-
board analysis software. AEL data for each participant (measured using an 
IOLMaster) was entered into the electronic patient record prior to image 
acquisition, and a correction for biometry was then made automatically by the 
system during lateral image scaling. The exact correction made is unknown, as this 
information has not been made available by the manufacturer. All images were also 
exported from the software, and underwent automated choroidal segmentation 
using the Iowa Reference Algorithms. Again, AEL-dependent scaling was used to 
minimise errors associated with ETDRS grid positioning (see Section 3.1).  
Mean choroidal thickness in 9 ETDRS subfields was produced for each image 
using both segmentation methods (Figure 3.13). Bland-Altman plots and CoR were 
used to assess intra-session repeatability and agreement of automated choroidal 
thickness measurements produced by the algorithms. The relationship between the 
absolute choroidal thickness difference between algorithms and mean choroidal 
thickness was investigated. A least squares linear regression was used to assess the 
statistical significance of the relationship between mean choroidal thickness and 
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agreement between segmentation methods (F statistic; P<0.05). A paired samples t-
test was also used to determine if the thickness values produced by each algorithm 
were significantly different (P<0.05). With no correction for multiple comparisons, 
the chance of finding one or more significant differences in 9 tests was 37%. 
Therefore, a Bonferroni adjustment was made to account for these multiple 
comparisons, by reducing the critical value from 0.05 to 0.006 (for n=9 comparisons; 
Altman 1991).  
3.4.3 Results 
Twenty-four eyes from 24 participants were included in the study. The mean 
(± SD) age of participants was 34.3 ± 13.5 years (range 19 to 63 years). Thirteen 
participants were female (54%). An automated segmentation result was produced 
for all images, by both algorithms.  
Mean choroidal thickness for 9 ETDRS subfields is shown in Table 3.10. The 
Triton on-board segmentation produced greater mean choroidal thickness values 
than the Iowa Reference Algorithms, in all subfields. The mean difference between 
algorithms was greater in the temporal and superior subfields, than the nasal and 
inferior subfields. However, the difference between algorithms was only statistically 
significant for the S2 subfield, and was no longer significant when a Bonferroni 
adjustment was applied.  
Figure 3.13 Example ETDRS grid overlays from (A) Triton on-board software; mean thickness 
(µm), and (B) Iowa Reference Algorithms; mean thickness (and SD; µm).  
A B
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Table 3.10 Comparison of mean choroidal thickness (CT; µm) produced by the two 
segmentation methods.  
ETDRS 
subfield 
Mean CT (Triton on-board 
segmentation; µm) 
Mean CT (Iowa Reference 
Algorithms; µm) 
P (t-test) 
F 268 245 0.074 
N1 246 232 0.156 
N2 193 188 0.511 
I1 259 236 0.103 
I2 244 220 0.075 
T1 268 238 0.061 
T2 260 227 0.055 
S1 281 245 0.053 
S2 275 237   0.033* 
*significant at 0.05 level  
 
There was no significant bias in choroidal thickness in the first and second 
set of acquired images, for either algorithm (paired t-test; P>0.05 in all cases). The 
CoR of both segmentation methods is shown in Figure 3.14. CoR was consistently 
lower for the Triton on-board segmentation than the Iowa Reference Algorithm 
segmentation, with the exception of the foveal subfield. A representative example of 
the Bland-Altman plots for each algorithm is shown in Figure 3.15.  
 
In general, the CoR was higher for thicker choroids. However, the 
relationship between absolute difference and mean thickness was only statistically 
significant for a subset of ETDRS subfields (Table 3.11). These subfields were not 
Figure 3.14 (A) ETDRS subfields; F=Foveal, N=Nasal; T=Temporal; S=Superior; I=Inferior. CoR 
(µm) for mean choroidal thickness values produced by (B) the Triton on-board software, and 
(C) the Iowa Reference Algorithms.  
A B  C 
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consistent across both segmentation algorithms (N2 for the Triton on-board 
segmentation, and F and I1 for the Iowa Reference Algorithms).  
Table 3.11 Mean difference (bias; µm) and 95% limits of agreement (µm) for mean choroidal 
thickness produced by each segmentation algorithm. P values represent statistical significance 
of the relationship between mean thickness and absolute difference between algorithms.    
ETDRS 
subfield 
Mean 
difference 
(µm) 
Limits of 
agreement (µm) 
P (F statistic)  
Triton on-board  
P (F statistic) 
Iowa Ref 
Algorithms 
F 22.3 -91.8 to 136.4   0.019*     0.002** 
N1 13.7 -76.1 to 103.6   0.008* 0.232 
N2 4.4 -58.7 to 67.5     0.005** 0.148 
I1 22.7 -105.6 to 151.0   0.039*     0.004** 
I2 23.3 -97.1 to 143.8   0.023* 0.469 
T1 29.9 -115.6 to 175.3   0.031* 0.465 
T2 33.2 -124.2 to 190.6 0.122 0.887 
S1 35.8 -132.6 to 204.2 0.090 0.479 
S2 38.1 -123.5 to 199.9 0.179   0.033* 
*significant at 0.05 level  
**significant with Bonferroni adjustment  
 
3.4.4 Discussion 
The Triton on-board software demonstrated better repeatability than the 
Iowa Reference Algorithms for these images. This was likely a result of optimisation 
Figure 3.15  Example Bland-Altman plots for intra-session repeatability of both segmentation 
algorithms; subfield I1 (representative of the 9 subfields). Solid line = mean difference; dashed 
lines = 95% limits of agreement.  
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of the segmentation algorithms for images from the parent device. The Iowa 
Reference Algorithms segmentation failed to accurately identify the posterior 
choroidal boundary on a number of images (Figure 3.16), resulting in an overall 
underestimation of mean choroidal thickness and a poorer repeatability. The 
difference in choroidal thickness between segmentation methods was not 
statistically significant, although was likely large enough to be considered clinically 
significant (ranging from 4.4 to 38.1 µm). This bias was more prominent for thicker 
choroids in several subfields (Table 3.11), where signal roll-off had a greater effect 
(i.e. it was more difficult to visualise the choroid-scleral boundary). In addition, the 
mean thickness difference between algorithms was lower in regions where the 
choroid is physiologically thinner (particularly subfield N2, due to its proximity to 
the ONH), providing further support for this argument.  
To summarise, the Triton on-board segmentation produced automated 
choroidal thickness values with high intra-session repeatability. It is therefore a 
potential method of automated segmentation of the choroid in healthy eyes, in 
future work. The Iowa Reference Algorithms had a relatively high frequency of 
posterior choroidal boundary misplacement, and is therefore not suitable for 
Triton on-board segmentation  Iowa Reference Algorithms 
Figure 3.16 Example choroidal segmentations, demonstrating good agreement between 
algorithms (top row) and poor agreement (bottom row). The images in the left column were 
exported directly from the Triton on-board review software, where they had undergone 
automated image enhancement for viewing purposes. The raw image files were imported into 
the Iowa algorithms (right column); this is why the contrast appears different between 
segmentation methods.  
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automated segmentation of images from the Triton device at this time. It may be 
possible to optimise the algorithm for these images, or conversely that the images 
could be manipulated to achieve repeatable segmentation (e.g. image 
brightness/contrast), although this would require further investigation. It should be 
noted that the version of the Iowa Reference Algorithms with the facility for 
choroidal segmentation (version 4.0.0 beta) is an experimental release, undergoing 
continued improvements. It is investigational software only, and is not approved for 
clinical use at this time.  
The majority of studies within this thesis utilised images acquired using a 
non-commercial device, which these segmentation algorithms have not been 
optimised for, and hence would be likely to perform poorly. Additionally, this study 
included only healthy eyes; a lower repeatability for segmentation of eyes with 
retinal pathology would be expected, due to reduced visibility of the choroidal 
boundaries. Therefore, all choroidal segmentation in this thesis was conducted 
using a manual segmentation protocol, as described and validated in Section 5.1.1.  
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4 Manual quantification of choroidal vasculature in AMD 
 
Having evaluated the feasibility and inter-session repeatability on healthy 
eyes (Section 3.2), the eight manual choroidal parameters could now be applied to 
a dataset of long-wavelength OCT images acquired from individuals with various 
stages of AMD. By doing this, these parameters could be assessed for their ability to 
quantify the choroidal structure throughout the disease process (furthering our 
knowledge of choroidal involvement in the pathogenesis of AMD), and for their 
diagnostic potential. This chapter describes the process of constructing this dataset, 
including participant identification and data collection (Section 4.1). A custom 
protocol for clinical classification of AMD disease severity, adapted from the AREDS 
classification system (AREDS 2001a), is then described and evaluated (Section 4.2). 
The results of a demographic analysis of the participants are presented in Section 
4.3. All statistical analyses were performed in SPSS (version 20; SPSS Inc., Chicago, 
IL), unless otherwise stated. Finally, the results from the application of the manual 
choroidal parameters to the dataset are presented and discussed, in relation to 
detecting and classifying AMD disease stage based on choroidal vascular structure 
(Sections 4.4 and 4.5).  
 
4.1 Participants and preliminary measurements 
The following section describes the identification and recruitment of 
participants for this study, as well as the methodology for the preliminary 
measurements collected. This cohort was used for all analysis in this chapter and 
Chapter 5; the participant demographics are also described in this section.  
 
4.1.1 Power calculation 
To estimate the sample size required to detect a significant difference 
between the disease groups, a power calculation was performed. Since vessel 
diameter was a relatively simple parameter, this was used to estimate the required 
sample size. No published data was available on changes in vessel size in AMD 
assessed with in vivo imaging, therefore the minimum significant difference and 
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assumed standard deviation were based on histological data. Spraul et al. (1996) 
reported a mean difference of ~8.5 µm in choroidal vessel diameter between eyes 
with AMD and age-matched controls. This difference is theoretically possible to 
detect with the long-wavelength OCT device used, with an axial resolution of ~5 µm 
in tissue. In the same study, the within-group standard deviation was ~10 µm. This 
calculation used the Altman Nomogram (Altman 1991) and the following values:  
Minimum significant difference (δ): 8.5 µm 
Assumed standard deviation (s): 10 µm 
Significance level: 95% 
Power: 90% 
 Using these values, the standardised difference (δ/s) was calculated as 0.85. 
Given the assumptions made in the calculation of standardised difference, a higher 
power than 80% was selected to increase the probability of correctly rejecting the 
null hypothesis, if the alternative hypothesis was true (i.e. to correctly identify a 
difference between disease groups, if such a difference exists). From the Altman 
Nomogram, a sample size of 25 participants per group was therefore required to 
detect a significant difference between groups, with a power of 90%, and 
significance level of 95%.  
 For validation, a further calculation was performed, based on published data 
on choroidal thickness measurement from long-wavelength OCT images of eyes 
with intermediate AMD, nAMD, and healthy controls (Esmaeelpour 2014a). The 
differences between the disease and healthy groups were 110 µm and 88 µm 
respectively, the smaller of these differences was used in this calculation, as well as 
the largest standard deviation of the groups (the healthy group; 95 µm).  This 
yielded a standardised difference of 0.93, resulting in a slightly smaller sample size 
of 23 participants per group, using the same significance level and power as the 
previous analysis. Therefore, a sample size of 25 eyes per group was deemed 
appropriate for the purpose of this research.  
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4.1.2 Participant identification and recruitment 
4.1.2.1 Ethical approval 
Ethical approval for this study was received from the South East Wales 
Research Ethics Committee (Panel D). All participants were provided with a copy of 
the Participant Information Sheet (Appendix D) prior to deciding whether to take 
part in the research. There was no time limit between receiving the information and 
participation in the study (until the end of the data collection period). Written 
informed consent was obtained from all participants on the day of data collection. 
The study adhered to the tenets of the Declaration of Helsinki.   
 
4.1.2.2 Participant recruitment  
Participants with AMD were primarily identified from patients attending 
scheduled outpatient appointments in the medical retinal clinic of Mr Ayed Al-
Bermani, at the University Hospital of Wales.  Additional participants were recruited 
from Cardiff University Optometrists. Healthy participants who acted as controls for 
the study were recruited from Cardiff University Optometrists, or were research 
volunteers at Cardiff University.  
 
4.1.2.3 Inclusion and exclusion criteria 
 A set of criteria for inclusion in the study, and exclusion criteria, are outlined 
below. For inclusion in the study, all participants had to meet all inclusion criteria 
and none of the exclusion criteria.  
Inclusion criteria 
 Aged 55 years or over 
 Male or female  
 With or without clinical signs or diagnosis of AMD 
 Willing and able to give consent and participate in the study 
Exclusion criteria 
 Any of the following ocular conditions: glaucoma; ocular hypertension      
(>21 mmHg); narrow anterior chamber angles (≤Grade 1 with Van Herick); 
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significant cataract (≥Grade 4 on any criterion with LOCS III); significant 
corneal or other media opacity; non-AMD related fundus changes.  
 Any of the following systemic conditions: diabetes mellitus; neurological 
disease (e.g. Alzheimer’s disease, Parkinson’s disease, epilepsy).  
 Currently taking medication known to affect retinal function (e.g. 
chloroquine, tamoxifen).  
 Refractive error ≥ ±6.00 dioptres in the most powerful meridian, or 
astigmatism > 3.00 dioptres.  
 Consumption of caffeinated tea or coffee on the day of data collection.  
 
4.1.3 Preliminary measurements  
To ensure that participants were suitable for inclusion in the study, a series 
of preliminary measurements were obtained. The following section is a list of the 
tests or procedures that were performed prior to OCT image acquisition, in 
chronological order. All tests were performed on both eyes, where possible, and by 
a single registered optometric researcher.  
Consent, medical and ocular history  
 Firstly, written informed consent was obtained. Participants were then asked 
a series of questions about their general health, medication, and ocular history, to 
ensure that they did not meet any of the exclusion criteria listed in Section 4.1.2.3. 
The patient’s sex, age, and ethnicity were also recorded to ensure that the disease 
and control groups were demographically similar (see Section 4.3). Patients were 
also asked to report their history of smoking and anti-VEGF therapy.  
Visual acuity  
 Visual acuity (VA) was measured monocularly using a standard ETDRS 
logMAR letter chart (Ferris et al. 1982). This was performed at 3 m (the distance for 
which the chart was calibrated), and reduced to 2 m or 1 m if the patient was unable 
to read any letters at the standard distance. Participants were encouraged to read 
as many letters as possible on the chart, and the acuity was measured on an 
individual letter basis, and recorded in conventional logMAR notation (i.e. each 
letter was equivalent to 0.02 logMAR).  
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Anterior chamber angle and pupil mydriasis  
 The anterior chamber angle was assessed using the Van Herick technique 
(Van Herick et al. 1969), adjacent to the temporal limbus. To minimise risk of angle 
closure glaucoma induced by pupil mydriasis, participants with narrow anterior 
chamber angles (Grade 0 or 1) did not undergo mydriasis, and were excluded from 
the study. For those with Grade 2 or above, both pupils were dilated using 1 drop of 
Tropicamide 1%. The drug expiry date, batch number, and time of instillation were 
recorded.  
Media assessment 
 The intra-ocular media (cornea, anterior chamber, lens, and anterior 
vitreous) were assessed for clarity using slit lamp biomicroscopy. The LOCS III 
grading system (Chylack et al. 1993) was used to quantify the extent of any opacities 
in the crystalline lens (nuclear, cortical and posterior subcapsular opacities were 
graded separately). Eyes with LOCS III Grade 4 or above in any criterion were 
excluded, as were those with significant corneal opacities. This relatively high grade 
was selected due to the enhanced performance of long-wavelength OCT in the 
presence of media opacities, when compared to conventional-wavelength OCT 
(Povazay et al. 2007).  
Axial eye length  
 Axial eye length (AEL) was measured using optical biometry (IOLMaster). An 
average of 5 measurements was calculated to ensure measurement accuracy. AEL 
was used to establish accurate lateral scaling of OCT images for each eye (see Section 
3.1).  
Refractive error 
 An objective measure of refractive error was obtained using autorefraction 
(KR-7500 Autokeratorefractor; Topcon, Tokyo, Japan). An average of 3 
measurements was used and the spherical and cylindrical components of the 
refraction were recorded. The mean spherical refraction was calculated as the 
spherical component plus half of the cylindrical component. Eyes with a refractive 
error over ±6.00 dioptres in the most powerful meridian, or astigmatism over 3.00 
dioptres, were excluded from the study.  
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Intra-ocular pressure 
 Intra-ocular pressure (IOP) was measured as an average of 4 reading 
acquired using a non-contact tonometer (CT80; Topcon, Tokyo, Japan). Eyes with an 
IOP >21 mmHg were classed as outside the normal range, as defined by the NICE 
guidelines (National Institute for Health and Care Excellence 2009), and were 
excluded from the study.  
Retinal photography  
 Retinal photographs were obtained using a Topcon 3D-OCT 1000 (Topcon, 
Tokyo, Japan). Images were 45° in diameter, centred on the fovea. These 
photographs were used to establish the disease classification of each eye in the 
study, according to the protocols described in Section 4.2.  
Blood pressure  
 Blood pressure (BP) was measured using an automated sphygmomanometer 
(Omron M5-I; Omron Corporation, Kyoto, Japan). A total of 3 readings from the left 
arm were averaged (systolic and diastolic), following a 5 minute seated rest period. 
This directly preceded image acquisition using the long-wavelength OCT.  
Study eye selection 
 If one eye of a participant met any of the exclusion criteria, the other eye was 
automatically selected as the study eye. If both eyes met none of the exclusion 
criteria, one eye was randomly selected as the study eye. Disease classification of the 
fellow eye was noted, but was not used for selection of the study eye (other than in 
the healthy control group, where neither eye had a classification of AMD).  
 
4.2 Clinical classification methodology 
As discussed in Section 1.4.7, imaging technology, understanding of AMD 
pathophysiology, and clinical requirements have changed since the development of 
the majority of classification systems (Klein et al. 1991; Bird et al. 1995; AREDS 
2001a; Ferris et al. 2013; Danis et al. 2013). Some aspects of these systems are now 
either inappropriate or not feasible for use in the contemporary clinical/research 
environment (e.g. stereoscopic retinal photography). Furthermore, OCT is an 
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imaging modality ideal for cross-sectional visualisation of the retina, and is now 
commonplace in the clinical environment, but is yet to be incorporated into a widely 
used classification system. The following section describes the protocol developed 
for categorising participants into disease groups for this thesis.  
The proposed protocol utilised three sources of data available to the 
researchers; retinal photography, OCT imaging, and ophthalmological diagnosis, 
with categorisation based on established AREDS definitions (AREDS 2001a). The 
definitions of macular regions and retinal features were kept largely in line with 
those established by the AREDS classification system, to maximise consistency and 
comparability with existing literature and practice.  
 
4.2.1 Retinal photography 
Retinal photographs (45°) obtained with a Topcon 3D-OCT 1000, centred on 
the fovea, were inspected. The photographs were viewed in a randomised order in 
PowerPoint (Microsoft, Richmond, WA). The image size could be adjusted at user 
discretion using the zoom function, and no time limit was set for assessing each 
image. Overlays of predetermined sizes were provided that could be moved freely 
across the images (but not resized). These were used to display the macula regions 
Figure 4.1  A 45° retinal photograph showing the outer boundary of the ETDRS grid, as defined 
by AREDS (solid line) and AREDS2 (dashed line). The size of a 20° × 20° OCT volume scan is 
shown by the dashed square, assuming an AEL of 24.5 mm.  
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defined by the ETDRS grid, and to determine the size of retinal lesions, such as 
atrophy, drusen or pigmentary disturbances. These overlays were sized according 
to the definitions set out by the AREDS classification (AREDS 2001a). AREDS2 
definitions were not used, as these define the macular region as 7200 µm in 
diameter, which is larger than the OCT images collected as part of this dataset 
(Figure 4.1).  
 
4.2.2 OCT imaging 
The second step was inspection of 20° × 20° (512 × 512) long-wavelength 
(1040 nm) OCT images, centred on the fovea. These were presented in Fiji software, 
in conjunction with the corresponding retinal photograph, for verification purposes. 
This was to ensure that signs of AMD not detected in the retinal photograph 
(particularly subtle signs of nAMD) were not overlooked due to lack of stereopsis. 
Again, the zoom function could be used freely, as could adjustment of brightness and 
contrast. Two optometrists were selected to grade a total of 149 images, and were 
masked to patient identity and data. In cases of disagreement, a classification by a 
third optometrist was used, and the three graders met to discuss each case and 
determine a final classification. If agreement could not be reached, the image was 
deemed ungradable. The classification criteria based on retinal appearance for both 
imaging modalities are shown in Table 4.1.   
Since the aim of this research was to assess parameters for their ability to 
quantify the choroidal structure with advancing disease, the severity groups used in 
the clinical classification were intentionally coarse. Furthermore, the exclusion 
criteria for media opacities in this study was not particularly stringent (LOCS III, 
Grade 4 or above), possibly resulting in a subset of retinal photographs of sub-
optimal quality to allow accurate grading with the 9-point scale utilised in the 
AREDS system (Davis et al. 2005). The disease status of the fellow eye was not 
considered during the classification process (as in the AREDS simplified severity 
scale; Ferris et al. 2005). 
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Table 4.1 Classification criteria for the three disease groups. Area definitions from AREDS 
(2001a): I-1 = 180 µm diameter; C-1 = 125 µm diameter; C-0 = 63 µm diameter.  
Class AREDS 
Level 
Photograph Criteria OCT Criteria 
Neovascular 
AMD 
(nAMD) 
4 
(advanced) 
Presence of ANY of the 
following:  
Fibrovascular/serous PED,  
Serous sensory retinal 
detachment,  
Subretinal/RPE 
haemorrhage, subretinal 
fibrous tissue,  
Photocoagulation for AMD 
Presence of ANY of the 
following:  
Fibrovascular/serous PED,  
Serous sensory retinal 
detachment,  
Subretinal/RPE 
haemorrhage, subretinal 
fibrous tissue,  
Photocoagulation for AMD 
Geographic 
atrophy 
(GA) 
4 
(advanced) 
Sharply demarcated 
depigmentation in central 
subfield, area > I-1 
AND no signs of nAMD 
Depigmentation at fovea, 
diameter > 11 pixels 
laterally 
AND no signs of nAMD 
Early AMD 2 and 3 No signs of GA or nAMD  
AND drusen max size ≥ C-0 
OR drusen total area ≥ C-1 
OR pigmentary changes, area 
≥ C-1 
No signs of GA or nAMD  
AND presence of drusen, 
max size ≥ 4 pixels laterally 
OR pigmentary changes, 
area ≥ 7 pixels laterally 
Normal 1 No signs of GA or nAMD  
Drusen max size < C-0  
AND drusen total area < C-1  
No signs of GA or nAMD  
AND no drusen ≥ 4 pixels 
laterally in size present  
Ungradable N/A Unable to determine a 
classification  
Unable to determine a 
classification  
   
4.2.3 Ophthalmological diagnosis  
The final aspect of this classification protocol was diagnosis by a consultant 
ophthalmologist. This was only used to determine a classification of inactive nAMD, 
following anti-VEGF treatment. In some cases, these patients have very few or no 
remaining signs of a previous neovascular episode, and may be misclassified as early 
AMD or even healthy if a classification is based solely on retinal appearance. This 
was used to override classification by the graders in these cases.  
 
4.2.4 Evaluation of classification system 
  A total of 149 eyes of 77 participants were classified using this approach, to 
evaluate the robustness of the classification system. Each eye was classified 
according to the above protocol, and assigned to one of five categories; normal, early 
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AMD, nAMD, GA, or ungradable (as defined in Table 4.1). Agreement of the two 
primary graders was achieved on 122 of these eyes (~82%; Table 4.2). Almost half 
of the images were of the non-study eye, which were classified to allow further sub-
analysis of fellow eye diagnosis. Since fellow eyes were not subject to the exclusion 
criteria used for the study eye (e.g. media clarity), images from these eyes were often 
of sub-optimal quality and more likely to be ungradable.  
Table 4.2 Inter-grader agreement for classification of all eyes classified during the evaluation 
of this grading system (n=149). Areas of agreement between graders are highlighted in grey.  
 Grader 1 
Normal Early AMD nAMD GA Ungradable 
G
ra
d
e
r 
2
 
Normal 43 4 0 0 0 
Early AMD 3 31 5 1 0 
nAMD 0 1 38 2 3 
GA 0 3 4 7 0 
Ungradable 0 1 0 0 3 
 
The study eye of each participant was selected as described in Section 4.1.3 
(n=75). Considering the classification of these eyes only, agreement between the 
primary graders was achieved on 64 of 75 eyes (~85%; Table 4.3). The largest 
source of disagreement between graders was the early versus nAMD classification; 
5 of the eyes that were classified as nAMD by Grader 1 were classified as early AMD 
by Grader 2. A potential source of these disagreements was the misclassification of 
large confluent drusen as drusenoid PED in the OCT images, and the differentiation 
of inactive nAMD (following anti-VEGF therapy) from early disease. These were the 
main sources of discussion between the three graders concerning disagreements, 
prior to final classification decisions.  
This final classification stage rendered this classification system suitably 
robust for use in this research. Following the group discussion, there were 25 eyes 
classified into each group (healthy, early AMD, and nAMD), agreed upon by all 
graders. Eyes classified as GA or ungradable were not used in further analysis.  
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Table 4.3 Inter-grader agreement for classification of the 75 study eyes used in further 
analysis. Areas of agreement between graders are highlighted in grey.  
 Grader 1 
Normal Early AMD nAMD GA Ungradable 
G
ra
d
e
r 
2
 
Normal 25 1 0 0 0 
Early AMD 2 22 5 0 0 
nAMD 0 0 17 1 0 
GA 0 1 1 0 0 
Ungradable 0 0 0 0 0 
 
4.3 Participant demographics  
A summary of participant demographics is shown in Table 4.4. There were a 
total of 25 participants classified in each group, all of which self-identified as ‘white 
British’. There was no statistically significant difference in the proportion of males 
in each group, nor the proportion of right eyes, pseudophakic eyes, or participants 
with a history of smoking (Chi-squared test; P>0.05). There was also no statistically 
significant difference in age, AEL, refractive error, IOP, systolic BP, diastolic BP, or 
time of day of image acquisition between groups (1-way ANOVA or Kruskal-Wallis 
test; P>0.05 in all cases).  
VA was significantly poorer in the nAMD group than the other two groups 
(Kruskal-Wallis test; P<0.001), although there was no significant difference 
between the healthy and early AMD groups. Many of the participants in the early 
AMD group may therefore be asymptomatic and, without having undergone 
ophthalmological examination, may have been unaware of their condition. This 
highlights the importance of thorough macular assessment in this age group, to 
identify those at risk of developing nAMD, and to inform clinical advice and 
monitoring. 
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Table 4.4 Summary of participant demographics for the 3 groups. Binary parameters are given 
as a percentage, and were tested for significance using a Chi-squared test. Other parameters 
are given as mean ± SD, and were tested for significance using a 1-way ANOVA (parametric) or 
Kruskal-Wallis test (non-parametric#). For VA, post hoc Dunn-Bonferroni analysis revealed 
that the nAMD group was significantly greater than the other two groups.  
Parameter Healthy Early AMD nAMD p 
n 25 25 25 - 
Ethnicity (% Caucasian) 100 100 100 - 
Sex (% male) 44 48 36 0.683 
Test eye (% right eye) 48 60 48 0.618 
Pseudophakic (%) 12 28 32 0.215 
History of smoking (%) 48 52 44 0.852 
Age (years) 73.3 ± 7.9 76.3 ± 7.6 77.7 ± 8.3 0.141 
AEL (mm) 23.44 ± 0.63 23.45 ± 0.95 23.52 ± 0.95 0.927 
Refractive error (dioptres)# 1.19 ± 1.66 0.30 ± 1.58 0.88 ± 1.82 0.342 
VA (logMAR)# 0.05 ± 0.14 0.06 ± 0.14 0.37 ± 0.37 <0.001* 
IOP (mmHg) 13.8 ± 2.2 14.2 ± 3.7 15.0 ± 2.8 0.356 
BP - systolic (mmHg)# 143.0 ± 23.3 149.0 ± 22.6 145.1 ± 23.0 0.773 
BP - diastolic (mmHg)# 77.0 ± 13.2 77.4 ± 9.1 79.1 ± 10.3 0.594 
Time of day# 11:37 ± 01:26 12:08 ± 01:28 12:11 ± 01:36 0.284 
*significant at 0.05 level 
#non-parametric statistical test applied 
 In the nAMD group, the mean number of anti-VEGF injections to the study 
eye was 10.2 ± 5.9 (range 0 to 25). Of the 25 eyes, 23 were currently undergoing 
anti-VEGF therapy; this is high due to the method of participant identification. It is 
unknown which anti-VEGF agent(s) were used to treat each eye, as well as the 
treatment duration. The remaining 2 eyes were treatment-naïve. Since access to 
treatment records were not available for this study, this data was based on self-
reported treatment history, and should therefore be interpreted with caution.  
Where possible, the fellow (non-study) eye was also classified according to 
the classification protocol described in Section 4.2. A summary of these is presented 
in Table 4.5. In total, 8 fellow eyes were ungradable. In the healthy group, this was 
due to presence of epiretinal membrane (n=3), or atypical retinal appearance not 
attributed to AMD (n=2). In the AMD groups, these represented previous trauma 
(n=1), toxoplasmosis scar (n=1), or retinal appearance atypical of AMD (n=1). A total 
of 4 fellow eyes did not undergo classification, since no OCT images were available. 
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This was due to refractive error outside the imaging capabilities of the OCT device 
(n=1), previous trauma resulting in no fundus view (n=1), or unilateral imaging at 
the request of the participant (n=2).  
Over half of the participants in the early AMD group had a fellow eye 
classification of nAMD. This was likely due to the primary source of participant 
recruitment, since the majority of patients attending the ophthalmology clinic had a 
diagnosis of nAMD and were receiving anti-VEGF therapy. However, if changes to 
the choroid precede development of CNV, these may be evident bilaterally, and may 
therefore have an effect on the appearance of the vascular structure in the fellow 
eye. Analysis of fellow eye diagnosis was therefore performed to investigate this 
potential effect.  
Table 4.5 Fellow eye status for all participants included in the study. Bilateral classifications 
(i.e. both eyes with the same disease stage) are highlighted in grey.  
 Study eye 
Healthy Early AMD nAMD 
F
e
ll
o
w
 e
y
e
 
Healthy 18 4 6 
Early AMD 0 7 0 
nAMD 0 12 13 
GA 0 0 3 
Ungradable 5 1 2 
Not classified 2 1 1 
Total 25 25 25 
 
4.4 Manual choroidal vasculature quantification results 
4.4.1 Between-group comparison 
The parameters described in Section 3.2 were obtained from all images in the 
dataset described in Section 4.3 (n=75) by a single observer. To maximise the 
accuracy of measurements, an observer experienced with acquiring and analysing 
long-wavelength OCT images was selected. Although this observer was an 
optometrist with experience in interpretation of OCT images, they were masked to 
the disease classification of the images (as established in Section 4.2) to minimise 
any bias in quantification. The order in which images were analysed was 
randomised for each choroidal parameter evaluated.  
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The mean value (±SD) of each parameter for each disease group is shown in 
Table 4.6. These are presented as bar charts in Figure 4.2, with error bars 
representing standard error of the mean (SE), and significant differences between 
groups indicated with an asterisk (*).  
Table 4.6 Mean (±SD) measurement for each parameter describing the choroidal vasculature, 
for the three disease groups. Significance was tested using a 1-way ANOVA (parametric) with 
post-hoc Bonferroni, or Kruskal-Wallis test (non-parametric#) with post-hoc Dunn-Bonferroni. 
The significant differences were between the healthy and nAMD group, and the early AMD and 
nAMD group, in all cases where P<0.05. SFCT = subfoveal choroidal thickness; VVD = visible 
vessel diameter; VR = vessel ratio; CA = choroidal area; LA = luminal area; CVI = choroidal 
vascularity index; LAR = luminal area ratio; LPR = luminal perimeter ratio.    
Parameter Mean (±SD) measurement p  
Healthy Early AMD nAMD 
SFCT (µm) 237.2 ± 88.9 255.7 ± 103.1 163.2 ± 61.8   0.001* 
VVD (µm) 133.8 ± 33.6 140.7 ± 35.0 118.4 ± 30.0 0.056 
VR# 0.606 ± 0.157 0.609 ± 0.185 0.780 ± 0.214   0.001* 
CA (mm2) 0.311 ± 0.103 0.317 ± 0.106 0.225 ± 0.086   0.002* 
LA (mm2) 0.223 ± 0.076 0.230 ± 0.078 0.158 ± 0.064   0.001* 
CVI# 0.718 ± 0.031 0.725 ± 0.048 0.698 ± 0.064 0.308 
LAR 0.560 ± 0.040 0.567 ± 0.042 0.552 ± 0.052 0.519 
LPR 0.112 ± 0.009 0.110 ± 0.011 0.107 ± 0.011 0.197 
*significant at 0.05 level  
#non-parametric statistical test applied 
SFCT was significantly lower in the nAMD group than both the healthy and 
early AMD groups (Figure 4.2A). There was no statistical significance between the 
healthy and early AMD groups. VVD was also lower in the nAMD group than the 
other two groups; although this did not reach statistical significance (Figure 4.2B; 
P=0.056). VR was significantly higher in the nAMD group than the healthy and early 
AMD groups (Figure 4.2C). Again, there was no significant difference between the 
healthy and early AMD groups.  
In the 2-D analysis (Figure 4.2D-F), choroidal area and luminal area were 
significantly lower in the nAMD group than both the healthy and early AMD groups. 
There was no significant difference between the healthy and early AMD groups. CVI 
was lowest in the nAMD group, although this difference did not reach statistical 
significance (P=0.308).  
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In the enface analysis (Figure 4.2G-H), LAR was not significantly different 
between the three groups. LPR showed a general negative trend with advancing 
disease stage, although this did not reach statistical significance (P=0.197).  
  
4.4.2 Relationship with fellow eye diagnosis 
To investigate the relationship with fellow eye status, the early AMD group 
was subdivided into three subgroups based on diagnosis of the fellow eye; no AMD 
Figure 4.2 Mean values (± SE error bars) for (A) SFCT, (B) VVD, (C) VR, (D) CA, (E) LA, (F) CVI, 
(G) LAR, and (H) LPR, for the three disease groups. SFCT = subfoveal choroidal thickness; VVD 
= visible vessel diameter; VR = vessel ratio; CA = choroidal area; LA = luminal area; CVI = 
choroidal vascularity index; LAR = luminal area ratio; LPR = luminal perimeter ratio. 
*significant at 0.05 level.  
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(n=4), early AMD (n=7), and nAMD (n=12). The parameters showing a significant 
difference (or near-significant in the case of VVD) between disease groups in the 
previous analysis were compared between these subgroups, to identify the presence 
or absence of a gross relationship between fellow eye diagnosis and choroidal 
structure. Since the groups were small, between-group differences were evaluated 
subjectively, and no statistical analyses were performed.  
The mean value of each parameter for each disease subgroup is shown in 
Figure 4.3, with error bars representing standard error of the mean. In general, SFCT 
was higher for early AMD eyes with healthy fellow eyes, than for bilateral early AMD 
or fellow eye nAMD. VR was lowest for the healthy fellow eye subgroup. There was 
little difference between subgroups for VVD, CA, or LA. There was also little 
difference between those with a fellow eye status of early AMD or nAMD, for any of 
the parameters.  
 
 
 
Figure 4.3 Mean values (± SE error bars) for eyes in the early AMD group, sub-divided by fellow 
eye diagnosis. SFCT = subfoveal choroidal thickness; VVD = visible vessel diameter; VR = vessel 
ratio; CA = choroidal area; LA = luminal area.  
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4.4.3 Diagnostic potential 
To investigate the diagnostic ability of the parameters, receiver operating 
characteristic (ROC) curves were produced (Figure 4.4). ROC curves are for 
dichotomous data (i.e. two groups), although this study had three disease groups. A 
one-versus-all approach was therefore used; since there was little difference in the 
parameter means and standard deviations between the healthy and early AMD 
groups (Table 4.6), these were pooled into a single group for this analysis. The 
ability to differentiate between nAMD and non-nAMD would likely be of greatest 
clinical value, since treatment is currently available only for the neovascular 
subtype. Reliable identification of this subtype through choroidal structure could be 
of potential benefit in triaging patients through referral refinement schemes, or in 
monitoring stable AMD in ‘virtual’ macular clinics in the hospital eye service. This 
could theoretically enhance prioritisation of patients requiring further 
ophthalmological assessment and/or treatment, whilst minimising the number of 
‘false positive’ referrals into secondary care.  
This analysis was performed only on those parameters with statistically 
significant differences (or near-significant in the case of VVD) between disease 
groups. A total of 5 parameters were therefore investigated further; SFCT, VVD, VR, 
CA, and LA.  
The diagnostic potential of each parameter to predict a classification of 
nAMD on the entire dataset (n=75) was assessed using the area under the curve 
(AUC). AUC ranged from 0.762 for VR to 0.658 for VVD. The optimum cut-off for 
Figure 4.4 Example receiver operating characteristic (ROC) curves assessing diagnostic 
potential for (A) SFCT and (B) VVD. AUC = area under the curve; SFCT = subfoveal choroidal 
thickness; VVD = visible vessel diameter.  
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prediction of nAMD with each parameter was determined subjectively as the point 
maximising sensitivity and specificity (i.e. the point on the ROC curve closest to the 
top left corner). These values are presented in Table 4.7.  
Table 4.7 The optimal cut-off value for each parameter to predict a classification of nAMD with 
maximum accuracy. Parameters are ordered by AUC (descending). SFCT = subfoveal choroidal 
thickness; VVD = visible vessel diameter; VR = vessel ratio; CA = choroidal area; LA = luminal 
area.  
Parameter AUC Optimal cut-off Sensitivity (%) Specificity (%) 
VR 0.762 0.635 80 66 
SFCT 0.750 198.8 µm 84 64 
LA 0.748 0.198 mm2 76 64 
CA 0.743 0.263 mm2 76 68 
VVD 0.658 127.4 µm 64 64 
  
4.5 Discussion 
A total of eight parameters describing the choroidal vascular structure were 
applied to a dataset of long-wavelength OCT images acquired from eyes without 
AMD (n=25), with early AMD (n=25), and with nAMD (n=25). A significant 
difference between the nAMD group and the other two groups was identified in the 
SFCT, VR, CA, and LA parameters. The difference in VVD between groups was 
nearing statistical significance (P=0.056). No significant difference between the 
healthy and early AMD groups was identified with any parameter evaluated.  
Considering SFCT firstly, the choroid was significantly thinner in the nAMD 
group than the healthy group (163.2 ± 61.8 µm and 237.2 ± 88.9 µm respectively; 
Figure 4.2A). This was equivalent to a mean difference between groups of ~75 µm 
(~32%); comparable to previously reported values of ~53 µm  (Chung et al. 2011), 
~88 µm  (Esmaeelpour 2014a), and ~95 µm (Lu et al. 2016). However, it should be 
noted that the majority of participants in the nAMD group of the present study were 
undergoing (or had previously undergone) anti-VEGF therapy. This study was 
limited by the lack of treatment history data; the number of injections were self-
reported, and anti-VEGF agent and treatment duration were unknown.  
Anti-VEGF therapy has been associated with a reduction in choroidal 
thickness, with reported mean decreases in thickness of 10-25 µm following a 12 
month treatment period (Yamazaki et al. 2012; Ting et al. 2016; Section 1.4.6). This 
172 
 
reduction in choroidal thickness was identified in the first 6 months of treatment 
only, with no further change over the following 6 months. The mean number of anti-
VEGF injections in these studies after the 12 month period were 5.8 ± 2.9 and 5.6 ± 
2.1 respectively, although there was no relationship between number of injections 
and decrease in choroidal thickness over time. However, it is unknown if this trend 
would extend to the mean number of injections in the present study (10.2 ± 5.9). 
Although the mean difference in SFCT between the treated nAMD and healthy 
groups of the present study (~75 µm) exceeded these reported longitudinal 
changes, it is not possible to separate choroidal changes associated with the 
pathology from changes resulting from pharmacological intervention. Any 
conclusions regarding the aetiology of the choroidal changes observed in the nAMD 
group would therefore be speculative. Further work would be required to 
investigate the effects of anti-VEGF therapy on choroidal structure and to 
differentiate these from changes associated with the underlying pathology.  
In keeping with previous literature, no difference in SFCT was identified 
between early AMD (255.7 ± 103.1 µm) and healthy age-similar controls (Wood et 
al. 2011; Kim et al. 2011; Lee et al. 2013b; Jonas et al. 2014; Lu et al. 2016). The mean 
and standard deviation of SFCT were comparable to previously reported values for 
healthy and early AMD groups (Wood et al. 2011), and for all three disease groups 
(Esmaeelpour 2014a), with both studies utilising a non-commercial long-
wavelength OCT device, similar to the one used in this thesis. 
The mean difference in VVD between the healthy and nAMD groups was ~15 
µm (~11%), although this did not reach statistical significance (Figure 4.2B). This 
may be due to the large within-group variation in VVD, and more data would likely 
be required to investigate this parameter further. The mean VVD in the healthy 
group was 133.8 ± 33.6 µm; this is similar to the control group of previous studies 
of vessel diameter in CSC, with reported mean values of 140 ± 40 µm (Yang et al. 
2013) and 160 ± 32 µm (Bittencourt et al. 2014). The mean ages of these groups 
were 47 and 30 years respectively, whereas the mean age of the healthy group in 
the present study was 73 years. This difference may explain the lower mean vessel 
diameter in this thesis, since age has been shown to negatively correlate with vessel 
diameter (Bittencourt et al. 2014).  
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Since the mean differences between groups were not known at the start of 
this research, the power calculation was performed using an estimate of this value 
and the within-group standard deviation (see Section 4.1.1). To detect such a small 
difference between groups with high standard deviation, with the power and 
significance level used, a far larger sample size would be required. Given the 
difference in the mean VVD between the healthy and nAMD groups of the present 
study (~15 µm), and the within-group standard deviation (~33 µm), a sample size 
of 75 participants per group would be required for a power of 80% and a 95% 
significance level (Altman 1991).  
The VR was significantly higher for the nAMD group than the other two 
groups (Figure 4.2C). In nAMD, the mean diameter of the largest choroidal vessels 
was 78% of the SFCT, compared to 61% in both the healthy and early AMD groups. 
The mean VR of the healthy group was very similar to a previously reported value 
of 61 ± 1% in healthy eyes (Bittencourt et al. 2014). There is no published data on 
vessel diameter or vessel ratio measured in vivo in AMD for comparison.  
 Considering the 2-D analysis (Figure 4.2D-F), CA and LA were both 
significantly lower in the nAMD group than the other two groups. The mean CA was 
~28% lower in the nAMD group than the healthy group, whilst the mean LA was 
~29% lower. CVI was also lowest for the nAMD group, although this difference did 
not reach statistical significance. Again, this may be due to large within-group 
variation.  
Comparing to the existing literature, mean values of CA and LA in the healthy 
group (0.311 mm2 and 0.223 mm2 respectively) were similar to values reported by 
Gupta et al. (2017) of 0.452 mm2 and 0.241 mm2 respectively, following the same 
measurement protocol. The lower CA in the present study may be explained by the 
lower mean SFCT (237 ± 89 µm versus 302 ± 63 µm) or the higher mean participant 
age (73 ± 8 versus 60 ± 7 years). Wei et al. (2016) found CVI to be reduced in eyes 
with nAMD by an average of 0.026, compared to the fellow eye with early AMD. This 
is highly comparable to the current study, where a mean difference of 0.027 was 
found between the early and nAMD groups. However, the absolute mean value and 
within-group variation of CVI in the nAMD group were higher in the present study 
(0.698 ± 0.064 compared to 0.601 ± 0.046). Since the same measurement protocol 
was followed, this difference may (in part) be attributed to the different OCT devices 
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used in these studies, possibly due to the wavelength-dependent reflectivity 
properties of the choroidal structures.  
 For the enface analysis, no significant difference was found between any of 
the three groups, for both LAR and LPR (Figure 4.2G-H). However, there was a 
general decrease in LPR with advancing disease stage. Again, the within-group 
variation was high in relation to the between-group variation, which is likely why 
this difference did not reach statistical significance. An arbitrary depth of 50% in the 
choroid was used for this analysis, to ensure sufficient vessel resolution (i.e. to avoid 
inclusion of the small vessels of the choriocapillaris nearing the resolution limit of 
the OCT), and to minimise inclusion of the sclera at the edges of the enface image 
(see Section 3.2.4). However, the use of this fixed percentage depth would not be 
sensitive to disease-related changes in vessel structure localised to other choroidal 
depths, for example at the level of choriocapillaris. Since these vessels are too small 
to resolve with this OCT, the parameters evaluated here would not be suitable for 
quantifying the vascular structure. Other image analysis methods such as texture 
analysis may be utilised for this purpose, as explored by Sohrab et al. (2012). This 
approach is employed in the machine learning methodology, as a way of extracting 
feature information from the OCT images (see Section 5.1.2).  
The early AMD group was sub-divided by fellow eye diagnosis, to investigate 
a potential relationship between fellow eye diagnosis and choroidal structure in this 
cohort. There was little difference between the three subgroups for VVD, CA, or LA. 
This suggests that fellow eye diagnosis did not influence these parameters, although 
the power of the sub-analysis is greatly reduced. However, the choroid was thicker 
in eyes with no signs of AMD in the contralateral eye than the other two groups. 
Assuming these individuals had relatively few signs of early AMD in the study eye 
(mild degenerative changes) compared to those with bilateral early AMD (including 
intermediate degeneration), this may indicate a level of symmetry in choroidal 
vessel changes with progression of early AMD. There was little difference between 
eyes with bilateral early AMD and those with fellow eye nAMD. If vessel abnormality 
is part of the pathogenesis of nAMD, choroidal changes would be expected to be 
more advanced in cases of fellow eye nAMD. This is the basis for the AREDS 
simplified scale, which takes into account fellow eye diagnosis for 5-year risk 
prediction (Ferris et al. 2005). However, this was not the case for this cohort. The 
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high proportion of fellow eye nAMD in this sample is therefore unlikely to contribute 
significantly to the inter-group findings. However, it should be noted that these 
subgroups were small, and larger sample sizes would be required to investigate this 
relationship further.  
The five parameters assessed diagnostically provided reasonable ability to 
predict a classification of nAMD (AUC ranging from 0.658 to 0.762; Table 4.7). The 
parameters showing greatest diagnostic potential were SFCT and VR. The optimal 
SFCT cut-off to predict a classification of nAMD was 200 µm, achieving a sensitivity 
of 84% and specificity of 64%. These values are not feasible for a clinical test, due to 
the frequency of false positives and negatives. However, SFCT is simplest and 
quickest measurement to perform, and provides one of the most accurate 
predictions of the parameters evaluated. Although it is of limited potential as a 
standalone biomarker, it may be a useful parameter to be used in conjunction with 
other clinical information to inform clinical follow-up (i.e. monitoring of those 
individuals likely to develop CNV). Further work would be required to investigate 
the optimum combination of potential structural and functional parameters for this 
purpose. However, it should also be noted that the majority of eyes in this group 
were of treated nAMD, and the change in choroidal structure in the nAMD group was 
likely attributed (at least in part) to anti-VEGF therapy rather than pathological 
change. This was therefore not a test of true diagnostic ability (which would be 
based on treatment-naïve eyes).  
The other structural parameters assessed in this chapter were limited in 
their ability to predict the disease classification, due to their relatively low 
sensitivity and specificity for a clinical test. Additionally, they require manual 
measurement of the vessels, which may not be practical for a clinical setting and 
may result in high inter-observer variability, and they offer no distinct advantage 
over the measurement of SFCT. To automate the disease group predictions, and to 
maximise sensitivity and specificity, the use of machine learning is explored in 
Chapter 5. This allows the development of a more complex model for predicting 
disease classification, which may also be sensitive to subtle differences in choroidal 
structure in the early disease stage, not detectable with the parameters evaluated in 
this chapter.  
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5 Automated disease stage classification using machine learning 
 
As discussed in Sections 2.4.2 and 3.2.5, manual choroidal parameter 
measurement is limited by several factors, including intra- and inter-observer 
variability, 2-D sampling of the 3-D vessel structure, and clinical feasibility of time-
consuming measurement protocols. This section describes the development of 
machine learning protocols for automated classification of AMD by disease severity, 
as outlined in Figure 5.1. 
5.1 Methodology 
 Firstly, images were acquired and pre-processed as described in Sections 2.2 
and 2.3, producing stack-registered volume scans (512 × 512). All images were then 
manually classified by AMD disease severity using a custom protocol (described in 
Section 4.2), adapted from the AREDS classification system (AREDS 2001a). This 
was used as the ground truth for automated classification.  
Manual segmentation was then used to distinguish the choroid from other 
structures in the OCT image (Section 5.1.1). Textural information was then extracted 
from this region, to describe and quantify features of the choroidal vasculature 
(Section 5.1.2). Various machine learning techniques were tested for automated 
classification of AMD by disease stage, based upon textural features within the 
choroid (Section 5.1.3). Finally, the accuracy of the classifiers was assessed using 
Figure 5.1 Flowchart depicting the development of automated classification protocols, along 
with the section of this thesis in which they are discussed. OCT images were acquired and 
processed, classified using a modified AREDS classification (AREDS 2001b), and the choroid 
was manually segmented. Textural features were extracted and used to train classifiers. These 
were evaluated for accuracy using cross-validation.  
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cross-validation (Section 5.1.4). All steps in the machine learning process (feature 
extraction, classifier training, and cross validation) were undertaken using custom 
programs written in MATLAB, unless otherwise stated. The methods in Sections 
5.1.2 to 5.1.4 were performed by collaborators from the Department of Computer 
Science, Swansea University (Dafydd Ravenscroft; Jingjing Deng; Xianghua Xie).  
 
5.1.1 Region of interest segmentation 
Since only the choroidal region of the OCT images was to be included in the 
automated classification, this region required identification in each image. As 
discussed in Section 3.4, at the time of writing, there was no validated method of 
automated choroidal segmentation. Hence, manual segmentation of the choroid was 
required (n=75 OCT images).  
 
5.1.1.1 Manual segmentation protocol 
Due to the time-consuming nature of manual segmentation, three observers 
were used to identify the ROI. For consistency, all observers followed the same 
protocol for segmentation (depicted in Figure 5.2). All observers were masked to 
the clinical classification of the images, and underwent training on a minimum of 2 
volume scans in order to familiarise themselves with the style of images and the 
segmentation protocol. A custom program in MATLAB was used to view images and 
manually identify the boundaries of the choroid. To improve visualisation, 
particularly of the posterior choroidal boundary, a rolling average of 10 consecutive 
b-scans was applied (for visualisation purposes only; Figure 5.2A-B).  
Starting in the lower left-hand corner of the first b-scan, observers identified 
the posterior choroidal boundary first, by manually selecting several points along 
the boundary. This was primarily defined as the choroidal-scleral junction, or the 
posterior vessel lumen if the junction was not visible. A minimum of 5 points was 
suggested, although it was at the observers’ discretion whether more points were 
deemed necessary. The minimum suggested value was implemented to produce a 
good approximation to the curvature of the choroidal boundary, using higher order 
polynomial interpolation (e.g. cubic and quartic polynomials; Figure 5.3).  
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Following identification of the posterior choroidal boundary, observers 
continued labelling the contour by identifying the right hand edge of the visible 
choroid (this varied due to lateral shift of b-scans during the preceding stack 
registration process). This was then extended to the anterior choroidal boundary, 
defined as the posterior of the most hyper-reflective line (RPE), and finally the left 
hand boundary of the visible choroid (Figure 5.2C-D).  
Figure 5.2 Steps (A-E) in the protocol for manual identification of the choroidal ROI, using a 
custom program in MATLAB. Volume scans were loaded into the program (A), and averaged to 
enhance boundary visualisation (B). The posterior choroidal boundary was manually 
identified (C), followed by the anterior boundary, creating a closed contour (D). This process 
was repeated for every tenth b-scan in the volume, and the Cartesian coordinates in image 
space of each identified boundary point were saved as a list for each b-scan (E).  
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Interpolation was used to join consecutive points within a segmented 
boundary to produce a closed contour, which was then saved in a coordinate system. 
This process was repeated at intervals of 10 b-scans throughout the image stack. A 
total of 51 b-scans per volume were therefore segmented (Figure 5.2E). 
Interpolation between b-scans was applied to produce an approximated 
segmentation of the choroid for all b-scans within each volume.  
 
5.1.1.2 Inter-observer validation 
Images were assigned to one of three observers (two clinical and one non-
clinical) to identify the choroidal ROI. The non-clinical observer underwent training 
and their performance was validated by one of the clinical observers. However, due 
to the complex clinical appearance of late-stage AMD, the non-clinical observer was 
restricted to assessing images classified as healthy or early AMD. Images in the 
nAMD class generally displayed poorer visibility of the choroidal boundaries caused 
by overlying retinal features (i.e. areas of relative low contrast caused by highly 
reflective neovascular membranes or fibrovascular scarring). This limitation in 
assignment methodology was a potential source of bias between classes, due to 
differences in segmentation technique between observers. To ensure this bias was 
not significant, a subset of images were segmented again by a different observer, 
masked to disease classification and previous segmentation results. The following 
section describes this validation process.  
Figure 5.3 Demonstration of the effect of the number of identified points on the accuracy of the 
curvature approximation, using polynomial interpolation.  
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Quality control/validation method  
A total of 15 volume scans (5 per disease class) were randomly selected to 
undergo validation (i.e. to ensure consistency in segmentation between observers). 
Of the 51 b-scans that were segmented (every 10th b-scan in the original volume), 
10 b-scans were randomly selected. Each volume was then randomly assigned to a 
different observer to the initial segmentation, and the same segmentation protocol 
was followed for the subset of 10 b-scans identified for validation per volume scan.  
Following segmentation by the second observer, the identified regions of 
interest were compared between the two observers, for each selected b-scan. The 
boundaries of the ROI identified for each b-scan were stored within a coordinate 
system. To quantify agreement between observers, a program written in MATLAB 
(see Appendix E) was used to establish the percentage overlap of the two regions. 
This was calculated using the number of common pixels between regions identified 
by each observer (Equation 5.1; top row), and the maximum number of pixels 
encompassed by the two regions (Equation 5.1; bottom row).  
Image⁡overlap =
100⁡ × ⁡number⁡of⁡common⁡pixels
pixels⁡in⁡ROI1 ⁡+ ⁡pixels⁡in⁡ROI2 ⁡− ⁡number⁡of⁡common⁡pixels
 
 
 
Equation 5.1 
 
 This parameter was chosen to ensure that the regions identified by both 
observers were consistent in size and location (Figure 5.4A). The median and 
interquartile range (IQR) of percentage overlap were calculated across all randomly 
Figure 5.4 Example ROI from the same b-scan from a healthy eye, identified by two observers 
(A). Percentage overlap in this case was 84.3%. Demonstration of variability in choroidal size 
and shape across a single volume scan (B); 10 b-scans are shown, each segmented by two 
observers. Particularly note the variation in position of the right hand vertical boundary, due 
to the preceding stack registration process.  
A B 
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selected b-scans within each disease group (a total of 50 b-scans per group). Figure 
5.4B highlights the need to label b-scans throughout the 3-D stack, since the size and 
shape of the choroidal region varied greatly across the volume scan from a single 
eye.   
 
Results  
 An example of the identified ROIs within a single volume, by 2 observers, can 
be seen in Figure 5.4B. There was substantial variation in choroidal size and shape 
between b-scans within a single volume scan, most notably in the position of the 
posterior choroidal boundary, and the vertical boundary on the right of the image. 
Median percentage overlap between the two observers was 88.4%, 86.3% and 
76.8% for the healthy, early AMD, and nAMD groups respectively. The range and IQR 
were similar between the healthy and early AMD group, but there was far more 
variation in percentage overlap within the nAMD group (Figure 5.5).  
Discussion 
Variation between b-scans in vertical boundary placement on the right of the 
images was caused by the preceding stack registration process (see Figure 5.6). It 
was imperative to eliminate any such artefacts from the images, to prevent inclusion 
of these regions in the training and testing data. Since this boundary was well 
Figure 5.5 Box plots showing the median, IQR and range of percentage overlap of the ROI 
between observers, for each disease group.  
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defined, there was little disagreement on the position between observers (for 
example, Figure 5.4A). The bold contrast in reflectivity between the RPE and the 
anterior choroid made the anterior choroidal boundary relatively easy to identify 
accurately, although this was poorer in eyes showing disruption to the RPE resulting 
from pathological changes. The majority of disagreements between observers 
originated in the position of the posterior choroidal boundary. This boundary had 
the smallest difference in reflectivity between layers (i.e. between the posterior 
choroid and sclera), making it difficult to accurately locate in some cases. Due to its 
physiological location posterior to the retina and RPE, this boundary also suffered 
most from signal roll-off, causing it to be poorly defined and difficult to identify in 
some eyes.  
The percentage agreement was lower in the nAMD group, although this was 
to be expected due to reduced visibility of the choroidal boundaries caused by a 
relative increase in reflectivity from overlying retinal features. However, this may 
have an effect on the training of neural networks used in further analysis. If regions 
of choroid were falsely being included or excluded preferentially from one group (in 
this case, the nAMD group), the training data may not be truly representative of the 
choroid in that disease stage. The posterior choroid was the region most likely to be 
excluded (or conversely, the anterior sclera to be included) during identification of 
the ROI. Since these regions had relatively low contrast (the main reason for 
Figure 5.6 Artefacts from stack registration process (dark areas) visible around lower and 
right side of image.  These were excluded from the identified ROI to ensure they were not used 
during classifier training.  
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boundary misplacement), it was unlikely that they would contribute strong 
representation within the neural networks. It was therefore probable that this 
limitation would not have a large direct effect on the automated classification 
results.  
Overall, the percentage overlap was reasonable, suggesting that observers 
were consistent in identifying the ROI. Since the purpose of this protocol was to 
identify a region of the image to be isolated for further analysis, the agreement did 
not need to be as high as would be required for direct quantitative analysis of the 
segmentation region (e.g. choroidal area). This protocol for manual segmentation of 
the choroidal layer was therefore suitable for use in this study.  
 
5.1.2 Feature extraction 
The next step in the classification process was to extract textural information 
from the ROI. This aim of this was to condense the image data in the ROI (i.e. pixel 
locations and intensities) into summarised textural information, such as spatial 
arrangement of pixel values. Assuming the OCT image accurately depicts the 
structure, the mathematically extracted shape and orientation information 
represents the underlying vascular structure. Although several methods for feature 
extraction have been described, Gabor filters are relatively simple to apply, and have 
been shown to perform well against alternative methods in textural analysis 
problems (Monadjemi 2004; Gonzalez-Lopez et al. 2015). They have been 
successfully applied to retinal image analysis, including retinal vessel and choroidal 
layer segmentation, drusen detection, and RNFL defect detection (Soares et al. 2006; 
Hayashi et al. 2007; Parvathi and Devi 2007; Gonzalez-Lopez et al. 2015; see Section 
1.7.3).  
A 2-D Gabor filter is a linear filter consisting of a sine wave grating multiplied 
by a Gaussian kernel function (Figure 5.7). A number of gratings of predefined 
spatial frequency and orientation are produced to form a Gabor filter bank (Figure 
5.8). This technique is therefore a multi-channel filtering approach, similar to that 
described by Jain and Farrokhnia (1990). The theory is based upon the 
deconstruction of images into a number of filtered images, each representing a 
narrow range of frequencies and orientations. This is analogous to early 
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descriptions of perception in the human visual system (Campbell and Robson 1968), 
with Gabor filters comparable to the simple cells of the visual cortex, responding 
primarily to oriented edges and gratings.  
Theoretically, a range of spatial frequencies is useful for detecting vessels of 
different diameters, for example the smaller vessels of the anterior choroid, and the 
larger vessels of Haller’s layer. The grating size giving the strongest response should 
correspond to the predominant vessel size in the image. Changes to the vessel sizes 
throughout the AMD disease process may therefore be detectable using these filters 
of varying spatial frequency.  
Since the choroid comprises a range of vessel sizes, the wavelengths (λ) of 
the sine wave gratings were selected to reflect this. The optimum wavelength 
required to detect a vessel would be double that of the vessel diameter, assuming 
the vessel diameter is equal to the spacing between vessels. However, due to the 
Figure 5.8 Visual representation of the Gabor filter bank used in this analysis. From top to 
bottom, the wavelength of the gratings are 6, 8, 10, 12 and 18 pixels, and orientations rotate 
from horizontal by 22.5° (left to right). 
Figure 5.7 The product of (A) a sine wave grating and (B) a Gaussian blob is (C) a Gabor patch. 
In this case, a wavelength of 10 pixels and an orientation of 22.5° from vertical are used.  
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decoupling of axial and lateral scaling in OCT, these wavelengths will equate to 
different vessel sizes in the two directions. For instance, a grating of λ = 8 pixels (λ/2 
= 4 pixels) would equate to vessel diameters of ~8 µm axially and ~46 µm laterally. 
This grating would therefore be sensitive to different vessel sizes in each meridian. 
To account for this, a range of wavelengths were employed in the Gabor filter bank; 
λ/2 = 3, 4, 5, 6, and 9 pixels. This equates to a range of vessel diameters of ~6 to 17 
µm axially, and ~34 to 102 µm laterally (assuming an AEL of 24 mm). Therefore, 
changes to the small vessels should produce differences in the horizontally oriented 
filters, and changes to the large vessels should produce differences in the vertically 
oriented filters. Orientations between these two axes were also used to complete the 
Gabor filter bank (every 22.5°), and account for the vessels between these sizes. A 
total of 40 filters were used (8 orientations of 5 spatial frequencies), each 39 × 39 
pixels in size.  
During feature extraction, each of the filters in the Gabor bank was convolved 
across the image, producing a series of filtered images with limited spectral 
information. The aim of this was to determine the ‘energy’ of each filtered image 
required to reconstruct the input image. As described by Jain and Farrokhnia 
(1990), the relative importance of each filtered image was represented in a 
histogram (Figure 5.9; Deng et al. 2016). Each image pixel was assigned to one of 11 
equally sized energy ‘bins’, each of which represented a discrete range of energy 
responses (shown along the x-axis). The relative frequency of pixels assigned to each 
bin (normalised from 0 to 1) defined the y-axis.  
 
Figure 5.9 Example energy histogram from an image produced by a single Gabor filter. The y-
axis represents relative frequency of each discrete ‘energy bin’, shown along the x-axis (a total 
of 11 bins were used). Image adapted from Deng et al. (2016).  
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This filtering process was repeated for all 40 filters in the Gabor bank (8 
orientations × 5 spatial frequencies), and the energy histograms were concatenated 
to form a total of 440 feature descriptors (40 filters × 11 bins), for each b-scan. 
These feature descriptors were then used as input to train and test the classifiers 
(described in Section 5.1.3 and 5.1.4 respectively).  
 
5.1.3 Classifier training 
Since the data used in classifier training was pre-classified into disease group 
by clinicians, this was a ‘supervised’ classification problem. The aim was to train 
classifiers to sort images into one of three groups; healthy, early AMD, or nAMD. The 
input to the classifiers was the feature descriptors described in Section 5.1.2, along 
with the ground truth classification (Section 4.2).  The output was one of the three 
disease groups. A subset of the data was used for training purposes, whilst the 
remaining data was used to test the classifiers for accuracy (see Section 5.1.4).  
Each b-scan within a volume was assigned the same class during the clinical 
classification. All b-scans from a single eye were given equal weighting in the 
classification, regardless of their proximity to the fovea, or signs of overlying retinal 
degeneration visible on the OCT scan. This was based on the assumption that vessel 
changes in AMD are uniform across the central 20° × 20° of sub-macular choroid. 
Since the aim of this research was to establish the feasibility of applying machine 
learning to automated disease severity classification, this assumption was made for 
ease of classifier training. Reasonable accuracy of a simple classifier acts as proof of 
concept, as well as indicating structural change to the choroidal vasculature 
throughout the disease process. Following this, the classifiers would require 
optimisation on a far larger dataset, to maximise accuracy of automated disease 
classification prior to clinical application. This optimisation process may include 
weighting of b-scans in the classification with relation to location or retinal features. 
The implications of this assumption are discussed further in Section 5.3.  
Three established types of classifier were evaluated on this dataset; K-
nearest neighbour (KNN), random forests (RFS), and support vector machines 
(SVM). Although all three classifiers have been shown to produce accurate 
classification of medical tomographic images (Koprowski et al. 2013; Bhuvaneswari 
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and Therese 2015; Albarrak et al. 2016), it was unknown which would have the best 
performance in this classification task. All three classifiers were therefore evaluated, 
and their performance is compared in Section 5.2. A study of the latter two of these 
methods applied to a preliminary dataset comprising OCT images of eyes with 
varying stages of AMD is described in Deng et al. (2016). The following sections are 
a description of the models and predictions made by each classifier type. A 
comprehensive explanation of each type of classifier, along with additional 
information, can be found in Alpaydin (2014).  
 
5.1.3.1 K-nearest neighbour (KNN) 
 KNN is a relatively basic classifier, which makes predictions directly from the 
entire training set. For a previously unseen image, the K-most similar images 
(‘nearest neighbours’) in the training set are identified and summarised to produce 
a classification for the new image (Figure 5.10). To measure similarity between the 
input and training set, distances in Euclidian space between images were calculated 
for each of the 440 feature descriptors. This distance was used to produce a 
weighted score, with the nearest neighbour having the highest weighing. The final 
classification of the new image was based on a majority vote from the K-highest 
weighted scores. For this analysis, K was set to 5 to maximise accuracy, whilst 
minimising over-fitting.  
Figure 5.10 K-nearest neighbour predicts the class of a new input (shaded square) by 
identifying the K-most similar data in the training set. The classification is determined by the 
most frequent class in this neighbourhood (in this case, Class 1).   
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Over-fitting is a common limitation of machine learning, referring to a 
classifier with high sensitivity to the training data, but poor accuracy when 
classifying previously unseen test data. This occurs when random patterns or noise 
in the test sample are learned by the classifier, and used as a basis for classifying 
data from a different sample during testing. This is often the case in relatively small 
datasets, resulting in poor generalisation of the model to previously unseen data in 
the population. The extent of over-fitting of all classifiers used was assessed using 
cross-validation (testing the classifiers by sampling previously unseen data; see 
Section 5.1.4).  
 
5.1.3.2 Random forests (RFS)  
A random forest classifier is a type of ensemble machine learning, combining 
a large number of weak classifiers (‘decision trees’) to create an accurate predictive 
model. A decision tree is a method of classifying data into discrete groups, using a 
series of successive binary criteria. Data is input at the top of the tree, and passes 
down each layer until it reaches an end node at the bottom of the tree, where a 
classification is output. The path followed (and hence the end node reached) is 
dependent on multiple split points in the tree, each based on a binary criterion 
designed to divide the data. These criteria generally determine whether a variable 
is less than or greater than a predefined threshold. An example of simple decision 
tree architecture is shown in Figure 5.11.  
Figure 5.11 (A) Simple decision tree architecture, showing the possible paths of input data, 
through a series of split points, leading to an end node denoting a classification. (B) An 
example of a simple decision tree, with binary criteria at each split-point. In this case, input 
data (X = 3, Y = 7) was allocated to Class C.  
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In this study, RFS classifier training involves constructing decision trees to 
classify into the disease groups, based on the labelled training data. These trees are 
sensitive to the specific data on which they are trained, and therefore are prone to 
over-fitting (resulting in poor classification accuracy on previously unseen data). 
Bootstrap aggregation (‘bagging’) can be used to minimise this problem; at each 
node within the tree, a random subset of all possible features for the binary criterion 
are made available to the learning algorithm. From this subset, the feature and 
threshold combination which produces the most discriminative data split are 
selected and assigned to that split-point. The size of the subset was set to 21 in the 
present study, calculated as the square root of the number of feature descriptors 
(√440; Breiman 2001). Trees are allowed to grow until a minimum number of 
samples at each split-point is reached (this was set to 3 in the present study to 
minimise overfitting). The result is a decision tree with multiple split points to 
separate data into the classes.  
This process was repeated with a different random subset of features, 
producing another decision tree based on different combinations of features and 
thresholds (due to the bagging process). This was repeated until a total of 50 trees 
were constructed, which were combined to form the decision forest (Figure 5.12). 
For previously unseen (test) data, the probability of the sample belonging to each 
class was assigned at the end node of each tree. The final classification was 
determined by combining weighted predictions from each tree in the forest.  
 
Figure 5.12 Random forest classifiers consist of multiple decision trees (n=3 shown here), 
each with a number of binary split-points (white squares). New data (shaded square) is 
entered at the top of each tree, and is classified at the end node. The final classification is 
based on the combined weighted predictions from each tree (in this case, Class 2).  
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5.1.3.3 Support vector machines (SVM) 
 This classifier describes how training data plotted in n-dimensional space (n 
representing the number of feature descriptors) can be separated by a ‘hyperplane’. 
This describes the plane that best separates the training data into two known 
classes. The position of this hyperplane is learned from the training data and used 
to determine the class of a new input; its mapped location in relation to the 
hyperplane is used to predict the classification.  
SVM is based upon the hypothetical ‘maximal-margin’ classifier. The 
maximal-margin hyperplane is the term given to the optimal hyperplane separating 
the classes. The ‘margin’ is defined as the perpendicular distance from the nearest 
correctly classified point of each group to the hyperplane (Figure 5.13). The smaller 
the margin (i.e. the closer the input is to the hyperplane), the less confidence the 
model gives to the class prediction. The points with the smallest margin (i.e. the 
closest correctly classified points to the hyperplane) are called the support vectors, 
and are used to define the hyperplane, and hence the construction of the classifier.  
With real data however, there will often be some overlap in space between 
classes; therefore a hyperplane may not perfectly separate all training points in the 
classes. The ‘soft margin’ classifier is used to relax the constraints of the hyperplane, 
allowing some points in the training data to violate the separating line (Cortes and 
Vapnik 1995). This accounts for outliers in the training data, and aids in reducing 
model over-fitting to these outliers.  
Figure 5.13 A support vector machine uses a hyperplane (solid line) to define the best 
separation between data belonging to two classes, shown here in 2-D space for simplicity. The 
support vectors (marked in grey boxes) are the correctly classified data points closest to the 
hyperplane, and the perpendicular distance from these to the hyperplane is known as the 
margin (black arrow). Image adapted from Cortes and Vapnik (1995). 
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In practice, the SVM algorithm is implemented using a kernel, defining the 
similarity between new data and the support vectors. This kernel may be linear, 
polynomial, or radial, to best separate the classes (allowing for curved or more 
complex hyperplanes). The present study used the established radial basis function 
(RBF) kernel, also known as the Gaussian kernel (Equation 5.2). This was capable of 
creating complex regions within the feature space, and hence maximise 
classification accuracy.  
𝐾(𝑥, 𝑥′) = exp(−
(𝑥 − 𝑥′)2
2𝜎2
) Equation 5.2 
where:  
(x - x’)2 is the squared Euclidian distance between vectors  
σ is a free parameter to be determined by the algorithm  
 
SVM was developed for binary classification (i.e. separating data into two 
classes only). Since there were three classes in this dataset, a one-against-all 
approach was used (Kim et al. 2002). In turn, each class was tested against all data 
from the remaining two classes combined. This produced multiple SVMs, of which 
the one with the strongest prediction (i.e. the maximal margin) for a particular input 
was used.  
 
5.1.3.4 Convolutional neural networks (CNN) 
In addition to these traditional classifiers, the use of neural networks for 
automated classification into disease groups was evaluated. This did not require the 
feature extraction techniques described in Section 5.1.2, and the results are 
therefore presented and discussed separately to the other classifiers (Section 5.2.3).  
Artificial neural networks are a commonly used approach to computational 
classification, modelled on biological neural networks, such as those behind image 
recognition in the human brain (Lippmann 1987). Convolutional neural networks 
(CNN) are a powerful machine learning technique, often applied to object 
recognition problems (LeCun et al. 2015). Unlike traditional neural network 
techniques, a CNN preserves the spatial relationship between pixels, to prevent loss 
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of spatial structure from the image during the learning process. A CNN is designed 
to learn and generalise features from an input image, in order to classify a previously 
unseen image. The input data for the CNN was intensity and spatial location of all 
pixels in the choroidal ROI. The ‘hand-crafted’ features used to train the other 
classifiers (produced by the Gabor filters) were therefore not required for this 
analysis.  
A CNN typically has a complex architecture, with three types of layers (from 
input to prediction); convolutional layers (typically coupled with normalisation 
layers), pooling layers, and fully-connected layers (Figure 5.14). The convolutional 
layers are comprised of filters, with the aim of extracting textural information from 
the image. The filters are a square of fixed size, known as a receptive field, which are 
convolved across the input image (in a similar manner to the Gabor filters described 
in Section 5.1.2). This is a method of combining pixels with their neighbours, 
accentuating or masking certain image features, depending on the kernel used. A 
predefined number of filters are used, which are initially randomised, but then 
undergo optimisation by the algorithm using back-propagation in the network. The 
output from the first layer is called a feature map, and forms the input for the next 
convolutional layer. A new set of optimisable features are then convolved across the 
feature map, the output of which feeds into the next layer, and so on.  
Normalisation layers are often utilised between convolutional layers, for 
spatial smoothing of the feature maps, following filtering. A commonly used type of 
normalisation is the ‘rectified linear unit’ (ReLU), which normalises values over a 
local region of defined size (LeCun et al. 2015).  
Figure 5.14 Schematic of a simplified convolutional neural network. Convolutional, 
normalising and pooling layers are used for extracting and generalising textural features 
within the image. Fully connected layers are used as a classifier to predict the class of a 
previously unseen image. Image adapted from Lawrence et al. (1997). 
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Pooling layers follow the convolutional layers, and down-sample the feature 
maps from the previous convolutional layer. These layers aim to consolidate and 
generalise the textural features across all input data, to reduce the effect of over-
fitting of the model to the training sample. Fully connected layers are implemented 
at the end of the network, to create non-linear combinations of features, for class 
prediction by the model.  
CNN typically relies on all input images being the same size. However, this 
was not true for the choroidal ROIs, which varied greatly in size and shape. 
Therefore, 50 patches were randomly selected from the ROI for this analysis, each 
40 × 40 pixels in size. These patches were used as the input for the CNN.  
The CNN used in this analysis was comprised of the following 21 layers, from 
input to prediction (architecture shown in Figure 5.15):  
Figure 5.15 Network architecture of the CNN, from input to prediction. Conv = convolutional 
layer; ReLU = ‘rectified linear unit’ normalisation layer; MaxPool = maximum pooling layer; FC. 
X = fully connected layer with X neurons; Softmax = layer to carry out error calculations in 
class prediction.  
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 5 convolutional layers, each with 128 filters with receptive field (kernel) size 
3 × 3 pixels. Although the number of filters was specified, the actual filters 
used were determined by the algorithm (Figure 5.16). A ReLU normalisation 
layer was used after each convolutional layer for spatial smoothing prior to 
entering the next layer.  
 3 pooling layers, to select the maximum pixel values in the feature maps, in a 
2 ×  2 pixel neighbourhood. This compressed the feature information, 
minimising the computational demand of the classifier.  
 3 fully connected layers to separate images into the classes based on the 
feature maps. The first two of these consisted of 200 neurons and were 
followed by a ReLU normalisation layer, whilst the final layer consisted of 3 
neurons (one for each class).  
 A ‘Softmax’ layer was added to the end of the network to carry out error 
calculations in class predictions. This layer outputs a ‘confidence score’, akin 
to the probability of each input sample belonging to each of the three classes. 
The largest confidence score was used to determine the final classification of 
each b-scan.  
Figure 5.16 The output of the 128 filters that were created by the first convolutional layer of 
the CNN (3 × 3 kernels convolved across an image patch 40 × 40 pixels in size). These were 
randomly generated filters, and included bar gratings and diagonal gradients, with a range of 
contrasts. Image adapted from Ravenscroft (2016).  
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5.1.4 Cross-validation 
For this analysis, each volume scan was separated into individual b-scans, 
each of which was treated as a single image. All 512 b-scans per volume were 
included in the analysis. Every b-scan in the volume scan was labelled with the class 
established by the protocol in Section 4.2; this was taken as the ground truth. This 
was repeated for all 75 volume scans. This produced a dataset of 38,400 labelled b-
scans, equally divided between three disease groups.  
To evaluate the accuracy of the classifiers, a proportion of the images were 
set aside as test data. This data was not used during the training process, and was 
therefore previously unseen by the classifiers. Each classifier was then used to 
classify these test images, and the accuracy of the classifiers was established (i.e. the 
percentage agreement between automated classification and ground truth). This 
process was called cross-validation. Three methods of cross-validation were 
conducted, based upon the proportion of data devoted to training and testing; 10-
fold, 2-fold, and leave-one-out (Figure 5.17).  
For 10-fold cross-validation, the 512 b-scans from each eye were randomly 
distributed amongst 10 equally sized groups. Nine of these groups were used for 
training, and the final group was used for testing. During cross-validation, the 
algorithmic prediction was compared to the clinical classification, and the 
percentage agreement between classification methods (automated and clinical) was 
established. The classifiers were then retrained, this time removing one of the other 
9 groups from the training phase, to be used for testing. The classification accuracy 
Figure 5.17 The total dataset comprised of 75 volume scans from 75 eyes, each consisting of 
512 b-scans. In the first run, one tenth or half of the b-scans were randomly selected for the test 
set, in 10-fold and 2-fold cross-validations respectively. The remainder were used to train the 
classifiers. For the leave-one-out cross-validation, all b-scans from 3 eyes (one per disease 
group) were used as the test set. This was repeated using each subset for testing, for a total of 
10, 2, and 25 runs for the 10-fold, 2-fold and leave-one-out cross-validation respectively.  
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was again assessed. This was repeated for a total of 10 ‘runs’ (each using a different 
subset for testing), and the mean accuracy was calculated. The agreement between 
classification methods was averaged across all runs, and presented in a ‘confusion 
matrix’. An example confusion matrix with fictional data is shown in Table 5.1, for 
interpretation guidance. These matrices are presented in Appendix F, and are 
summarised in Section 5.2.1 (for KNN, RFS, and SVM), and Section 5.2.3 (for CNN). 
A 2-fold cross-validation was also conducted, in which the data was 
randomly divided in half; the training and test datasets were therefore equal in size. 
There were two runs in this cross-validation, using each half of the dataset for 
training and testing. This is generally a more robust measure of classifier accuracy, 
since more data is used in the testing phase. 
Finally, a leave-one-out cross-validation was used. For this, all b-scans from 3 
eyes (one per disease group) were set aside for testing. All b-scans from the 72 
remaining eyes were used to train the classifiers. During testing, each b-scan from 
the test eyes were classified individually. The class of highest frequency amongst the 
b-scans was taken as the final classification for each eye (i.e. a majority vote). This 
was repeated for a total of 25 runs, with a different random eye from each class 
being removed in turn for testing. This form of cross-validation is the most robust, 
and mimics the clinical scenario of classifying images from eyes previously unseen 
by the classifiers.  
Table 5.1 Fictional confusion matrix for interpretation guidance. Ground truth (analogous to 
clinical classification) is divided by column and algorithmic prediction is divided by row. 80% 
of group B were correctly classified by the algorithm, whilst 15% were classed as group A, and 
5% were classed as group C.  
 Ground truth (clinical classification) 
A B C 
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 A 100% 15% 0% 
B 0% 80% 10% 
C 0% 5% 90% 
 
To summarise, the methodology for automated classification of images using 
machine learning has been presented in this chapter. A method for manually 
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segmenting the choroidal region of interest was described, along with a study of the 
inter-observer variability of this method. Following this, the use of Gabor filters for 
feature extraction was outlined, with a view to producing automated quantification 
of textural features within the choroid. Three types of classifier (K-nearest 
neighbour, random forest, and support vector machine) were then described, each 
of which are designed to predict the class of a previously unseen image, based on 
training data. The accuracy of these three classifiers can be assessed using cross-
validation (10-fold, 2-fold, and leave-one-out). The accuracy of each classifier at 
predicting AMD disease severity is presented in the following sections, along with a 
discussion of their performance relative to each other, and to the literature. The 
feasibility of applying a further classifier, not requiring the hand-crafted feature 
extraction process (convolutional neural network), is also explored. 
 
5.1.5 Methodology summary 
The methods described in Section 5.1 were applied to a dataset of long-
wavelength OCT images acquired from individuals at different stages of AMD. The 
training and testing of the classifiers was performed with collaborators from the 
Department of Computer Science, Swansea University (Dafydd Ravenscroft; Jingjing 
Deng; Xianghua Xie). Interpretation of the results (including association of image 
features to the choroidal structure), and a discussion of subsequent clinical 
implication, was undertaken by the author of this thesis.  
The aim of this analysis was to evaluate the feasibility of applying machine 
learning techniques to automated classification of AMD by disease severity, based 
on choroidal appearance. By proxy, successful classification would indicate that 
changes to the texture of the choroidal region of OCT images, with advancing disease 
severity, are detectable in vivo. A successful classification was defined as high 
classification accuracy achieved using 10-fold and 2-fold cross-validation, in 
conjunction with reasonable accuracy with leave-one-out cross-validation (which 
was expected to be lower due to the limited size of the training dataset). The results 
of the classifications are presented in this chapter, with results from the 
convolutional neural network (CNN) presented separately due to the difference in 
feature extraction method. The discriminative features that were considered 
important to the classification are explored, and are compared to the vascular 
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changes described in the literature. Additional results can be found in Appendix F, 
including confusion matrices of each classifier, for each cross-validation method 
used.  
 
5.2 Results  
5.2.1 Cross-validation  
The choroidal ROI from OCT images (n=75) was used to train and test 
classifiers to predict AMD disease severity by classification into three groups; 
healthy, early AMD, or nAMD. The accuracy (percentage agreement between 
classifier and ground truth) of each classifier, evaluated with 10-fold cross-
validation, is shown in Table 5.2. Support vector machine (SVM) was the best-
performing classifier, with mean accuracy of 98.3%. K-nearest neighbour (KNN) 
also performed well, with 94.9% mean accuracy, and random forest (RFS) was the 
poorest of the three classifiers in this analysis, with 89.2% mean accuracy. For KNN 
and SVM, the healthy class had the highest accuracy, whilst with RFS and SVM, the 
early group had the lowest accuracy.  
Table 5.2 Classification accuracy (%) of 10-fold cross-validation for each classifier. KNN = K-
nearest neighbour; RFS = random forest; SVM = support vector machine. 
 Healthy Early AMD nAMD Mean 
KNN 97.3 94.6 92.9 94.9 
RFS 90.9 85.1 91.7 89.2 
SVM 98.6 97.9 98.4 98.3 
 
The classification accuracies were slightly lower for the 2-fold than the 10-
fold cross-validation for all three classifiers (Table 5.3), although the same patterns 
as described above were observed. This reduction in accuracy was expected for this 
method of cross-validation, since less data is used for classifier training.  
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Table 5.3 Classification accuracy (%) of 2-fold cross-validation for each classifier. KNN = K-
nearest neighbour; RFS = random forest; SVM = support vector machine. 
 Healthy Early AMD nAMD Mean 
KNN 96.7 93.8 91.4 94.0 
RFS 88.3 81.7 90.2 86.7 
SVM 97.7 96.7 97.6 97.3 
 
 For the leave-one-out cross-validation, the mean accuracy was substantially 
lower for all classifiers (Table 5.4). For this validation method, no b-scans from the 
eyes in the test set had been used for classifier training. In the 10-fold and 2-fold 
cross-validations however, all b-scans were randomly assigned to the training and 
test sets. Therefore, a number of b-scans from each eye (90% or 50% on average, 
respectively) were used to train the classifiers. The large differences in accuracy 
between cross-validation methods suggests that the classifiers were poor at 
generalising to the population, from the sample used for each class (n=25).  
Table 5.4 Classification accuracy (%) of leave-one-out cross-validation for each classifier. KNN 
= K-nearest neighbour; RFS = random forest; SVM = support vector machine.  
 Healthy Early AMD nAMD Mean 
KNN 40 48 48 45.3 
RFS 56 44 80 60.0 
SVM 40 60 72 57.3 
 
The best-performing classifier in this analysis was the RFS (60.0% mean 
accuracy), whilst the poorest was KNN (45.3% mean accuracy). This is unsurprising, 
since KNN is the most basic of the classifiers used, and RFS is the least prone to over-
fitting. Despite the ability of RFS to generalise to the population, classes with high 
within-class variability still result in limited classification accuracy. The poorest 
performance was for the early AMD group, suggesting that this group had high 
within-class variability. This is not surprising, since this disease group contained 
both early and intermediate AMD (as defined by AREDS 2001a), and had the highest 
standard deviation in several of the choroidal parameters evaluated in Section 4.4.  
The nAMD class had the highest accuracy for all three classifiers. This 
indicated that the choroidal structure is most different in this group, compared to 
the early AMD and healthy groups. Choroidal structure may have been more similar 
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in eyes with no disease or early disease, with more overlap in textural appearance 
between groups, resulting in limited ability of the classifiers to distinguish between 
these two groups. This is consistent with the findings of the manual choroidal 
parameters, where no significant differences were found between early AMD and 
healthy eyes with any parameter evaluated (see Section 4.4).  
 The sensitivity and specificity of each classifier were evaluated for each 
cross-validation method (Figure 5.18). For this analysis, classes were combined to 
allow two different comparisons: AMD (combining early and nAMD) versus non-
AMD (healthy); and neovascular (nAMD) versus non-neovascular (combining early 
AMD and healthy). Specificity of the leave-one out cross-validation was considerably 
higher for the latter of these comparisons, whilst sensitivity was similar. This 
suggests that the classifiers were more accurate at identifying the presence of nAMD 
than of any stage of AMD, supporting the hypothesis that the choroid has a more 
Figure 5.18 Sensitivity (%) and specificity (%) of each classifier, using the three methods of 
cross-validation. The diagnostic ability of the classifiers to identify any stage of AMD (left 
column) and nAMD (right column) were evaluated. For the purposes of this figure, AMD = early 
+ nAMD groups; non-AMD = healthy group; neovascular = nAMD group; non-neovascular = 
healthy + early AMD groups. KNN = K-nearest neighbour; RFS = random forest; SVM = support 
vector machine; LOOCV = leave-one-out cross-validation.  
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distinct appearance in nAMD than in the other groups. This is in agreement with the 
results in Section 4.4, whereby little difference in choroidal structure was found 
between healthy eyes and early AMD, but was significantly different in nAMD. 
However, this was a predominantly treated-nAMD group, and the potential 
implications of anti-VEGF therapy on the choroidal structure must be considered 
(discussed further in Section 5.3). SVM consistently performed the best of all 
classifiers, with the exception of the leave-one-out cross-validation, where it was 
out-performed by RFS.  
 To improve classifier accuracy in the leave-on-out cross-validation, a 
substantially larger dataset would be required, to compensate for the large within-
class variation, and improve generalisation of the choroidal features of each group 
to the population, hence minimising over-fitting (discussed in Section 5.3). Despite 
this, the accuracy of all classifiers evaluated was considerably higher than chance 
(33% for three classes), confirming the feasibility of applying machine learning 
techniques to classification of AMD by disease severity, based on the choroidal 
region in long-wavelength OCT images.  
However, it was not possible to conclude from these findings whether the 
features used in the classification were true structural features, or ‘artefactual’ 
image features produced during image acquisition or processing. It was therefore 
necessary to evaluate the textural image features in the classifier used to 
discriminate between classes, and to associate these with previously demonstrated 
changes to choroidal physiology with advancing disease.  
 
5.2.2 Associating textural image features to choroidal structure  
To provide an indication of the choroidal features used to predict the disease 
stage, the relative importance of each image feature in the classifier (i.e. each of the 
Gabor filters used) was established. The size and orientation of these filters was 
associated with the structural features of the choroidal vasculature, predominantly 
from the histological literature. The possible influence of artefacts was also 
considered (e.g. those inherent to OCT imaging).  
The classifier with the highest accuracy in the leave-one-out cross-validation 
(RFS) was used for this analysis. The ‘permuted delta error’ was used as a measure 
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of importance of each image feature to the classifier (Ishwaran 2007; Baas 2016). 
The increase in prediction error (i.e. misclassification rate) in the leave-one-out 
cross-validation was established for when the values from each Gabor filter (n=40) 
were permuted (i.e. removed from each decision tree). Delta error was calculated as 
the average of the errors for each tree in the decision forest, divided by the standard 
deviation of the errors. This was performed for each b-scan, and then averaged 
across all b-scans in the dataset. These values were normalised from 0 to 1, and the 
results are shown in Figure 5.19. The higher the delta error, the greater the increase 
in prediction error of the classifier, and therefore the more important that feature 
was in determining the classification of each previously unseen image.  
 For the 3 smallest filters, the vertical gratings (90°) were of highest 
importance to the classifier. In OCT imaging, each a-scan is acquired sequentially, 
representing a reflectivity profile with increasing depth in the imaged structure. The 
reflectivity at a given depth in each a-scan is relative to the proportion of light 
reflected by overlying structures. For instance, more light is reflected from a CNV, 
resulting in an area of relatively reduced intensity in the underlying choroid, when 
compared to choroid without overlying retinal disruption. This can result in 
vertically-oriented, sharply demarcated intensity boundaries between 
neighbouring a-scans (Figure 5.20).  
 
Figure 5.19 Relative feature importance (delta error; y-axis) for each Gabor filter (n=40; x-
axis). Filter orientations are indicated by different colours (see key), whilst filters of the same 
grating size are grouped along the x-axis.  
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These vertical features are likely to be increasingly common in advancing 
disease, due to increased disruption of the retinal layers (particularly the hyper-
reflective RPE). This orientation was likely to produce discriminative features for 
classification influenced by features of the overlying retina, rather than solely the 
choroidal structure. This argument is supported by an analysis of the 10 most 
important features in the classifier, which included all 5 gratings with vertical 
orientation (Figure 5.21). There was little difference in discriminative ability 
between the other filter orientations (Figure 5.22A).  
The mean delta error for each filter size and orientation was calculated, and 
was used as an indicator of feature importance to disease classification. The largest 
grating size (lowest spatial frequency; wavelength 18 pixels) was generally of high 
importance to the classifier, with 5 of the 8 orientations appearing in the top 10 
features (Figure 5.21 and Figure 5.22B). The size of this grating equated to a vessel 
diameter of ~102 µm for the vertical grating orientation; most similar in size to the 
large choroidal vessels of this cohort. This indicates that the size of the large 
choroidal vessels was discriminative between disease groups, and therefore that the 
large vessels may be most affected throughout the disease process. This is supported 
Figure 5.20 An increase in the number of shadow artefacts caused by overlying retinal features 
can typically be seen with advancing disease stage. These produce sharply demarcated vertical 
features in the deeper structures (choroid and sclera; examples indicated by arrows in the 
sclera, where they are most visible).  
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by the results of the manual choroidal parameters evaluated in Section 4.4, in which 
the mean visible vessel diameter (VVD) was lower in nAMD than the other two 
groups. However, it is difficult to draw direct comparisons between these analyses, 
due to the difference in measurement orientations. VVD was consistently measured 
axially, whilst the largest grating was applied at various orientations, with 
marginally higher discriminative ability in the near-vertical orientations (Figure 
5.19). Although there is little literature on histological changes to the large vessels 
in AMD, Spraul et al. (1999) reported a decrease in vascular density, which is 
consistent with the decrease in choroidal vascular index (CVI) identified using in 
vivo imaging (Sonoda et al. 2014; Wei et al. 2016).  
Figure 5.22 Mean (± SE) delta error for each Gabor filter orientation (A) and grating size (B). 
The vertical gratings were excluded from the grating size analysis (B), due to their likely non-
choroidal origin.  
Figure 5.21 The top 10 features sorted by relative importance to the classifier (A). The 
corresponding Gabor filters are also shown (B).  
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 The smaller grating sizes (particularly the filter with highest spatial 
frequency; wavelength 6 pixels) also contributed to disease classification (Figure 
5.22B). This filter was more discriminative for the near-horizontal orientations (0°, 
22.5°, and 157.5°) than the near-vertical orientations (67.5° and 112.5°; Figure 
5.19). In fact, with increasing filter size, the features of higher importance 
transitioned from the near-horizontal orientations to the near-vertical orientations 
(when considering the 90° filters as non-choroidal). This trend is in line with the 
expected energy response for each filter, considering the difference in axial and 
lateral scaling, and the resulting axial and lateral components of each grating size 
(described in Section 5.1.2 and demonstrated in Figure 5.23). Due to the decoupling 
of axial and lateral scaling in OCT imaging, filters of different orientation were 
theoretically more sensitive to vessels of different diameter. Considering the image 
scaling factors (x1.9 axially and x11.3 laterally, assuming an AEL of 24 mm), the 
range of filter sizes used corresponds to vessel diameters of approximately 6 µm to 
17 µm axially, and 34 µm to 102 µm laterally. In other words, the higher spatial 
frequency filters should generate a greater response to the small choroidal vessels, 
with highest sensitivity in the axial direction (near-horizontal filters). For the larger 
filters, the response should be greatest for the large choroidal vessels, particularly 
Figure 5.23 Equivalent feature size for the smallest and largest Gabor filters used, with 
varying orientation. The equivalent size describes the vessel diameter with the expected 
greatest energy response to a given filter, at a given orientation.   
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in the lateral direction (near-vertical filters). This is consistent with the trend seen 
in Figure 5.19.  
 
5.2.3 Investigation of convolutional neural networks (CNN) 
The evaluated classifiers required input of ‘hand-crafted’ features; responses 
from the Gabor filters were used in this case. However, defining the features on 
which to base the classification may introduce an element of bias. In an attempt to 
minimise the effect of this, the filters used were selected to correspond to a wide 
range of vessel sizes, in both the axial and lateral directions (discussed in the 
previous section). To eliminate this bias altogether, the use of an alternative 
classifier (CNN) was also explored, which produced a classification without the need 
for predefined hand-crafted features.  
For this type of machine learning technique to be successful, very large 
datasets are typically required, to include the wide range of textural appearances, 
thereby allowing generalisation to the population (Krizhevsky et al. 2012). A total 
of 75 eyes were included in this analysis (n=25 per class), which is unlikely to 
include the sufficient range of choroidal appearances in eyes with and without AMD, 
for accurate results with this type of classifier. Therefore, the aim of this analysis 
was to explore the feasibility of applying CNN to a dataset of OCT images of various 
AMD disease stages. This would be confirmed by a high accuracy of the 2-fold cross-
validation, although the size of this dataset was expected to result in over-fitting of 
the classifier, and therefore limited accuracy in the leave-one-out cross-validation. 
Due to the computational time required to train the CNN, the 10-fold cross-
validation (the least stringent validation method due to the smallest number of 
samples in the testing set) was not performed as part of this analysis.  
The CNN yielded near-perfect classification accuracy with 2-fold cross-
validation (Table 5.5). The accuracy was improved when the individual patches in a 
b-scan were combined to determine the final classification, and was higher-still 
when all b-scans in the volume were considered in the final decision for that eye. 
Although the CNN showed near-perfect sensitivity and specificity with this method 
of cross-validation (Table 5.6), it performed poorly in the leave-one-out cross-
validation (no better than chance; 33% for three classes; Table 5.5).  
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Table 5.5 Classification accuracy (%) of the convolutional neural network (CNN), with 2-fold 
cross-validation, and leave one out cross-validation (LOOCV). 2-fold cross-validation was 
evaluated by establishing the classification accuracy per patch, by combining all patches 
within a single b-scan (per b-scan), and by combining all b-scans within a single volume (per 
eye).  
 Healthy Early AMD nAMD Mean 
2-fold (per patch) 92.5 91.1 92.0 91.9 
2-fold (per b-scan) 100.0 99.6 99.3 99.6 
2-fold (per eye) 100.0 100.0 100.0 100.0 
LOOCV (per eye) 25 25 33 27.7 
 
Table 5.6 Sensitivity (%) and specificity (%) of the convolutional neural network (CNN), using 
the 2-fold and leave-one-out cross-validation (LOOCV). The diagnostic ability of the classifiers 
to identify any stage of AMD (3rd column) and nAMD (4th column) were evaluated. For the 
purposes of this table, AMD = early + nAMD groups; non-AMD = healthy group; neovascular = 
nAMD group; non-neovascular = healthy + early AMD groups. 
  AMD vs. non-AMD Neovascular vs. non-neovascular 
2-fold  Sensitivity 99.9 99.3 
Specificity 100.0 99.8 
LOOCV  Sensitivity 64.6 33.0 
Specificity 25.0 64.6 
 
As expected, this large difference in accuracy between validation methods 
indicates that the within-class variability of the data was large, and the classifier was 
over-fit to the training data. However, the classifier accuracy with 2-fold cross-
validation was higher than that of the classifiers evaluated in Section 5.2.1. This 
suggests that CNN may be a promising technique for this application, given a 
sufficient sample size; its full potential for automated classification of AMD severity 
should therefore be evaluated on a substantially larger dataset (discussed further in 
Section 5.3). This could provide further knowledge of changes to the vasculature in 
AMD, without the bias of handcrafted features.  
 
5.3 Discussion  
The three classifiers evaluated in Section 5.2.1 produced high classification 
accuracy for the 10-fold and 2-fold cross-validation, confirming the feasibility of 
applying these machine learning techniques to automated classification of AMD 
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disease stage, based on choroidal appearance. The accuracy was substantially lower 
for the leave-one-out cross-validation, suggesting poor generalisation of the 
classifiers to the population. This was likely due to limited sample size and high 
within-group variability in choroidal structure. The best-performing classifier in the 
leave-one-out cross-validation was RFS, followed by SVM. KNN produced the lowest 
classification accuracy, which is unsurprising since this was the most basic of the 
methods evaluated.  
The use of a CNN was also explored, as an alternative to these classifiers 
(Section 5.2.3). This is a deep learning technique, using the image data as input, 
rather than hand-crafted features. Salient image features are learnt through a series 
of feedback loops in the network, and are used as a basis for classification of 
previously unseen images. As expected, the classification accuracy of the leave-one-
out cross-validation was substantially lower for this method, likely due to high 
within-class variability in choroidal appearance. Despite this, the CNN produced 
near-perfect classification accuracy with 2-fold cross-validation; this demonstrates 
excellent potential for this application given the relatively small sample sized used, 
and indicates likely success should it be applied to a substantially larger dataset (e.g. 
n≈1500 eyes; discussed later in this section).  
From the literature, only one study has applied machine learning techniques 
to automated classification of OCT images based on choroidal structure. Koprowski 
et al. (2013) used RFS to classify macular lesions as neovascular, ischemic, or 
fibrovascular scarring. Using 20% of the images for testing, accuracies of 73%, 83%, 
and 69% were achieved for the three groups respectively. These values are 
comparable to the current study, with an accuracy of 80% for the nAMD group using 
the RFS classifier (Table 5.4). Since the groups were not the same (i.e. there were no 
healthy or early disease groups), potential comparisons are of limited value. 
However, this does support the hypothesis that structural choroidal differences are 
present within OCT images, and that these images can be used to detect and assess 
this pathology.  
Other studies classifying AMD from OCT images have been published, in 
particular using SVM as a classifier (Srinivasan et al. 2014b; Albarrak et al. 2016; 
Section 1.7.3). The more recent of these studies classified images into two groups 
(healthy or AMD), and demonstrated performance ranging between 86% and 100% 
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with 10-fold cross-validation. The mean accuracy of the present study was 98.3% 
with SVM (Table 5.2), which was at the higher end of this range, despite the use of a 
smaller dataset (n=75 eyes, versus n=140 eyes).  
Srinivasan et al. (2014b) achieved an average of 93.3% accuracy with leave-
one-out cross-validation for normal versus dry AMD, using an SVM classifier. This is 
higher than the present study (57.3%), likely because the analysis was based on 
retinal (rather than choroidal) features. The difference in these textural features 
between groups would be expected to be well-defined, due to the distinct 
characteristic retinal appearance of the disease (e.g. disruptions to the RPE 
overlying drusen). Images were cropped to exclude the choroidal region, making 
comparison between these findings difficult. Furthermore, two eyes with AMD were 
selectively excluded from classifier training, as they were ‘unrepresentative’ of the 
dataset (although the nature of this was not defined by the authors). No eyes were 
excluded from classifier training in the present study, which may have limited the 
accuracy of the results, but is more likely to be representative of the population. In 
relatively small training samples (such as the dataset used in this thesis), the 
inclusion of atypical disease appearance may skew the importance of features in the 
classifier. However, this is of particular importance with regard to large-scale 
clinical application, where accurate classification of atypical disease would require 
the classifier to be exposed to atypical clinical appearance during the training 
process.  
A further study evaluated the use of CNN to classify normal (n=1259) versus 
AMD (n=347) from OCT images (Lee et al. 2017). This study used one of the most 
extensive datasets to date for this type of analysis, and achieved a sensitivity of 
88.6% and specificity of 87.8%, with one fifth of images used for testing only (no b-
scans from test eyes were used in classifier training). The patients in the AMD group 
had nAMD in at least one eye, and VA poorer than 0.20 logMAR in the better-seeing 
eye. The mean VA of that group was 0.38 ± 0.50 logMAR, which is similar to that of 
the nAMD group in the present study (0.37 ± 0.37 logMAR; see Section 4.3), 
suggesting similar functional disease severity between studies. For this reason, the 
results are compared to the nAMD versus non-nAMD analysis in the present study. 
Although the results of the CNN classifier were poor due to over-fitting, the RFS 
classifier yielded a sensitivity of 80% and specificity of 76%. These values are lower 
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than those reported by Lee and colleagues, although this is be expected due to the 
inclusion of retinal features in the classification, and the substantial difference in 
sample size.  
The nAMD group typically had the highest classification accuracy of the three 
classes. This suggests that this group had a distinct choroidal appearance, detectably 
different to that of the other two groups. This is consistent with the results of the 
manual choroidal parameters evaluated in Section 4.4, with significant differences 
in choroidal structure detectable only in the nAMD group. From this, one may 
conclude that the majority of detectable choroidal changes occur in the more 
advanced disease stages. This is also consistent with the literature, where significant 
thinning of the choroid has predominantly been identified in late-stage disease 
(Chung et al. 2011; Esmaeelpour 2014a; Lu et al. 2016; Wei et al. 2016). However, 
since the majority of individuals in the nAMD group were currently undergoing (or 
had previously undergone) anti-VEGF therapy, it was not possible to determine 
whether the vascular features used to classify this disease group were attributed to 
pathological degeneration or resulting from pharmacological intervention (see 
Sections 1.4.6 and 4.5).  
Classification accuracy was considerably higher than chance (range 40-60%, 
versus 33%) for the differentiation of early AMD and healthy eyes. This suggests that 
there are changes in the textural appearance of the vasculature visible in OCT 
images, even at the early stages of the disease. To further explore these structural 
differences, the discriminative image features in the classification were compared 
to the physiological structure of the choroid, established with histological 
techniques (Ramrattan et al. 1994; Spraul et al. 1999). This analysis was performed 
on the classifier yielding the highest accuracy (RFS), as this would provide greatest 
confidence that the features used by the classifier reflect the choroidal structure. 
Although knowledge of the features learnt by the CNN would provide structural 
information unbiased by the use of hand-crafted features, the classification accuracy 
was not significantly better than chance for the sample size used here. It would not 
be possible to have confidence in the features learnt, and this analysis was therefore 
not undertaken.  
The importance of the vertical features in the classifier was likely (at least in 
part) artefactual, resulting from pathological disruption to the overlying retina. An 
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area of relative retinal hyper- or hypo-reflectance caused differences in choroidal 
intensity between neighbouring a-scans, producing vertical intensity boundaries. 
Whilst present in all images, the prevalence of these shadow artefacts may be 
expected to increase with advancing disease stage, due to an increase in retinal 
disruption (Figure 5.20). Since it is likely that this artefact contributed to accurate 
classification of disease groups in this analysis, the classification was influenced by 
overlying retinal features, rather than being based solely on choroidal appearance. 
For this reason, the artefactual delta errors were removed prior to association of the 
discriminative filters to choroidal structure. Since this ‘shadow’ artefact is inherent 
to OCT imaging, this filter orientation should be removed from feature extraction of 
sub-retinal structures in future analysis, where possible.  
Both the small and large Gabor filters were discriminative between disease 
groups, with the medium-sized filters providing a smaller contribution to the 
classification (Figure 5.19). For the small filters, the near-horizontally oriented 
filters were most discriminative, which equated to ~6-10 µm vessel diameter. This 
corresponds to the vessels of the choriocapillaris (mean diameter ~7-10 µm; 
Ramrattan et al. 1994; Spraul et al. 1999), suggesting that the choriocapillaris 
becomes increasingly abnormal throughout the AMD disease process. This is 
consistent with histologically identified changes primarily to diameter and density 
of the choriocapillaris in both early- and late-stage AMD, compared to healthy 
control eyes (Sarks 1976; Ramrattan et al. 1994; Spraul et al. 1999; McLeod et al. 
2009). It should be noted that this filter size is nearing the axial resolution limit of 
the OCT device (~6 µm); structures smaller than this would therefore not be 
detectable with this imaging technique.  
For the large filters, there was less difference between the filter orientations, 
although the near-horizontal orientations were generally of less importance to the 
classification. Considering the near-vertical orientations (excluding the 90° 
orientation), these filters correspond to vessel diameters of ~68-102 µm (i.e. the 
vessels of the Haller and Sattler layers). This suggests that changes to the larger 
vessels also occur with advancing disease. This is again consistent with Spraul et al. 
(1999), who reported a lower density of veins in eyes with AMD than healthy 
controls (by nearly 50%). To summarise, these findings support the reported 
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histological changes to the structure of all vessel layers (choriocapillaris and the 
medium/large choroidal vessels), throughout the AMD disease process.  
  There were a number of limitations to this work, which will be outlined and 
discussed here. Firstly, the sample size was relatively small for a study applying 
machine learning techniques. However, the aim of this research was to investigate 
the feasibility of this analysis for automated classification of AMD by disease 
severity, which has been achieved. To confirm these findings, and to fully investigate 
the potential of these techniques for large-scale clinical application, a large dataset 
would be required. The findings are consistent with reported histological changes 
to the choroidal structure in AMD, and suggest that these changes are detectable in 
vivo, using long-wavelength OCT imaging.  
Based on previous studies which have applied machine learning to AMD 
disease classification from OCT images, the sample size required to achieve accurate 
classification would likely be ~1000-1600 images (Koprowski et al. 2013; Lee et al. 
2017). The upper end of this range relates to the application of CNN to a binary 
classification problem (i.e. disease versus non-disease); for accurate classification 
into three groups, an even larger dataset may therefore be required. However, 
considering that these previous studies utilised conventional OCT, optimisation of 
imaging techniques to enhance visualisation of the choroidal features (e.g. long-
wavelength OCT imaging, in conjunction with enhanced depth imaging and swept-
source OCT) may result in a smaller dataset proving sufficient to identify the 
choroidal features which best discriminate between groups.  
The selection of handcrafted features limited the range of feature sizes that 
could be detected and utilised by the classifiers. To minimise the effect of this, Gabor 
filter sizes were selected to reflect an appropriate range of vessel sizes in both the 
axial and lateral orientations (Figure 5.23; see Section 5.1.2). The smallest filter size 
used was equivalent to ~6 µm. The inclusion of smaller filters than this (i.e. higher 
spatial frequency) would exceed the axial resolution limit of the OCT; they would 
therefore not be capable of detecting smaller features in the image, and would 
become sensitive to high-frequency noise. However, the filters used did not 
encompass the largest choroidal vessels (>102 µm), as described by the VVD 
parameter in Section 4.4. Since the largest Gabor filter used was generally the most 
discriminative in the classifier, and the large choroidal vessels were found to be 
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smaller in this nAMD cohort, it would be interesting to explore the potential of larger 
filters (i.e. lower spatial frequency) for including these larger vessels in the 
classification.  
Every b-scan from a volume scan was given the same ground truth 
classification. Each b-scan was then treated individually by the algorithm, and a 
majority voting system used to determine the final classification for each eye. This 
system is based on the assumption that any choroidal changes with advancing 
disease occur uniformly across the central 20° × 20° of choroid. Although areas of 
vascular change have been shown to correlate with areas of retinal atrophy in GA 
(McLeod et al. 2002), it is unclear from the literature whether structural changes in 
the choroid in early AMD are diffuse, or localised to the regions of overlying retinal 
features. In nAMD, a decrease in percentage vascular area (similar to CVI) has been 
demonstrated to extend beyond the area of the CNV, by at least 1 mm (McLeod et al. 
2009). In the present study, every b-scan was given equal weighting in the final 
classification, regardless of position in relation to the foveal pit, or the presence or 
absence of overlying retinal features indicative of disease (Figure 5.24). During the 
majority voting of an eye with nAMD, if the choroid had a healthy appearance in a 
high proportion of b-scans (over one third of the total), the eye would have been 
given an incorrect final classification of healthy. This may have limited the 
sensitivity of the classifiers, particularly for the detection of nAMD.  
The ground truth data was based on clinical grading, using an adapted 
version of the AREDS classification system (AREDS 2001a). This system is based 
upon the appearance of retinal features (described in Section 4.2), although how this 
relates to choroidal appearance throughout the disease process is unclear. The 
Figure 5.24 Retinal photograph of an eye with nAMD (A). The visible retinal features on OCT 
are confined to the foveal and parafoveal area (outlined in white). A b-scan through the fovea 
(B) shows visible disruption to the retinal layers, whilst a b-scan of a more peripheral location 
(C) contains no obvious retinal signs of any stage of AMD. Both b-scans are given equal 
weighting in the final disease classification of the eye.  
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correlation between AREDS disease severity and structural change to the choroid is 
not known (despite a gross relationship shown with histology), although the results 
of Section 4.3 suggest that these changes are detectable only at the nAMD stage 
(group 4; advanced). Additionally, the early AMD group included AREDS groups 2 
and 3 (early and intermediate). This was partially for ease of classifier training, but 
also since the original statistical power was calculated assuming three groups. 
Dividing the dataset into four groups would reduce the amount of training data 
available for each group. However, since the early group was less easily 
differentiated from the healthy group, comparing between an early and 
intermediate group may help to pinpoint where in the disease process the observed 
vessel changes occur.  
Furthermore, the disease status of the fellow eye was not considered in this 
analysis. In the early AMD group, the increased risk of progression to nAMD in those 
with a diagnosis of nAMD in the fellow eye may be related to choroidal structure 
(see Section 4.4.2). Given a dataset of sufficient size, inclusion of fellow eye diagnosis 
in the classifier may reveal potential for using machine learning techniques to 
predict the development of late-stage AMD. The present study was cross-sectional, 
and therefore no conclusions can be drawn regarding vessel changes over time. A 
longitudinal study could be conducted to investigate the timeline of vascular 
changes throughout the AMD disease process, as well as the effect of anti-VEGF 
therapy on choroidal structure, to differentiate structural changes relating to 
pathology and intervention.  
To summarise, the novel use of machine learning techniques for automated 
classification of AMD by disease severity, based on choroidal appearance, was 
shown to be feasible. Reasonable classification accuracy was achieved using 
classifiers trained with hand-crafted features. Despite limitations in the size of the 
training dataset, the application of an additional classifier based on self-learnt 
features (CNN) produced promising results. These findings suggest that changes to 
the choroidal vasculature occur throughout the AMD disease process, and that these 
changes are detectable using in vivo long-wavelength OCT imaging.  
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6 Discussion, conclusions, and future work 
 
6.1 General discussion 
The overall aim of this research was to determine whether structural 
changes to the choroidal vasculature in AMD are detectable using in vivo OCT 
imaging. It was evident from the literature (Chapter 1) that such changes have been 
identified ex vivo, using histological techniques. However, in vivo quantification of 
the choroid using OCT imaging has mostly been limited to choroidal thickness 
measurement, which is highly variable between individuals, and is affected by many 
physiological factors. A literature review revealed a small number of other 
quantification techniques that had been applied to images of other choroidal 
pathologies, such as central serous chorioretinopathy. From this review, three 
supplementary aims were developed: to optimise image acquisition and processing 
protocols to allow enhanced visualisation of the choroidal vasculature; to develop 
and evaluate repeatable parameters for describing and quantifying the vasculature; 
and to explore the feasibility of applying machine learning techniques to automated 
classification of AMD by disease severity, based on choroidal appearance.  
 The studies in this thesis utilised a non-commercial long-wavelength       
(1040 nm) OCT, intended to maximise visualisation of the choroidal vasculature 
compared to the conventional OCT devices available at the outset of this work. 
Image acquisition and processing techniques were optimised for choroidal 
visualisation, including scan parameters, artefact correction, and noise reduction 
(Chapter 2). To ensure that these investigations would be clinically applicable, it was 
decided that the images used in further analysis should be of comparable size to 
those commonly collected on commercial devices. Isometric volume scans were 
used to provide a three-dimensional representation of the vasculature, whilst 
averaged, over-sampled line scans allowed for higher definition of the structural 
boundaries.  
To ensure that images were scaled appropriately, a study investigating the 
effect of lateral scaling on image quantification was performed (Chapter 3). It was 
shown that inappropriate scaling resulted in errors which affected the consistency 
and reliability of image measurements, and therefore axial eye length (AEL)-
dependent lateral scaling should be employed (Terry et al. 2016). For this reason, 
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the AEL of all participants included in this thesis was acquired to allow for accurate 
quantification of the OCT images.  
The feasibility of eight parameters were then evaluated for quantifying the 
choroidal structure, and inter-session repeatability on healthy eyes (n=25) was 
established. All parameters demonstrated reasonable repeatability (CoR < 20% in 
all cases), and were therefore likely sufficient to detect structural differences 
between disease groups. The over-sampled line scans produced more reliable 
measurements, due to improved visibility of the deeper vessels and posterior 
choroidal boundary, particularly in eyes with thicker choroids. The volume scans 
allowed for enface analysis of vessels across the entire macula, at a given depth 
beneath the RPE. To ensure a consistent sampling depth across the scan, a MATLAB-
based program was developed to flatten the scans to the RPE. Furthermore, an 
existing device-independent algorithm for automated choroidal segmentation was 
evaluated (Iowa Reference Algorithms), albeit at a beta stage of development. Its 
performance was not reliable enough to be applied to this work, although it showed 
potential for future work. Manual segmentation of the choroid was therefore used 
throughout this thesis.  
A 3-D analysis approach was also attempted, however, this did not yield 
meaningful results due to the low SNR inherent to choroidal imaging. This should be 
revisited with the advent of long-wavelength SS-OCT, which demonstrates reduced 
signal roll-off, and allows acquisition of higher quality images than the non-
commercial device used in this study.  
A dataset of long-wavelength OCT images was acquired from eyes with early 
AMD (n=25), nAMD (n=25), and healthy controls (n=25). Due to the limitations of 
the established grading scales (associated with imaging modalities and the 
introduction of anti-VEGF therapy), a modified AREDS classification system was 
developed for clinical classification of eyes by disease severity (Chapter 4). A 
significant difference in the nAMD group was identified in four of the eight manual 
choroidal parameters evaluated (subfoveal choroidal thickness, vessel ratio, 
choroidal area, and luminal area). Visible vessel diameter was also found to produce 
a difference which neared statistical significance. Subfoveal choroidal thickness and 
vessel ratio demonstrated the greatest diagnostic potential for nAMD, although the 
sensitivity and specificity were relatively low for a potential clinical test. 
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Nevertheless, in conjunction with other structural and functional measures (e.g. 
retinal layer disruption, visual acuity, etc.), these parameters show potential for 
monitoring of AMD, particularly for those with late-stage disease. No significant 
difference was found between the healthy and early AMD groups, with any of the 
parameters used.  
It should be noted that it was not possible to differentiate pathological 
structural changes from the changes caused by anti-VEGF therapy (Yamazaki et al. 
2012; Koizumi et al. 2015; Ting et al. 2016) in the nAMD group. There was no access 
to participants’ medical records in the present study, and treatment history 
(approximate number of injections) was self-reported. For this reason, no further 
analysis was performed to investigate the relationship between anti-VEGF therapy 
and choroidal structure.  
The sample size used in the analysis in Chapter 4 was based on a power 
calculation, and was selected to detect a predefined minimum difference between 
groups of 8.5 μm. This difference was based on histological data, which may not have 
been a suitable approximation to differences in the parameters evaluated in vivo. 
The mean differences and within-group standard deviations found in this study (e.g. 
~15 μm and ~30 μm respectively for vessel diameter) could be used in future power 
calculations investigating changes to the choroidal vasculature. Since the intra-
group variation was higher than expected, a larger sample size would be required 
to detect a significant difference between disease groups (with the same power and 
significance level), particularly for the parameters with little inter-group difference.  
 Since these manual measurements were time-consuming and likely to be 
limited by inter-observer variability, the use of machine learning techniques for 
automated disease classification was investigated (Chapter 5). This technique had 
not been previously used to investigate pathological changes to choroidal structure 
in different stages of AMD. Since the dataset used was relatively small for a study of 
this nature, the aim was to determine the feasibility of these techniques, rather than 
to develop a classifier with near-perfect classification accuracy. Of the classifiers 
investigated, the random forest (RFS) classifier achieved the highest accuracy, 
particularly in the leave-one-out cross-validation (representing the clinical scenario 
of an eye previously unseen by the classifier). This demonstrated the feasibility of 
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applying machine learning techniques to automated classification of AMD by disease 
severity, based on choroidal appearance.  
 Classification accuracy was highest for the nAMD group, suggesting that 
vascular changes were most pronounced in this group, which was consistent with 
the manual choroidal parameters evaluated in Chapter 4, and both histological and 
in vivo evidence (McLeod et al. 2009; Lu et al. 2016; Wei et al. 2016). However, since 
this disease stage is more easily diagnosed from other pathological signs visible on 
OCT imaging (e.g. CNV development and/or intra- or sub-retinal fluid), 
identification of nAMD based solely on choroidal appearance alone has limited 
clinical applications. Optimisation of machine learning algorithms to include both 
choroidal and retinal features, similarly to that performed by Lee et al. (2017), 
allows for automated detection of nAMD with high accuracy. For this to be effective 
for automated clinical diagnosis of nAMD, training data should include untreated 
(newly diagnosed) eyes with nAMD, to minimise the effects of anti-VEGF therapy on 
the appearance of the structures. This may be of benefit in triaging patients in 
referral refinement schemes, prioritising those individuals requiring therapeutic 
intervention. There may also be potential for monitoring AMD in ‘virtual’ macular 
clinics within the hospital eye service, allowing for clinical follow-up without the 
need for extensive ophthalmological examination. To this end, an ‘active’ versus 
‘inactive’ nAMD classification protocol would be required. These applications could 
provide potential benefits to the health service, including reduction of clinic 
oversubscription and costs. This is particularly pertinent, given the ageing 
population and the predicted increase in AMD prevalence (Owen et al. 2012; Wong 
et al. 2014).  
The RFS classifier was successful at differentiating between the early AMD 
and healthy groups. However, the possibility of the discriminative image features 
being artefactual rather than structural must be considered, particularly the 
influence of shadow artefacts from overlying retinal features. Although these 
contributed in part to the classifier accuracy, other (non-vertical) structural features 
were also discriminative between disease groups, which were more likely of 
choroidal origin. This suggests that structural changes to the choroid may occur 
early in the disease process. These changes were not detected by applying the 
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manual choroidal parameters to the same image dataset, indicating that the machine 
learning techniques were potentially more sensitive to early structural change.  
These findings are consistent with the hypothesis that the choroid is involved 
in the pathogenesis of AMD, although the extent of this involvement (i.e. a cause or 
effect relationship) would be speculative at this time. If these changes occur prior to 
retinal degeneration, identification of this could be significant for early detection of 
AMD (alongside other biomarkers, e.g. from dark adaptation; Owsley et al. 2016), 
prior to onset of symptoms including visual loss, and irreversible retinal damage. 
Furthermore, this could have a potential application in disease monitoring, through 
identification of patients at risk of progressing to the sight-threatening late-stages 
of the disease. However, longitudinal investigation is required to identify those 
participants who develop AMD, or progress to nAMD, and to explore choroidal 
changes associated with this progression.  
It is important to note that the ground truth classification (i.e. the method by 
which images were labelled with a disease group), was based upon clinical 
appearance. This was undertaken using a modified AREDS system (AREDS 2001a), 
and was therefore based on retinal features, with no influence from the structure of 
the choroid. Results obtained from this dataset are therefore dependent on the 
assumption that changes to the choroidal vasculature throughout the disease 
process are congruous with the retinal changes upon which the classification system 
is based. The exact relationship between choroidal and retinal changes throughout 
the AMD process is unclear, although a gross relationship has been demonstrated 
with histology (McLeod et al. 2009; Whitmore et al. 2015). It is possible that there 
are choroidal changes which precede the development of clinically detectable early 
AMD or nAMD, but would be classified as healthy or early AMD respectively using 
this clinical classification. Whilst these features would be considered sub-clinical, 
they may affect the outcome measures of these groups. This limitation is inherent to 
cross-sectional study designs such as this one, which involve dividing data based on 
assumptions. A definitive method of identifying these individuals with sub-clinical 
disease is to conduct a longitudinal study, and to retrospectively subdivide these 
groups by stable versus advancing disease severity. However, this was not feasible 
in the timescale of this project.  
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Furthermore, the ‘early AMD’ group included AREDS severity groups 2 and 3 
(early and intermediate AMD). The three groups used in the present study were 
expected to produce relatively large differences in choroidal appearance between 
groups, as indicated by previous histological and in vivo studies (Spraul et al. 1999; 
Sigler and Randolph 2013; Wei et al. 2016). These coarse groups were chosen to 
explore the feasibility of detecting structural differences in vivo. No significant 
difference was found between the healthy and early AMD groups using manual 
quantification, although the difference between the early and nAMD groups was 
significant. The within-group variability was highest in the early AMD group, 
suggesting a large range of choroidal appearances within this disease stage. Given 
that there is some evidence of a detectable difference in choroidal structure between 
intermediate AMD and nAMD (Esmaeelpour 2014a), this should be explored further 
by subdividing into early and intermediate disease groups. However, this sub-
analysis was not performed in the present study, due to sample size restrictions.  
 
6.2 Summary and conclusions 
The main aim of this research was to determine whether structural changes to 
the choroidal vasculature in AMD are detectable using in vivo imaging. To achieve 
this, three supplementary aims were developed (outlined in Section 1.7), which 
have been addressed as follows:  
1) To optimise protocols for image acquisition and processing for enhanced 
visualisation of the choroidal vasculature.  
A series of preliminary investigations were carried out to determine the 
optimal protocols for visualising the vasculature. The importance of image over-
sampling, and accurate lateral image scaling were demonstrated. A non-commercial 
long-wavelength (1040 nm) SD-OCT was successfully used to acquire volume scans, 
and over-sampled line scans from the participants included in this thesis, which 
underwent AEL-dependent lateral scaling. Using the acquisition and processing 
protocols developed, the choroidal vasculature could be visualised in all 
participants.  
2) To evaluate parameters describing the choroidal vasculature, including 
assessment of inter-session repeatability.  
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Eight parameters were developed to quantify the choroidal structure, and 
assessed for inter-session repeatability. The over-sampled line scans produced 
more reliable measurements than the volume scans, and hence were used for these 
measurements (with the exception of the enface analysis). All parameters 
demonstrated high inter-session repeatability, and were therefore assessed for 
their ability to distinguish between disease severity groups. Four of these 
parameters identified a statistically significant difference in late-stage disease. The 
choroid was shown to be thinner in eyes with advanced disease, with a reduction in 
luminal area, although it is not possible to differentiate between changes caused by 
the disease and by anti-VEGF therapy. No changes to the choroidal structure were 
identified in early AMD. Although these parameters are easily applied to OCT 
images, their diagnostic ability is limited due to a relatively poor sensitivity and 
specificity for a clinical test. Despite their limitations as standalone biomarkers, they 
may be useful parameters to be used in conjunction with other clinical information, 
to inform clinical follow-up (i.e. monitoring of individuals likely to progress to late-
stage disease).  
3) To explore the feasibility of applying machine learning techniques to 
automated classification of AMD by disease severity, based on choroidal 
appearance.  
Due to the relatively low contrast and SNR of the choroidal images, a texture 
analysis-based machine learning approach was utilised. Although the restricted size 
of this dataset did not allow for the development of highly accurate classifiers, it was 
of sufficient size to confirm that textural changes to the choroidal region with 
advancing disease are detectable in long-wavelength OCT images. The 
discriminative features in the classifier were consistent with previous histological 
findings; this supported the hypothesis that structural changes to the choroidal 
vasculature are detectable in vivo. Although these changes are most pronounced in 
the advanced disease stage, it is not known whether this is due to the pathology or 
pharmacological intervention. The classification results indicate that changes are 
present in early disease stage, supporting the theory that the choroid is involved in 
the pathogenesis of AMD. Although very large datasets are required to enable highly 
accurate classifiers to be trained, machine learning shows great potential for 
222 
 
automated screening and computer-aided diagnosis of AMD from OCT images 
(Apostolopoulos et al. 2016; Lee et al. 2017).  
To conclude, these results show that structural changes to the choroidal 
vasculature in AMD are detectable in vivo with OCT imaging, using both manual and 
automated analysis techniques. Although these changes are prominent in late-stage 
disease, subtle structural changes in early AMD can be identified with texture 
analysis. This furthers our understanding of changes to the choroidal structure 
throughout the disease progression.  
 
6.3 Future work  
 Following on from the work in this thesis, future research should be directed 
towards optimising machine learning algorithms for automated detection and 
classification of AMD by disease severity. This would be extended from solely the 
choroidal region (as in this thesis) to include pathological retinal signs visible on 
OCT images (e.g. disruption to the intra-retinal layers and RPE), allowing for highly 
accurate prediction of disease stage. Such a study would require a large dataset of 
clinically labelled OCT images (n≈1500 eyes; Koprowski et al. 2013; Lee et al. 2017) 
of various disease stages (healthy, early, intermediate, and advanced AMD) in order 
to train convolutional neural networks capable of generalisation to the population. 
The learned features could then be explored to further our understanding of 
choroidal involvement in the pathogenesis of AMD.  
To maximise the clinical applicability of the classifiers, images from a 
commercial OCT device should be used for training (and testing). These devices are 
commonplace in primary and secondary care, facilitating data collection and 
subsequent integration of algorithms into these clinical settings. However, 
conventional-wavelength OCT devices do not provide sufficient visualisation of the 
choroidal vasculature to obtain reliable results. Long-wavelength swept-source OCT 
devices are now commercially available (Topcon DRI OCT Triton, and Zeiss PLEX 
Elite 9000), which are optimised for visualising the choroid. Images from these 
devices would produce the clearest view of the choroidal vasculature but, to the 
author's knowledge, no large AMD datasets have yet been acquired with these 
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devices. The potential of OCT imaging for automated screening and computer-aided 
diagnosis of AMD should be investigated using these devices.  
 The effects of nAMD and anti-VEGF therapy on choroidal structure were 
confounded in the research, since the majority of the nAMD group were undergoing 
(or had previously undergone) this treatment. To differentiate the treatment effects 
from those of the underlying pathology, it would be necessary to obtain long-
wavelength OCT images from treatment-naïve eyes. The simplest and most ethically 
acceptable method of achieving this would be to acquire images at the time of 
diagnosis, i.e. prior to the initial intravitreal injection. If choroidal changes are part 
of the natural history of AMD, one would expect to observe these changes in 
choroidal structure at this point in time (prior to pharmacological intervention). To 
further explore the effects of treatment, subsequent OCT images could be obtained 
from the same cohort in a longitudinal study. For example, given that AMD 
progresses slowly, if significant changes to the choroidal vasculature were observed 
one month post-treatment follow-up, the most likely explanation would be that 
these observed effects are related to the treatment rather than the disease. 
Additional longitudinal data may be used to determine the characteristics of the 
dose-response relationship.    
  With the increasing need for large datasets, particularly for studies applying 
machine learning techniques (Krizhevsky et al. 2012), multi-centre studies will 
likely be used to meet this demand. Due to the imaging equipment available at each 
centre, these studies often include images from a number of different OCT devices. 
Due to the size of these datasets, device-independent algorithms for automated 
segmentation of the choroidal boundaries (such as the Iowa Reference Algorithms) 
should be optimised and validated on each device, to minimise analysis time and 
inter-observer variability associated with manual segmentation. 
 Finally, the time-course of structural changes to the choroid in the AMD 
disease process could be investigated. If these changes occur prior to severe retinal 
degeneration, and are detectable with in vivo imaging, this may provide novel 
biomarkers for identifying individuals at risk of progressing to nAMD, which could 
help inform clinical follow-up regimes. A large longitudinal study utilising long-
wavelength SS-OCT imaging, with retrospective subgroup analysis of stable versus 
progressing disease, would strengthen our understanding of the underlying 
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pathophysiology of AMD. This may identify vascular features which predispose an 
individual to retinal degeneration, allowing early detection of disease prior to 
irreversible visual loss.  
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A – Specifications of a subset of commercially available OCT devices 
 
*Information from product manuals.  
#The Topcon 3D-OCT 1000 (as described in this thesis) is no longer manufactured.  
 
 
Device* Heidelberg Spectralis Zeiss Cirrus HD-OCT 5000 Topcon 3D-OCT 2000# Topcon DRI-OCT Triton 
Centre wavelength 870 nm 840 nm 840 nm 1050 nm 
Imaging type Spectral-domain Spectral-domain Spectral-domain Swept-source 
Scanning speed 40,000 a-scans/sec 27,000-68,000 a-scans/sec 27,000-50,000 a-
scans/sec 
100,000 a-scans/sec 
Axial resolution 3.5 µm (digital) 
7 µm (optical) 
5 µm 5-6 µm 2.6 µm (digital) 
8 µm (optical) 
Transverse 
resolution 
14 µm 15 µm 20 µm 20 µm 
Minimum pupil 
diameter 
unstated 2 mm 2.5 mm 2.5 mm 
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B – MATLAB code to flatten OCT images to the RPE 
%--------------------------------------------------------------------- 
%NAME 
%  main.m 
%PURPOSE 
%  Main program 
%ACRONYM 
%  MAIN 
%DESCRIPTION 
%  This program flattens choroidal OCT images by displacing columns of  
%  pixels vertically. The input images are stacked TIFF files, with 8  
%  bit greyscale (0 is black, 255 is white). 
%AUTHORS 
%  Louise Terry 
%  Tom Bower 
%--------------------------------------------------------------------- 
%===================================================================== 
%               INITIALISE 
%===================================================================== 
%              Clear MATLAB workspace and variables 
clear; clc; 
%              Get filename from user with "open" windows dialog 
[ifile path fi] = uigetfile('*.tif','Select the MATLAB code file'); 
%              Concatenate strings for path and filename into ifile 
ifile=strcat(path,ifile); 
%              Add suffixes to generate temp and output filename 
strings 
ofile=strcat(ifile(1:end-4),'-temp.tif'); 
ofile2=strcat(ifile(1:end-4),'-flat.tif'); 
%              Print the input and output files to the command windows 
disp(ifile); 
disp(ofile2); 
%              Open TIFF file for reading 
tin = Tiff(ifile); 
%              Store TIFF information (dimensions, compression...) 
info = imfinfo(ifile); 
  
%===================================================================== 
%               GET USER INPUT DATA 
%===================================================================== 
%               Maximum possible number of slices assumed (nmax) 
nmax = 1024; 
%              First assume zero slices 
nslice = 0; 
last = 0; 
%              Loop until last slice, or maximum slices 
while (nslice <= nmax) && (last~=1) 
%              Increment slice counter 
  nslice=nslice+1; 
%              Set the current slice to the new counted slice 
  setDirectory(tin,nslice); 
%              Binary query for last slice, last=0 unless current  
%              slice is the final slice, loop exits when last==1 
  last=lastDirectory(tin); 
end 
%              Print the total number of slices to the command window 
disp(['Number of slices: ' num2str(nslice)]); 
%              Get image dimensions 
width=int64(tin.getTag('ImageWidth')); 
height=int64(tin.getTag('ImageLength')); 
%               Print image dimensions to command window 
disp(['Image width: ' num2str(width)]); 
disp(['Image height: ' num2str(height)]); 
260 
 
%               Call slicenos function, this asks the user which  
%               slices to sample 
[slices nsample] = slicenos(nslice); 
  
%===================================================================== 
%               PROCESS INPUT DATA AND APPLY TRANSFORMATIONS 
%===================================================================== 
%               Call sampleddisps function, asks the user for clicks  
%               on each sampling image, then interpolates the parabola  
%               using fourth order regression 
sampled = sampleddisps(tin,slices,nslice,nsample,width,height); 
  
%               Print current stage to command window 
disp('Interpolating columns with polyfit'); 
%               Call alldisp funcion, this interpolates each parabola  
%               between slices and outputs the displacement matrix for 
%               the entire stacked image 
alldisps = alldisp(width,nslice,slices,nsample,sampled); 
  
%               Start timer 
tic; 
%               Print current stage to command window 
disp('Applying interpolated displacements'); 
%               Call applydisps function, this takes the displacement 
%               matrix and transforms the image, the output is a three 
%               dimensional matrix containing the 0-255 greyscale  
%               values for each pixel in the TIFF stack 
newimg=applydisps(alldisps,width,height,nslice,tin); 
  
%===================================================================== 
%               SAVE NEW IMAGE 
%===================================================================== 
%               Print current stage to command window 
disp('Saving image'); 
%               Create new image and store in t 
t = Tiff(ofile,'w'); 
%               Set properties for new image 
t.setTag('ImageLength',size(newimg,1)); 
t.setTag('ImageWidth',size(newimg,2)); 
t.setTag('Photometric',Tiff.Photometric.MinIsBlack); 
t.setTag('BitsPerSample',8); 
t.setTag('PlanarConfiguration', Tiff.PlanarConfiguration.Chunky); 
t.setTag('Software', 'MATLAB'); 
%               Save the 3-D matrix in the new TIFF file 
saveimg(newimg,nslice,tin,ofile); 
%               Duplicate the written file (workaround for TIFF save 
%               failure) 
copyfile(ofile,ofile2,'f'); 
%               Close the file 
close(t); 
%               Delete the temporary file 
delete(ofile); 
%               Print completion notification to the command window 
disp('--------------------------------------------'); 
disp('Program complete'); 
%               Stop timer, this command also outputs the elapsed time 
to 
%               the command window 
toc;  
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%--------------------------------------------------------------------- 
%NAME 
%  slicenos.m 
%PURPOSE 
%  Gets the sample slice numbers from the user 
%ACRONYM 
%  SLICE_NumberS 
%DESCRIPTION 
%  The user is first asked to enter the number of slices to be  
%  sampled,this function then asks the user to type each slice number.  
%  The total number of slices has already been displayed and an error  
%  shows when the user input is out of range.  
%AUTHORS 
%  Louise Terry 
%  Tom Bower 
%--------------------------------------------------------------------- 
  
function [slices nsample]=slicenos(nslice) 
%               Ask user for input of slice numbers 
nsample=input('Enter the number of slices to be sampled: '); 
%               Initialise counter 
i = 1; 
%               Loop over entered number of samples 
while i<=nsample 
%               Output message to user 
  disp(['Enter slice number ',num2str(i)]); 
%               Request user input in command window 
  slices(i)=input('-> '); 
%               If out of range, re-enter 
  if(slices(i)>nslice || slices(i)<=0) 
    disp(['Please enter value between 1 and ',num2str(nslice)]); 
    i=i-1; 
  end 
  i=i+1; 
end 
end 
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%--------------------------------------------------------------------- 
%NAME 
%  applydisps.m 
%PURPOSE 
%  Applies the displacements to each slice and stores in a 3-D matrix 
%ACRONYM 
%  APPLY_DISPlacementS 
%DESCRIPTION 
%  This function takes the transformation matrix (alldisps) and  
%  applies it to the original image (tin) to create the new image  
%  matrix (newimg). The   image is also cropped to remove black  
%  regions generated by the transformation. 
%AUTHORS 
%  Louise Terry 
%  Tom Bower 
%--------------------------------------------------------------------- 
  
function newimg=applydisps(alldisps,width,height,nslice,tin) 
%               largest displacement below original 
lgblw = min(alldisps(:)); 
%               largest displacement above original 
lgabv = max(alldisps(:)); 
%               Set the size of image depending on smallest and  
%               largest displacement 
newheight = height + lgabv - lgblw; 
%               loop over slices 
for islice=1:nslice 
  disp(['processing slice ' num2str(islice) ' of ' num2str(nslice)]); 
%               Get the displacements for the current slice 
  d=alldisps(islice,:); 
%               Set next slice 
  setDirectory(tin,islice); 
%               Get the image matrix from the current slice 
  img=tin.read; 
%               Apply displacements to current slice 
  newslice=imgproc(img,d,width,height,newheight,lgabv); 
%               Store current slice in 3-D matrix which will form the  
%               new image 
  newimg(:,:,islice)=newslice; 
end 
end 
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%--------------------------------------------------------------------- 
%NAME 
%  imgproc.m 
%PURPOSE 
%  Applies displacements to a single slice 
%ACRONYM 
%  IMaGe_PROCess 
%DESCRIPTION 
%  This function takes the displacements for a single slice (d) and  
%  applies them to a single slice. lim1 and lim2 are the new limits  
%  for the top and bottom of each column, the original column is moved  
%  to between these limits. 
%AUTHORS 
%  Louise Terry 
%  Tom Bower 
%--------------------------------------------------------------------- 
  
function newimg=imgproc(im8,d,width,height,newheight,lgabv); 
%               Set size of new matrix 
newimg=zeros(newheight,width); 
%               Apply the vertical displacement 
%               Loop over each column, then apply the displacement to  
%               the entire height 
for iw=1:width 
%               Set lower limit 
  lim1 = lgabv-d(iw)+1; 
%               Upper limit is the lower limit plus the image height 
  lim2 = lim1+height-1; 
%               Place the column from the original slice (im8) and  
%               place between the limits in the new image 
  newimg(lim1:lim2,iw)=im8(1:height,iw); 
end 
%               Scale colour values for greyscale 
newimg=newimg-min(min(newimg,[],1)); 
newimg=newimg/max(max(newimg,[],1)); 
end 
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%--------------------------------------------------------------------- 
%NAME 
%  sampleddisps.m 
%PURPOSE 
%  Gets displacements for each sampled slice 
%ACRONYM 
%  SAMPLED_DISPlacementS 
%DESCRIPTION 
%  This function loops over each sample slice and uses the 'disp'  
%  function to interpolate within each slice. 
%AUTHORS 
%  Louise Terry 
%  Tom Bower 
%--------------------------------------------------------------------- 
function sampled = 
sampleddisps(tin,slices,nslice,nsample,width,height) 
%               Initialise displacements (ds) to zero 
ds(1:nsample,1:width)=0; 
%               Loop over each sample image 
for isample=1:nsample 
%               Store the slice number 
  slice=slices(isample); 
%               Set the next slice 
  setDirectory(tin,slice); 
%               Get the current slice 
  im=tin.read; 
%               Call disps fucntion to get displacements for current  
%               slice 
  d=disps(im,width,height); 
%               Store in displacement matrix ds 
  sampled(isample,1:width)=d(1:width); 
end 
end 
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%--------------------------------------------------------------------- 
%NAME 
%  disps.m 
%PURPOSE 
%  Gets displacements for one sampled slice 
%ACRONYM 
%  DISPlacementS 
%DESCRIPTION 
%  This takes user clicks for a given slice, and interpolates a  
%  polynomial using a fourth order regression 
%AUTHORS 
%  Louise Terry 
%  Tom Bower 
%--------------------------------------------------------------------- 
function d=disps(img,width,height) 
%               Initialise displacement vector 
d=zeros(width,1); 
%               Get mouse clicks 
[x,y]=clicks(img); 
%               Get number of clicks 
nclicks=size(x,1); 
%               Order of curve fitting algorithm 
order=4; 
%               Curve fitting between points 
p=polyfit(x,y,order); 
%               Set up x linear spaced array for each column 
x1=linspace(1,single(width),single(width)); 
%               Convert the polynomial into an array of ordinates 
f1=polyval(p,x1); 
%               Use the midpoint as a datum for all displacements 
y0=height/int64(2); 
%               Convert to vertical displacement 
d=int64(f1)-y0; 
end 
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%--------------------------------------------------------------------- 
%NAME 
%  clicks.m 
%PURPOSE 
%  Gets x-y coordinates of user clicks for one slice 
%ACRONYM 
%  CLICKS 
%DESCRIPTION 
%  This function displays a slice, then records user clicks on the  
%  image. 
%AUTHORS 
%  Louise Terry 
%  Tom Bower 
%--------------------------------------------------------------------- 
function [x,y]=clicks(img) 
%               Display original image 
imageHandle=imshow(img); 
%               Get mouse clicks from user until Return key pressed 
[x,y]=ginput; 
%               Close the image 
close; 
end 
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%--------------------------------------------------------------------- 
%NAME 
%  alldisp.m 
%PURPOSE 
%  Interpolates the displacements between sampling slices 
%ACRONYM 
%  ALL_DISPlacementS 
%DESCRIPTION 
%  This function interpolates the displacements between each sampled  
%  slice for every column in turn. A second order polynomial  
%  regression is used here. 
%AUTHORS 
%  Louise Terry 
%  Tom Bower 
%--------------------------------------------------------------------- 
function alldisps=alldisp(width,nslice,slices,nsample,sampled) 
%               loop over each column 1-> 512 
for icol=1:width 
%               Convert to single precision (required for polyfit) 
%               X values 
    x=single(slices'); 
%               Displacements for column 
    y=single(sampled(:,icol)); 
%               Order of polynomial interpolation algorithm 
    order=2; 
%               Interpolate displacements between slices 
    p=polyfit(x,y,order); 
%               Set up x array for displacement curve 
    x1=linspace(1,single(nslice),single(nslice)); 
%               Get displacement for each x1 value 
    f1=polyval(p,x1); 
%               Store displacements in alldisps 
    alldisps(:,icol)=int64(f1); 
end 
end 
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%--------------------------------------------------------------------- 
%NAME 
%  saveimg.m 
%PURPOSE 
%  Saves the final processed image to a file 
%ACRONYM 
%  SAVE_IMaGe 
%DESCRIPTION 
%  The input for this function is a three dimensional matrix  
%  containing the greyscale pixel values (newimg). This function  
%  writes the image to a stacked TIFF file. The first slice is saved  
%  as a new image, hence use of the 'Overwrite' tag; all slices  
%  thereafter simply 'Append' to the image to generate the new stack. 
%AUTHORS 
%  Louise Terry 
%  Tom Bower 
%--------------------------------------------------------------------- 
  
function saveimg(newimg,nslice,tin,ofile) 
%               Loop over each slice 
for islice = 1:nslice 
%               Provide some output to the user 
  disp(['saving slice ' num2str(islice) ' of ' num2str(nslice)]);  
%               Set the active slice to 'islice' 
  setDirectory(tin,islice); 
%               Store 2D slice into 'newslice' 
  newslice(:,:) = newimg(:,:,islice); 
  if islice==1 
%               For the first slice only, allow overwriting of  
%               previously flattened file 
    imwrite(newslice,ofile,'tif','WriteMode','Overwrite', 
'compression','none'); 
  else 
%               For subsequent slices, add each slice to the stack 
    imwrite(newslice,ofile,'tif','WriteMode','Append', 
'compression','none'); 
  end 
end 
end 
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C – Image quality grading instructions 
 
Task 
You will be presented with 135 macular OCT en-face images of the choroid of several 
individuals. These images will be of the central 3° of choroid, centred on the fovea. 
Please assess each image on the two grading criteria explained below. Try to assess 
each image as a whole, rather than concentrating on individual vessels.  
We will start with 5 test images; these are to allow you to familiarise yourself with 
the images, and your grades for these will not be used. These test images are a cover 
a range of good and poor quality images.  
After every 10 images, you will be presented with a blank frame. This allows you 
time for a short break, and to check that you are in the correct place on your record 
sheet.  
 
Grading Criteria 
1. Overall contrast of the image 
This is the difference in luminance between the vessels (dark) and the surrounding 
tissue (light). A bigger difference in luminance scores a good grade, whereas a small 
difference in luminance scores a poor grade (see below for grading scale).   
 
The example above shows poor contrast (left) and excellent contrast (right).  
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2. Overall edge definition of the vessels 
This is how distinct the edges of the vessels appear in the image. A sharp, distinct 
edge scores a good grade, whereas a blurred, indistinct edge scores a poor grade.  
 
The diagram above shows luminance profiles for 2 different edges. Edge (a) has a 
more gradual change in luminance than Edge (b). They both undergo the same 
change in luminance, therefore have the same contrast, but Edge (b) is more clearly 
defined than Edge (a).  
 
The example above shows poorly-defined edges (left) and well-defined edges 
(right).  
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Grading Scale 
Each of the criteria listed above will be graded on a scale of 1 to 5, as follows:  
1. Poor 
2. Restricted 
3. Sufficient 
4. Good 
5. Excellent 
 
Please record a grade (1-5) for the each of the three criteria, for each image 
presented, on the grading sheet provided.  
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D – Participant information sheet and consent form 
 
Participant Information Sheet 
An In vivo investigation of choroidal vasculature 
in Age-related Macular Degeneration (Study A) 
 
We would like to invite you to take part in our research study. Before you decide, we 
would like you to understand why the research is being done and what it would 
involve for you. Please take the time to read this information sheet, feel free to talk 
to others about the study if you wish. Prior to beginning the study we will go through 
the information sheet with you and answer any questions you may have. Ask us if 
there is anything that is not clear. 
 
It is up to you to decide to join the study. If you agree to take part, we will then ask 
you to sign a consent form. You are free to withdraw at any time, without giving a 
reason. This would not affect the usual care that you receive. 
 
 
The following information sheet has two parts as follows: 
Part 1 tells you the purpose of this study and what will happen if you take part. 
Part 2 gives you more detailed information about the conduct of the study. 
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PART 1 
What is this study about? 
Age-related Macular Degeneration (AMD) is a common eye condition that mostly 
affects those aged 55 and over. AMD affects the retina at the back of the eye 
responsible for detailed vision which can affect the ability to carry out activities such 
as reading, driving and recognising familiar faces.  
Many affected individuals only develop early AMD with only some ageing changes 
visible at the back of the eye and often do not experience any change to their vision. 
However these individuals, particularly with increasing age, are at greater risk of 
developing more advanced types of AMD. In some individuals new blood vessels can 
grow beneath the retina, this is known as “Wet” or neovascular AMD, which can 
cause a loss of vision but may be treated if detected quickly. In other individuals both 
the blood vessels and overlying retina may slowly degenerate leading to a gradual 
loss of vision, often over many years.  
We are carrying out research to improve our understanding of AMD and in 
particular how changes to the blood vessels beneath the retina contribute to the 
disease. We aim to use the results of this research to help us develop tests that can 
identify and monitor those at most risk of advanced AMD. To do this we are looking 
for people with (both early and advanced) AMD and without AMD to help us with 
this research. 
 
How will we find these things out? 
This study will also use a new clinical technique to take a detailed three-dimensional 
photograph of the back of the eye. These images will allow us to see and measure 
the individual layers of cells which make up the retina and the blood vessels 
beneath. We would like to see people with and without AMD to allow comparison. 
 
What will happen to me if I take part? 
If you decide to volunteer for this study, we will ask you to give up approximately 1 
hour and a half of your time. The study will take place in the School of Optometry 
and Vision Sciences on Maindy Road.  
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Firstly we will collect some background information about your eyes and give you 
an opportunity to ask any questions about the research. We will then assess 
different aspects of your vision and examine the front and back of your eyes, using 
tests and techniques found in everyday optometric practice. We will also perform a 
quick blood pressure check, and check the pressure in your eyes using a small puff 
of air (you may remember this from visits to the optician). We will then put some 
drops into your eyes (Tropicamide*) to enlarge the pupils before taking the 3-D 
photographs of the back of your eyes. If you are interested we will be happy to show 
the completed image(s) to you.  
You will be asked not to drink tea or coffee on the day of the visit, prior to the session. 
This is to minimise the potential effect that caffeine has on the circulation of the eye.   
*If you have a known allergy to Tropicamide or other dilating drops, please inform 
one of the investigators and you should not particpate in the study.  
 
Are there any risks involved? 
This study is very safe, however the drops that enlarge the pupil may make your 
vision temporarily a little blurred and more sensitive to bright lights, these effects 
can last for about 6 hours. During this time we advise you not to drive or to operate 
any dangerous machinery. You may find that the drops sting slightly when they go 
in, this is normal and the stinging wears off quickly. The drops have been known to, 
on the very rare occasion, cause closed-angle glaucoma, resulting in red and sore 
eyes a few hours after putting in the eye drops. In the extremely unlikely event that 
this should occur you should contact any of us on the numbers shown below (we are 
all registered optometrists). If however we are unavailable then you should attend 
eye casualty for assessment.  
If you are taking part in any other research projects, please inform one of the 
investigators and you should not participate in this study.  
 
Is this the same as having an ‘eye test’ with my own optometrist or optician? 
No. This does not replace any examination by your regular optometrist (optician). 
Everybody should have regular check-ups with their optician at least every two 
years.   
  
275 
 
What are the possible disadvantages of taking part? 
If the researchers discover anything that indicates you should see another eye 
specialist or your GP, they will explain why and write to your GP with your 
permission, but remember this is not a complete eye examination and does not 
replace regular appointments with your ophthalmologist and optometrist. 
 
What are the possible benefits of taking part? 
There are no intended benefits.  
 
Do I have to take part? 
No – it is up to you whether you decide to take part or not. Participation in this study 
is purely voluntary and you will receive £20 towards your expenses. If you do decide 
to take part, you will be given this information sheet to keep and be asked to sign a 
consent form. You can withdraw at any time without giving a reason. Please note 
that if you do not wish to take part in the study it will not affect your current or 
future care. 
 
What if there is a problem? 
If you do have a concern about any aspect of this study, you should ask to speak to 
the researchers (contact details below) who will do their best to answer your 
questions. If you remain unhappy and wish to complain formally, you can do this 
through the Cardiff University Complaints Procedure – details can be obtained from 
the researchers. 
 
What if I have any questions? 
Please ask. We are very happy to discuss any aspect of the study.  
Miss Louise Terry E-mail: TerryL1@cardiff.ac.uk              Tel: (029) 20870247 
Dr Ashley Wood E-mail: WoodA2@cardiff.ac.uk            Tel: (029) 20875063 
Prof Rachel North E-mail: North@cardiff.ac.uk              Tel: (029) 20875114 
Dr Tom Margrain E-mail: MargrainTH@cardiff.ac.uk             Tel: (029) 20876118 
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School of Optometry & Vision Sciences 
College of Biomedical and Life Sciences 
Cardiff University 
Maindy Road 
Cardiff 
CF24 4HQ 
 
 
 
 
PART 2 
 
What will happen if I don’t want to carry on with the study? 
The study will usually require only a single visit to the School of Optometry and 
you are free to withdraw at any time without giving a reason; however we will 
retain non identifiable data collected up to your withdrawal. Please note that if you 
do not wish to take part in the study it will not affect your current or future care.  
 
What if there is a problem? 
In the unlikely event that harm should occur as a result of negligence, cover is 
provided by the Cardiff University insurance policy. 
 
Will my taking part in this study be kept confidential? 
All information collected during the study will be processed and stored securely by 
the researchers using password-protected systems. Your personal information will 
be coded and only the researchers will be able to identify you during the study. 
When the study is over, the data may be retained for use in future studies, but will 
be anonymous from this point. All procedures are compliant with the Data 
Protection Act 1998.  
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What will happen to the results of the research study? 
The study results will be analysed and presented at national and international 
meetings, as well as comprising part of a PhD thesis. A copy of the thesis will 
eventually be held in Cardiff University’s Bute Library. Identities of participating 
volunteers will not be revealed in any resulting published material. If you wish to be 
provided with a summary of the research findings at the end of the study please tick 
the appropriate box on the consent form.   
 
Who is organising and funding the research? 
This study is funded by Cardiff University. 
 
Who has reviewed the study? 
This study was reviewed and approved by the South East Wales Research Ethics 
Committee.  
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School of Optometry & Vision Sciences 
College of Biomedical and Life Sciences 
Cardiff University 
Maindy Road 
Cardiff 
CF24 4HQ 
 
Study Number: 
 
Patient Identification Number for this trial: 
CONSENT FORM 
Title of Project: An In vivo investigation of choroidal vasculature in Age-related Macular 
Degeneration (Study A) 
Name of Researcher: Miss Louise Terry 
Please initial all 
boxes  
1. I confirm that I have read and understand the information sheet dated Jun2015 
(version A5) for the above study.  I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time without giving any reason, without my medical care or legal rights being 
affected. 
 
3. I understand that relevant sections of my medical notes and data collected during the 
study, may be looked at by individuals from Cardiff University, from regulatory 
authorities or from the NHS Trust, where it is relevant to my taking part in this 
research.  I give permission for these individuals to have access to my records. 
 
4. I agree to my GP being informed of my participation in the study.    
 
5. I agree to take part in the above study.   
 
6. I would like to receive a summary of the research findings at the end of the study. 
 
                
Name of participant   Date    Signature 
                                
                
Name of person taking consent  Date    Signature  
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E – MATLAB code to establish inter-observer agreement of manual 
choroidal segmentation 
%--------------------------------------------------------------------- 
%NAME 
%  imageoverlap.m 
%PURPOSE 
%  Establishes percentage overlap between two labelled regions of  
%  interest 
%DESCRIPTION 
%  This function loads two sets of labelled regions of interest and  
%  calculates the area of overlap as a percentage of the total area  
%  contained within the two regions. The regions are also displayed  
%  graphically.  
%  Inputs 'labs1'and 'labs2' are the names of files containing the  
%  choroidal labels. 'islice' is an integer which selects the slice  
%  number within the volume to use. 
%AUTHOR 
%  Dafydd Ravenscroft 
%--------------------------------------------------------------------- 
 
function imageoverlap(labs1, labs2, islice) 
%               Load two sets of labels defining the region of  
%               interest 
labels1=load(labs1); 
labels2=load(labs2); 
%               Select the slice number in the volume   
slice1=islice;  
slice2=slice1;  
%               Ensure all values are of the same type  
for i=1:length(labels1.labelAll) 
    labels1.labelAll{i,1}=uint16(labels1.labelAll{i,1}); 
end 
for i=1:length(labels2.labelAll) 
    labels2.labelAll{i,1}=uint16(labels2.labelAll{i,1}); 
end 
%               Create a mask from the labels 
x1=labels1.labelAll{cell2mat(labels1.labelAll(:,1))==slice1,3}(:,1); 
y1=labels1.labelAll{cell2mat(labels1.labelAll(:,1))==slice1,3}(:,2); 
x2=labels2.labelAll{cell2mat(labels2.labelAll(:,1))==slice2,3}(:,1); 
y2=labels2.labelAll{cell2mat(labels2.labelAll(:,1))==slice2,3}(:,2); 
%               Convert cell array to ordinary array 
x1=cell2mat(x1); 
y1=cell2mat(y1); 
x2=cell2mat(x2); 
y2=cell2mat(y2); 
%                
x1(length(x1)+1)=x1(1); 
y1(length(y1)+1)=y1(1); 
x2(length(x2)+1)=x2(1); 
y2(length(y2)+1)=y2(1); 
%               Plot both regions of interest 
plot(x1,y1); 
hold on; 
plot(x2,y2); 
%               Convert region of interest polygon to region mask 
Image1=poly2mask(x1,y1,1024,512); 
Image2=poly2mask(x2,y2,1024,512); 
%               Create overlap of the two regions 
overlapImage = Image1 & Image2; 
%               Count number of common pixels  
numOverlapPixels = nnz(overlapImage); 
%               Count number of pixels in each region 
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numPixels1=nnz(Image1); 
numPixels2=nnz(Image2); 
%               Calculate percentage overlap of the two regions 
ImgOverlap=100*numOverlapPixels/numPixels1+numPixels2-
numOverlapPixels); 
%               Display percentage image overlap 
fprintf('Image overlap is %.1f%% \n',ImgOverlap); 
end 
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F – Supplementary machine learning results 
 
10-fold cross-validation 
 
Table 1 Confusion matrix for 10-fold cross-validation of K-nearest neighbour (KNN).  
KNN (%) Clinical classification 
Healthy Early AMD nAMD 
A
lg
o
ri
th
m
ic
 
p
re
d
ic
ti
o
n
 Healthy 97.3 3.4 3.1 
Early AMD 0.9 94.6 4.0 
nAMD 1.8 1.9 92.9 
 
Table 2 Confusion matrix for 10-fold cross-validation of random forest (RFS). 
RFS (%) Clinical classification 
Healthy Early AMD nAMD 
A
lg
o
ri
th
m
ic
 
p
re
d
ic
ti
o
n
 Healthy 90.9 5.6 4.5 
Early AMD 3.7 85.1 3.8 
nAMD 5.4 9.2 91.7 
 
Table 3 Confusion matrix for 10-fold cross-validation of support vector machine (SVM). 
SVM (%) Clinical classification 
Healthy Early AMD nAMD 
A
lg
o
ri
th
m
ic
 
p
re
d
ic
ti
o
n
 Healthy 98.6 0.8 0.5 
Early AMD 0.6 97.9 1.1 
nAMD 0.8 1.3 98.4 
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2-fold cross-validation 
 
Table 4 Confusion matrix for 2-fold cross-validation of K-nearest neighbour (KNN).  
KNN (%) Clinical classification 
Healthy Early AMD nAMD 
A
lg
o
ri
th
m
ic
 
p
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d
ic
ti
o
n
 Healthy 96.7 3.9 3.8 
Early AMD 1.2 93.8 4.8 
nAMD 2.1 2.4 91.4 
 
Table 5 Confusion matrix for 2-fold cross-validation of random forest (RFS).  
RFS (%) Clinical classification 
Healthy Early AMD nAMD 
A
lg
o
ri
th
m
ic
 
p
re
d
ic
ti
o
n
 Healthy 88.3 7.0 5.0 
Early AMD 5.4 81.7 4.9 
nAMD 6.3 11.3 90.2 
 
Table 6 Confusion matrix for 2-fold cross-validation of support vector machine (SVM).  
SVM (%) Clinical classification 
Healthy Early AMD nAMD 
A
lg
o
ri
th
m
ic
 
p
re
d
ic
ti
o
n
 Healthy 97.7 1.2 0.7 
Early AMD 1.1 96.7 1.7 
nAMD 1.2 2.1 97.6 
 
Table 7 Confusion matrix for 2-fold cross-validation per b-scan of convolutional neural 
network (CNN).  
CNN (%) Clinical classification 
Healthy Early AMD nAMD 
A
lg
o
ri
th
m
ic
 
p
re
d
ic
ti
o
n
 Healthy 100.0 0.0 0.1 
Early AMD 0.0 99.6 0.5 
nAMD 0.0 0.3 99.3 
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Leave-one-out cross-validation (LOOCV) 
 
Table 8 Confusion matrix for LOOCV of K-nearest neighbour (KNN).  
KNN (%) Clinical classification 
Healthy Early AMD nAMD 
A
lg
o
ri
th
m
ic
 
p
re
d
ic
ti
o
n
 Healthy 40 32 24 
Early AMD 32 48 28 
nAMD 28 20 48 
 
Table 9 Confusion matrix for LOOCV of random forest (RFS). 
RFS (%) Clinical classification 
Healthy Early AMD nAMD 
A
lg
o
ri
th
m
ic
 
p
re
d
ic
ti
o
n
 Healthy 56 24 0 
Early AMD 28 44 20 
nAMD 16 32 80 
 
Table 10 Confusion matrix for LOOCV of support vector machine (SVM). 
SVM (%) Clinical classification 
Healthy Early AMD nAMD 
A
lg
o
ri
th
m
ic
 
p
re
d
ic
ti
o
n
 Healthy 40 16 8 
Early AMD 36 60 20 
nAMD 24 24 72 
 
Table 11 Confusion matrix for LOOCV of convolutional neural network (CNN). 
CNN (%) Clinical classification 
Healthy Early AMD nAMD 
A
lg
o
ri
th
m
ic
 
p
re
d
ic
ti
o
n
 Healthy 25.0 37.5 33.3 
Early AMD 41.7 25.0 33.3 
nAMD 33.3 37.5 33.3 
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Abstract
Retinal and intra-retinal layer thicknesses are routinely generated from optical coherence
tomography (OCT) images, but on-board software capabilities and image scaling assump-
tions are not consistent across devices. This study evaluates the device-independent
Iowa Reference Algorithms (Iowa Institute for Biomedical Imaging) for automated intra-reti-
nal layer segmentation and image scaling for three OCT systems. Healthy participants
(n = 25) underwent macular volume scans using a Cirrus HD-OCT (Zeiss), 3D-OCT 1000
(Topcon), and a non-commercial long-wavelength (1040nm) OCT on two occasions.
Mean thickness of 10 intra-retinal layers was measured in three ETDRS subfields (fovea,
inner ring and outer ring) using the Iowa Reference Algorithms. Where available, total reti-
nal thicknesses were measured using on-board software. Measured axial eye length
(AEL)-dependent scaling was used throughout, with a comparison made to the system-
specific fixed-AEL scaling. Inter-session repeatability and agreement between OCT sys-
tems and segmentation methods was assessed. Inter-session coefficient of repeatability
(CoR) for the foveal subfield total retinal thickness was 3.43μm, 4.76μm, and 5.98μm for
the Zeiss, Topcon, and long-wavelength images respectively. For the commercial soft-
ware, CoR was 4.63μm (Zeiss) and 7.63μm (Topcon). The Iowa Reference Algorithms
demonstrated higher repeatability than the on-board software and, in addition, reliably
segmented all 10 intra-retinal layers. With fixed-AEL scaling, the algorithm produced sig-
nificantly different thickness values for the three OCT devices (P<0.05), with these dis-
crepancies generally characterized by an overall offset (bias) and correlations with axial
eye length for the foveal subfield and outer ring (P<0.05). This correlation was reduced to
an insignificant level in all cases when AEL-dependent scaling was used. Overall, the
Iowa Reference Algorithms are viable for clinical and research use in healthy eyes imaged
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with these devices, however ocular biometry is required for accurate quantification of OCT
images.
Introduction
Optical coherence tomography (SD-OCT) is an essential imaging tool for the diagnosis and
monitoring of retinal diseases such as age-related macular degeneration (AMD) [1,2] and dia-
betic macular oedema [3,4]. This non-invasive technique allows clinicians to produce three-
dimensional (3-D) images of intraocular structures in vivo. In addition to subjective qualitative
assessment, images can be analyzed objectively, providing quantitative measurements includ-
ing retinal thickness. Such metrics are commonly used clinically and as outcome measures in
research, for example in clinical trials [5,6]. Quantitative analysis of OCT images has become
increasingly sophisticated [7,8] as image quality and software capabilities improve.
Whilst manual caliper tools and hand segmentation (hand tracing of intra-retinal layer
boundaries) can be simple to perform, it is time consuming (particularly when implemented in
3-D scans) and subject to significant inter-observer variation [9]. These methods are therefore
not feasible for use clinically or in large, multi-center clinical trials.
Commercial OCT devices are generally supplied with on-board segmentation software,
designed to generate fast, reliable values for interpretation by clinicians. This software has
historically been limited to total retinal thickness. Additionally, the definition of the retinal
boundaries varies between manufacturers, with different reflective bands, as seen in OCT
images, being chosen to represent the posterior retinal margin. This makes quantitative retinal
thickness comparisons between commercial devices difficult [10]. Some instruments, such as
the Topcon DRI OCT-1 Atlantis (Topcon Corp, Tokyo, Japan) and the latest Spectralis OCT
(Heidelberg Engineering, Heidelberg, Germany), are now supplied with software that is capable
of segmenting a number of intra-retinal layers. Furthermore, the commercial software is almost
always limited to use with images captured by the parent device, and cannot be applied to
images from other OCT devices. The diversity of segmentation methods and normative values
confound comparisons between commercial systems [11–13].
OCTSeg is a module of OCT Explorer, itself part of the Iowa Reference Algorithms (Retinal
Image Analysis Lab, Iowa Institute for Biomedical Imaging, Iowa City, IA). It is a publicly
available, device-independent, graph theory-based tool for segmentation of 10 retinal layers in
volumetric OCT images [7,14,15]. It produces retinal thickness values comparable to manual
measurements of OCT images by retinal specialists [14,16], and to analysis by the Heyex soft-
ware (Heidelberg Engineering) of images from participants with diabetic macular oedema [17].
Unlike the majority of commercial software, it can be applied to images from all widely-avail-
able clinical OCT devices, allowing direct comparison of images from multiple devices.
Since the segmentation software may be used with images from several different OCT instru-
ments, it is important to establish agreement between devices. The majority of current devices
utilize broad-band light sources with centre wavelengths (λc) of ~850nm, but longer wavelength
OCT (λc ~1040nm) has recently become commercially available. The algorithmmay perform
differently on these images, due to differences in reflectivity of retinal layer boundaries at these
wavelengths. We used a non-commercial long-wavelength OCT (λc ~1040nm) in our evaluation
of the algorithm.
Based on the work of Littmann and others [18,19], the transverse size of any retinal feature
can be calculated using the appropriate ocular biometry and instrument meta-data. A reasonably
Evaluation of Retinal Layer Segmentation Algorithm
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accurate lateral scaling (converting feature sizes from pixels to microns) of any OCT image can
be determined using (i) an estimate of the principal plane to retina distance of the eye (axial eye
length (AEL) - 1.8mm), (ii) the angle of the OCT scan in air and (iii) an estimate of the bulk ocu-
lar refractive index. The on-board software of the two commercial instruments used in this
study provide only a single lateral scaling value for all patients regardless of AEL, resulting in an
error in the reported size of the image which scales with AEL. This error manifests as a discrep-
ancy between the fixed size ETDRS grid and the AEL-dependent image size. Therefore, the
position of retinal layer measurements and hence the regional thickness values become AEL-
dependent; an important consideration when comparing different OCT instruments. By con-
verting all our image files to a compatible TIFF format we were able to use the ability of OCTEx-
plorer to accept an independently calculated, AEL-dependent lateral scaling for images from all
devices used.
To the authors’ knowledge, inter-session repeatability of the Iowa Reference Algorithms has
not been assessed to date. Given the potential clinical and research utility of quantitative intra-
retinal layer analysis [20–22], investigation of this feature of the algorithm is a key step in vali-
dating the sensitivity of this tool to detect retinal changes. Furthermore, to our knowledge,
there has been no formal comparison between retinal thickness measurements produced by
the Iowa algorithm and the on-board segmentation algorithms of many commonly available
commercial devices.
The aims of the present study are to evaluate the use of Iowa Reference Algorithms as a
means of generating repeatable intra-retinal layer thickness values from images of healthy eyes,
captured using two commercial SD-OCT devices (λc ~850nm) and one non-commercial long-
wavelength (λc ~1040nm) device. Secondary objectives are to assess agreement between the
algorithm and commercial, device-dependent software, as well as inter-device agreement.
Materials and Methods
Participants
Healthy participants (n = 25) were recruited from staff, students and volunteers at the School
of Optometry and Vision Sciences, Cardiff University. All participants had a corrected visual
acuity of 0.0 logMAR (20/20) or better using a high contrast Early Treatment of Diabetic Reti-
nopathy Study (ETDRS) chart and a mean refractive error of ±6.00 diopters in the test eye.
Approval for this study was obtained from the South East Wales NHS Research Ethics Com-
mittee. All experimental procedures adhered to the tenets of the Declaration of Helsinki, and
written informed consent was obtained before data collection commenced.
Participants with disease affecting retinal function were excluded, including diabetes, glau-
coma, and significant media opacities (Lens Opacities Classification System III grade 3 or more
for any criteria [23]). These were identified using a medical history questionnaire, slit lamp
examination and fundus photography. Those with narrow iridocorneal angles (grade 1 or less
assessed by Van Herick) or intraocular pressure over 21mmHg were also excluded, as were
those taking medication known to affect retinal function.
One eye was selected as the test eye for each participant; this was the eye with the better
visual acuity (or lower refractive error if one eye was outside the ±6.00D range). One drop of
Tropicamide 0.5% was instilled into the test eye of each participant prior to imaging. Following
sufficient pupil dilation, fundus photographs were obtained to ensure participants did not have
retinal disease. AEL (cornea to retinal pigment epithelium (RPE)) was measured using optical
biometry (IOL Master, Carl Zeiss, Jena, Germany) to enable accurate lateral scaling calcula-
tions for all OCT images.
Evaluation of Retinal Layer Segmentation Algorithm
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OCT Imaging
OCT images were obtained from all participants using a 3D-OCT 1000 (Topcon Corp, Tokyo,
Japan), Cirrus HD-OCT (Carl Zeiss Meditec, Inc., Dublin, CA), and a non-commercial long-
wavelength (λc 1040nm) SD-OCT [24–26]. Images from the latter were obtained using less
than the maximum permissible corneal exposure for unlimited duration at this wavelength
(less than 5mW/cm2 averaged over a 7mm pupil) [27].
Volume scans centered on the fovea were acquired using each device. For comparison, all
images had a scan angle of 20° x 20°, comprising 512 x 128 A-scans. Following dilation, all
images were obtained by a single trained operator (LT). A second session was conducted within
1 month, using the same protocol and scheduled for the same time of day as the previous ses-
sion (± 30 minutes).
Data Analysis
Long-wavelength OCT images were exported to Fiji (Rasband; National Institute of Health,
USA) [28] and underwent stack registration, using the Fiji plugin StackReg [29], to remove eye
movement artefacts. Images were then exported to OCTExplorer 3.5. Images from the two
commercial instruments were directly imported into the Iowa software, with no alteration
when using the instrument-supplied scaling, or via conversion to a standard TIFF format (via
Fiji) in order to apply an AEL-dependent lateral scaling.
Automated retinal layer segmentation using the Iowa Reference Algorithms was performed
on all images. Mean retinal thickness values of 10 retinal layers were obtained on all images for
the foveal subfield and the inner and outer rings of a standard ETDRS grid (shown in Fig 1).
Total retinal thickness was also calculated, as the distance from the most anterior hyper-reflec-
tive line (corresponding to the inner limiting membrane; ILM) to the posterior of the outer-
most hyper-reflective line (corresponding to the outer boundary of RPE).
For all comparisons with the commercial software, the posterior retinal boundary used by
the commercial segmentation was adopted in the Iowa Reference Algorithm segmentation
(inner boundary of outer segment photoreceptor/RPE complex, and inner boundary of RPE
for Topcon and Zeiss respectively; see Fig 1). These parameters will be referred to in this paper
as ‘equivalent retinal thicknesses’.
Fig 1. ETDRS grid and example 10 intra-retinal layer segmentation. (A) Standard ETDRS grid showing the foveal subfield (black). The
inner ring is an average of the four parafoveal subfields (dark grey) and the outer ring of the four perifoveal subfields (light grey). (B)
Screenshot of 10 layer (11 boundary) segmentation of a long-wavelength OCT image, produced by the Iowa Reference Algorithms. The left
half of the image shows the image prior to segmentation. Layers 1–10 (top to bottom; as defined by the software): retinal nerve fiber layer
(RNFL); ganglion cell layer (GCL); inner plexiform layer (IPL); inner nuclear layer (INL); outer plexiform layer (OPL); outer plexiform layer-
Henle fiber layer to boundary of myoid and ellipsoid of inner segments (OPL-HFL ~ BMEIS); photoreceptor inner/outer segments (IS/OS);
inner/outer segment junction to inner boundary of outer segment photoreceptor/retinal pigment epithelium complex (IS/OSJ ~ IB_RPE);
outer segment photoreceptor/retinal pigment epithelium complex (OPR); retinal pigment epithelium (RPE).
doi:10.1371/journal.pone.0162001.g001
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For images from the two commercial instruments, meta-data supplied by the manufacturer
were used in determining lateral pixel size for analyses using the on-board software to show
the importance of correct scaling. In all other cases, lateral scaling was obtained from the scan
angle, measured AEL and an assumed bulk ocular refractive index of 1.336. Axial scaling of all
images was obtained from the supplied instrument meta-data. This included a group refractive
index for retinal tissue of 1.4, 1.38 and 1.36 for the long-wavelength, Topcon and Zeiss instru-
ments respectively.
Coefficients of repeatability (CoR), a measure of repeatability familiar to clinicians [30],
were used to assess the inter-session variations in retinal thickness values produced by both the
Iowa Reference Algorithms and on-board software of each device (versions 3.51.003.04 and
7.0.1.290 for the Topcon and Zeiss instruments respectively). CoR was calculated as 1.96 times
the standard deviation (SD) of the differences between sessions [31], and is also expressed as a
percentage of the mean retinal layer thickness. Bland-Altman plots [31] were used to assess
agreement between these segmentation methods, and for inter-device comparisons. The bias
(mean difference) and 95% limits of agreement (LoA) were calculated for each comparison,
and Friedman’s two way ANOVA was used to identify statistically significance differences. In
these comparisons, data points outside ±3 SD of the difference were defined as significant outli-
ers (by Grubbs’ test [32] for n = 25) and were excluded from the analysis. These were classified
as failings of the segmentation algorithm.
The relationship between retinal thickness discrepancies using the commercial instrument
scaling and the AEL-correct scaling for our long wavelength images vs measured AEL was eval-
uated using Spearman’s rank correlation.
Results
Twenty-five eyes from 25 healthy participants were included in the study. The age range of the
participants was 20 to 62 years (mean ± SD, 34.9 ± 13.5 years). Sixteen participants were female
(64%). The mean AEL and refractive error (mean sphere) were 23.7 ± 1.3 mm (range 21.6 to
26.6) and -0.58 ± 1.93 diopters (range -4.50 to +3.00) respectively. The maximum cylindrical
power was 3.00 diopters.
Lateral scaling for AEL
OCTSeg reported automated segmentation of 10 intra-retinal layers for all images. Mean values
across all eyes for each retinal layer are shown in Table 1. These values underwent AEL-cor-
rected lateral scaling as described above. The percentage difference of these corrected values
from the fixed scaling values (by OCTSeg) ranged from -15% to +26% (corresponding to Top-
con and Zeiss GCL layer respectively, both in the foveal subfield). Mean total retinal thickness
measurements produced by both segmentation methods for the three devices can be seen in
Table 2. These values underwent fixed-AEL scaling to allow comparison to the commercial
software. In this case, correcting for AEL yielded mean differences of less than 2% in all cases
when compared to the fixed-AEL scaling (by OCTSeg).
An inter-device comparison of AEL-corrected scaled retinal thickness measurements pro-
duced by the Iowa Reference Algorithms is shown in Table 3. One significant outlier was
removed from the 1040nm-Topcon comparison (foveal subfield only). Images from the Top-
con instrument yielded significantly higher values for retinal thickness than the long-wave-
length system (Friedman test, P<0.05), but significantly lower values than the Zeiss OCT (with
the exception of the foveal subfield). This bias between the Zeiss and long-wavelength OCT
images was similar across the three ETDRS subfields. However, the bias between the Topcon
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and long-wavelength images decreases in magnitude with eccentricity (largest in the foveal
subfield and smallest in the outer ring).
Discrepancies in fixed-AEL scaled retinal thickness measurements between the commercial
and long-wavelength devices showed a strong correlation with AEL, for the commercial
Table 1. Mean thickness of 10 intra-retinal layers. Thickness values (mean ± SD; μm) produced by segmentation of images at session 1 using the Iowa
Reference Algorithms.
Layer Fovea Inner ring Outer ring
Topcon Zeiss 1040nm Topcon Zeiss 1040nm Topcon Zeiss 1040nm
1. RNFL 7.0 ± 2.3 5.9 ± 2.9 5.2 ± 2.2 25.5 ± 2.3 25.2 ± 2.3 24.2 ± 2.4 39.3 ± 7.0 40.9 ± 5.9 39.3 ± 5.0
2. GCL 17.0 ± 6.3 13.4 ± 5.4 17.2 ± 5.1 48.5 ± 5.9 52.4 ± 5.7 50.5 ± 6.2 24.7 ± 3.0 27.2 ± 3.1 29.3 ± 3.8
3. IPL 29.3 ± 2.9 27.5 ± 4.1 24.4 ± 4.2 42.5 ± 4.2 40.7 ± 3.5 39.9 ± 4.2 35.3 ± 2.8 37.3 ± 2.8 36.0 ± 3.8
4. INL 17.7 ± 4.6 22.5 ± 5.3 18.9 ± 4.2 37.8 ± 3.5 43.2 ± 3.8 37.5 ± 3.6 28.1 ± 3.3 32.9 ± 3.0 29.6 ± 3.3
5. OPL 23.0 ± 3.4 20.7 ± 4.9 20.3 ± 5.3 29.6 ± 3.8 28.0 ± 5.0 30.0 ± 5.1 26.2 ± 2.6 24.1 ± 3.0 28.4 ± 4.2
6. OPL-HFL ~BMEIS 120.8 ± 10.2 122.3 ± 9.2 116.5 ± 10.7 95.5 ± 8.8 96.9 ± 9.2 90.3 ± 8.8 79.7 ± 10.1 79.4 ± 6.4 71.6 ± 6.8
7. IS/OS 13.9 ± 0.9 11.7 ± 0.6 14.8 ± 2.4 12.6 ± 0.6 10.3 ± 0.4 13.7 ± 1.7 12.5 ± 1.2 10.2 ± 0.8 13.0 ± 1.7
8. IS/OSJ ~IB_OPR 17.0 ± 1.8 19.7 ± 2.2 17.3 ± 3.0 11.7 ± 1.4 14.0 ± 2.9 12.6 ± 2.4 10.3 ± 2.1 15.5 ± 4.3 15.8 ± 4.4
9. OPR 20.1 ± 2.6 20.7 ± 3.0 20.6 ± 3.8 19.8 ± 2.2 21.3 ± 3.3 20.7 ± 3.4 18.5 ± 2.3 17.8 ± 4.8 15.2 ± 3.8
10. RPE 18.6 ± 2.1 15.5 ± 0.5 15.6 ± 0.2 18.6 ± 1.7 15.5 ± 0.4 15.5 ± 0.2 18.6 ± 1.6 15.3 ± 0.5 15.5 ± 0.4
doi:10.1371/journal.pone.0162001.t001
Table 2. Total retinal thicknessmeasurements from different segmentation methods. Thickness values (mean ± SD; μm) for the three ETDRS regions
of images acquired at session 1.
Fovea Inner ring Outer ring
Iowa Reference Algorithms 1040nm 270.9 ± 16.8 335.2 ± 17.4 294.0 ± 20.6
Topcon 281.5 ± 16.9 342.8 ± 18.0 295.2 ± 21.8
Zeiss 280.8 ± 17.5 347.0 ± 18.0 302.0 ± 21.4
On-board segmentation Topcon 244.6 ± 17.4 306.0 ± 17.6 260.9 ± 21.4
Zeiss 263.1 ± 17.4 325.4 ± 18.1 281.2 ± 21.4
Iowa equivalent retinal thickness* Topcon 242.8 ± 22.9 304.4 ± 19.3 258.0 ± 21.6
Zeiss 265.4 ± 18.6 331.6 ± 18.7 286.8 ± 21.6
*Equivalent values from the Iowa Reference Algorithms (Topcon, ILM to inner boundary of OPR; Zeiss, ILM to inner boundary of RPE) are quoted for
comparison to the commercial on-board software segmentation.
doi:10.1371/journal.pone.0162001.t002
Table 3. Agreement of total retinal thickness between OCT devices. Mean difference (bias; μm) and 95% limits of agreement (μm) for mean retinal thick-
ness at session 1 produced by the Iowa Reference Algorithms, using AEL-dependent scaling, for each pairing of OCT instruments.
Fovea Inner ring Outer ring
1040nm-Topcon Mean difference -14.18 -7.05 0.80
Limits of agreement -20.05 to -8.30 -14.65 to 0.55 -6.95 to 8.55
Friedman test P 0.000* 0.000* 0.317
1040nm-Zeiss Mean difference -13.89 -12.46 -6.62
Limits of agreement -21.62 to -6.16 -18.91 to -6.00 -13.53 to 0.30
Friedman test P 0.000* 0.000* 0.000*
Topcon-Zeiss Mean difference -0.21 -5.41 -7.42
Limits of agreement -4.18 to 3.75 -8.67 to -2.15 -10.66 to -4.17
Friedman test P 0.841 0.000* 0.000*
*signiﬁcant at 0.05 level.
doi:10.1371/journal.pone.0162001.t003
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instrument data, in both the foveal subfield and the outer ring (Spearman rank ρ>0.50,
P<0.05 in all cases), although only moderate to weak for the inner ring (Spearman ρ<0.50). A
weak correlation was also seen across all subfields when comparing Topcon with Zeiss data. In
all cases, the correlation was reduced and/or became not significant when the AEL-dependent
scaling was used in the comparisons between data from any of the three sources (Fig 2).
Inter-Session Repeatability
Intra-retinal layer thickness values produced by the Iowa software were compared between ses-
sion 1 and session 2. For these comparisons, AEL-corrected scaled data was used. Differences
outside 3 SD of the mean difference (Grubbs’ test) were considered failings in segmentation
and were removed from further analysis (n = 26 of 2250 comparisons). Of these, 46%, 42% and
12% were attributed to images from the long-wavelength, Topcon and Zeiss instruments
respectively. In general, CoR was similar across images from all devices, and across the three
ETDRS subfields (Fig 3).
For layer thickness averaged across the entire ETDRS grid, the layers with best repeatability
(as a percentage of the mean) were layer 10 (RPE; 1.2%), layer 4 (INL; 6.2%), and layer 10
(RPE; 4.1%) for the Zeiss, Topcon and long-wavelength devices respectively. The layers with
poorest repeatability were layer 8 (IS/OSJ ~ IB_RPE; 22.5%), layer 1 (RNFL; 19.1%), and layer
8 (IS/OSJ ~ IB_RPE; 36.9%) respectively.
Total retinal thickness values were also compared between session 1 and session 2. In all
cases, the mean bias was between ±1 μm, and there was no significant difference between ses-
sion 1 and session 2 for any device or ETDRS subfield (P>0.05 in all cases). Fixed-AEL scaling
was used to allow comparison to the commercial segmentation. One significant outlier was
Fig 2. Correlation of retinal thickness differences against AEL.Difference in retinal thickness measurements (μm)
versus axial eye length (mm) for the foveal subfield, as produced by the Iowa Reference Algorithms using two different
transverse scaling methods.
doi:10.1371/journal.pone.0162001.g002
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removed from the long-wavelength data (all subfields), as identified by Grubbs’ test. For the
Iowa Reference Algorithms, the CoR for the foveal subfields was 4.76μm and 3.43μm for Top-
con and Zeiss OCT images respectively. The CoR of both instruments was lower than that of
the long-wavelength OCT, which had a CoR of 5.98μm. In all cases the CoR was higher for the
foveal subfield than the inner and outer rings (Table 4).
Fig 3. Intra-retinal layer thickness and CoR.Mean thickness of 10 intra-retinal layers segmented by the
Iowa Reference Algorithms at session 1, on images from all three OCT devices. Error bars and table values
represent inter-session CoR (μm) for each layer.
doi:10.1371/journal.pone.0162001.g003
Table 4. Inter-session repeatability of the Iowa Reference Algorithms. Coefficients of repeatability (μm; and percentage) of mean retinal thickness pro-
duced by the Iowa Reference Algorithms at session 1 and session 2.
Fovea Inner ring Outer ring
1040nm Full thickness 5.98 (2.2%) 5.86 (1.7%) 5.48 (1.9%)
Topcon Full thickness 4.76 (1.7%) 3.99 (1.2%) 4.10 (1.4%)
Equivalent thickness* 3.90 (1.6%) 3.48 (1.1%) 3.78 (1.5%)
Zeiss Full thickness 3.43 (1.2%) 2.92 (0.8%) 3.19 (1.1%)
Equivalent thickness* 3.37 (1.3%) 2.95 (0.9%) 3.14 (1.1%)
*Equivalent values from the Iowa Reference Algorithms (Topcon, ILM to inner boundary of OPR; Zeiss, ILM to inner boundary of RPE) are quoted for
comparison to the commercial on-board software segmentation.
doi:10.1371/journal.pone.0162001.t004
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For the commercial segmentation, no AEL-correction was made in the scaling. Two signifi-
cant outliers were removed from the Topcon segmentation data (foveal and inner ring sub-
fields only). The CoR of the foveal subfield was 7.63μm and 4.63μm for the Topcon and Zeiss
OCT respectively. Again, the CoR was higher for the foveal subfield than the inner and outer
rings for the Topcon OCT images, but was similar across all subfields for the Zeiss OCT images
(Table 5).
To allow for comparison between segmentation methods, the Iowa Reference Algorithm
‘equivalent retinal thicknesses’ were used (Table 4; Fig 4). The on-board software of both com-
mercial instruments was less repeatable than the Iowa Reference Algorithms, for all three sub-
fields (Fig 5).
Table 5. Inter-session repeatability of the on-board software. Coefficients of repeatability (μm; and per-
centage) of mean retinal thickness produced by the on-board analysis software of the commercial instru-
ments at session 1 and session 2.
Fovea Inner ring Outer ring
Topcon 7.63 (3.1%) 4.68 (1.5%) 5.68 (2.2%)
Zeiss 4.63 (1.8%) 5.06 (1.6%) 5.04 (1.8%)
doi:10.1371/journal.pone.0162001.t005
Fig 4. Bland-Altman plots showing inter-session repeatability. Total retinal thickness difference (μm) against mean (μm)
for inter-session repeatability of the foveal subfield for both segmentation methods. 95% limits of agreement shown by dashed
lines. Note that two significant outliers were removed from the Topcon on-board segmentation data.
doi:10.1371/journal.pone.0162001.g004
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Segmentation Software Agreement
A comparison of retinal thickness measurements produced by the Iowa Reference Algorithms
and the commercial segmentation software for the two commercial instruments is shown in
Table 6. Again, the thickness values were fixed-AEL scaled to allow comparison between algo-
rithms. One significant outlier was removed from the analysis of the Topcon data (foveal sub-
field only). The commercial segmentation software yielded similar to or marginally higher
retinal thickness values than the Iowa Reference Algorithms for the Topcon OCT images.
These differences were significant only in the outer ring (Friedman test, P<0.05). The commer-
cial software yielded significantly lower values than the Iowa Reference Algorithms for the
Zeiss OCT images in all three subfields (Friedman test, P<0.05).
Discussion
The Iowa Reference Algorithms produced automated segmentation of 10 intra-retinal layers
on all images from all three devices. We have demonstrated a substantial impact of AEL-cor-
rected lateral scaling on mean intra-retinal layer thickness values. If an AEL-dependent lateral
scaling is not used, the ETDRS grid (defined in mm units at the retinal surface) will overlay a
smaller or larger area of retina, depending on the AEL. The ETDRS subfield sizes could vary by
up to 30% assuming a normal AEL range of 20-28mm, which is a little larger than for the
cohort of this present study. Appropriate scaling to account for AEL is therefore an important
Fig 5. Comparison of inter-session repeatability for the two segmentation methods. Coefficients of repeatability for
segmentation by the Iowa Reference Algorithms and on-board software are shown for the Topcon (left) and Zeiss (right)
systems. The ‘equivalent retinal thickness’ values from the Iowa Reference Algorithms were used in this analysis.
doi:10.1371/journal.pone.0162001.g005
Table 6. Agreement of total retinal thickness between segmentation methods. Mean difference (bias; μm) and 95% limits of agreement (μm) for mean
retinal thickness at session 1 produced by the Iowa Reference Algorithms and the commercial on-board equivalent.
Fovea Inner ring Outer ring
Topcon Mean difference 0.11 -1.65 -2.91
Limits of agreement -13.05 to 13.28 -10.96 to 7.66 -12.97 to 7.15
Friedman test P 0.414 0.549 0.009*
Zeiss Mean difference 2.00 6.07 5.73
Limits of agreement -5.76 to 9.75 -5.95 to 17.82 -6.03 to 16.42
Friedman test P 0.028* 0.003* 0.009*
*signiﬁcant at 0.05 level
doi:10.1371/journal.pone.0162001.t006
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consideration for any quantitative retinal thickness analysis, particularly in cross-sectional
applications.
The Iowa Reference Algorithms demonstrated good agreement between the Topcon and
Zeiss instruments (as shown previously; [33]), and with the long-wavelength device. However,
the Iowa Reference Algorithms produced significantly higher retinal thickness values on
images from both commercial systems than the long-wavelength system, across all subfields,
even when the AEL-dependent scaling was used. Refractive index assumptions for retinal tis-
sues used by each instrument could result in a small difference in axial scaling. Knowing the
assumptions made for each device, we expect a difference in absolute thickness values between
instruments of between 1.4% and 2.9%, with largest thickness values from the Zeiss images
(n = 1.36), then Topcon images (n = 1.38) and finally the long-wavelength OCT (n = 1.4). In
general, this is consistent with our findings (Table 2).
Discrepancies in retinal thickness measurement between images from the long-wavelength
and commercial systems were significantly correlated with AEL for the foveal and outer ring
subfields, when using the fixed-AEL scaling. When the AEL-dependent scaling was used
throughout this analysis, all these correlations were reduced and were no longer significant
(Fig 2). This effect is consistent with the expected transverse magnification error that arises
when fixed-AEL scaling is used for images from either of the commercial instruments. This
confirms that the on-board software of the Zeiss and Topcon instruments used in this study do
not make a scaling correction for AEL. The Iowa Reference Algorithms allow for direct input
of transverse scaling factors prior to image segmentation which should be used, where possible,
to reduce these demonstrated magnification errors.
Inter-session repeatability of the Iowa Reference Algorithms was assessed for each of the 10
intra-retinal layers on images from each device. Although the CoR was similar across the three
devices and three ETDRS subfields, there were far fewer significant outliers excluded from the
Zeiss data by Grubbs’ test. Had these outliers been included, inter-session repeatability would
have been poorer for the other two devices. Overall, RPE thickness was the most repeatable
measure, particularly for the Zeiss and long-wavelength OCT (CoR 0.5μm for both). As a
change in thickness of this layer greater than this value would indicate change outside the nor-
mal variation, these measures represent a useful clinical biomarker for diseases that affect the
RPE, such as AMD [34].
The least repeatable measures were the inner retinal layers (1–5) in the foveal subfield (Fig
3). This is expected, since these layers are thin in this region. Additionally, some layers are
more difficult to distinguish due to near iso-reflectivity, for example GCL from IPL, and HFL
from OPL. The HFL commonly fluctuates in appearance between acquisitions, dependent on
angle of incidence, which would also likely limit the repeatability of segmentation of this layer
[35]. The inner retinal layers were generally more repeatable in the outer ring across all devices.
However, the outer ring has the lowest RNFL repeatability across all devices, possibly attributed
to the thickness variability due to nasal/temporal asymmetry at this eccentricity. However, if
analyzed in an appropriate manner (by quadrant, for instance), this may have applications in a
number of conditions [36–39].
Total retinal thickness in the foveal subfield was less repeatable than the inner and outer
rings, which is also likely attributable to retinal anatomy (greater thickness variability in the
foveal subfield). All repeated measures using the Iowa Reference Algorithms on the Topcon
and Zeiss OCT images were within 1.7% and 1.3% of mean retinal thickness respectively for all
subfields (Table 4). The long-wavelength OCT images had a marginally higher CoR (within
2.2% for all subfields, with one outlier removed). This non-commercial device was designed for
optimal imaging of the deeper structures, including the choroid, due to reduced scatter at this
wavelength [25]. However, differences in reflective properties of the layer boundaries are likely
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to occur at this longer wavelength, which the Iowa Reference Algorithms may not be optimized
to detect. Since the main function of the long-wavelength OCT is to image the deeper retinal
structures, the acquisition protocol used to collect these images was similar to enhanced depth
imaging [40], with the choroid intentionally positioned closer to the zero delay line. This may
have resulted in reduced signal from the more superficial retinal layers, and may explain the
reduced repeatability compared to the commercial devices.
The Iowa Reference Algorithms measurements were more repeatable than the equivalent
commercial segmentation software assessed. The inter-session repeatability analysis of the
Topcon commercial segmentation software revealed two clear outliers. Both images were of
poorer quality than the rest of the sample (image quality<25 in the Topcon-generated report)
which led to marked errors in ILM boundary position in the foveal subfield during segmenta-
tion. Removing these outliers from this subfield, the CoR was reduced from 21.56μm to
7.63μm, which is more comparable to the other subfields and to the Zeiss commercial software.
It should be noted that segmentation of these same two images using the Iowa Reference Algo-
rithms produced no marked errors in boundary placement in any subfield.
Since the majority of these CoR values are nearing the resolution limit of all three instru-
ments (~5μm axially), this small inter-session thickness variation is unlikely to be clinically
meaningful. However, since many thickness values are averaged over each region and/or over
the entire cohort in this study, significant results of boundary positions can be obtained to a
higher precision than the optical resolution of the instrument. The axial sampling resolution
(3.5μm for the Topcon, and ~2μm for the Zeiss and long-wavelength systems) is another
potential limiting factor but averaging over many thickness measurements can again, in theory,
provide even higher resolution results limited ultimately by the signal-to-noise ratio of the
devices and the repeatability of the scanning geometry.
Our inter-session findings for the Zeiss instrument are comparable to, if not slightly more
repeatable than, previous findings [11,41]. Kotera and colleagues [42] reported slightly higher
repeatability than our findings for the Topcon segmentation software (total retinal thickness CoR
of 3.10μm and 2.01μm for the inner ring and outer ring respectively, in comparison to our values
of 5.99μm and 5.68μm). However, their assessment was an intra- rather than inter-session repeat-
ability, and did not include the ETDRS foveal subfield since their main outcome measure was ret-
inal nerve fiber layer (RNFL) thickness in glaucoma. It is worth noting that we would expect the
inter-session repeatability to be poorer in eyes with macular disease due to the nature of the path-
ological retinal features [43,44]. In some cases, the segmented boundaries may require manual
repositioning to ensure accurate quantification. Measures in healthy participants were the focus
of the present study, to evaluate the repeatability of the algorithm under ideal conditions.
Good agreement was shown between the Iowa Reference Algorithms and the commercial
software, when equivalent segmentation boundaries were used (as shown in Table 6). There was
slight bias in both cases, with the Topcon segmentation producing slightly higher values (Fried-
man test, P<0.05 in the outer ring only), and the Zeiss segmentation producing lower values
than the Iowa Reference Algorithms (Friedman test, P<0.05 in all subfields). However, these dis-
crepancies accounted for less than 2% of total retinal thickness in all subfields, and are unlikely
to be significant in clinical applications. This is consistent with previous comparative studies
using the Iowa Reference Algorithms and Cirrus and Spectralis OCT commercial software
[17,45]. To our knowledge, no previous comparison has been made using the Topcon 3D-OCT.
This study had a relatively small sample size (n = 25) for an inter-session repeatability study
and a relatively narrow distribution of AEL. Only participants without retinal disease were
included in this study, therefore conclusions can only be applied to this group. Further study is
necessary to assess the repeatability of the segmentation software in ocular disease. Lastly, the high
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repeatability of the intra-retinal layer segmentation by the Iowa Reference Algorithms is promis-
ing, although further analysis is required to compare this with the available on-board software.
In conclusion, we have confirmed that lateral magnification errors affect the consistency
and reliability of generated thickness values, and are therefore an important consideration in
quantitative OCT retinal layer analysis. Nevertheless, the Iowa Reference Algorithms provide
repeatable automated retinal thickness measurements, which outperform the commercial seg-
mentation software, and allow a convenient mechanism to apply an accurate AEL-dependent
lateral scaling to images from any OCT device. In these respects, this algorithm is viable for
clinical and research applications, for eyes without ocular disease imaged using the three OCT
devices in this study.
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